Filed by the
Registrant ☒ Filed by a Party other than the
Registrant ☐
You are
cordially invited to attend a special meeting of stockholders of CLARCOR Inc. (Clarcor, the Company, we, our or us) to be held at Clarcors offices located at 840 Crescent Centre
Drive, Suite 600, Franklin, Tennessee 37067, on [ ], 2017, at [
], local time (such meeting, including any adjournment or postponement thereof, the special meeting).
At the special meeting, holders of our common stock, par value $1.00 per share (Clarcor common stock), will be asked to consider
and vote on (1) a proposal to adopt the Agreement and Plan of Merger, dated as of December 1, 2016 (as it may be amended from time to time, the merger agreement), by and among Clarcor, Parker-Hannifin Corporation, an Ohio
corporation (Parker), and Parker Eagle Corporation, a Delaware corporation and a wholly owned subsidiary of Parker (Merger Sub), pursuant to which Merger Sub will be merged with and into Clarcor (the merger), with
Clarcor surviving the merger as a wholly owned subsidiary of Parker, (2) a proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Clarcors named executive officers in connection
with the consummation of the merger, and (3) a proposal to approve the adjournment of the special meeting from time to time, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the
special meeting to adopt the merger agreement or in the absence of a quorum.
If the merger is completed, you will be entitled to receive
$83.00 in cash, without interest and less any applicable withholding taxes, for each share of Clarcor common stock you own.
The Clarcor
board of directors has unanimously determined that the merger agreement, the merger and the other transactions contemplated by the merger agreement are advisable, fair to and in the best interests of Clarcor and its stockholders and has unanimously
approved the merger agreement, the merger and the other transactions contemplated by the merger agreement. The Clarcor board of directors unanimously recommends that stockholders of Clarcor vote (1)
FOR
the proposal to adopt
the merger agreement, (2)
FOR
the proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Clarcors named executive officers in connection with the consummation
of the merger, and (3)
FOR
the proposal to approve the adjournment of the special meeting from time to time, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of
the special meeting to adopt the merger agreement or in the absence of a quorum.
The accompanying proxy statement provides detailed
information about the merger agreement and the merger and provides specific information about the special meeting. A copy of the merger agreement is attached as
Annex A
to the proxy statement. The accompanying proxy statement also
describes the actions and determinations of the Clarcor board of directors in connection with its evaluation of the merger agreement and the merger. We urge you to read the proxy statement, including any documents incorporated by reference, and the
annexes carefully and in their entirety. In addition, you may obtain information about Clarcor from documents filed with the Securities and Exchange Commission (the SEC). See
Where You Can Find Additional Information
.
If you have any questions or need assistance in voting your shares, please contact our proxy solicitor, Innisfree M&A
Incorporated, toll-free at (877) 825-8793. Banks and brokers may call collect at (212) 750-5833.
On behalf of your board of
directors, thank you for your continued support.
Christopher L. Conway
Certain Prospective Financial Information
Clarcor does not as a matter of general practice make public projections as to future performance other than providing estimated ranges of
certain expected financial results for the current year in its quarterly earnings press releases (which guidance may also be included in investor presentations from time to time), due to, among other reasons, the inherent difficulty of accurately
predicting financial performance for future periods and the uncertainty of underlying assumptions and estimates. However, Clarcor is including in this proxy statement a summary of certain limited unaudited prospective financial information for
Clarcor on a stand-alone basis (the Clarcor Projections), without giving effect to the merger, to give Clarcor stockholders access to certain nonpublic information which was, as more specifically outlined below (and except as otherwise
noted below), provided to the Clarcor board of directors, Clarcors financial advisor, Goldman Sachs, and Parker. The Clarcor Projections were prepared by Clarcors management for internal use and provided to the Clarcor board of directors
for the purposes of considering, analyzing and evaluating Clarcors strategic and financial alternatives, including the merger. The Clarcor Projections were also provided to Goldman Sachs in connection with rendering its fairness opinion to the
Clarcor board of directors and in performing the related analyses. The Clarcor Projections were also provided to Parker in connection with its consideration and evaluation of a merger with Clarcor. Notwithstanding the foregoing, the Applicable
2016/2017 GAAP Information (as defined below), which is set forth in the chart below in italics, was not provided to the Clarcor board of directors, Goldman Sachs or Parker, but is being presented in order to comply with SEC rules regarding the
presentation of non-GAAP financial measures in light of the non-GAAP financial measures for fiscal years 2016 and 2017 set forth in the chart below, which were included in the Clarcor Projections and provided to the Clarcor board of directors,
Goldman Sachs and Parker. The inclusion of the Clarcor Projections in this proxy statement should not be regarded as an indication that the Clarcor board of directors, Clarcor, Parkers board of directors, Parker, Merger Sub, Goldman Sachs or
any other recipient of this information considered, or now considers, it to be an assurance of the achievement of future results or an accurate prediction of future results, and they should not be relied on as such.
The following is a summary of the Clarcor Projections:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summary of Clarcor Projections
|
|
|
|
($ in Millions except per share data)
|
|
|
|
Fiscal Year
|
|
|
|
2016
1,2
|
|
|
2017
1
|
|
|
2018
|
|
|
2019
|
|
|
2020
|
|
|
2021
|
|
Net sales
|
|
$
|
1,388
|
|
|
$
|
1,417
|
|
|
$
|
1,533
|
|
|
$
|
1,634
|
|
|
$
|
1,750
|
|
|
$
|
1,873
|
|
Gross profit
|
|
|
459
|
|
|
|
481
|
|
|
|
521
|
|
|
|
565
|
|
|
|
613
|
|
|
|
661
|
|
Non-GAAP gross profit
|
|
|
464
|
|
|
|
488
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
|
|
|
186
|
|
|
|
189
|
|
|
|
230
|
|
|
|
261
|
|
|
|
292
|
|
|
|
318
|
|
Non-GAAP operating profit
|
|
|
191
|
|
|
|
200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
|
143
|
|
|
|
127
|
|
|
|
157
|
|
|
|
181
|
|
|
|
204
|
|
|
|
223
|
|
Non-GAAP net earnings
|
|
|
128
|
|
|
|
134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings per share
Diluted
3
|
|
$
|
2.91
|
|
|
$
|
2.60
|
|
|
$
|
3.22
|
|
|
$
|
3.74
|
|
|
$
|
4.23
|
|
|
$
|
4.64
|
|
Non-GAAP net earnings per share-
Diluted
3
|
|
$
|
2.61
|
|
|
$
|
2.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
4
|
|
|
251
|
|
|
|
263
|
|
|
|
295
|
|
|
|
329
|
|
|
|
362
|
|
|
|
390
|
|
Cash flows from operating activities
|
|
|
263
|
|
|
|
202
|
|
|
|
212
|
|
|
|
242
|
|
|
|
266
|
|
|
|
287
|
|
Non-GAAP cash flows from operating activities
|
|
|
248
|
|
|
|
209
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted free cash flow
5
|
|
|
217
|
|
|
|
159
|
|
|
|
172
|
|
|
|
202
|
|
|
|
226
|
|
|
|
247
|
|
Net sales growth %
|
|
|
-6.3
|
%
|
|
|
2.1
|
%
|
|
|
8.2
|
%
|
|
|
6.6
|
%
|
|
|
7.1
|
%
|
|
|
7.0
|
%
|
Gross profit %
|
|
|
33.1
|
%
|
|
|
33.9
|
%
|
|
|
34.0
|
%
|
|
|
34.6
|
%
|
|
|
35.0
|
%
|
|
|
35.3
|
%
|
Non-GAAP gross profit %
|
|
|
33.4
|
%
|
|
|
34.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Non-GAAP gross profit, non-GAAP operating profit, non-GAAP net earnings, non-GAAP net earnings per share-Diluted,
non-GAAP cash flows from operating activities, and non-GAAP gross profit percentage (the Applicable 2016/2017 Non-GAAP Information) (1) with respect to the fiscal year 2016 forecast set forth above, exclude the impact of the $27.3
million patent litigation award received from 3M Company in the second
38
quarter of 2016, and (2) with respect to the fiscal year 2016 forecast and fiscal year 2017 projections set forth above, exclude upfront expenses associated with cost reduction initiatives
incurred or expected to be incurred in those periods (such adjustments, collectively, the 2016/2017 Adjustments). The Applicable 2016/2017 Non-GAAP Information was included in the Clarcor Projections provided to the Clarcor board of
directors, Goldman Sachs and Parker. For a reconciliation of the Applicable 2016/2017 Non-GAAP Information to the most comparable GAAP measures, and a discussion of the purposes for which Clarcor management uses Applicable 2016/2017 Non-GAAP
Information, see below under
Reconciliation of Non-GAAP to GAAP Financial Measures
. The following GAAP measures for fiscal years 2016 and 2017 were not included in the Clarcor Projections provided to the Clarcor board of
directors, Goldman Sachs and Parker, but are included in the chart above in order to comply with SEC rules regarding the presentation of non-GAAP financial measures: gross profit, operating profit, net earnings, net earnings per-share-Diluted, cash
flows from operating activities and gross profit percentage (collectively, the Applicable 2016/2017 GAAP information), which Applicable 2016/2017 GAAP Information is italicized in the chart above. The chart set forth above does not
present figures for non-GAAP gross profit, non-GAAP operating profit, non-GAAP net earnings, non-GAAP net earnings per share-Diluted, non-GAAP cash flows from operating activities, and non-GAAP gross profit percentage for fiscal years 2018 through
2021 as the result of the fact that the gross profit, operating profit, net earnings, net earnings per share-Diluted, cash flows from operating activities and gross profit percentage figures included in the Clarcor Projections provided to the
Clarcor board of directors, Goldman Sachs and Parker with respect to fiscal years 2018 through 2021 did not include any non-GAAP adjustments.
2
Calculated using actual financial results for the first eleven fiscal months of 2016 and estimated financial results for the twelfth fiscal month of fiscal year 2016. Fiscal year 2016 includes fifty-three weeks while all other fiscal years presented
include fifty-two weeks.
3 For purposes of determining net earnings per share Diluted and non-GAAP net earnings per share Diluted in
the Clarcor Projections, the number of outstanding shares for the fiscal years set forth above was calculated based on the treasury stock method and assumed that (taking into account assumptions regarding stock repurchases and equity grants) the
amount of outstanding shares in fiscal year 2016 (49,100,000) decreased by 300,000 shares in fiscal year 2017, and decreased by an additional 200,000 shares in each fiscal year thereafter through 2021. The Clarcor Projections also assume
dividends per share equal to $0.90 in fiscal 2016, $1.02 in fiscal 2017, $1.13 in fiscal 2018, $1.25 in fiscal 2019, $1.38 in fiscal 2020, and $1.53 in fiscal 2021.
4 Adjusted EBITDA, a non-GAAP financial measure, means earnings before interest, taxes, depreciation and amortization, and further adjusted, for fiscal
years 2016 and 2017, to take into account the 2016/2017 Adjustments. For a reconciliation of Adjusted EBITDA to net earnings, the most comparable GAAP measure, and a discussion of the purposes for which Clarcor management uses Adjusted EBITDA, see
below under
Reconciliation of Non-GAAP to GAAP Financial Measures
.
5 Adjusted free cash flow, a non-GAAP financial measure, is
calculated as cash flows from operating activities, less capital expenditures, and further adjusted, for fiscal years 2016 and 2017, to take into account the 2016/2017 Adjustments. For a reconciliation of adjusted free cash flow to cash flows from
operating activities, the most comparable GAAP measure, and a discussion of the purposes for which Clarcor management uses adjusted free cash flow, see below under
Reconciliation of Non-GAAP to GAAP Financial Measures
.
Clarcor management also approved certain estimates of unlevered free cash flow, defined as tax effected earnings before interest and taxes
plus depreciation and amortization, less capital expenditures and the change in net working capital, and plus or minus other operating cash flows adjusted to remove the impact of stock-based compensation expense, which was treated as a cash expense
(taking into account, for fiscal year 2017, $11 million of estimated upfront expenses associated with cost reduction initiatives) (unlevered free cash flow), as calculated by Goldman Sachs for use in its discounted cash flow analysis
using information set forth in the Clarcor Projections and other information provided by Clarcor management. Unlevered free cash flows for fiscal years 2017, 2018, 2019, 2020 and 2021, as calculated by Goldman Sachs and approved by Clarcor
management, were $147 million, $169 million, $197 million, $221 million and $241 million, respectively. These calculations of unlevered free cash flow were not shared with Parker or its financial advisor, although various components of unlevered
free cash flow were provided to Parker and its financial advisor.
39
As explained in the Background of the Merger section above, at the meeting of Parker
and Clarcor on October 7, 2016 (the initial meeting at which confidential financial information of Clarcor was communicated to Parker), Clarcor management provided to Parker limited financial information, including the then current forecast for
fiscal year 2016, reflecting actual financial results for the first nine months of fiscal year 2016 and estimated financial results for the tenth through twelfth months of fiscal year 2016, and then current preliminary projections for fiscal year
2017 (the Preliminary Forecasts/Projections). Clarcor management prepared the Preliminary Forecasts/Projections recognizing that such forecasts were preliminary in nature in light of the fact that the budget process for fiscal year 2017
was at a preliminary stage at that time. However, Clarcor provided the Preliminary Forecasts/Projections to Parker at this meeting on October 7, 2016 to assist Parker in its assessment and due diligence review of Clarcor, and indicated to
Parker that the numbers were preliminary in nature and subject to change. Clarcor also prepared the Preliminary Forecasts/Projections to assist Goldman Sachs in its analysis at that time of Clarcor and the potential transaction with Parker, and
Goldman Sachs utilized the Preliminary Forecasts/Projections in connection with the analysis provided by Goldman Sachs at the meetings of the Clarcor board held on September 20, 2016, and October 21, 2016, as summarized in the
Background of the Merger section above, and also informed Goldman Sachs of the preliminary nature of this information. In addition to including the same forecast for fiscal year 2016 and the preliminary projections for fiscal year 2017
that were provided to Parker, the preliminary financial information provided to Goldman Sachs at this time included preliminary projections for fiscal years 2018 through 2021.
The Preliminary Forecasts/Projections reflected fiscal year 2016 net sales of $1.388 billion, non-GAAP net earnings per share Diluted
of $2.63 and Adjusted EBITDA of $252 million, and fiscal year 2017 net sales of $1.432 billion, non-GAAP net earnings per shareDiluted of $2.84 and Adjusted EBITDA of $267 million (for a reconciliation of non-GAAP net earnings per share
Diluted and Adjusted EBITDA for fiscal years 2016 and 2017, as included in the Preliminary Forecasts/Projections, to the most comparable GAAP measures, and a discussion of the purposes for which Clarcor management uses such non-GAAP financial
measures, see below under Reconciliation of Non-GAAP to GAAP Financial Measures). Clarcor updated the Preliminary Forecasts/Projections as it finalized its budget and financial planning process for fiscal year 2017, and provided certain
updates to Parker (including providing financial projections for fiscal years 2018 through 2021, which had not been included in the Preliminary Forecasts/Projections) in connection with Parkers ongoing due diligence review of Clarcor. Clarcor
provided to Parker the projections that constituted the Clarcor Projections on November 21, 2016, which Clarcor Projections reflected figures derived from the Clarcor financial and budgeting process, which was substantially complete at this
time. These Clarcor Projections were also utilized by Goldman Sachs in connection with the analysis it provided at the meetings of the Clarcor board held on November 19, 2016, November 28, 2016, and November 30, 2016 as
summarized in the Background of the Merger section summarized above. The variations between the Preliminary Forecasts/Projections and the Clarcor Projections were due to the preliminary nature of the information included in the
Preliminary Forecasts/Projections as the result of the preliminary nature of the budget process for fiscal year 2017 at the time the Preliminary Forecasts/Projections were prepared, as well as the additional time that elapsed between the preparation
of the Preliminary Forecasts/Projections and the Clarcor Projections (including the additional two months of historical financial results that were included in the Clarcor Projections that were not included in the Preliminary Forecasts/Projections).
The information about the Preliminary Forecasts/Projections is being provided solely for factual context, because this information was
provided to Parker. The boards of directors of Parker and Clarcor did not rely upon the Preliminary Forecasts/Projections in deciding whether to approve the merger agreement, and Goldman Sachs did not rely upon the Preliminary Forecasts/Projections
in connection with its fairness opinion and in performing the related analyses.
The unaudited prospective financial information presented
herein, including the Clarcor Projections, the unlevered free cash flow amounts and the Preliminary Forecasts/Projections (the Unaudited Prospective Financial Information), and the underlying assumptions upon which the Unaudited
Prospective Financial Information were based are subjective in many respects, and are subject to multiple interpretations and potential
40
frequent revisions attributable to the cyclicality of Clarcors industry and actual experience and business developments. The Unaudited Prospective Financial Information reflects numerous
assumptions with respect to company performance, industry performance, general business, economic, regulatory, market and financial conditions and other matters and are subject to significant economic, competitive and other uncertainties, many of
which assumptions and uncertainties are difficult to predict and are beyond Clarcors control. A variety of risks and uncertainties, both known and unknown, and including those described in the section entitled
Cautionary Statement
Concerning Forward-Looking Statements
, could cause the Unaudited Prospective Financial Information or the underlying assumptions to be inaccurate. As a result, there can be no assurance that the Unaudited Prospective Financial Information
will be realized or that actual results will not be significantly higher or lower than projected. In addition, because the Unaudited Prospective Financial Information covers multiple years, such information by its nature becomes less reliable with
each successive year. The Unaudited Prospective Financial Information does not take into account any circumstances or events occurring after the date on which they were prepared. Economic and business environments, as well as foreign exchange rates,
can and do change quickly, which adds an additional significant level of uncertainty regarding the results portrayed in the Unaudited Prospective Financial Information. As a result, the inclusion of the Unaudited Prospective Financial Information in
this proxy statement does not constitute an admission or representation by Clarcor or any other person that the information is material. The summary of the Unaudited Prospective Financial Information is not provided to influence Clarcor
stockholders decisions regarding whether to vote for the merger proposal or any other proposal.
The Unaudited Prospective Financial
Information was not prepared with a view toward public disclosure or toward compliance with United States generally accepted accounting principles (GAAP), published guidelines of the SEC or the guidelines established by the American
Institute of Certified Public Accountants for preparation and presentation of prospective financial information. Neither Clarcors independent registered public accounting firm, nor any other accounting firm, has examined, compiled or performed
any procedures with respect to any of the Unaudited Prospective Financial Information, and accordingly, no accounting firm expresses an opinion or any other form of assurance with respect thereto. The report of Clarcors independent registered
public accounting firm incorporated by reference in this proxy statement relates to Clarcors historical financial information. It does not extend to the Unaudited Prospective Financial Information and should not be read to do so.
The Unaudited Prospective Financial Information does not take into account the possible financial and other effects on Clarcor of the merger
and does not attempt to predict or suggest future results of the combined company. The Unaudited Prospective Financial Information does not give effect to the merger, including the impact of negotiating or executing the merger agreement, the
expenses that may be incurred in connection with consummating the merger, the potential synergies that may be achieved by the combined company as a result of the merger, the effect on Clarcor of any business or strategic decision or action that has
been or will be taken as a result of the merger agreement having been executed, or the effect of any business or strategic decisions or actions that would likely have been taken if the merger agreement had not been executed, but that were instead
altered, accelerated, postponed or not taken in anticipation of the merger. Further, the Unaudited Prospective Financial Information does not take into account the effect on Clarcor of any possible failure of the merger to occur.
For the foregoing reasons, and considering that the special meeting will be held several months after the Unaudited Prospective Financial
Information was prepared, as well as the uncertainties inherent in any forecasting information, readers of this proxy statement are cautioned not to place unwarranted reliance on the Unaudited Prospective Financial Information set forth above. No
one has made or makes any representation to any stockholder regarding the information included in the Unaudited Prospective Financial Information. Clarcor urges all Clarcor stockholders to review its most recent SEC filings for a description of its
reported financial results. See the section entitled
Where You Can Find Additional Information
.
41
In addition, the Unaudited Prospective Financial Information has not been updated or revised to
reflect information or results after the date the Unaudited Prospective Financial Information was prepared (except for the fact that the Preliminary Forecasts/Projections were superseded by the Clarcor Projections, as noted above) or as of date of
this proxy statement, and except as required by applicable securities laws, Clarcor does not intend to update or otherwise revise the Unaudited Prospective Financial Information or the specific portions presented to reflect circumstances existing
after the date when the Unaudited Prospective Financial Information was prepared or to reflect the occurrence of future events, even in the event that any or all of the assumptions underlying the Unaudited Prospective Financial Information are shown
to be in error.
Reconciliation of Non-GAAP to GAAP Financial Measures
. The first table below presents a reconciliation of non-GAAP
gross profit, non-GAAP operating profit, non-GAAP net earnings per sharediluted, non-GAAP net earnings, Adjusted EBITDA, adjusted free cash flow and non-GAAP gross profit percentage, in each case, as presented in the Clarcor Projections and
for each of the fiscal years presented in the Clarcor Projections, to the most comparable GAAP measure. The most comparable GAAP measures are gross profit, operating profit, net earnings per sharediluted, net earnings, net earnings, cash
provided by operating activities and gross profit percentage, respectively. The second table below presents a reconciliation of non-GAAP net earnings per sharediluted and Adjusted EBITDA, in each case, as reflected in the Preliminary
Forecasts/Projections for each of the periods presented in the Preliminary Forecasts/Projections to the most comparable GAAP measure.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Clarcor Projections
|
|
($ in Millions)
|
|
|
|
|
|
Fiscal Year
|
|
|
|
2016
|
|
|
2017
|
|
|
2018
|
|
|
2019
|
|
|
2020
|
|
|
2021
|
|
Gross profit
|
|
|
459
|
|
|
|
481
|
|
|
|
521
|
|
|
|
565
|
|
|
|
613
|
|
|
|
661
|
|
add: Upfront cost reduction expenses
|
|
|
5
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP gross profit
|
|
|
464
|
|
|
|
488
|
|
|
|
521
|
|
|
|
565
|
|
|
|
613
|
|
|
|
661
|
|
Operating profit
|
|
|
186
|
|
|
|
189
|
|
|
|
230
|
|
|
|
261
|
|
|
|
292
|
|
|
|
318
|
|
add: Upfront cost reduction expenses
|
|
|
5
|
|
|
|
11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP operating profit
|
|
|
191
|
|
|
|
200
|
|
|
|
230
|
|
|
|
261
|
|
|
|
292
|
|
|
|
318
|
|
Net earnings per share Diluted
|
|
$
|
2.91
|
|
|
$
|
2.60
|
|
|
$
|
3.22
|
|
|
$
|
3.74
|
|
|
$
|
4.23
|
|
|
$
|
4.64
|
|
add: Upfront cost reduction expenses, net of taxes
|
|
|
.07
|
|
|
|
.15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
less: Patent litigation award, net of taxes
|
|
|
(.37
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net earnings per share Diluted
|
|
$
|
2.61
|
|
|
$
|
2.75
|
|
|
$
|
3.22
|
|
|
$
|
3.74
|
|
|
$
|
4.23
|
|
|
$
|
4.64
|
|
Net earnings
|
|
$
|
143
|
|
|
$
|
127
|
|
|
$
|
157
|
|
|
$
|
181
|
|
|
$
|
204
|
|
|
$
|
223
|
|
add: Upfront cost reduction expenses, net of taxes
|
|
|
3
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
less: Patent litigation award, net of taxes
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net earnings
|
|
$
|
128
|
|
|
$
|
134
|
|
|
$
|
157
|
|
|
$
|
181
|
|
|
$
|
204
|
|
|
$
|
223
|
|
add: Income taxes
|
|
|
56
|
|
|
|
60
|
|
|
|
70
|
|
|
|
78
|
|
|
|
87
|
|
|
|
96
|
|
add: Interest and other
|
|
|
7
|
|
|
|
6
|
|
|
|
4
|
|
|
|
2
|
|
|
|
1
|
|
|
|
|
|
add: Depreciation
|
|
|
35
|
|
|
|
38
|
|
|
|
40
|
|
|
|
42
|
|
|
|
45
|
|
|
|
47
|
|
add: Amortization
|
|
|
25
|
|
|
|
25
|
|
|
|
25
|
|
|
|
25
|
|
|
|
25
|
|
|
|
25
|
|
Adjusted EBITDA
|
|
$
|
251
|
|
|
$
|
263
|
|
|
$
|
295
|
|
|
$
|
329
|
|
|
$
|
362
|
|
|
$
|
390
|
|
Cash provided by operating activities
|
|
|
263
|
|
|
|
202
|
|
|
|
212
|
|
|
|
242
|
|
|
|
266
|
|
|
|
287
|
|
add: Upfront cost reduction expenses, net of taxes
|
|
|
3
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
less: Patent litigation award, net of taxes
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP cash provided by operating activities
|
|
|
248
|
|
|
|
209
|
|
|
|
212
|
|
|
|
242
|
|
|
|
266
|
|
|
|
287
|
|
less: Capital expenditures
|
|
|
(31
|
)
|
|
|
(50
|
)
|
|
|
(40
|
)
|
|
|
(40
|
)
|
|
|
(40
|
)
|
|
|
(40
|
)
|
Adjusted free cash flow
|
|
|
217
|
|
|
|
159
|
|
|
|
172
|
|
|
|
202
|
|
|
|
226
|
|
|
|
247
|
|
Gross profit %
|
|
|
33.1
|
%
|
|
|
33.9
|
%
|
|
|
34.0
|
%
|
|
|
34.6
|
%
|
|
|
35.0
|
%
|
|
|
35.3
|
%
|
add: Upfront cost reduction expenses
|
|
|
0.3
|
%
|
|
|
0.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP gross profit %
|
|
|
33.4
|
%
|
|
|
34.4
|
%
|
|
|
34.0
|
%
|
|
|
34.6
|
%
|
|
|
35.0
|
%
|
|
|
35.3
|
%
|
42
|
|
|
|
|
|
|
|
|
Reconciliation of Preliminary Forecasts/Projections
|
|
($ in Millions)
|
|
|
|
|
|
Fiscal Year
|
|
|
|
2016
|
|
|
2017
|
|
Net earnings per share Diluted
|
|
$
|
2.92
|
|
|
$
|
2.64
|
|
add: Upfront cost reduction expenses, net of taxes
|
|
|
.08
|
|
|
|
.20
|
|
less: Patent litigation award, net of taxes
|
|
|
(.37
|
)
|
|
|
|
|
Non-GAAP net earnings per share Diluted
|
|
$
|
2.63
|
|
|
$
|
2.84
|
|
Net earnings
|
|
$
|
144
|
|
|
$
|
129
|
|
add: Upfront cost reduction expenses, net of taxes
|
|
|
3
|
|
|
|
10
|
|
less: Patent litigation award, net of taxes
|
|
|
(18
|
)
|
|
|
|
|
Non-GAAP net earnings
|
|
$
|
129
|
|
|
$
|
139
|
|
add: Income taxes
|
|
|
56
|
|
|
|
64
|
|
add: Interest and other
|
|
|
7
|
|
|
|
5
|
|
add: Depreciation
|
|
|
35
|
|
|
|
35
|
|
add: Amortization
|
|
|
25
|
|
|
|
24
|
|
Adjusted EBITDA
|
|
$
|
252
|
|
|
$
|
267
|
|
Clarcor believes that non-GAAP gross profit, non-GAAP operating profit, non-GAAP net earnings per share -
diluted, non-GAAP net earnings, Adjusted EBITDA, and non-GAAP gross profit percentage are useful in understanding and evaluating Clarcors historical and prospective operational performance by excluding certain items that may not fully reflect
the ongoing operational performance of Clarcors business. Clarcor believes that adjusted free cash flow is useful in assessing the ability of Clarcor to generate excess cash from its business operations and to generate cash available to make
strategic acquisitions and investments, fund ongoing operations, and fund other uses of capital.
These non-GAAP financial measures may
have limitations as analytical tools, and Clarcor management does not intend these measures to be considered in isolation or as a substitute for the related GAAP measures. Not all companies calculate these non-GAAP financial measures in the same
manner, and Clarcors calculation of these non-GAAP measures may not be comparable to similarly titled measures used by other companies.
Fairness Opinion of Goldman Sachs
At a meeting of the Clarcor board of directors held on November 30, 2016, Goldman
Sachs rendered its oral opinion to the Clarcor board of directors, subsequently confirmed in writing, to the effect that, as of December 1, 2016, and based upon and subject to the factors and assumptions set forth in the Goldman
Sachs written opinion, the $83.00 in cash per share of Clarcor common stock to be paid to the holders (other than Parker and its affiliates) of the outstanding shares of Clarcor common stock pursuant to the merger agreement was fair from a
financial point of view to such holders.
The full text of the written opinion of Goldman Sachs, dated December 1, 2016, which sets
forth assumptions made, procedures followed, matters considered and limitations on the review undertaken in connection with the opinion, is attached as Annex B. Goldman Sachs provided its opinion for the information and assistance of the
Clarcor board of directors in connection with its consideration of the merger. The Goldman Sachs opinion is not a recommendation as to how any holder of Clarcor common stock should vote with respect to the proposal to adopt the merger agreement or
any other matter.
In connection with rendering the opinion described above and performing its related financial analyses, Goldman
Sachs reviewed, among other things:
|
|
|
annual reports to stockholders and Annual Reports on Form 10-K of Clarcor for the five fiscal years ended November 28, 2015;
|
|
|
|
certain interim reports to stockholders and Quarterly Reports on Form 10-Q of Clarcor;
|
43
|
|
|
certain other communications from Clarcor to its stockholders;
|
|
|
|
certain publicly available research analyst reports for Clarcor; and
|
|
|
|
the Clarcor Projections, which were approved by Clarcor for Goldman Sachs use.
|
Goldman
Sachs also (i) held discussions with members of the senior management of Clarcor regarding their assessment of the past and current business operations, financial condition and future prospects of Clarcor; (ii) reviewed the reported price
and trading activity for shares of Clarcor common stock; (iii) compared certain financial and stock market information for Clarcor with similar information for certain other companies the securities of which are publicly traded;
(iv) reviewed the financial terms of certain recent business combinations in the filtration industry and other industries; and (v) performed such other studies and analyses, and considered such other factors, as Goldman Sachs deemed
appropriate.
For purposes of rendering its opinion, Goldman Sachs, with Clarcors consent, relied upon and assumed the accuracy and
completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by it, without assuming any responsibility for independent verification thereof. In that regard, Goldman Sachs
assumed, with Clarcors consent, that the Clarcor Projections were reasonably prepared on a basis reflecting the best currently available estimates and judgments of Clarcors management. Goldman Sachs did not make an independent evaluation
or appraisal of the assets and liabilities (including any contingent, derivative or other off-balance-sheet assets and liabilities) of Clarcor or any of its subsidiaries and Goldman Sachs was not furnished with any such evaluation or appraisal.
Goldman Sachs assumed that all governmental, regulatory or other consents and approvals necessary for the consummation of the merger will be obtained without any adverse effect on the expected benefits of the merger in any way meaningful to its
analysis. Goldman Sachs has also assumed that the merger will be consummated on the terms set forth in the merger agreement, without the waiver or modification of any term or condition the effect of which would be in any way meaningful to its
analysis.
Goldman Sachs opinion does not address the underlying business decision of Clarcor to engage in the merger or the
relative merits of the merger as compared to any strategic alternatives that may be available to Clarcor; nor does it address any legal, regulatory, tax or accounting matters. Goldman Sachs was not requested to solicit, and did not solicit, interest
from other parties with respect to an acquisition of, or other business combination with, Clarcor or any other alternative transaction. Goldman Sachs opinion addresses only the fairness from a financial point of view to the holders (other than
Parker and its affiliates) of Clarcor common stock, as of the date of the opinion, of the $83.00 in cash per share to be paid to such holders pursuant to the merger agreement. Goldman Sachs opinion does not express any view on, and does not
address, any other term or aspect of the merger agreement or the merger or any term or aspect of any other agreement or instrument contemplated by the merger agreement or entered into or amended in connection with the merger, including the fairness
of the merger to, or any consideration received in connection therewith by, the holders of any other class of securities, creditors, or other constituencies of Clarcor; nor as to the fairness of the amount or nature of any compensation to be paid or
payable to any of the officers, directors or employees of Clarcor, or class of such persons, in connection with the merger, whether relative to the $83.00 in cash per share of Clarcor common stock to be paid to the holders (other than Parker and its
affiliates) of Clarcor common stock pursuant to the merger agreement or otherwise. Goldman Sachs did not express any opinion as to the impact of the merger on the solvency or viability of Clarcor or Parker or the ability of Clarcor or Parker to pay
their respective obligations when they come due. Goldman Sachs opinion was necessarily based on economic, monetary, market and other conditions, as in effect on, and the information made available to Goldman Sachs as of, the date of the
opinion and Goldman Sachs assumed no responsibility for updating, revising or reaffirming its opinion based on circumstances, developments or events occurring after the date of its opinion. Goldman Sachs opinion was approved by a fairness
committee of Goldman Sachs.
The following is a summary of the material financial analyses delivered by Goldman Sachs to the Clarcor board
of directors in connection with rendering the opinion described above. The following summary, however,
44
does not purport to be a complete description of the financial analyses performed by Goldman Sachs, nor does the order of analyses described represent relative importance or weight given to those
analyses by Goldman Sachs. Some of the summaries of the financial analyses include information presented in tabular format. The tables must be read together with the full text of each summary and are alone not a complete description of Goldman
Sachs financial analyses. Except as otherwise noted, the following quantitative information, to the extent that it is based on market data, is based on market data as it existed on or before November 29, 2016, the last trading day before
the meeting of the Clarcor board of directors that approved the merger, and is not necessarily indicative of current market conditions.
Historical
Stock Trading Analysis
Goldman Sachs reviewed historical trading prices and volumes for shares of Clarcor common stock. In
addition, Goldman Sachs analyzed the consideration to be paid to holders of shares of Clarcor common stock pursuant to the merger agreement in relation to (i) the closing price per share of Clarcor common stock on November 29, 2016, the
last trading day before the meeting of the Clarcor board of directors that approved the merger; (ii) the closing price per share of Clarcor common stock on September 20, 2016, the date of the initial proposal from Parker; (iii) the
closing price per share of Clarcor common stock on October 18, 2016, the date of an updated proposal from Parker; (iv) the closing price per share of Clarcor common stock on November 8, 2016, the last trading day before the results of
the 2016 United States presidential election; (v) the volume weighted average price per share of common stock (VWAP) for the preceding thirty-day and ninety-day periods ended November 29, 2016; (vi) the all-time high
trading price per share of Clarcor common stock as of November 29, 2016; (vii) the high and low trading prices per share of Clarcor common stock over the one-year period ended November 29, 2016; and (viii) the median research
target price of $62.50 as of November 29, 2016. This analysis indicated that the price per share of common stock to be paid to Clarcor stockholders pursuant to the merger agreement represented:
|
|
|
a premium of 18.7% based on the closing price per share of Clarcor common stock of $69.92 on November 29, 2016;
|
|
|
|
a premium of 31.6% based on the closing price per share of Clarcor common stock of $63.07 on September 20, 2016;
|
|
|
|
a premium of 34.8% based on the closing price per share of Clarcor common stock of $61.56 on October 18, 2016;
|
|
|
|
a premium of 33.1% based on the closing price per share of Clarcor common stock of $62.38 on November 8, 2016;
|
|
|
|
a premium of 27.0% based on thirty-day VWAP of $65.33;
|
|
|
|
a premium of 29.4% based on the ninety-day VWAP of $64.14;
|
|
|
|
a premium of 17.1% based on the all-time high trading price per share of Clarcor common stock as of November 29, 2016 of $70.86;
|
|
|
|
a premium of 17.1% based on the highest trading price per share of common stock over the one-year period ended November 29, 2016 of $70.86;
|
|
|
|
a premium of 88.1% based on the lowest trading price per share of common stock over the one-year period ended November 29, 2016 of $44.13; and
|
|
|
|
a premium of 32.8% based on the median research target price as of November 29, 2016 of $62.50.
|
Selected Companies Analysis
Goldman Sachs reviewed and compared certain financial information for Clarcor to corresponding financial information, ratios and public market
multiples for a selected filtration company, Donaldson Company, Inc., and for selected diversified industrial companies with filtration segments (DI with Filtration), including Danaher Corporation, 3M Company, Pentair plc, Eaton
Corporation plc and Parker-Hannifin Corporation.
45
Although none of the selected companies are directly comparable to Clarcor, the selected
companies included were chosen because they are publicly traded companies with operations that for purposes of analysis may be considered similar to certain operations of Clarcor.
Goldman Sachs calculated and compared various financial multiples based on market data as of November 29, 2016 and Institutional
Brokers Estimate System (IBES) estimates and, in the case of Clarcor, both IBES estimates and the Clarcor Projections. With respect to its analysis, Goldman Sachs calculated for Clarcor and the selected companies:
|
|
|
enterprise value (which is defined as the equity value, calculated using the number of fully diluted shares of common stock, as publicly available except for with respect to Clarcor, which was provided by Clarcor
management, and the treasury stock method, plus total debt, less total cash and cash equivalents) (EV), as a multiple of estimated sales for fiscal years 2016, 2017 and 2018;
|
|
|
|
EV, as a multiple of estimated earnings before interest, taxes, depreciation and amortization (EBITDA), for fiscal years 2016, 2017 and 2018; and
|
|
|
|
closing price per share as of November 29, 2016 as a multiple of estimated earnings per share for fiscal years 2017 and 2018. The results of these analyses are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FY 2016 EV/
Sales
|
|
|
FY 2017 EV/
Sales
|
|
|
FY 2018 EV/
Sales
|
|
Donaldson
|
|
|
2.6x
|
|
|
|
2.5x
|
|
|
|
2.4x
|
|
DI with Filtration
|
|
|
2.9x
|
|
|
|
3.0x
|
|
|
|
2.9x
|
|
Clarcor
|
|
|
|
|
|
|
|
|
|
|
|
|
Current, Clarcor Projections
|
|
|
2.6x
|
|
|
|
2.6x
|
|
|
|
2.4x
|
|
Current, IBES
|
|
|
2.6x
|
|
|
|
2.6x
|
|
|
|
2.5x
|
|
Merger Consideration, Clarcor Projections
|
|
|
3.1x
|
|
|
|
3.0x
|
|
|
|
2.8x
|
|
Merger Consideration, IBES
|
|
|
3.1x
|
|
|
|
3.1x
|
|
|
|
2.9x
|
|
|
|
|
|
|
|
FY 2016 EV/
EBITDA
|
|
|
FY 2017 EV/
EBITDA
|
|
|
FY 2018 EV/
EBITDA
|
|
Donaldson
|
|
|
15.4x
|
|
|
|
14.8x
|
|
|
|
14.0x
|
|
DI with Filtration
|
|
|
13.3x
|
|
|
|
12.9x
|
|
|
|
12.4x
|
|
Clarcor
|
|
|
|
|
|
|
|
|
|
|
|
|
Current, Clarcor Projections
|
|
|
14.5x
|
|
|
|
13.8x
|
|
|
|
12.3x
|
|
Current, IBES
|
|
|
14.6x
|
|
|
|
14.3x
|
|
|
|
13.6x
|
|
Merger Consideration, Clarcor Projections
|
|
|
17.2x
|
|
|
|
16.3x
|
|
|
|
14.6x
|
|
Merger Consideration, IBES
|
|
|
17.3x
|
|
|
|
16.9x
|
|
|
|
16.1x
|
|
|
|
|
|
|
|
FY 2017 P/E
|
|
|
FY 2018 P/E
|
|
|
|
|
Donaldson
|
|
|
24.7x
|
|
|
|
22.8x
|
|
|
|
|
|
DI with Filtration
|
|
|
19.4x
|
|
|
|
17.7x
|
|
|
|
|
|
Clarcor
|
|
|
|
|
|
|
|
|
|
|
|
|
Current, Clarcor Projections
|
|
|
25.4x
|
|
|
|
21.7x
|
|
|
|
|
|
Current, IBES
|
|
|
26.0x
|
|
|
|
24.5x
|
|
|
|
|
|
Merger Consideration, Clarcor Projections
|
|
|
30.2x
|
|
|
|
25.8x
|
|
|
|
|
|
Merger Consideration, IBES
|
|
|
30.9x
|
|
|
|
29.1x
|
|
|
|
|
|
Present Value of Future Share Price Analysis
Goldman Sachs performed an illustrative analysis of the implied present value of the future price per share of Clarcor common stock, which was
designed to provide an indication of the present value of a theoretical future value of Clarcors common stock as a function and sum of (i) theoretical future values for Clarcors common stock as calculated using Clarcors
estimated next twelve months price to earnings multiples, and (ii) the
46
dividends per share forecasted to be paid through each year, as reflected in the Clarcor Projections. For this analysis, Goldman Sachs used the Clarcor Projections for each of the fiscal years
2017 through 2020 and the number of fully diluted shares of Clarcor as provided to Goldman Sachs by Clarcor management. Goldman Sachs calculated illustrative implied future equity values per share of Clarcor common stock at the end of each of the
fiscal years 2017 through 2020 by first applying the next twelve (12) month price to forward earnings per share of common stock (Forward P/E) multiples ranging from 19.0x to 26.0x to estimated earnings per share of common stock for
each of the fiscal years 2017 through 2020. Goldman Sachs then discounted each of the implied fiscal year-end 2017 to 2020 equity values and the cumulative future dividends per share, as reflected in the Clarcor Projections, back to December 3,
2016, using an illustrative discount rate of 11.75%, reflecting Goldman Sachs estimate of Clarcors cost of equity. The resulting ranges of present value of future stock price and dividends were then summed to yield a range of each
years illustrative present values per share of Clarcors common stock. This analysis resulted in an illustrative range of implied present values per share of $60 to $81 using the Forward P/E multiples (values rounded).
Discounted Cash Flow Analysis
Using the Clarcor Projections, Goldman Sachs performed an illustrative discounted cash flow analysis on Clarcor to derive a range of
illustrative present values per share of Clarcor common stock. Using discount rates ranging from 10.00% to 11.50%, reflecting Goldman Sachs estimates of Clarcors weighted average cost of capital, Goldman Sachs discounted to present value
as of December 3, 2016, (1) estimates of unlevered free cash flow for Clarcor for the fiscal years 2017 through 2021, such estimates as approved by Clarcor management after being calculated by Goldman Sachs using information set forth in
the Clarcor Projections; and (2) a range of illustrative terminal values for Clarcor as of November 27, 2021, which were calculated by applying a terminal multiple range of 11.0x to 14.5x to an estimate of Clarcors Adjusted EBITDA
for fiscal year 2021 as reflected in the Clarcor Projections and disclosed above under the section entitled
Certain Prospective Financial Information
. Goldman Sachs derived ranges of illustrative enterprise values for Clarcor by
adding the ranges of present values it derived in (1) and (2) above. Goldman Sachs then subtracted the amount by which Clarcors indebtedness exceeded its cash as of December 3, 2016, as provided by Clarcor management, from the
range of illustrative enterprise values it derived for Clarcor to derive a range of illustrative equity values for Clarcor. Goldman Sachs then divided the range of illustrative equity values it derived by the number of fully diluted outstanding
shares of Clarcor, as provided to Goldman Sachs by Clarcor management, to derive a range of illustrative present values per share of common stock ranging from $62 to $83 (values rounded).
Selected Transactions Analysis
Goldman Sachs analyzed certain information relating to the following selected transactions in the filtration industry:
|
|
|
|
|
Target
|
|
Acquiror
|
|
Date Announced
|
Ionics Inc.
|
|
General Electric Co.
|
|
November 2004
|
CUNO Inc.
|
|
3M Company
|
|
May 2005
|
domnick hunter group plc
|
|
Parker-Hannifin Corporation
|
|
September 2005
|
Norit Holding, B.V. (Clean Process Technologies)
|
|
Pentair, Inc.
|
|
April 2011
|
Pall Corporation (Transfusion Medicine)
|
|
Haemonetics Corporation
|
|
April 2012
|
Met-Pro Corporation
|
|
CECO Environmental Corp.
|
|
April 2013
|
Stanadyne Corporation (Filtration)
|
|
CLARCOR Inc.
|
|
April 2014
|
Polypore International, Inc.
|
|
Asahi Kasei Corp.
|
|
February 2015
|
Pall Corporation
|
|
Danaher Corporation
|
|
May 2015
|
Affinia Group
|
|
The MANN+HUMMEL Group
|
|
August 2015
|
47
Although none of the selected transactions is directly comparable to the merger, the target
companies in the selected transactions are companies with operations that, for the purposes of analysis, may be considered similar to certain operations of Clarcor, such that the selected transactions may be considered similar to the merger. For
each of the selected transactions, Goldman Sachs calculated and compared the implied enterprise value of the target company based on the announced transaction price as a multiple of the target companys EBITDA for the most recently reported
last twelve months ending prior to the announcement of the transaction.
The following table presents the results of this analysis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selected Transactions
|
|
|
Proposed
Transaction
|
|
|
Range
|
|
|
Median
|
|
|
EV/LTM EBITDA
|
|
|
8.0x 21.0x
|
|
|
|
13.4x
|
|
|
|
17.2x
|
|
Based on its review of the selected transactions and its professional judgment and experience, Goldman Sachs
applied illustrative enterprise value to last twelve month adjusted EBITDA multiples ranging from 13.0x to 16.0x to Clarcors last twelve month EBITDA as of August 27, 2016 to derive illustrative values per share of Clarcor common stock
ranging from $63 to $77 (values rounded).
Selected Historical Premia Analysis
Goldman Sachs reviewed and analyzed, using publicly available data, those acquisition premia for all-cash acquisition transactions involving a
public company based in the United States as the target and a public company as the acquiror with disclosed enterprise values between $1 billion and $10 billion for each year from January 1, 2007 to November 29, 2016. Announced premia
were calculated relative to (i) the targets closing share price one day prior to announcement, (ii) the targets highest trading price over the one-year period prior to announcement and (iii) the targets VWAP for the
preceding thirty-day period prior to announcement.
The results of this analysis showed an average acquisition premium of 35% (34% for the
period from January 1, 2012 to November 29, 2016) relative to the targets closing share price one day prior to announcement, an average acquisition premium of 10% (12% for the period from January 1, 2012 to November 29,
2016) relative to the targets highest trading price over the one-year period prior to announcement, and an average acquisition premium of 34% (35% for the period from January 1, 2012 to November 28, 2016) relative to the
targets VWAP for the preceding thirty-day period prior to announcement. The premium for the acquisition offer for Clarcor relative to Clarcors closing share price on November 29, 2016 was 18.7%, the premium relative to
Clarcors highest trading price over the one-year period prior to November 29, 2016 was 17.1%, and the premia relative to Clarcors VWAP for the preceding thirty-day period prior to November 29, 2016 was 27.0%. Goldman Sachs also
calculated the quartile medians for acquisition premia relative to (i) the targets closing share price one day prior to announcement and (ii) the targets highest trading price over the one-year period prior to announcement. The
following table summarizes the results of this analysis:
|
|
|
|
|
|
|
|
|
|
|
Average Acquisition Premia
Relative to Closing Share Price
One Day Prior to Announcement
|
|
|
Average Acquisition Premia
Relative to Highest Trading Price
Over One-Year Period Prior to
Announcement
|
|
1
st
Quartile Median
|
|
|
55.4
|
%
|
|
|
30.6
|
%
|
2
nd
Quartile Median
|
|
|
34.8
|
%
|
|
|
14.1
|
%
|
3
rd
Quartile Median
|
|
|
20.8
|
%
|
|
|
3.1
|
%
|
4
th
Quartile Median
|
|
|
6.6
|
%
|
|
|
(15.5
|
)%
|
Goldman Sachs also analyzed the acquisition premia for six transactions announced following the results of the
2016 U.S. presidential election, which showed acquisition premia ranging from a low of 12.5% to a high of 82.5% (including all but one transaction with premia of 27.8% or lower) when compared to the targets closing
48
share price one day prior to announcement, and acquisition premia or discounts ranging from a discount of 3.2% to a premium of 20.4% when compared to the targets highest trading price over
the one-year period prior to announcement.
As a result of the review by Goldman Sachs of the implied premia for the selected
transactions, Goldman Sachs applied the illustrative premia ranging from 20% to 40% to the closing price per share of Clarcor common stock on November 29, 2016, and derived an illustrative range of implied values per share of Clarcor common
stock ranging from $84 to $98 (values rounded). Goldman Sachs also applied the illustrative premia ranging from 10% to 15% to the highest trading price per share of Clarcor common stock over the one-year period prior to November 29, 2016, and
derived an illustrative range of implied values per share of Clarcor common stock ranging from $78 to $81 (values rounded).
The
preparation of a fairness opinion is a complex process and is not necessarily susceptible to partial analysis or summary description. Selecting portions of the analyses or of the summary set forth above, without considering the analyses as a whole,
could create an incomplete view of the processes underlying Goldman Sachs opinion. In arriving at its fairness determination, Goldman Sachs considered the results of all of its analyses and did not attribute any particular weight to any factor
or analysis considered by it. Rather, Goldman Sachs made its determination as to fairness on the basis of its experience and professional judgment after considering the results of all of its analyses. No company or transaction used in the above
analyses as a comparison is directly comparable to Clarcor or the merger.
Goldman Sachs prepared these analyses for purposes of providing
its opinion to the Clarcor board of directors as to the fairness from a financial point of view of the $83.00 in cash per share of Clarcor common stock to be paid to the holders (other than Parker and its affiliates) of Clarcor common stock pursuant
to the merger agreement. These analyses do not purport to be appraisals nor do they necessarily reflect the prices at which businesses or securities actually may be sold. Analyses based upon forecasts of future results are not necessarily indicative
of actual future results, which may be significantly more or less favorable than suggested by these analyses. Because these analyses are inherently subject to uncertainty, being based upon numerous factors or events beyond the control of the parties
or their respective advisors, none of Clarcor, Parker, Goldman Sachs, any of their affiliates or any other person assumes responsibility if future results are materially different from those forecast.
The consideration payable to holders of shares of Clarcor common stock was determined through arms-length negotiations between Clarcor
and Parker, and was approved by the Clarcor board of directors. Goldman Sachs provided advice to Clarcor during these negotiations. Goldman Sachs did not, however, recommend any specific amount of consideration to Clarcor or the Clarcor board of
directors or that any specific amount of consideration constituted the only appropriate consideration for the merger.
As described above,
Goldman Sachs opinion to the Clarcor board of directors was one of many factors taken into consideration by the Clarcor board of directors in making its determination to approve the merger agreement. The foregoing summary does not purport to
be a complete description of the analyses performed by Goldman Sachs in connection with the fairness opinion and is qualified in its entirety by reference to the written opinion of Goldman Sachs attached as
Annex B
.
Goldman Sachs and its affiliates are engaged in advisory, underwriting and financing, principal investing, sales and trading, research,
investment management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs and its affiliates and employees, and funds or other entities they manage or in which they invest or have other
economic interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of
Clarcor, Parker, any of their respective affiliates and third parties, or any currency or commodity that may be involved in the transaction contemplated by the merger agreement. Goldman Sachs acted as financial advisor to Clarcor in connection with,
and participated in certain of the negotiations leading to, the transaction. Goldman Sachs has provided certain
49
financial advisory and/or underwriting services to Clarcor and/or its affiliates from time to time. During the two year period ended December 1, 2016, the Investment Banking Division of
Goldman Sachs has not been engaged by Clarcor or its affiliates to provide financial advisory or underwriting services for which Goldman Sachs has received compensation. Goldman Sachs also has provided certain financial advisory and/or underwriting
services to Parker-Hannifin and/or its affiliates from time to time. During the two year period ended December 1, 2016, the Investment Banking Division of Goldman Sachs has not been engaged by Parker-Hannifin or its affiliates to provide
financial advisory or underwriting services for which Goldman Sachs has received compensation. Goldman Sachs may also in the future provide financial advisory and/or underwriting services to Clarcor, Parker and their respective affiliates, for which
its Investment Banking Division may receive compensation.
The Clarcor board of directors selected Goldman Sachs as its financial advisor
because it is an internationally recognized investment banking firm that has substantial experience in transactions similar to the merger and its prior experience working with Clarcor. Pursuant to a letter agreement dated September 28, 2016,
Clarcor engaged Goldman Sachs to act as its financial advisor in connection with the merger. The engagement letter between Clarcor and Goldman Sachs provides for a transaction fee that is estimated, based on the information available as of the date
of announcement, at approximately $28 million, approximately $5,500,000 of which was paid upon the execution of the merger agreement, and the remainder of which is contingent upon, and will be payable upon, consummation of the merger. In
addition, Clarcor has agreed to reimburse Goldman Sachs for certain of its expenses, and to indemnify Goldman Sachs and related persons against various liabilities, including certain liabilities under the federal securities laws.
Financing Related to the Merger
In connection with execution of the merger agreement, Parker received debt financing commitments in the amount of $3.1 billion. The merger,
however, is not conditioned upon Parker obtaining this or any other financing. See the section entitled
The Merger Agreement Financing and Financing Cooperation
.
Interests of Clarcors Directors and Executive Officers in the Merger
In considering the recommendation of the Clarcor board of directors that Clarcor stockholders adopt the merger agreement and thereby approve
the merger, Clarcor stockholders should be aware that the directors and executive officers of Clarcor have certain interests in the merger that may be different from, or in addition to, those of Clarcor stockholders generally. The Clarcor board of
directors was aware of these interests and considered them, among other matters, in adopting the merger agreement and approving the merger and making its recommendation that Clarcor stockholders adopt the merger agreement and thereby approve the
merger. These interests are described below.
Treatment of Outstanding Equity Awards
Pursuant to the terms of the merger agreement, Clarcor equity awards held by the executive officers and directors of Clarcor that are
outstanding immediately prior to the effective time will be subject to the following treatment.
Options
At the effective time, each option held by a director or executive officer that is outstanding as of immediately prior to the effective time,
whether vested or unvested, will be cancelled in exchange for the right to receive a cash payment from the surviving corporation (without interest and subject to applicable withholding taxes) equal to the product of (i) the number of shares of
Clarcor common stock subject to such option and (ii) the excess, if any, of the merger consideration over the exercise price per share of Clarcor common stock
50
subject to such option. Each option outstanding as of immediately prior to the effective time with an exercise price equal to or in excess of the merger consideration will be cancelled at the
effective time without any payment to the holder thereof.
Time-Vesting Restricted Stock Unit Awards
At the effective time, each RSU award held by an executive officer (including any award that previously vested but receipt of which has been
deferred by the holder) that is outstanding immediately prior to the effective time will, if granted on or prior to the date of the merger agreement, be cancelled in exchange for the right to receive a cash payment (without interest and subject to
applicable withholding taxes) equal to the product of (i) the number of shares of Clarcor common stock subject to such award and (ii) the sum of (A) the merger consideration and (B) any cash dividend equivalents per share accrued
but unpaid immediately prior to the effective time with respect to such award. At the effective time, each RSU award granted after the date of the merger agreement (including the RSU awards granted on December 19, 2016, as noted below) will be
cancelled in exchange for the right to receive a cash payment (without interest and subject to applicable withholding taxes) equal to the product of (i) the number of shares of Clarcor common stock subject to the vested portion of such award as
of immediately prior to the effective time and (ii) the sum of (A) the merger consideration and (B) any cash dividend equivalents per share accrued but unpaid immediately prior to the effective time with respect to the vested portion
of such award. The unvested portion of each time-vesting restricted stock unit award granted after the date of the merger agreement will be cancelled at the effective time without payment to the holder thereof. None of our directors hold RSU awards.
On December 19, 2016, Clarcor issued RSU awards to certain employees, including each of its executive officers, as part of
Clarcors annual compensation program for fiscal year 2017. These awards are subject to a four-year vesting schedule which is generally consistent with the vesting schedule of the RSU awards granted by Clarcor in fiscal year 2016; provided,
that, in the event the merger is consummated, each award will vest (with the vested portion entitled to receive the merger consideration and any unvested portion being cancelled as described in the immediately preceding paragraph) as follows:
(i) if the effective time occurs on or after December 19, 2017, the award will fully vest as of immediately prior to the effective time; or (ii) if the effective time occurs prior to December 19, 2017, a pro rata portion of the
award will vest as of immediately prior to the effective time based on the number of months between December 19, 2016 and the effective time, but in no event will less than 7/12th of such award vest immediately prior to the effective time.
Performance-Based Restricted Stock Unit Awards
.
At the effective time, each Company performance-based restricted stock unit (a PSU) award held by an executive officer that is
outstanding as of immediately prior to the effective time will be cancelled in exchange for the right to receive a cash payment from the surviving corporation (without interest and subject to applicable withholding taxes) equal to the product of
(1) the total number of shares of Clarcor common stock subject to such award as of the effective time and (2) the sum of (a) the merger consideration and (b) any cash dividend equivalents per share accrued but unpaid immediately
prior to the effective time with respect to such award. None of our directors hold PSU awards.
51
Quantification of Outstanding Equity Awards
The following table shows the estimated cash amounts that each of Clarcors executive officers and directors would be eligible to receive
(without subtraction of applicable withholding taxes) in connection with the consummation of the merger with regard to options (vested and unvested), time-vesting restricted stock unit awards (including any award that previously vested but receipt
of which has been deferred by the holder), and performance-based restricted stock unit awards.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
No. of Shares
of Clarcor
Common
Stock Subject
to Options(1)
|
|
|
Value of
Options
($)(2)
|
|
|
No. of
Time-
Vesting
Restricted
Stock
Units(3)
|
|
|
Value of
Time-
Vesting
Restricted
Stock
Units
($)(4)
|
|
|
No. of
Performance-
Based
Restricted
Stock Units(5)
|
|
|
Value of
Performance-
Based
Restricted
Stock Units
($)(6)
|
|
|
Total Value
($)
|
|
Executive Officers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher L. Conway
|
|
|
595,000
|
|
|
|
18,422,250
|
|
|
|
54,709
|
|
|
|
4,540,847
|
|
|
|
12,121
|
|
|
|
1,024,588
|
|
|
|
23,987,685
|
|
David J. Fallon
|
|
|
172,735
|
|
|
|
5,147,149
|
|
|
|
18,268
|
|
|
|
1,516,244
|
|
|
|
6,288
|
|
|
|
531,525
|
|
|
|
7,194,918
|
|
Richard M. Wolfson
|
|
|
135,000
|
|
|
|
4,557,694
|
|
|
|
13,168
|
|
|
|
1,092,944
|
|
|
|
5,152
|
|
|
|
435,498
|
|
|
|
6,086,136
|
|
David J. Lindsay
|
|
|
114,000
|
|
|
|
3,603,630
|
|
|
|
7,821
|
|
|
|
649,143
|
|
|
|
4,394
|
|
|
|
371,425
|
|
|
|
4,624,198
|
|
Keith A. White
|
|
|
26,250
|
|
|
|
773,869
|
|
|
|
5,794
|
|
|
|
480,902
|
|
|
|
4,773
|
|
|
|
403,461
|
|
|
|
1,658,232
|
|
Jacob Thomas
|
|
|
26,875
|
|
|
|
981,625
|
|
|
|
8,059
|
|
|
|
668,897
|
|
|
|
4,049
|
|
|
|
342,262
|
|
|
|
1,992,784
|
|
|
|
|
|
|
|
|
|
Non-Employee Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James W. Bradford, Jr.
|
|
|
15,000
|
|
|
|
544,350
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
544,350
|
|
Robert J. Burgstahler
|
|
|
37,500
|
|
|
|
1,692,075
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,692,075
|
|
Wesley M. Clark
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nelda J. Connors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Paul Donovan (7)
|
|
|
37,500
|
|
|
|
1,692,075
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,692,075
|
|
Mark A. Emkes
|
|
|
15,000
|
|
|
|
544,350
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
544,350
|
|
Thomas W. Giacomini
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert H. Jenkins
|
|
|
45,000
|
|
|
|
2,074,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,074,875
|
|
Philip R. Lochner, Jr.
|
|
|
15,000
|
|
|
|
544,350
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
544,350
|
|
James L. Packard
|
|
|
45,000
|
|
|
|
2,074,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,074,875
|
|
(1)
|
This column includes vested and unvested options.
|
(2)
|
The per share consideration for options is equal to the total number of shares of Clarcor common stock subject to outstanding options multiplied by $83.00, less the applicable exercise price of the option.
|
(3)
|
This column includes the total number of shares of Clarcor common stock subject to outstanding RSU awards (including any award that previously vested but receipt of which has been deferred by the holder).
|
(4)
|
The per share consideration for RSU awards in this column is equal to the total number of shares of Clarcor common stock subject to the award multiplied by $83.00. There are no currently accrued but unpaid dividend
equivalents applicable to any RSU awards.
|
(5)
|
This column includes the total number of shares of Clarcor common stock subject to outstanding PSU awards.
|
(6)
|
The per share consideration for PSU awards in this column is equal to the total number of shares of Clarcor common stock subject to the award multiplied by $84.53 ($83.00 plus $1.53 of currently accrued but unpaid
dividend equivalent payments).
|
(7)
|
Includes options to purchase 15,000 shares of Clarcor common stock held by Mr. Donovans spouse.
|
52
Quantification of Clarcor Common Stock Consideration
The following table shows the estimated amounts that each of Clarcors executive officers and directors would be eligible to receive in
connection with the consummation of the merger with regard to outstanding shares of Clarcor common stock held by the individual, including outstanding shares of Clarcor common stock that have been acquired pursuant to the Companys equity
compensation plans and the ESPP.
|
|
|
|
|
|
|
|
|
Name
|
|
No. of Shares of Clarcor
common stock(1)
|
|
|
Value
($)(4)
|
|
Executive Officers
|
|
|
|
|
|
|
|
|
Christopher L. Conway
|
|
|
9,961
|
|
|
|
826,763
|
|
David J. Fallon
|
|
|
3,923
|
|
|
|
325,609
|
|
Richard M. Wolfson
|
|
|
22,899
|
|
|
|
1,900,617
|
|
David J. Lindsay
|
|
|
23,267
|
(2)
|
|
|
1,931,161
|
|
Keith A. White
|
|
|
2,086
|
|
|
|
173,138
|
|
Jacob Thomas
|
|
|
195
|
|
|
|
16,185
|
|
|
|
|
Non-Employee Directors
|
|
|
|
|
|
|
|
|
James W. Bradford, Jr.
|
|
|
16,930
|
|
|
|
1,405,190
|
|
Robert J. Burgstahler
|
|
|
26,453
|
|
|
|
2,195,599
|
|
Wesley M. Clark
|
|
|
8,328
|
|
|
|
691,224
|
|
Nelda J. Connors
|
|
|
3,085
|
|
|
|
256,055
|
|
Paul Donovan
|
|
|
1,898
|
(3)
|
|
|
157,534
|
|
Mark A. Emkes
|
|
|
10,825
|
|
|
|
898,475
|
|
Thomas W. Giacomini
|
|
|
5,074
|
|
|
|
421,142
|
|
Robert H. Jenkins
|
|
|
45,598
|
|
|
|
3,784,634
|
|
Philip R. Lochner, Jr.
|
|
|
31,802
|
|
|
|
2,639,566
|
|
James L. Packard
|
|
|
54,448
|
|
|
|
4,519,184
|
|
(1)
|
The share numbers in this column have been rounded to the nearest whole share.
|
(2)
|
Includes 11,002 shares held by a family trust.
|
(3)
|
Includes 16 shares held by Mr. Donovans spouse.
|
(4)
|
The value in this column is equal to the number of shares of Clarcor common stock owned multiplied by $83.00.
|
Executive Benefit Trust Funding
Clarcor is party to an Executive Benefit Trust which requires Clarcor to fund the trust by an amount equal to 125% of the obligations owed to
certain individuals, including Clarcors executive officers and directors, upon a change in control of Clarcor plus such additional amount as is reasonably estimated to be necessary to pay the expenses of maintaining the trust,
within 5 days of consummation of the change in control. The merger will constitute a change in control under the terms of the Executive Benefit Trust, and as a result, Clarcor will be required to fund the trust by an amount
as explained in the preceding sentence within 5 days of the effective time.
Change of Control Agreements
Clarcor has entered into a change of control agreement with each of its executive officers providing for the continued employment of such
executive for a period of three years following a change of control of Clarcor (or until such executives normal retirement date under Clarcors retirement plans, if earlier). Generally, each change of control agreement provides that, for
so long as the executive remains employed during such three-year period, his position, authority, and duties will be at least commensurate with those performed by the executive during the ninety day period immediately prior to the change of control
and his compensation, benefits and perquisites will be at least commensurate with the greatest of those in effect during the thirty-six month period prior to the change of control. The merger will constitute a change of control under
each change of control agreement.
53
Under each change of control agreement, in the event of a termination (as defined
below) of the executive within three years following the merger (or prior to the merger, if it is reasonably demonstrated by the executive that such termination was related to the merger), then, in addition to any accrued and unpaid salary, benefits
and vacation time, the executive is entitled to receive:
|
|
|
within thirty days following such termination, a lump sum cash severance payment equal to three times the sum of (i) the executives highest annual base salary in effect during the thirty-six month
period prior to the change of control (the Base Salary) and (ii) the greater of (A) the executives target bonus for the fiscal year of termination, and (B) the average of the actual bonuses the executive received (or
was entitled to receive) in respect of the three fiscal years prior to the year of termination (such higher amount, the Annual Bonus);
|
|
|
|
within thirty days following such termination, a lump sum prorated cash bonus payment equal to the Annual Bonus multiplied by a fraction, the numerator of which is the number of days worked in the fiscal
year through the date of the termination and the denominator of which is 365;
|
|
|
|
continued benefits and perquisites for a three-year period following the termination, or to the extent continued participation in benefit plans or perquisites is not allowed pursuant to the terms of such benefit plan or
by law, within thirty days following such termination, a lump sum cash payment equal to such benefits and perquisites the executive would have been entitled to receive if he had continued participation in such plans or programs during
the three-year period following the termination;
|
|
|
|
in the case of Mr. Lindsay, a lump-sum cash payment equal to the present value of the excess of (i) the actuarial equivalent of the benefit under Clarcors pension plan and supplemental pension plan that
he would have received had he remained employed by Clarcor during the three-year period immediately following such termination, over (ii) the aggregate benefit actually payable to Mr. Lindsay under such plans (or successor programs)
assuming: (i) executives Base Salary would have remained the same for the thirty-six month period following executives termination, (ii) executives benefits under Clarcors pension plan and supplemental pension plan
are fully vested, and (iii) executives benefit is determined as of either executives early or normal retirement date (whichever would produce the greater present value); and
|
|
|
|
full vesting as of the date of termination of all outstanding options and restricted stock units.
|
If any payment subjects the executive (other than Mr. White and Mr. Thomas) to excise taxes under Section 4999 of the Internal
Revenue Code (the Excise Tax), Clarcor is required to pay such executive a tax gross-up payment to cover the Excise Tax, provided, however, that if the Excise Tax can be avoided by reducing the total payments due to the executive by no
more than 10% of what he would otherwise receive, then the payments will be so reduced. In the case of Mr. White and Mr. Thomas, if any payments subject them to the Excise Tax, they will receive the greater of: (i) an amount of
payments reduced to the level such that the Excise Tax is not triggered; or (ii) the full amount of payments due to the executive, with such executive being obliged to pay the Excise Tax.
Each change of control agreement defines termination to mean termination of employment by Clarcor for reasons other than death,
disability or cause, or resignation by the executive upon the occurrence of any of the following events: (i) a material adverse reduction in the nature or scope of the executives authorities, duties or responsibilities, as
determined in good faith by the executive; (ii) a relocation of the executive to a location more than 35 miles away from his current place of employment without the consent of the executive; (iii) a reduction in the executives
compensation, benefits or perquisites from those provided for in the change of control agreement; (iv) failure of any successor to Clarcor to assume the change of control agreement or a breach by Clarcor (or successor) of any provision of the
agreement; or (v) a good faith determination by the executive that, as a result of the change of control, he is unable to exercise the authority, power, function or duties attached to his position and as contemplated by the change of control
agreement.
54
Each change of control agreement defines cause as fraud, misappropriation or
intentional material damage to the property or business of Clarcor or the commission of a felony.
Following a termination, each executive
is generally subject for at least two years to restrictive covenants relating to non-competition, non-solicitation, non-disparagement and confidentiality.
Quantification of Potential Payments to Named Executive Officers in Connection with the Merger
As required by Item 402(t) of Regulation S-K, the table below sets forth the estimated payments that each of Clarcors named
executive officers could receive that is based on or otherwise related to the merger. These amounts have been calculated assuming the merger was consummated on January 2, 2017 and, where applicable, assuming each named executive officer
experiences a qualifying termination, as such terms are defined in the relevant change of control agreement, immediately following the assumed effective time of January 2, 2017. See the section entitled
The Merger (Proposal
1) Interests of Clarcors Directors and Executive Officers in the Merger
for further information about the compensation disclosed in the table below. The amounts set forth in the table below are the subject of a non-binding,
advisory vote of Clarcor stockholders, as described in the section entitled
Advisory Vote on Named Executive Officer Merger-Related Compensation Arrangements (Proposal 2)
.
Clarcors named executive officers for purposes of this disclosure are (i) Christopher L. Conway, Chief Executive Officer;
(ii) David J. Fallon, Vice President Chief Financial Officer; (iii) David J. Lindsay, Vice President Chief Administrative Officer; (iv) Keith A. White, PresidentIndustrial Air Group; and (v) Richard M.
Wolfson, Vice President General Counsel & Secretary. Although Sam Ferrise, Clarcors former President Engine/Mobile Group, was a named executive officer for purposes of Clarcors most recent annual proxy
statement, Mr. Ferrise ceased his employment with Clarcor on November 27, 2015 and has no interest in the merger (except insofar as he may be a holder of shares of Clarcor common stock or continue to have vested options to acquire Clarcor
common stock) or any rights to compensation that are based on or otherwise related to the merger, and is therefore not included in the disclosure that follows.
The amounts in the table below do not include amounts that were vested as of January 2, 2017, or amounts under contracts, agreements,
plans or arrangements to the extent they do not discriminate in scope, terms or operation in favor of executive officers and that are available generally to all of the salaried employees of Clarcor. In addition, the amounts indicated below are
estimates of amounts that would be payable to the named executive officers, and the estimates are based on multiple assumptions that may not prove correct, including assumptions described in this proxy statement. Accordingly, the actual amounts, if
any, to be received by a named executive officer may differ in material respects from the amounts set forth below.
Golden Parachute
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
Cash
($)(1)
|
|
|
Equity
($)(2)
|
|
|
Pension /
NQDC
($)(3)
|
|
|
Perquisites/
Benefits
($)(4)
|
|
|
Tax
Reimbursement
($)(5)
|
|
|
Other
($)
|
|
|
Total
($)
|
|
Christopher L. Conway
|
|
|
5,132,076
|
|
|
|
11,044,675
|
|
|
|
|
|
|
|
456,242
|
|
|
|
3,126,991
|
|
|
|
|
|
|
|
19,759,984
|
|
David J. Fallon
|
|
|
2,203,368
|
|
|
|
3,664,793
|
|
|
|
|
|
|
|
272,329
|
|
|
|
1,256,817
|
|
|
|
|
|
|
|
7,397,307
|
|
Richard M. Wolfson
|
|
|
1,663,997
|
|
|
|
2,685,149
|
|
|
|
|
|
|
|
220,735
|
|
|
|
|
|
|
|
|
|
|
|
4,569,881
|
|
David J. Lindsay
|
|
|
1,360,382
|
|
|
|
1,943,673
|
|
|
|
317,510
|
|
|
|
199,275
|
|
|
|
|
|
|
|
|
|
|
|
3,820,840
|
|
Keith A. White
|
|
|
1,745,386
|
|
|
|
1,537,848
|
|
|
|
|
|
|
|
190,808
|
|
|
|
|
|
|
|
|
|
|
|
3,474,042
|
|
(1)
|
Cash
. The amounts in this column represent the value of the cash severance payments payable under the
applicable named executive officers change of control agreement, as described above in the section entitled
The Merger (Proposal 1) Interests of Clarcors Directors and Executive Officers in the Merger Change of
Control Agreements
. The severance amounts in this column are all double trigger in nature,
|
55
|
which means that payment of these amounts is conditioned upon a qualifying termination during the three-year period following the merger (or prior to the merger, if it is reasonably demonstrated
by the executive that such termination was related to the merger) in accordance with the terms of their change of control agreement. The estimated amount of each such payment is shown in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
Severance ($)
|
|
|
Pro-Rata Share
of Annual Bonus ($)
|
|
|
Total ($)
|
|
Christopher L. Conway
|
|
|
5,058,841
|
|
|
|
73,235
|
|
|
|
5,132,076
|
|
David J. Fallon
|
|
|
2,178,012
|
|
|
|
25,356
|
|
|
|
2,203,368
|
|
Richard M. Wolfson
|
|
|
1,647,109
|
|
|
|
16,888
|
|
|
|
1,663,997
|
|
David J. Lindsay
|
|
|
1,347,600
|
|
|
|
12,782
|
|
|
|
1,360,382
|
|
Keith A. White
|
|
|
1,724,556
|
|
|
|
20,830
|
|
|
|
1,745,386
|
|
(2)
|
Equity
. The amounts in this column represent the aggregate payments to be made in respect of unvested options, unvested RSU awards and unvested PSU awards, in each case that are outstanding as of the assumed
effective time of January 2, 2017. All such awards are single trigger in connection with the merger. The per share consideration for unvested options is equal to the number of shares of Clarcor common stock subject to the option
multiplied by $83.00, less the applicable exercise price of the option. The per share consideration for RSU awards is equal to the number of shares of Clarcor common stock subject to the award multiplied by $83.00; provided, that the per share
consideration for RSU awards granted on December 19, 2016 is equal to the number of shares of Clarcor common stock subject to the vested portion of such award (based on assumed effective time of January 2, 2017), multiplied by $83.00. The
per share consideration for PSU awards is equal to the number of shares of Clarcor common stock subject to the award multiplied by $84.53 ($83.00 plus $1.53 of accumulated but unpaid dividend equivalents as of the assumed effective time of
January 2, 2017). Treatment of all such awards in the merger is described in greater detail above in the section entitled
The Merger (Proposal 1) Interests of
Clarcors Directors and Executive Officers in the Merger
Treatment of Outstanding Equity Awards
. The estimated value of these equity awards is shown in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
Stock
Options ($)
|
|
|
Time-Vesting
Restricted Stock
Units ($)
|
|
|
Performance-
Based
Restricted
Stock Units
($)
|
|
|
Total ($)
|
|
Christopher L. Conway
|
|
|
6,782,312
|
|
|
|
3,237,775
|
|
|
|
1,024,588
|
|
|
|
11,044,675
|
|
David J. Fallon
|
|
|
2,114,450
|
|
|
|
1,018,818
|
|
|
|
531,525
|
|
|
|
3,664,793
|
|
Richard M. Wolfson
|
|
|
1,560,419
|
|
|
|
689,232
|
|
|
|
435,499
|
|
|
|
2,685,150
|
|
David J. Lindsay
|
|
|
1,078,108
|
|
|
|
494,141
|
|
|
|
371,425
|
|
|
|
1,943,673
|
|
Keith A. White
|
|
|
773,869
|
|
|
|
360,517
|
|
|
|
403,462
|
|
|
|
1,537,848
|
|
(3)
|
Pension/Non-Qualified Deferred Compensation
. The amount in this column represents the estimated present value of three additional years of service for purpose of calculating the benefit payable to
Mr. Lindsay under Clarcors supplemental pension plan in accordance with the terms of his change of control agreement. Such benefit is double trigger in nature, which means that payment of this amount is conditioned upon a
qualifying termination during the three-year period following the merger (or prior to the merger, if it is reasonably demonstrated by the executive that such termination was related to the merger) in accordance with the terms of Mr. Lindsays
change of control agreement.
|
(4)
|
Perquisites/Benefits
. The amounts in this column represent the estimated value of continued coverage for
three years for the following benefits: (i) medical and dental; (ii) life insurance; (iii) long-term disability insurance; (iv) 401(k) match; (v) 401(k) Restoration Program match; (vi) company car; (vii) financial
planning services; and (viii) executive physical. Amounts in this column are all double trigger in nature, which means that payment of these amounts is conditioned upon a qualifying termination during the three-year period following
the merger (or prior to the merger, if it is reasonably demonstrated by the executive
|
56
|
that such termination was related to the merger) in accordance with the terms of their change of control agreement. In accordance with applicable SEC rules, the estimated value of health care and
life insurance benefits was calculated based on the same assumptions used for financial reporting purposes. The estimated values of these benefits is shown in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Named Executive Officer
|
|
Medical
and
Dental
($)
|
|
|
Life
Insurance
($)
|
|
|
Long-
Term
Disability
Insurance
($)
|
|
|
401(k)
Match
($)
|
|
|
401(k)
Restoration
Program
Match ($)
|
|
|
Company
Car ($)
|
|
|
Financial
Planning
Services
($)
|
|
|
Executive
Physical
($)
|
|
|
Total ($)
|
|
Christopher L. Conway
|
|
|
38,166
|
|
|
|
|
|
|
|
13,531
|
|
|
|
32,800
|
|
|
|
201,283
|
|
|
|
71,055
|
|
|
|
77,915
|
|
|
|
21,492
|
|
|
|
456,242
|
|
David J. Fallon
|
|
|
55,638
|
|
|
|
|
|
|
|
8,766
|
|
|
|
32,800
|
|
|
|
65,290
|
|
|
|
64,451
|
|
|
|
40,418
|
|
|
|
4,965
|
|
|
|
272,329
|
|
Richard M. Wolfson
|
|
|
35,741
|
|
|
|
|
|
|
|
11,522
|
|
|
|
32,800
|
|
|
|
39,356
|
|
|
|
49,046
|
|
|
|
33,114
|
|
|
|
19,156
|
|
|
|
220,735
|
|
David J. Lindsay
|
|
|
38,167
|
|
|
|
39,457
|
|
|
|
18,229
|
|
|
|
12,300
|
|
|
|
9,935
|
|
|
|
45,908
|
|
|
|
28,244
|
|
|
|
7,036
|
|
|
|
199,276
|
|
Keith A. White
|
|
|
55,681
|
|
|
|
|
|
|
|
9,616
|
|
|
|
32,800
|
|
|
|
|
|
|
|
49,046
|
|
|
|
31,263
|
|
|
|
12,402
|
|
|
|
190,808
|
|
(5)
|
Tax Reimbursements.
The amounts in this column represent the estimated amount of the reimbursement of taxes to which the executive would be entitled under his change of control agreement, as described in the
section entitled
The Merger (Proposal 1) Interests of Clarcors Directors and Executive Officers in the Merger Change of Control Agreements
.
|
Insurance and Indemnification of Directors and Executive Officers
The terms of the merger agreement provide for certain post-closing covenants related to insurance and indemnification of directors and
executive officers. For a description of such covenants, see the section entitled
The Merger Agreement Directors and Officers Indemnification and Insurance
.
Benefits Arrangements with the Surviving Corporation
The terms of the merger agreement provide for certain post-closing covenants related to employee benefit arrangements. For a description
of such covenants, see the section entitled
The Merger Agreement Employee Benefits Matters
.
Material U.S. Federal Income Tax Consequences of the Merger
The following is a general discussion of the material U.S. federal income tax consequences of the merger to U.S. holders (as defined below) of
Clarcor common stock whose shares are converted into the right to receive the merger consideration in the merger. This discussion does not address any tax consequences of the merger arising under the laws of any state, local or foreign jurisdiction
or United States federal laws other than United States federal income tax laws. This discussion is based on the Internal Revenue Code of 1986, as amended (the Code), applicable U.S. Treasury Regulations issued under the Code, judicial
opinions and administrative rulings, published positions of the Internal Revenue Service and other applicable authorities, all as currently in effect and all of which are subject to change or differing interpretations (possibly with retroactive
effect), and any such change or interpretation could affect the accuracy of the statements and conclusions set forth in this discussion. This discussion is for general information purposes only and does not purport to be a complete analysis of all
potential tax considerations. This discussion does not address any tax consequences arising under the unearned income Medicare contribution tax pursuant to the Health Care and Education Reconciliation Act of 2010. This discussion is not binding on
the IRS or the courts and, therefore, could be subject to challenge, which could be sustained. No ruling is intended to be sought from the IRS with respect to the merger.
57
This discussion applies only to Clarcor stockholders that hold their shares of Clarcor common
stock as a capital asset within the meaning of Section 1221 of the Code (generally, property held for investment). Further, this discussion does not address all aspects of U.S. federal income taxation that may be applicable to U.S. holders of
Clarcor common stock in light of their particular circumstances or U.S. holders of Clarcor common stock subject to special treatment under U.S. federal income tax law, such as:
|
|
|
entities treated as partnerships for U.S. federal income tax purposes or Clarcor stockholders that hold their shares through entities treated as partnerships for U.S. federal income tax purposes;
|
|
|
|
persons who hold Clarcor common stock as part of a straddle, hedging transaction, short-sale, synthetic security, conversion transaction or other integrated investment or risk reduction transaction;
|
|
|
|
U.S. holders whose functional currency is not the U.S. dollar;
|
|
|
|
persons who acquired Clarcor common stock through the exercise of employee stock options or otherwise as compensation;
|
|
|
|
persons subject to the U.S. alternative minimum tax;
|
|
|
|
banks, insurance companies, mutual funds and other financial institutions;
|
|
|
|
regulated investment companies;
|
|
|
|
real estate investment trusts;
|
|
|
|
tax-exempt organizations;
|
|
|
|
governmental agencies or instrumentalities;
|
|
|
|
tax-qualified retirements plans;
|
|
|
|
brokers or dealers in securities or foreign currencies;
|
|
|
|
holders who exercise appraisal rights;
|
|
|
|
traders in securities that elect the mark-to-market method of accounting.
|
For purposes of
this discussion, the term U.S. holder means a beneficial owner of Clarcor common stock that is:
|
|
|
a citizen or individual resident of the United States;
|
|
|
|
a corporation, or other entity taxable as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States, any state thereof or the District of Columbia;
|
|
|
|
a trust if it (i) is subject to the primary supervision of a court within the United States, and one or more United States persons (as defined in the Code) have the authority to control all substantial decisions of
the trust, or (ii) has a valid election in effect under applicable Treasury regulations to be treated as a United States person (as defined in the Code); or
|
|
|
|
an estate that is subject to U.S. federal income tax on its income regardless of its source.
|
Tax
Consequences of the Merger to U.S. Holders Generally
The exchange of shares of Clarcor common stock for cash in the merger will be
a taxable transaction to U.S. holders for U.S. federal income tax purposes. In general, a U.S. holder whose shares of Clarcor common stock are converted into the right to receive cash in the merger will recognize capital gain or loss for U.S.
federal income tax purposes in an amount equal to the difference, if any, between the amount of cash received with respect to such shares and the U.S. holders adjusted tax basis in such shares. A U.S. holders adjusted tax basis
58
in his or her shares of Clarcor common stock surrendered in the merger generally will equal the price the U.S. holder paid for such shares. Gain or loss will be determined separately for each
block of shares of Clarcor common stock (i.e., shares of Clarcor common stock acquired at the same cost in a single transaction). Such gain or loss generally will be treated as long-term capital gain or loss if the U.S. holders holding period
in the shares of Clarcor common stock exceeds one year at the time of the completion of the merger. Long-term capital gains of non-corporate U.S. holders generally are subject to reduced rates of taxation compared to short-term capital gains or
ordinary income. In addition, depending on the effective time of the merger and a U.S. Holders particular circumstances, a U.S. holder may also be subject to an additional 3.8% net investment income tax. The deductibility of capital losses is
subject to limitations.
Information Reporting and Backup Withholding
Payments made in exchange for shares of Clarcor common stock pursuant to the merger generally will be subject to information reporting unless
the holder is an exempt recipient and may also be subject to backup withholding (currently at a rate of 28%). To avoid backup withholding, a U.S. holder that does not otherwise establish an exemption must complete and return to the
applicable withholding agent a properly completed and executed IRS Form W-9, certifying that such U.S. holder is a U.S. person, that the taxpayer identification number provided is correct, and that such U.S. holder is not subject to backup
withholding.
Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules will generally be
refunded or credited against a holders U.S. federal income tax liability, if any, provided that such holder timely furnishes the required information to the Internal Revenue Service.
This discussion of certain material U.S. federal income tax consequences of the merger is for general information only and does not
constitute tax advice. You are urged to consult your tax advisor with respect to the application of U.S. federal income tax laws to your particular situation as well as any tax consequences of the merger arising under the U.S. federal estate or gift
tax rules, under the laws of any state, local, foreign or other taxing jurisdiction or under any applicable tax treaty.
Regulatory Clearances and Approvals
Under the HSR Act, and related rules, certain transactions, including the merger, may not be completed until notifications have been given and
information furnished to the FTC and the DOJ, and all statutory waiting period requirements have been terminated or have expired. On December 15, 2016, Parker and Clarcor each filed the requisite notification and report forms under the HSR Act
with the DOJ and the FTC. The waiting period will expire at 11:59 p.m. on January 15, 2017, unless the DOJ or FTC earlier terminates the waiting period or the DOJ or the FTC makes a request for additional information related to the merger,
which may extend the waiting period.
Completion of the merger is further subject to notification or receipt of regulatory approvals,
including notification, clearance and/or approval, in Germany and Austria.
At any time before or after the expiration of the statutory
waiting periods under the HSR Act, the DOJ or the FTC may take action under the antitrust laws, including seeking to enjoin the completion of the merger, to rescind the merger, or to conditionally permit completion of the merger subject to
regulatory conditions or other remedies. In addition, non-U.S. regulatory bodies and U.S. state attorneys general could take action under the antitrust laws as they deem necessary or desirable in the public interest, including, without limitation,
seeking to enjoin the completion of the merger or permitting completion of the merger subject to regulatory conditions. Private parties may also seek to take legal action under the antitrust laws under some circumstances. Although we believe that
all required regulatory clearances and approvals will be obtained, there can be no assurance that the granting of regulatory clearances and approvals will not involve the imposition of additional conditions on the completion of the merger, including
the requirement to divest assets, that a significant period of time will not
59
elapse prior to receipt of all such regulatory clearances and approvals, that a challenge to the merger on antitrust grounds will not be made or, if such a challenge is made, that any such
challenge will not be successful.
Under the terms of the merger agreement, Parker has agreed, among other things, to take, and to cause
its subsidiaries to take (including, with respect to any action to be effective as of or after the effective time, Clarcor and its subsidiaries) any and all steps necessary to avoid, eliminate or resolve any impediments under any antitrust laws that
may be asserted by any governmental entity, and obtain all clearances, consents, approvals and waivers under antitrust laws that may be required by any governmental entity, so as to enable the parties to complete the merger as soon as practicable,
including committing to and effecting the sale, divestiture, license or other disposition of any subsidiaries, operations, divisions, businesses, product lines, customers or assets of Parker, Clarcor or any of their respective subsidiaries. The
merger agreement also requires Parker take certain additional actions to the extent that there are impediments under antitrust laws, including taking all actions necessary to defend, including through pursuing litigation on the merits, any
administrative or judicial action or proceeding asserted or threatened by any governmental entity or other person under antitrust laws that seeks, or would reasonably be expected to seek, to restrain the merger. However, under the terms of the
merger agreement, Parker will not be required to sell, divest, license or otherwise dispose of any subsidiaries, operations, divisions, businesses, product lines, customers or assets of Parker, Clarcor or any of their respective subsidiaries
representing, in the aggregate, in excess of $200 million of net sales, measured, (a) with respect to Clarcor and its subsidiaries, by reference to the net sales associated with any such subsidiary, operation, division, business, product line,
customer or asset for the fiscal year ended November 28, 2015, and (b) with respect to Parker and its subsidiaries, by reference to the net sales associated with any such subsidiary, operation, division, business, product line, customer or
asset for the fiscal year ended June 30, 2016.
Delisting and Deregistration of Clarcor Common Stock
Upon completion of the merger, the Clarcor common stock currently listed on the NYSE will be delisted from the NYSE and deregistered under the
Exchange Act.
60
THE MERGER AGREEMENT
The following summary describes the material provisions of the merger agreement and is qualified in its entirety by reference to the merger
agreement, a copy of which is attached to this proxy statement as
Annex A
and which is incorporated by reference into this proxy statement. This summary does not purport to be complete and may not contain all of the information
about the merger agreement that may be important to you. We encourage you to read the merger agreement carefully and in its entirety, as it is the legal document governing the merger.
Explanatory Note Regarding the Merger Agreement
The merger agreement is included in this proxy statement to provide you with information regarding its terms and is not intended to provide and
should not be relied upon as providing any factual information about Clarcor, Parker or any of their respective subsidiaries or affiliates. Such information about Clarcor can be found elsewhere in this proxy statement or in the public filings we
make with the SEC, as described in the section entitled
Where You Can Find Additional Information
. The merger agreement contains representations and warranties by, and covenants of, Clarcor, Parker and Merger Sub which were made
solely for the purposes of the merger agreement and as of specific dates and solely for the benefit of parties to the merger agreement. Further, the representations and warranties in the merger agreement:
|
|
|
are not intended as statements of fact, but rather as a way of allocating the risk between the parties in the event the statements therein prove to be inaccurate;
|
|
|
|
in many cases are subject to important qualifications and limitations, including certain confidential disclosures that were made between the parties in connection with the negotiation of the merger agreement, which
disclosures are not reflected in the merger agreement itself and may or may not be fully reflected in Clarcors public disclosures;
|
|
|
|
may no longer be true as of a given date; and
|
|
|
|
may apply standards of materiality or material adverse effect in a way that is different from what may be viewed as material by you or other stockholders.
|
Accordingly, you should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the
actual state of facts or condition of Clarcor, Parker or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the merger agreement,
which subsequent information may or may not be fully reflected in Clarcors public disclosures. Accordingly, the representations and warranties and other provisions of the merger agreement (including the description of them in this proxy
statement) should not be read alone, but instead should be read together with the other information contained in the reports, statements and filings Clarcor files with the SEC. Such information can be found elsewhere in this proxy statement and in
the public filings Clarcor makes with the SEC, as described in the section entitled
Where You Can Find Additional Information
. Any material facts in Clarcors public reports previously filed with the SEC that are incorporated
by reference into this proxy statement that contradict factual disclosures about Clarcor contained in the representations and warranties in the merger agreement shall modify such factual disclosures.
Structure of the Merger; Certificate of Incorporation; Bylaws; Directors and Officers
Upon the terms and subject to the conditions set forth in the merger agreement and in accordance with the DGCL, at the effective time, Merger
Sub will be merged with and into Clarcor, whereupon the separate existence of Merger Sub will cease, and Clarcor will continue as the surviving corporation in the merger and a wholly owned subsidiary of Parker.
At the effective time, the certificate of incorporation of Clarcor will be amended in its entirety to read as set forth in Exhibit A to the
merger agreement. The bylaws of Clarcor in effect immediately prior to the effective
61
time will be the bylaws of the surviving corporation. The parties have agreed to take all actions reasonably necessary so that the directors of Merger Sub immediately prior to the effective time
will be the initial directors of the surviving corporation. Except as otherwise determined by Parker prior to the effective time, the officers of Clarcor immediately prior to the effective time will be the initial officers of the surviving
corporation.
Effective Time of the Merger
Unless the parties agree otherwise in writing, the closing of the merger will take place at 10:00 a.m., local time, on the third business day
after the satisfaction or, to the extent permitted by applicable law, waiver of all the conditions to the completion of the merger (other than those conditions that are to be satisfied at closing, but subject to the satisfaction or, to the extent
permitted by applicable law, waiver of such conditions). On the closing date, Clarcor and Merger Sub will file a certificate of merger with the Secretary of State of the state of Delaware. The merger will be effective at the time when the
certificate of merger is duly filed with the Secretary of State of the State of Delaware, or at such later time as the parties agree and specify in the certificate of merger in accordance with the relevant provisions of the DGCL.
As of the date of this proxy statement, we expect to complete the merger by or during the first quarter of Parkers fiscal year 2018
(July September 2017). However, the merger is subject to receipt of various regulatory clearances and approvals and satisfaction or waiver of other conditions, which are described below, and it is possible that factors outside the control of
Clarcor, Parker and/or Merger Sub could delay the completion of the merger, or prevent it from being completed at all. There may be a substantial amount of time between the special meeting and the completion of the merger. We expect to complete the
merger promptly following the receipt of all required regulatory clearances and approvals.
Effect of the Merger on Common
Stock
At the effective time, each share of Clarcor common stock issued and outstanding as of immediately prior to the effective time
(other than any shares owned by Clarcor, Parker, Merger Sub or any of their respective wholly owned subsidiaries, which will be cancelled, and other than any dissenting shares) will be converted into the right to receive the merger consideration of
$83.00 in cash, without interest, subject to any applicable withholding taxes.
At the effective time, each share of common stock of
Merger Sub will be converted into one share of common stock of the surviving corporation.
Treatment of Equity Awards;
Employee Stock Purchase Plan
Stock Options
. At the effective time, each option that is outstanding as of immediately prior to
the effective time, whether vested or unvested, will be cancelled in exchange for the right to receive a cash payment from the surviving corporation (without interest and subject to applicable withholding taxes) equal to the product of (1) the
total number of shares of Clarcor common stock subject to such option as of immediately prior to the effective time and (2) the excess, if any, of the merger consideration over the exercise price per share of such option as immediately prior to
of the effective time. Each option outstanding as of immediately prior to the effective time with an exercise price equal to or in excess of the merger consideration will be cancelled at the effective time without any payment to the holder thereof.
Time-Vesting Restricted Stock Unit Awards
. At the effective time, each Clarcor RSU award granted on or prior to the date of the
merger agreement that is outstanding as of immediately prior to the effective time (including any such award that previously vested but receipt of which has been deferred by the holder) will be cancelled in exchange for the right to receive a cash
payment from the surviving corporation (without interest and subject to applicable withholding taxes) equal to the product of (1) the total number of shares of Clarcor common stock subject to such award as of immediately prior to the effective
time and (2) the sum of (A) the
62
merger consideration and (B) any cash dividend equivalents per share accrued but unpaid as of immediately prior to the effective time with respect to such award. RSU awards granted after the
date of the merger agreement will not entitle the holders to any payment with respect to the portion of such award that is not vested as of immediately prior to the effective time in accordance with the terms of the applicable award agreement.
Instead, holders of RSU awards granted after the date of the merger agreement will be entitled to receive a cash payment from the surviving corporation equal to the product of (i) the total number of shares of Clarcor common stock subject to
the vested portion of such award as of immediately prior to the effective time and (ii) the sum of (A) the merger consideration and (B) any cash dividend equivalents per share accrued but unpaid immediately prior to the effective time
with respect to the vested portion of such award immediately prior to the effective time. The unvested portion of all RSU awards granted after the date of the merger agreement will be cancelled at the effective time without any payment to the holder
thereof.
Performance-Based Restricted Stock Unit Awards
. At the effective time, each Clarcor PSU award that is outstanding as of
immediately prior to the effective time will be cancelled in exchange for the right to receive a cash payment from the surviving corporation (without interest and subject to applicable withholding taxes) equal to the product of (1) the total
number of shares of Clarcor common stock subject to such award as of the effective time and (2) the sum of (A) the merger consideration and (B) any cash dividend equivalents per share accrued but unpaid immediately prior to the
effective time with respect to such award.
Clarcor Stock Purchase Program
. Prior to the effective time, Clarcor, the Clarcor board
of directors or the appropriate committee of the Clarcor board of directors, as applicable, will adopt any resolutions and take any actions necessary to: (1) terminate the ESPP, subject to, and effective immediately prior to the effective time;
(2) ensure that no new offering period under the ESPP will be commenced after the date of the merger agreement; (3) prohibit participants in the ESPP from altering their payroll deductions from those in effect on the date of the merger
agreement (other than to discontinue their participation in the ESPP in accordance with the terms and conditions of the ESPP); (4) ensure participant accounts will be applied to the purchase of Clarcor common stock immediately prior to the
effective time in accordance with the terms and conditions of the ESPP; and (5) provide that accumulated contributions of each participant in the ESPP immediately prior to the effective time, to the extent not used to purchase shares of Clarcor
common stock, will be refunded (without interest) to such participant as soon as reasonably practicable following the effective time in accordance with the terms and conditions of the ESPP.
Payment for Common Stock
Prior to the effective time, Parker and Merger Sub will deposit, or cause to be deposited, with a financial institution or trust company
selected by Parker and approved in advance by Clarcor (paying agent), for the benefit of the holders of Clarcor common stock, all of the cash sufficient to pay the aggregate merger consideration. Parker will instruct the paying agent to
mail (or in the case of The Depository Trust Company on behalf of street holders, deliver), as soon as reasonably practicable (but no later than the three business days) following the effective time, to each holder of record of Clarcor
common stock whose shares were converted into the right to receive the merger consideration (1) a letter of transmittal and (2) instructions for use in effecting the surrender of certificates or book-entry shares formerly representing
shares of Clarcor common stock in exchange for payment of the merger consideration. Upon surrender of certificates or book-entry shares, as applicable, to the paying agent together with the letter of transmittal, duly executed, and such other
documents as may reasonably be required by Parker or the paying agent, the holder of such certificates or book-entry shares will be entitled to receive the merger consideration (less any amount that may be withheld with respect to any applicable
withholding taxes). The certificates or book-entry shares may be surrendered to the paying agent until the date that is six months after the effective time.
Lost, Stolen or Destroyed Certificates
In the event any Clarcor common stock certificate has been lost, stolen or destroyed, upon the making of an affidavit of that fact by the
person claiming such certificate to be lost, stolen or destroyed and, to the extent
63
reasonably required by Parker, the posting by such person of a bond in reasonable amount as indemnity against any claim that may be made against it with respect to such certificate, the paying
agent will pay in exchange for such lost, stolen or destroyed certificate the merger consideration that would be payable in respect thereof pursuant to the merger agreement had such lost, stolen or destroyed certificate been surrendered as provided
in the merger agreement.
Representations and Warranties
The merger agreement contains representations and warranties made by Clarcor, subject to important limitations and qualifications in the merger
agreement, in the disclosure schedules delivered in connection with the merger agreement and in Clarcors publicly available filings filed with or furnished to the SEC on or after November 28, 2015 but publicly available prior to
December 1, 2016. Clarcors representations and warranties under the merger agreement relate to, among other things:
|
|
|
the valid existence, good standing and corporate (or other entity) power of Clarcor and each of its subsidiaries;
|
|
|
|
the capitalization of Clarcor, including the number of shares of Clarcor common stock, options and other stock-based awards outstanding and the ownership of the equity interests of Clarcors subsidiaries;
|
|
|
|
Clarcors corporate authority and authorization relating to the execution, delivery and performance of the merger agreement, including the required vote of Clarcors stockholders;
|
|
|
|
the absence of (1) any breach of, conflict with or violation of the organizational documents of Clarcor or any of its subsidiaries, (2) any violation of, conflict with, loss of benefit under, default under,
termination right triggered or lien created with respect to the properties or assets of Clarcor or its subsidiaries under any contract or permit to which Clarcor or its subsidiaries is bound and (3) any conflict with or violation of applicable
laws or orders, in each case, as a result of the execution and delivery by Clarcor of the merger agreement, the performance of Clarcors obligations under the merger agreement and the consummation by Clarcor of the transactions contemplated by
the merger agreement, including the merger;
|
|
|
|
the consents and approvals required by, or filings or notices required to be made with, governmental authorities in connection with the transactions contemplated by the merger agreement;
|
|
|
|
the reports, forms, documents and financial statements of Clarcor required by the SEC;
|
|
|
|
the establishment and maintenance of certain disclosure controls and procedures and internal control over financial reporting;
|
|
|
|
the absence of undisclosed liabilities;
|
|
|
|
the absence of certain material changes or events in the business of Clarcor, including that there was not a material adverse effect with respect to Clarcor and its subsidiaries taken as a whole from August 28,
2016 until the date of the merger agreement;
|
|
|
|
compliance with applicable laws and permits;
|
|
|
|
the absence of certain legal proceedings and governmental orders;
|
|
|
|
tax returns and other tax matters;
|
|
|
|
the employee benefit plans and other agreements, plans and policies with or concerning employees of Clarcor and its subsidiaries;
|
64
|
|
|
title to or valid leasehold interests in real property;
|
|
|
|
environmental matters and the absence of lawsuits against Clarcor and its subsidiaries pertaining to environmental laws and Clarcors and its subsidiaries compliance with such laws;
|
|
|
|
labor and employment matters;
|
|
|
|
transactions with Clarcors affiliates;
|
|
|
|
Clarcors top customers and suppliers;
|
|
|
|
product liability and asbestos;
|
|
|
|
the inapplicability of any anti-takeover laws or similar anti-takeover provisions of Clarcors certificate of incorporation or bylaws to the merger;
|
|
|
|
brokers and finders fees related to the merger; and
|
|
|
|
the receipt by the Clarcor board of directors of the opinion from Clarcors financial advisor as to the fairness, from a financial point of view, of the consideration to be paid to the holders of shares of Clarcor
common stock pursuant to the merger agreement.
|
The merger agreement also contains representations and warranties made by
Parker and Merger Sub, subject to specified exceptions contained in the merger agreement and in the disclosure schedules delivered in connection with the merger agreement. Parkers and Merger Subs representations and warranties to Clarcor
under the merger agreement relate to, among other things:
|
|
|
Parker and Merger Subs valid existence, good standing and corporate power;
|
|
|
|
Parkers and Merger Subs corporate authority and authorization relating to the execution, delivery and performance of the merger agreement, including the required vote of Parkers stockholders;
|
|
|
|
the absence of (1) any breach of, conflict with or violation of the organizational documents of Parker or Merger Sub, (2) any violation of, conflict with, loss of benefit, default under, termination right
triggered or lien created with respect to the properties or assets of Parker or Merger Sub under any contract or permit to which Parker or Merger Sub is bound and (3) any conflict with or violation of applicable laws, in each case, as a result
of the execution and delivery by Parker or Merger Sub of the merger agreement, the performance of the Parker and Merger Subs obligations under the merger agreement and the consummation by Parker or Merger Sub of the transactions contemplated
by the merger agreement, including the financing and the merger;
|
|
|
|
the consents and approvals required by, or filings or notices required to be made with, governmental authorities in connection with the transactions contemplated by the merger agreement;
|
|
|
|
the absence of certain legal proceedings and governmental orders;
|
|
|
|
the ownership and operations of Merger Sub;
|
|
|
|
the absence of a need for a vote of Parker stockholders on the merger;
|
|
|
|
brokers and finders fees related to the merger;
|
|
|
|
the delivery to Clarcor by Parker of evidence of debt commitments for the financing required to consummate the transaction and the enforceability of such commitments; and
|
|
|
|
the ownership by Parker and its subsidiaries (including Merger Sub) of Clarcor common stock.
|
None of the representations and warranties in the merger agreement survive after the completion of the merger.
65
Many of the representations and warranties in the merger agreement are qualified by a
materiality or material adverse effect standard (that is, they will not be deemed to be untrue or incorrect unless a materiality threshold is satisfied or their failure to be true or correct has had, or would be reasonably
expected to have, individually or in the aggregate, a material adverse effect).
For purposes of the merger agreement, a material
adverse effect means, with respect to Parker, any event, change, circumstance or effect that, individually or in the aggregate with any other event, change, circumstance or effect, has or would reasonably be expected to prevent or materially
impair or would reasonably be expected to delay to a date following December 1, 2017, the ability of Parker to consummate the merger or the other transactions contemplated by the merger agreement.
For purposes of the merger agreement, a material adverse effect means, with respect to Clarcor, any event, change, circumstance or
effect that prevents or materially impairs or would reasonably be expected to delay to a date after December 1, 2017 the ability of Clarcor to consummate the merger or the other transactions contemplated by the merger agreement or that has
material adverse effect on the business, results of operations or financial condition of Clarcor and its subsidiaries, taken as a whole, except that no event, change, circumstance, or effect will be deemed to constitute, nor will any of the
following be taken into account in determining whether there has been or would reasonably be expected to be, a material adverse effect with respect to Clarcor, to the extent that such event, change, circumstance, or effect results from, arises out
of, or relates to:
|
|
|
any changes in general United States or global economic conditions, except to the extent that such changes have a materially disproportionate adverse effect on Clarcor and its subsidiaries, taken as a whole, relative to
the adverse effect such changes have on others operating in the industries in which Clarcor and any of its subsidiaries operate;
|
|
|
|
any changes in conditions generally affecting any industry or geographic region in which Clarcor or any of its subsidiaries operate, except to the extent that such changes have a materially disproportionate adverse
effect on Clarcor and its subsidiaries, taken as a whole, relative to the adverse effect such changes have on others operating in the industries in which Clarcor and any of its subsidiaries operate;
|
|
|
|
any decline in the market price or trading volume of Clarcor common stock (it being understood that the foregoing shall not preclude Parker from asserting that the facts or occurrences giving rise to or contributing to
such decline that are not otherwise excluded from the definition of material adverse effect should be deemed to constitute, or be taken into account in determining whether there has been a material adverse effect);
|
|
|
|
any changes in regulatory, legislative or political conditions or securities, credit, financial, debt or other capital markets conditions, including interest or currency exchange rates, except to the extent that such
changes or conditions have a materially disproportionate adverse effect on Clarcor and its subsidiaries, taken as a whole, relative to the adverse effect such changes or conditions have on others operating in the industries in which Clarcor and any
of its subsidiaries operate;
|
|
|
|
any failure, in and of itself, by Clarcor to meet any internal or published projections, forecasts, estimates or predictions, or analysts estimates, in respect of revenues, earnings or other financial or operating
metrics for any period (it being understood that the foregoing shall not preclude Parker from asserting that the facts or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of material
adverse effect should be deemed to constitute, or be taken into account in determining whether there has been, a material adverse effect);
|
|
|
|
the public announcement or pendency of the merger agreement, the merger or the taking of any action required by the merger agreement or the identity of, or any facts or circumstances relating to, Parker, Merger Sub or
their respective subsidiaries, including the impact of any of the foregoing on the relationships, contractual or otherwise, of Clarcor or any of its subsidiaries with customers, suppliers, officers or employees;
|
66
|
|
|
any adoption, implementation, promulgation, repeal, modification, amendment, reinterpretation, change or proposal of any law following the date of the merger agreement, except to the extent that such changes have a
materially disproportionate adverse effect on Clarcor and its subsidiaries, taken as a whole, relative to the adverse effect such changes have on others operating in the industries in which Clarcor and any of its subsidiaries operate;
|
|
|
|
any change in accounting requirements or principles required by GAAP (or authoritative interpretations thereof) following the date of the merger agreement;
|
|
|
|
any geopolitical conditions, the outbreak or escalation of hostilities, any acts of war, sabotage or terrorism, or any escalation or worsening of any such acts of war, sabotage or terrorism threatened or underway as of
the date of the merger agreement, except to the extent that such changes have a materially disproportionate adverse effect on Clarcor and its subsidiaries, taken as a whole, relative to the adverse effect such changes have on others operating in the
industries in which Clarcor and any of its subsidiaries operate;
|
|
|
|
any taking of any action at the request of Parker or Merger Sub; or
|
|
|
|
any hurricane, strong winds, ice event, fire, tornado, tsunami, flood, earthquake or other natural disaster, acts of God or any change resulting from weather events, conditions or circumstance, except to the extent that
such changes have a materially disproportionate adverse effect on Clarcor and its subsidiaries, taken as a whole, relative to the adverse effect such changes have on others operating in the industries in which Clarcor and any of its subsidiaries
operate.
|
Access
Subject to certain exceptions and limitations, Clarcor is required to afford Parkers representatives reasonable access during normal
business hours to its and its subsidiaries properties, books and records (including tax records and information to the extent reasonably necessary to confirm disclosures in this proxy statement) and personnel, and to furnish as promptly as
reasonably practicable to Parker all other information concerning Clarcors and its subsidiaries business, properties and personnel as Parker may reasonably request.
Conduct of Business Pending the Merger
During the period from December 1, 2016 until the earlier of the effective time and the termination of the merger agreement in accordance
with its terms, except (1) as prohibited or required by applicable law or order, (2) as set forth in the disclosure schedules to the merger agreement, (3) as required or expressly permitted by the merger agreement or (4) as
consented to by Parker (which consent shall not be unreasonably withheld, conditioned or delayed), Clarcor will use reasonable best efforts to conduct the businesses of itself and its subsidiaries in the ordinary course in all material respects and
to preserve intact, in all material respects, the business organization of Clarcor and its subsidiaries and the current relationships of Clarcor and its subsidiaries with persons having material business dealings with Clarcor or any of its
subsidiaries and will not, and will not permit any of its subsidiaries to, take any of the following actions:
|
|
|
amend, modify, waive any provision of or otherwise change its certificate of incorporation, bylaws or similar organizational documents;
|
|
|
|
(1) declare, set aside, make or pay any dividend or other distribution (whether in cash, stock, property or
otherwise) in respect of any of its capital stock, except for dividends or distributions by any subsidiary of Clarcor to Clarcor or to any borrower or guarantor under Clarcors existing credit agreement or any other wholly owned subsidiary of
Clarcor, (2) adjust, split, combine, subdivide, or reclassify any of its capital stock or securities convertible into capital stock or issue or propose or authorize the issuance of any other securities (including options, warrants or any
similar security exercisable for, or convertible into, such other security) in respect of, in lieu of, or in substitution for, shares of its capital stock, except with respect to the capital stock or securities of any wholly owned
|
67
|
subsidiary of Clarcor, in connection with transactions among Clarcor and its wholly owned subsidiaries or among Clarcors wholly owned subsidiaries or (3) repurchase, redeem or
otherwise acquire, directly or indirectly, any shares of the capital stock or securities of Clarcor or any of its subsidiaries, or any other equity interests or any rights, warrants or options to acquire any such shares, securities or interests,
except (i) for quarterly cash dividends in respect of shares of Clarcor common stock (and, with respect to Clarcor equity awards, dividends or dividend equivalents to the extent required by the terms of such awards as in effect on the date of
the merger agreement) on a schedule consistent with Clarcors current practices and in an amount per share not in excess of $0.25 per quarter, (ii) for acquisitions, or deemed acquisitions, of shares of Clarcor common stock or other equity
securities of Clarcor solely in connection with forfeitures of awards, the exercise of options or in connection with the vesting or settlement of Clarcor equity awards (including in satisfaction of any amounts required to be deducted or withheld
under applicable law), in each case outstanding as of the date of the merger agreement or (iii) with respect to the capital stock or securities of any wholly owned subsidiary, in connection with transactions among Clarcor and one or more of its
wholly owned subsidiaries or among Clarcors wholly owned subsidiaries;
|
|
|
|
issue, sell, grant, pledge, dispose of or otherwise encumber, or, with respect to any subsidiary of Clarcor, transfer, any shares of its capital stock or other securities (including any options, warrants or any similar
security exercisable for, or convertible into, such capital stock or similar security), including Clarcor common stock and/or preferred stock of Clarcor, except for (1) the issuance of shares of Clarcor common stock pursuant to contracts in
effect prior to the execution and delivery of the merger agreement, (2) the issuance of shares of Clarcor common stock pursuant to the ESPP during the current offering period pursuant to participant elections and the terms thereof as of the
date of the merger agreement, (3) the issuance of shares of Clarcor common stock in connection with the exercise of options or the vesting or settlement of Clarcor equity awards outstanding as of the date of the merger agreement,
(4) issuances by a wholly owned subsidiary of Clarcor of capital stock to such subsidiarys parent, Clarcor or another wholly owned subsidiary of Clarcor, (5) transfers to any borrower or guarantor under Clarcors existing credit
agreement or (6) liens granted by Clarcor and its subsidiaries in connection with Clarcors existing credit agreement;
|
|
|
|
(1) merge or consolidate with any other entity, or (2) acquire any assets from or make an investment in (whether through the acquisition of stock, assets or otherwise) any other entity (excluding subsidiaries of
Clarcor), except for acquisitions of inventory, equipment and other assets in the ordinary course of business, any such acquisition or investment where the consideration is not in excess of $5,000,000 individually or $25,000,000 in the aggregate, or
any capital expenditures permitted by the merger agreement;
|
|
|
|
transfer, sell, lease, license, subject to a lien (except for liens permitted by the merger agreement or liens
granted by Clarcor and its subsidiaries in connection with its existing credit agreement), divest, cancel, abandon, allow to lapse or expire or otherwise dispose of any assets (including intellectual property owned by Clarcor), product lines or
businesses of Clarcor or any of its subsidiaries (including capital stock or other equity interests of any subsidiary) except (1) pursuant to contracts which were entered into in the ordinary course of business or which were set forth in the
disclosure schedules to the merger agreement, in each case, which were in effect prior to the execution and delivery of the merger agreement and ordinary course renewals thereof, (2) sales, leases or licenses of inventory and dispositions of
obsolete or surplus equipment in the ordinary course of business consistent with past practice, (3) transfers, sales, leases, licenses or other dispositions between and/or among Clarcor or any of its subsidiaries, (4) abandonment,
cancellation, lapses or expirations of immaterial intellectual property owned by Clarcor in the ordinary course of business, (5) non-exclusive license grants to intellectual property owned by Clarcor which were granted by Clarcor or any of its
subsidiaries in connection with the sale or distribution of products in the ordinary course of business, (6) non-exclusive license grants to contract manufacturers that manufacture products on behalf of Clarcor or any of its subsidiaries in the
ordinary course of business and (7) any such transaction involving assets
|
68
|
of Clarcor or any of its subsidiaries with a fair market value not in excess of $1,000,000 individually or $10,000,000 in the aggregate;
|
|
|
|
make any capital expenditures except to the extent set forth in, and consistent with, Clarcors capital expenditure budget for the fiscal year ending December 2, 2017 (plus a 5% variance);
|
|
|
|
(1) make any loans, advances (other than to directors and officers with respect to any indemnification obligation) or capital contributions to any other person or entity other than in the ordinary course of business so
long as such loans, advances or capital contributions are not material to Clarcor and its subsidiaries, taken as a whole or (2) create, incur, guarantee or assume any indebtedness for borrowed money, or issue or sell any debt securities or
warrants or other rights to acquire any debt security of Clarcor or any of its subsidiaries, in excess of $5,000,000 in the aggregate, except for, in the case of each of clause (1) and clause (2), (a) transactions among Clarcor and its
wholly owned subsidiaries or among Clarcors wholly owned subsidiaries, (b) borrowings under the revolving credit facility of Clarcors credit agreement that are incurred in the ordinary course of business or that are incurred in
order to pay any fees and expenses of financial or other advisors of Clarcor in connection with the transactions contemplated by the merger agreement, (c) guarantees by Clarcor of indebtedness for borrowed money of any of its subsidiaries or
guarantees by any of Clarcors subsidiaries of indebtedness of Clarcor or any of its subsidiaries that is permitted by the merger agreement, (d) obligations in respect of letters of credit, performance bonds or similar instruments issued
for the account of Clarcor and/or any of its subsidiaries in the ordinary course of business, (e) any hedging, swap or similar arrangement entered into in the ordinary course of business and consistent with Clarcors hedging policy, and
(f) indebtedness for borrowed money incurred to replace, renew, extend, refinance or refund any existing indebtedness and in amounts not materially in excess of such existing indebtedness, provided that such amounts are prepayable at any time
without penalty or premium, or (3) cancel any debt of any person or entity owed to Clarcor or any of its subsidiaries (other than in connection with transactions between or among Clarcor and/or any of its subsidiaries) or waive any claims or
rights of value, except for cancellations or waivers that are not expected to be outside the ordinary course of business and that are not in excess of $2,500,000 individually;
|
|
|
|
except as required by contracts in effect prior to the execution of the merger agreement, Clarcor benefit plans as in effect on the date of the merger agreement or applicable law, (1) increase the compensation or
other benefits payable or provided to Clarcors or its subsidiaries officers, directors or employees; (2) enter into any employment, change of control, severance or retention agreement with any employee, director or officer of
Clarcor or any of its subsidiaries; (3) amend any Clarcor benefit plan, except (a) in the ordinary course of business consistent with past practices and as would not result in a material increase in cost to Clarcor and its subsidiaries
with respect to such Clarcor benefit plan or (b) as is required to comply with Section 409A of the Code or other applicable law; (4) change in any material respect any actuarial or other assumptions used to calculate funding
obligations with respect to any Clarcor benefit plan or to change the manner in which contributions to such plans are made or the basis on which such contributions are determined, except as may be required by applicable law; (5) forgive any
loans to directors, officers or employees of Clarcor or any of its subsidiaries; or (6) hire or terminate without cause any executive officer or any employee with a target base salary in excess of $150,000;
|
|
|
|
other than in respect of claims, liabilities or obligations in connection with any litigation or proceedings
arising from the merger or merger agreement, (1) waive, release, settle or compromise any suit action, claim, proceeding, arbitration or litigation for an amount in excess of the amount of the corresponding reserve established on the
consolidated balance sheet of Clarcor as reflected in the most recent applicable Clarcor SEC filing, except (a) for any settlements or compromises involving payments not in excess of $1,000,000 individually or $5,000,000 in the aggregate, net
of any insurance and indemnity, contribution and similar obligations for the benefit of Clarcor or any of its subsidiaries in respect thereof (it being understood that this clause (a) shall operate in addition to and not in limitation of clause
(1) above) and (b) settlements of any workers compensation or U.S. Equal Employment
|
69
|
Opportunity Commission charges, or (2) agree or enter into any settlement agreement, consent decree, injunction or similar restraint or form of equitable relief in settlement of any claim
(including in connection with any proceeding) or audit, in each case, that would materially restrict the operations of the business of Clarcor or its subsidiaries after the effective time;
|
|
|
|
(1) enter into certain specified contracts that would have been a material contract under the merger agreement, (2) except in the ordinary course of business, enter into any contract (other than those subject to
clause (1) above) that would have been a material contract had it been entered into prior to the merger agreement, or (3) except in the ordinary course of business, materially amend or terminate any material contract, or cancel, modify or
waive any material debts, rights or claims thereunder;
|
|
|
|
materially alter or amend any existing accounting methods, principles or material practices, except as may be required by GAAP or applicable law (including changes thereto);
|
|
|
|
(1) make or change any material tax election other than in the ordinary course of filing annual tax returns, (2) materially change any method of accounting of Clarcor or any of its subsidiaries for tax purposes,
(3) file any material amended tax return, (4) settle, concede, compromise or abandon any material tax claim or assessment, (5) surrender any right to a refund of material taxes, or (6) consent to any extension or waiver of the
limitation period applicable to any claim or assessment with respect to any U.S. federal, state or local income tax return;
|
|
|
|
adopt or initiate any plan of complete or partial liquidation, dissolution, restructuring, closure or recapitalization of Clarcor or any of its subsidiaries or any of their respective operations or facilities to the
extent outside of the ordinary course of business;
|
|
|
|
fail to maintain in full force and effect material insurance policies or comparable replacement policies covering Clarcor and its subsidiaries and their respective properties, assets and businesses in a form and amount
consistent with past practice; or
|
|
|
|
authorize, agree or obligate itself to take any of the foregoing actions.
|
No
Solicitation of Alternative Proposals; Changes in Board Recommendation
Pursuant to the merger agreement, Clarcor agreed to immediately
cease all discussions or negotiations existing as of the date of the merger agreement with any person (other than Parker and Merger Sub) that may have been ongoing with respect to an acquisition proposal and promptly inform any such person of the
non-solicitation obligations under the merger agreement and to return or destroy all confidential information.
For the purposes of the
merger agreement and as used in this proxy statement, the term acquisition proposal means any proposal or offer (whether or not in writing) from any person (other than Parker or any of its subsidiaries or affiliates) relating to, or that
would reasonably be expected to lead to (1) any direct or indirect acquisition or purchase, in one transaction or a series of related transactions, of assets (including equity securities of any subsidiary of Clarcor) or businesses that
constitute 20% or more of the assets of Clarcor and its subsidiaries, taken as a whole, or 20% or more of any class of equity securities of Clarcor, (2) any tender offer or exchange offer that if consummated would result in any person or group
of persons beneficially owning (as defined in Section 13(d) of the Exchange Act) securities of Clarcor representing 20% or more of the aggregate voting power of all securities of Clarcor or (3) any merger, consolidation, business
combination, recapitalization, liquidation, dissolution, joint venture, share exchange or similar transaction involving Clarcor or any of its subsidiaries, in each case, pursuant to which any person or the stockholders of any person would own
securities of Clarcor or of any resulting direct or indirect parent company of Clarcor representing 20% or more of the aggregate voting power of all securities of Clarcor or of any resulting direct or indirect parent company of Clarcor.
From the date of the merger agreement until the earlier of the effective time or the termination of the merger agreement in accordance with
its terms, subject to certain exceptions described below, Clarcor has agreed that it
70
will not, and will cause each of its subsidiaries and its and their respective officers, directors, employees and agents not to, and will direct each of its other representatives not to, directly
or indirectly:
|
|
|
solicit, initiate or knowingly facilitate or encourage any inquiries or the making of any proposal or offer which constitutes, or could reasonably be expected to lead to, any acquisition proposal;
|
|
|
|
furnish any nonpublic information regarding Clarcor or its subsidiaries to any person in connection with or in response to an acquisition proposal;
|
|
|
|
engage in, continue or otherwise participate in, any negotiations or discussions regarding any acquisition proposal; or
|
|
|
|
approve, recommend or enter into, or propose to approve, recommend or enter into, any letter of intent, memorandum of understanding, agreement in principle, acquisition agreement, merger agreement or similar agreement
(other than an acceptable confidentiality agreement entered into in accordance with the merger agreement) with respect to any acquisition proposal.
|
Receipt of Acquisition Proposals
Notwithstanding the provisions of the merger agreement described above, if contacted by a person making an acquisition proposal after the date
of the merger agreement, Clarcor and its representatives may contact the person making such acquisition proposal and its representatives to ascertain facts or clarify terms and conditions for the sole purpose of the Clarcor board of directors
informing itself about the acquisition proposal and the person who made it. Additionally, notwithstanding the provisions of the merger agreement described above, if contacted by a person making an acquisition proposal after the date of the merger
agreement and if, prior to obtaining requisite stockholder vote, following the receipt of a bona fide written proposal that did not result from a breach of the non-solicitation provisions of the merger agreement, which the Clarcor board of directors
determines in good faith, after consultation with its advisors, constitutes, or could reasonably be expected to lead to, a superior proposal (as defined below), Clarcor and Clarcors representatives may, in response to such acquisition
proposal:
|
|
|
furnish information with respect to Clarcor and its subsidiaries to the person making such acquisition proposal and its representatives and financing sources pursuant to an acceptable confidentiality agreement; provided
that to the extent not previously made available to Parker, Clarcor furnishes Parker with all such nonpublic information delivered to such person promptly after its delivery to such person; and
|
|
|
|
engage in discussions or negotiations with such person regarding such acquisition proposal.
|
Clarcor has agreed that a breach of the non-solicitation provisions of the merger agreement by any representative of Clarcor, acting by or on
behalf of Clarcor, will constitute a breach by Clarcor of such non-solicitation provisions of the merger agreement.
For the purposes of
the merger agreement and as used in this proxy statement, the term superior proposal means any unsolicited bona fide written acquisition proposal (with all references to 20% in the definition of acquisition proposal being
deemed to be references to 50%) made that is on terms that the Clarcor board of directors determines in good faith (after consulting with its financial advisor and outside legal counsel), taking into account the timing and likelihood of
consummation, legal, financial, regulatory and other aspects of the proposal (including any conditions to consummation and financing terms), and such other factors as the Clarcor board of directors considers to be appropriate, is more favorable to
Clarcor stockholders than the merger and the other transactions contemplated by the merger agreement (after taking into account any revisions to the terms of the merger agreement proposed by Parker as described below in this section).
In addition to its other non-solicitation obligations, Clarcor will promptly (and in any event no later than 48 hours after it receives any
acquisition proposal or request for information) advise Parker in writing of any request
71
for confidential information in connection with an acquisition proposal or of any acquisition proposal, the material terms and conditions of such request or acquisition proposal and the identity
of the person making such request or acquisition proposal and, if applicable, provide copies of any such written request or acquisition proposal, including any proposed agreements between Clarcor and the parties making the acquisition proposal, to
Parker and shall keep Parker reasonably informed on a reasonably current basis (but in no event more often than once every 48 hours) of all material modifications to the terms of any acquisition proposal.
Changes in Board Recommendation
The Clarcor board of directors has unanimously recommended that Clarcor stockholders vote
FOR
the merger proposal.
Except as expressly permitted by the merger agreement, neither the Clarcor board of directors, nor any committee thereof, may:
|
|
|
withdraw (or modify or qualify in a manner adverse to Parker) the recommendation of the Clarcor board of directors to adopt the merger agreement;
|
|
|
|
fail to include the recommendation of the Clarcor board of directors to adopt the merger agreement in this proxy statement; or
|
|
|
|
approve, adopt or recommend, or publicly propose to approve, adopt or recommend, any acquisition proposal.
|
The actions described in the three bullet points above constitute a recommendation withdrawal (recommendation withdrawal). The
merger agreement permits the Clarcor board of directors to make a recommendation withdrawal only in certain limited circumstances, as described below.
Prior to the receipt of the requisite stockholder vote, the Clarcor board of directors may, in response to any unsolicited, bona fide
acquisition proposal that did not result from a breach of the non-solicitation provisions of the merger agreement, effect a recommendation withdrawal and terminate the merger agreement in order to enter into a binding, definitive acquisition
agreement, merger agreement or similar agreement in respect of an acquisition proposal (subject to paying a termination fee to Parker under the terms of the merger agreement as further described below) if:
|
|
|
the Clarcor board of directors concludes in good faith after consultation with its outside financial advisors and outside legal counsel that such acquisition proposal constitutes a superior proposal;
|
|
|
|
the Clarcor board of directors concludes in good faith, after consultation with its outside legal counsel, that the failure to make a recommendation withdrawal would be inconsistent with its fiduciary duties to Clarcor
stockholders under applicable law;
|
|
|
|
the Clarcor board of directors provides Parker four business days prior written notice (or such shorter period as specified in the fifth bullet point below) of its intention to take such action, which notice must
include the material terms and conditions of such acquisition proposal and the identity of the person making such request or acquisition proposal, as well as a copy of such acquisition proposal;
|
|
|
|
during the four business days following such written notice (or such shorter period as is specified in the fifth bullet point below), if requested by Parker, the Clarcor board of directors and its representatives have
negotiated in good faith with Parker regarding any revisions to terms of the merger agreement proposed by Parker in response to such acquisition proposal; and
|
|
|
|
at the end of such four business day period, the Clarcor board of directors concludes in good faith, after
consultation with its outside legal counsel and financial advisors and taking into account any adjustment or modification of the terms of the merger agreement proposed by Parker, that the acquisition proposal continues to be a superior proposal, and
that the failure to make a recommendation
|
72
|
withdrawal in respect of such superior proposal would be inconsistent with its fiduciary duties to Clarcor stockholders under applicable law. The parties have agreed that any material amendment
to any superior proposal will be deemed to be a new acquisition proposal for purposes of the merger agreement, except that the notice period and the period during which Clarcor and its representatives are required, if requested by Parker, to
negotiate with Parker regarding any revisions to the terms of the merger agreement proposed in writing by Parker in response to such new acquisition proposal pursuant to the preceding two bullet points and this bullet point shall expire two business
days after Clarcor provides written notice of such new acquisition proposal to Parker.
|
Further, the Clarcor board of
directors may effect a recommendation withdrawal at any time prior to obtaining the requisite stockholder vote if an intervening event (as defined below) has occurred and is continuing and the Clarcor board of directors concludes in good
faith (after consultation with outside legal counsel) that the failure to effect a recommendation withdrawal in response to such intervening event would be inconsistent with its fiduciary duties to Clarcor stockholders under applicable law;
provided, that no recommendation withdrawal with respect to an intervening event may be made unless:
|
|
|
The Clarcor board of directors has provided Parker four business days prior written notice that it intends to take such action and has provided reasonable detail with respect to such intervening event;
|
|
|
|
during the four business days following such written notice, if requested by Parker, the Clarcor board of directors and its representatives have negotiated in good faith with Parker regarding any revisions to the terms
of the merger agreement; and
|
|
|
|
at the end of such four business day period, the Clarcor board of directors concludes in good faith, after consultation with its outside legal counsel and financial advisors and taking into account any adjustment or
modification of the terms of the merger agreement proposed by Parker, that the failure to make a recommendation withdrawal would be inconsistent with its fiduciary duties to Clarcor stockholders under applicable law.
|
For the purposes of the merger agreement and as used in this proxy statement, intervening event means a material event or
circumstance that first arises or occurs after the date of the merger agreement and prior to the requisite stockholder vote that was not known and was not reasonably foreseeable to the Clarcor board of directors on the date of the merger agreement,
which material event or circumstance becomes known to the Clarcor board of directors prior to the time at which Clarcor obtains the requisite stockholder vote and does not relate to (1) any acquisition proposal, (2) the regulatory
approvals required under the merger agreement or certain actions taken by Parker or Merger Sub or any of their subsidiaries or affiliates in connection with the special meeting or the consequences of any such action, (3) changes in the market
price or trading volume of shares of Clarcor common stock (except that the facts or occurrences giving rise to or contributing to any such change, to the extent such facts or circumstances otherwise fall within the definition of intervening
event, may be considered in evaluating whether an intervening event has occurred) or (4) Clarcor or any of its subsidiaries exceeding, or failing to meet, internal or published projections, forecasts, estimates or predictions in respect
of revenues, earnings or other financial or operating metrics for any period (except that the facts or occurrences giving rise to or contributing to the foregoing, to the extent such facts or occurrences otherwise fall within the definition of
intervening event, may be considered in evaluating whether an intervening event has occurred).
The merger agreement does not
prohibit Clarcor or the Clarcor board of directors from any of the following actions, provided that a recommendation withdrawal may only be made as described above:
|
|
|
taking and disclosing to Clarcor stockholders a position contemplated by Rule 14e-2(a) under the Exchange Act or making a statement contemplated by Item 1012(a) of Regulation M-A or Rule 14d-9 under the Exchange
Act;
|
|
|
|
making any disclosure to Clarcor stockholders if the Clarcor board of directors determines in good faith, after consultation with its outside legal counsel, that the failure to make such disclosure would be inconsistent
with applicable law; or
|
73
|
|
|
informing any person of the existence of the non-solicitation provisions contained in the merger agreement.
|
If any disclosure permitted under the first bullet above or, to the extent related to an acquisition proposal or intervening event, the second
bullet point above does not reaffirm the recommendation of the Clarcor board of directors to adopt the merger agreement, such disclosure will be deemed to be a recommendation withdrawal and Parker will have the right to terminate the merger
agreement in accordance with its terms. The parties agreed that any stop, look and listen communication to Clarcor stockholders pursuant to Rule 14d-9(f) under the Exchange Act will not in and of itself be deemed to be or constitute a
recommendation withdrawal. The parties further agreed that a factually accurate statement that describes Clarcors receipt of an acquisition proposal and the operation of the merger agreement with respect thereto will not, in and of itself, be
deemed to be a recommendation withdrawal.
Obligations with Respect to the Special Meeting
As promptly as reasonably practicable (and in any event no more than 25 business days) after the date of mailing of this proxy statement,
Clarcor, acting through its board of directors, and in accordance with applicable law, the rules and regulations of NYSE and Clarcors charter and bylaws, is required to duly call, give notice of, convene and hold the special meeting.
Notwithstanding anything in the merger agreement to the contrary, Clarcor is permitted to adjourn, delay or postpone the special meeting (a) with the consent of Parker, (b) if as of the time of the special meeting, there are insufficient
shares of Clarcor common stock represented (either in person or by proxy) to constitute a quorum necessary to conduct business at such special meeting, (c) if as of the time of the special meeting, there are insufficient shares of Clarcor
common stock with respect to which proxies have been submitted to vote in favor of the adoption of the merger agreement to obtain the requisite stockholder vote or (d) to allow additional time for the filing and/or mailing of any supplemental
or amended disclosure that Clarcor has determined in good faith (after consultation with its outside legal advisors) is required under applicable law and for such supplemental or amended disclosure to be disseminated and reviewed in compliance with
applicable law by Clarcor stockholders prior to the special meeting. Subject to the non-solicitation provisions of the merger agreement described above, Clarcor must use its reasonable best efforts to solicit the requisite stockholder vote at the
special meeting.
Clarcor will keep Parker reasonably informed regarding its solicitation efforts and proxy tallies following the mailing
of this proxy statement, including by allowing Parker and its representatives to participate in any substantive meeting or discussion with such proxy solicitor and directing such proxy solicitor to deliver proxy tally reports to Parker concurrently
with delivery of such reports to Clarcor.
Financing and Financing Cooperation
In connection with signing the merger agreement, Parker delivered to Clarcor a true, correct and complete fully executed copy of the commitment
letter, dated as of December 1, 2016 among Parker and Morgan Stanley Senior Funding, Inc., pursuant to which, upon the terms and subject to the conditions set forth therein, the financing sources party thereto have agreed to lend Parker a total
of $3.1 billion. Parker has agreed to use its reasonable best efforts to take, or cause to be taken, all actions and do, or cause to be done, all things necessary, proper or advisable to consummate the financing contemplated by the commitment letter
on or prior to the closing date. Parker has the right under the merger agreement to substitute the proceeds of consummated equity or debt offerings or other incurrences of debt for all or any portion of the financing contemplated by the commitment
letter, subject to certain conditions. Clarcor will, and will cause its subsidiaries to, use reasonable best efforts to provide such customary cooperation as may be reasonably requested by Parker in connection with the financing.
Employee Benefits Matters
The merger agreement provides that until the first anniversary of the effective time (the continuation period), the surviving
corporation will provide or cause to be provided for those employees of Clarcor and its
74
subsidiaries who continue as employees of the surviving corporation or any of its subsidiaries during all or a portion of the continuation period (collectively, the continuing
employees), compensation, including salary or hourly wage rate and annual target and maximum bonus opportunities (but excluding equity-based incentive compensation opportunities and employee stock purchase plans) and employee benefits that, in
the aggregate, are substantially similar to the compensation and employee benefits provided to such continuing employee immediately prior to the effective time. With respect to the fiscal year in which the closing of the merger occurs, the merger
agreement provides that the surviving corporation will pay a pro rata portion of the bonus each continuing employee would be eligible to receive under the Clarcor Value Added Plan (the CVA) for such fiscal year as if the applicable
performance goals had been achieved at the target level of performance based on the number of days that lapse beginning on the first day of such fiscal year and ending on the closing date (provided such continuing employee is not otherwise eligible
or entitled to receive a CVA cash bonus for the same period).
The merger agreement also provides that the surviving corporation will use
reasonable best efforts to (1) waive any applicable pre-existing condition exclusions and waiting periods with respect to participation and coverage requirements in any replacement or successor welfare benefit plan of the surviving corporation
in which a continuing employee is eligible to participate following the effective time to the extent such exclusions or waiting periods were inapplicable to, or had been satisfied by, such continuing employee immediately prior to the effective time
under the analogous benefit plan in which such continuing employees participated, (2) provide each continuing employee with credit for any co-payments and deductibles paid prior to the effective time during the plan year that includes the
effective time (to the same extent such credit was given under the analogous benefit plan prior to the effective time) in satisfying any applicable deductible or out-of-pocket requirements for the plan year that includes the effective time and
(3) recognize service prior to the effective time with Clarcor or any of its subsidiaries for purposes of eligibility to participate and vesting and level of benefits for vacation and severance benefits under any employee benefit plan of the
surviving corporation in which a continuing employee is eligible to participate following the effective time that is analogous and corresponding to a benefit plan in which such continuing employee participated immediately prior to the effective time
to the same extent such service was recognized by Clarcor or any of its subsidiaries under such analogous and corresponding benefit plan. The foregoing will not apply to the extent it would result in duplication of benefits for the same period of
service, and the surviving corporation will not be obligated to provide credit for years of service for benefit accrual purposes under any defined benefit pension plan maintained by the surviving corporation or its subsidiaries prior to the date on
which the continuing employee actually becomes a participant in such plan.
The merger agreement provides that, from and after the
effective time, Parker will or will cause the surviving corporation to honor, in accordance with its terms, each change in control agreement and nonqualified deferred compensation plan listed in the disclosure schedules to the merger agreement and
each other benefit plan expressly requiring the surviving corporation or its successor to assume such benefit plan. Parker also will, or will cause the surviving corporation to, provide eligible continuing employees who experience a qualifying
employment termination during the continuation period with the severance benefits as provided in the disclosure schedules to the merger agreement. Clarcor shall take all actions necessary to terminate certain benefit plans and amend certain benefit
plans as included in the disclosure schedules to the merger agreement and requested by Parker within thirty business days prior to the effective time.
With respect to any continuing employees who are covered by a collective bargaining agreement or labor union contract, or who are based
outside of the United States, Parkers obligations under the merger agreement will be in addition to, but without duplication, and not in contravention of, any obligations under the applicable collective bargaining agreement or labor union
contract or under the laws of the foreign countries in which such continuing employees are based.
Nothing contained in the merger
agreement, whether express or implied, (1) shall be treated as an amendment or other modification of any Clarcor benefit plan or any employee benefit plan of Parker or its subsidiaries, (2) shall create any third-party beneficiary rights
in any continuing employee or any other person, or
75
(3) shall limit the right of Parker or the surviving corporation or any of their subsidiaries to amend, terminate or otherwise modify any Clarcor benefit plan following the effective time.
Consents, Approvals and Filings
Clarcor and Parker have agreed to use their reasonable best efforts to consummate the merger, including to use reasonable best efforts to, as
promptly as practicable, (1) cause all of the conditions to the closing of the merger to be satisfied, (2) prepare and file all filings and submissions under the HSR Act, in connection with the regulatory approvals required under the
merger agreement and in connection with any other antitrust law that the parties mutually agree is advisable, (3) obtain all consents, orders, actions or nonactions, waivers and clearances required under the HSR Act and in connection with the
regulatory approvals required under the merger agreement and in connection with any other antitrust law that the parties mutually agree is advisable and (4) obtain all necessary material consents or waivers from non-governmental third parties
(provided that in no event shall Clarcor or its subsidiaries be required to pay or to commit to pay any cash or other consideration or make any agreements or commitments or incur any liability or other obligation in connection with such consent or
waiver). Clarcor and Parker have each agreed to promptly notify the other party of any notice or other communication from any governmental entity received by such party alleging that such governmental entitys consent is or may be required in
connection with or as a condition of the merger.
Clarcor and Parker have also agreed to use their reasonable best efforts to
(1) cooperate and coordinate in the taking of actions in connection with the consents, approvals, filing and other items advisable to consummate the merger, (2) provide such assistance as the other party may reasonably request in
connection with the consents, approvals, filing and other items advisable to consummate the merger, including supplying one another with any information that the other party may reasonably request in connection with such actions and (3) keep
the other party reasonably and timely informed of any developments, meetings or discussions with any governmental entity under any antitrust laws and any inquiries or requests for additional information from any governmental entity under any
antitrust laws. Both Clarcor and Parker have agreed that if either party receives a formal or informal request for additional information or documentary material from any governmental entity under any antitrust laws with respect to the merger, then
such party will use reasonable best efforts to make as promptly as reasonably practicable and after consultation with the other party, an appropriate response in compliance with such request. Both Clarcor and Parker have agreed, to the extent
practicable, not to participate in any substantive meeting or conference with any governmental entity in connection with any filing, proceeding, investigation, litigation, or other inquiry under any antitrust laws unless the other party is consulted
in advance and, where permitted by the governmental entity, the other party is allowed to participate. To the extent reasonably practicable, legal counsel for Parker and Clarcor shall have the right to review in advance, and will consult with the
other party on and consider in good faith the views of the other party in connection with, all of the information relating Parker or Clarcor, as the case may be, and any of their respective subsidiaries and representatives, that appears in any
filing made with, or written materials submitted to, any third party or governmental entity in connection with the consummation of the merger and the other transactions contemplated by the merger agreement. Parker has the principal responsibility to
devise and implement the strategy for obtaining antitrust related approvals and other antitrust related matters and to lead and direct all submissions to, meetings and communications with any governmental entity or other party in connection with
related antitrust matters, but must consult in advance with Clarcor (to the extent reasonably practicable) and in good faith take into account Clarcors views regarding the overall strategic direction before taking any material substantive
positions, making dispositive motions or other material substantive filings or submissions or entering in any negotiations concerning such approvals. Clarcor and Parker also agree not to voluntarily extend any waiting period associated with any
consent of any governmental entity or enter into any agreement with any governmental entity not to consummate the merger and the other transactions contemplated hereby, except with the prior written consent of the other party(ies).
Under the terms of the merger agreement, Clarcor and Parker have agreed to take, as promptly as practicable (and in any event prior to the
outside date), any and all steps necessary to avoid, eliminate or resolve each and
76
every impediment under any antitrust law that may be asserted by any governmental entity and obtain all clearances, consents and approvals and waivers under such antitrust laws, so as to enable
the parties to consummate the merger and the transactions contemplated by the merger agreement as soon as practicable (and in any event prior to the outside date, including proposing, negotiating, committing to and effecting, by consent decree, hold
separate orders, trust, or otherwise, (1) the sale, divestiture, license or other disposition of any of their respective subsidiaries, operations, divisions, businesses, product lines, customers or assets of Parker and/or Clarcor or any of
their respective subsidiaries, (2) any limitation or modification of any of their businesses, services, products or operations of Parker and/or Clarcor or any of their respective subsidiaries, (3) the termination, relinquishment,
modification, or waiver of their existing relationships, ventures, contractual rights, obligations or other arrangements of Parker and/or Clarcor or any of their respective subsidiaries and/or (4) the creation of any relationships, ventures,
contractual rights, obligations or other arrangements of Parker and/or Clarcor or any of their respective subsidiaries (each a remedial action).
However, under the terms of the merger agreement, neither Parker nor Clarcor or any of their subsidiaries are required to take any remedial
action that is not conditioned upon the consummation of the merger, and Parker is not required to take or commit to take any remedial action that would require the sale, divestiture, license or other disposition of any subsidiaries, operations,
divisions, businesses, product lines, customers or assets of Parker, Clarcor or any of their respective subsidiaries representing, in the aggregate, in excess of $200 million of net sales, measured, (1) with respect to Clarcor and its
subsidiaries, by reference to the net sales associated with any such subsidiary, operation, division, business, product line, customer or asset for the fiscal year ended November 28, 2015, and (2) with respect to Parker and its
subsidiaries, by reference to the net sales associated with any such subsidiary, operation, division, business, product line, customer or asset for the fiscal year ended June 30, 2016.
Additionally, without limiting Parkers obligations to eliminate every impediment under antitrust laws, Parker is obligated to take all
action (1) necessary to defend, including through pursuing litigation on the merits, any administrative or judicial action or proceeding asserted or threatened by any governmental entity or any other person under antitrust laws that seeks, or
would reasonably be expected to seek, to prevent, restrain, impede, delay, enjoin, or otherwise prohibit the consummation of the merger and the transactions contemplated by the merger agreement and (2) necessary in order to avoid entry of, or
to have vacated or terminated, any order entered, issued or threatened that would prevent, restrain, impede, delay, enjoin or otherwise prohibit the consummation of the merger and the transactions contemplated by the merger agreement, prior to the
outside date.
Furthermore, Clarcor and Parker have agreed not to, directly or indirectly, acquire, purchase, lease or license, by merging
with or into or consolidating with, or by purchasing a substantial portion of the assets of or equity in, any business or any corporation, partnership, association or other business organization or division or part thereof, or any securities or
collection of assets, if doing so would reasonably be expected to: (1) impose any material delay in the obtaining of, or materially increase the risk of not obtaining, any consent, action or nonaction, waiver, clearance or exemption of any
governmental entity necessary to consummate the merger and the transactions contemplated by the merger agreement or the expiration or termination of any applicable waiting period; (2) materially increase the risk of any governmental entity
entering an order preventing, restraining, impeding, delaying, enjoining or otherwise prohibiting the consummation of the merger and the other transactions contemplated by the merger agreement; (3) materially increase the risk of not being able
to remove any such order on appeal or otherwise or (4) prevent or materially delay the consummation of the merger and the transactions contemplated by the merger agreement.
Directors and Officers Indemnification and Insurance
From and after the effective time, Parker is required to cause the surviving corporation, to the fullest extent permitted by law, to indemnify,
defend and hold harmless (and promptly advance expenses from time to time as incurred to the fullest extent permitted by law) each person who is or has been prior to the effective time, a director or officer of Clarcor or any of its subsidiaries and
any person acting as director, officer, trustee,
77
fiduciary, employee or agent of another entity or enterprise (including a Clarcor benefit plan) who is or has acted as such at the request of Clarcor (each an indemnified party) from
and against any costs or expenses (including attorneys fees, expenses and disbursements), judgments, fines, losses, claims, damages, penalties, liabilities and amounts paid in settlement or incurred in connection with any actual or threatened
claim, action, audit, demand, suit, proceeding or investigation arising out of or relating to or in connection with any circumstances, developments or matters in existence, or acts or omissions occurring or alleged to occur prior to or at the
effective time, including by reason of such indemnified partys service as a director or officer of Clarcor or its subsidiaries or as such a director, officer, trustee, fiduciary, employee or agent of another person, whether asserted or claimed
prior to, at or after the effective time.
The certificate of incorporation and bylaws of the surviving corporation will include
provisions for indemnification, advancement and reimbursement of expenses and exculpation of the indemnified parties on the same basis set forth in Clarcors charter and bylaws in effect as of the date of the merger agreement. Following the
effective time, the surviving corporation shall, and Parker shall cause the surviving corporation to, maintain in effect the provisions in its certificate of incorporation and bylaws providing for indemnification, advancement and reimbursement of
expenses and exculpation of indemnified parties, as applicable, with respect to the facts or circumstances occurring at or prior to the effective time, to the fullest extent permitted under law. These provisions will not be amended except as
required by law or to make changes permitted by law that would enlarge the scope of the indemnified parties indemnification and advancement rights thereunder.
Additionally, the surviving corporation is to either (1) maintain in full force and effect for six years from the effective time, if
available, the current directors and officers liability insurance and fiduciary liability insurance maintained by Clarcor or (2) purchase a six year extended reporting period endorsement with respect to the current director and
officer liability insurance and fiduciary liability insurance and maintain the insurance in full force and effect for its full term. Parkers or the surviving corporations obligation to provide this insurance will be capped at 300% of the
annual premium amount Clarcor is currently paying for such insurance. If the annual premium amount for such coverage exceeds the cap, the surviving corporation must obtain a policy with the greatest coverage available for a cost not exceeding such
amount, or if the current policies are maintained, Parker or the surviving corporation must obtain as much coverage as possible under substantially similar policies for such maximum annual amount in aggregate annual premiums.
Coordination on Litigation
Clarcor will promptly notify Parker in writing of any stockholder litigation or other litigation or proceedings arising from the merger
agreement or the merger that is brought against Clarcor or any of its affiliates or members of its board of directors. Clarcor will keep Parker sufficiently informed on a reasonably current basis with respect to the status of any such litigation
(including by promptly furnishing to Parker such information relating to the litigation as may reasonably be requested). Clarcor will give Parker the opportunity to participate in (at Parkers sole cost and subject to a joint defense agreement)
the defense of any stockholder litigation or other litigation or proceedings against Clarcor or any of its affiliates or members of its board of directors relating to the merger agreement, the merger and/or the other transactions contemplated by the
merger agreement. Clarcor will not agree to any settlement with respect to such litigation or proceeding without the prior written consent of Parker (which consent cannot be unreasonably withheld, conditioned or delayed).
Other Covenants and Agreements
The merger agreement contains certain other covenants and agreements, including covenants relating to:
|
|
|
the preparation and filing of this proxy statement;
|
|
|
|
public announcements with respect to the transactions contemplated by the merger agreement;
|
|
|
|
ensuring that no state anti-takeover laws become applicable to the merger;
|
78
|
|
|
delisting and deregistration of the Clarcor common stock; and
|
|
|
|
reporting requirements under Section 16 of the Exchange Act.
|
Conditions to
Completion of the Merger
Under the merger agreement, each partys obligation to complete the merger is subject to the
satisfaction or, to the extent permitted by applicable law, waiver on or prior to the closing date of the merger, of the following conditions:
|
|
|
the adoption of the merger agreement by the affirmative vote of stockholders holding a majority of the outstanding shares of Clarcor common stock entitled to vote at the special meeting;
|
|
|
|
no governmental entity of competent jurisdiction having issued an order or having taken any other action restraining, enjoining or otherwise prohibiting the merger, in each case, that remains in effect as of the closing
date of the merger, and no applicable law prohibiting the consummation of the merger is in effect; and
|
|
|
|
the early termination or expiration of the waiting period under the HSR Act and the making or obtaining of required foreign antitrust approvals, filings and consents and the lapse or expiration of such required waiting
periods.
|
In addition, the obligations of Parker and Merger Sub to effect the merger are subject to the satisfaction or, to
the extent permitted by applicable law, waiver by Parker (in writing) on or prior to the closing date of the merger, of the following conditions:
|
|
|
the accuracy of the representations and warranties of Clarcor set forth in the merger agreement both at and as of December 1, 2016 and as of and as though made on the closing date (except for such representations
and warranties that are expressly made as of a specified date, which must be true and correct as of such specified date), but subject to a material adverse effect, materiality or other standard, as applicable, as provided in the merger
agreement;
|
|
|
|
Clarcor having performed or complied in all material respects with all obligations required to be performed by Clarcor under the merger agreement at or prior to the closing;
|
|
|
|
since the date of the merger agreement, the absence of any event, change, circumstance or effect that has had or is reasonably expected to have, individually or in the aggregate, a material adverse effect with respect
to Clarcor; and
|
|
|
|
Parkers receipt of a signed certificate from a senior executive officer of Clarcor confirming the satisfaction of the conditions described in the three preceding bullet points.
|
Clarcors obligations to effect the merger are subject to the satisfaction or, to the extent permitted by applicable law, waiver by
Clarcor (in writing), on or prior to the closing date of the merger, of the following additional conditions:
|
|
|
the accuracy of the representations and warranties of Parker and Merger Sub set forth in the merger agreement in all respects both at and as of December 1, 2016 and as of and as though made on the closing date
(except for any representations and warranties that are expressly stated to have been made as of a specified date, which must be true and correct as of such specific date), but subject to a material adverse effect, materiality or other
standard, as applicable, as provided in the merger agreement;
|
|
|
|
each of Parker and Merger Sub having performed or complied in all material respects with all obligations required to be performed by Parker or Merger Sub, as applicable, under the merger agreement at or prior to the
closing date; and
|
79
|
|
|
Clarcors receipt of a signed certificate from an executive officer of Parker confirming the satisfaction of the conditions described in the two preceding bullet points.
|
Termination of the Merger Agreement
The merger agreement may be terminated and the merger may be abandoned at any time prior to the completion of the merger in the following
circumstances:
|
|
|
by mutual written consent of Clarcor and Parker;
|
|
|
|
by either Clarcor or Parker if:
|
|
|
|
the merger has not been completed on or before December 1, 2017; provided, that if all of the conditions to closing, other than those pertaining to an injunction under antitrust laws, waiting periods under the HSR
Act or receipt of specified notices, approvals or clearances, have been satisfied or waived at such time, the outside date may be extended upon written notice by either Clarcor or Parker to March 1, 2018, subject to certain limitations as set
forth in the merger agreement (December 1, 2017 or, if so extended, March 1, 2018, being the outside date);
|
|
|
|
a governmental entity of competent jurisdiction has issued an order or taken any other action permanently restraining, enjoining or otherwise prohibiting the consummation of the merger, and such order or other action
has become final and nonappealable, except that a party will not have the right to terminate if such party has failed to comply with its obligations to use reasonable best efforts to take all actions necessary to complete the merger under the merger
agreement; or
|
|
|
|
if the requisite stockholder vote has not been obtained when voted upon at the special meeting or at any adjournment or postponement of the special meeting; or
|
|
|
|
Clarcor has breached or failed to perform any of its representations, warranties, covenants or other agreements contained in the merger agreement (with certain exceptions), which (1) would result in a failure of
any condition to the obligations of Parker and Merger Sub to effect the merger and (2) is either not curable by the outside date or is not cured within 30 days following written notice of such breach from Parker or Merger Sub to Clarcor stating
Parkers intention to terminate the merger agreement;
|
|
|
|
prior to obtaining the requisite stockholder vote, the Clarcor board of directors or any committee thereof has effected a recommendation withdrawal, failed to include the recommendation of the Clarcor board of directors
in this proxy statement or failed to reaffirm the recommendation of the Clarcor board of directors within five business days of receipt of any written request to do so from Parker following the public announcement of an acquisition proposal; or
|
|
|
|
prior to obtaining the requisite stockholder vote, Clarcor is in willful and material breach of its obligations under the non-solicitation provisions of the merger agreement or specified provisions of the merger
agreement related to preparing this proxy statement and obtaining the requisite stockholder vote; or
|
|
|
|
Parker or Merger Sub has breached or failed to perform any of its representations, warranties, covenants or agreements contained in the merger agreement (with certain exceptions), which (1) would result in a
failure of a condition to the obligations of Clarcor to effect the merger and (2) is either not curable by the outside date or is not cured within 30 days following written notice of such breach from Clarcor to Parker stating Clarcors
intention to terminate the merger agreement; or
|
80
|
|
|
Prior to obtaining the requisite stockholder vote, Clarcor terminates to enter into a definitive agreement relating to a superior proposal and prior to or concurrently with such termination pays Parker a termination fee
of $113 million.
|
Termination Fee; Effect of Termination
Under the merger agreement, Clarcor will be required to pay Parker a termination fee equal to $113 million (the termination fee)
if:
|
|
|
the merger agreement is terminated by Clarcor in accordance with its right to terminate the merger agreement to enter into a definitive agreement relating to a superior proposal;
|
|
|
|
the merger agreement is terminated by Parker because, prior to obtaining the requisite stockholder vote, (1) the Clarcor board of directors has effected a recommendation withdrawal, failed to include the
recommendation of the Clarcor board of directors to adopt the merger agreement in this proxy statement or failed to reaffirm the recommendation of the Clarcor board of directors to adopt the merger agreement within five business days of receipt of
any written request to do so from Parker following the public announcement of an acquisition proposal or (2) Clarcor has willfully and materially breached any of its obligations under the non-solicitation provisions of the merger agreement or
specified provisions of the merger agreement related to preparing this proxy statement and obtaining the requisite stockholder vote; or
|
|
|
|
the merger agreement is terminated by Parker or Clarcor because:
|
|
|
|
(i) the merger has not been completed by the outside date or (ii) Clarcor breached or failed to perform any of its representations, warranties, covenants or agreements, leading to a termination right, and an
acquisition proposal was publicly proposed or announced by any person after December 1, 2016 and prior to such termination;
|
|
|
|
the requisite stockholder vote was not obtained and an acquisition proposal was publicly proposed or announced by any person after December 1, 2016 and prior to such termination; and
|
|
|
|
(A) Clarcor enters into a definitive agreement with respect to any acquisition proposal within 12 months after such termination of the merger agreement or (B) Clarcor consummates any acquisition proposal
within 12 months after the termination of the merger agreement.
|
Under the merger agreement, for purposes of the immediately
preceding three bullet points, each reference to 20% in the definition of acquisition proposal will be deemed to be a reference to 50%.
If the merger agreement is validly terminated, the obligations of the parties will terminate and there will be no liability on the part of any
party with respect thereto, except for the confidentiality provisions, the general provisions and certain provisions relating to expenses, the effect of termination and the termination fee, and the absence of a financing condition and any additional
representations and warranties, each of which will survive the termination of merger agreement; provided, however, that no party to the merger agreement will be relieved from liability to the other party for damages arising out of any willful and
material breach of the merger agreement. In addition, the merger agreement provides that any failure by a party to consummate the merger and the other transactions contemplated by the merger agreement (regardless of whether, in the case of Parker,
Parker has obtained or received any proceeds of any financing) when required under the merger agreement shall constitute a willful and material breach of the merger agreement.
For purposes of the merger agreement, a willful and material breach means a material breach that is a consequence of an act
undertaken or a failure to take an act by the breaching party with knowledge that the taking of such act or the failure to take such act would, or would reasonably be expected to, result in a material breach of the merger agreement.
81
Expenses
Whether or not the merger is consummated, all expenses incurred in connection with the merger agreement and the transactions contemplated
thereby will be paid by the party incurring such expenses, with certain exceptions set forth in the merger agreement, including that Parker will reimburse Clarcor for all reasonable and documented out-of-pocket expenses related to Clarcors
cooperation in connection with Parkers financing of the merger.
Jurisdiction; Specific Performance
Under the merger agreement, each of the parties has agreed that irreparable harm would occur for which monetary damages would not be an
adequate remedy in the event that any of the provisions of the merger agreement are not performed in accordance with their specific terms or are otherwise breached. Accordingly, the parties have agreed that in the event of any breach or threatened
breach by any other party of any covenant or obligation in the merger agreement, the non-breaching party shall be entitled to (in addition to any other remedy available, including monetary damages) an injunction restraining such breach or threatened
breach of the merger agreement and an order of specific performance to enforce the observance and performance of such covenant or obligation (including the obligation of the parties to consummate the transaction contemplated by the merger agreement
and the obligation of Parker and Merger Sub to pay, and Clarcors equity holders rights to receive, the aggregate consideration payable to them in accordance with the terms and conditions set forth in the merger agreement) without proof
of actual damages, and each of the parties has further agreed to waive any requirement for the securing or posting of any bond in connection with such remedy. Pursuant to the merger agreement, each of the parties has agreed not to raise any
objections (including any defense or counterclaim that there is an adequate remedy in law) to the availability of the equitable remedy of specific performance to prevent or restrain breaches or threatened breaches of, or to enforce compliance with,
the covenants and obligations of such party under the merger agreement.
Each of the parties (i) irrevocably submitted itself to the
personal jurisdiction of each state or federal court sitting in the State of Delaware, as well as to the jurisdiction of all courts to which an appeal may be taken from such courts, in any suit, action or proceeding arising out of, relating to or
contemplated by the merger agreement (including any proceeding seeking equitable relief under the merger agreement) (ii) agreed that every such suit, action or proceeding will be brought, heard and determined exclusively in the Court of
Chancery of the State of Delaware (or, only if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any state or federal court within the State of Delaware), (iii) agreed that it will not attempt to deny or
defeat such personal jurisdiction by motion or other request for leave from such court, (iv) agreed not to bring any suit, action or proceeding arising out of, relating to or contemplated by the merger agreement in any other court and
(v) waived any defense of inconvenient forum to the maintenance of any suit, action or proceeding so brought. Each party irrevocably consented to the service of process outside the territorial jurisdiction of the courts referenced in the
preceding sentence in any such action or proceeding by mailing copies thereof by registered or certified United States mail, postage prepaid, return receipt requested, to its address as specified in the merger agreement. However, the foregoing will
not limit the right of a party to effect service of process on the other party by any other legally available method. Parker, Merger Sub and Clarcor agreed that a final judgment in any action or proceeding in such court as provided above shall be
conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.
Notwithstanding
anything to the contrary in the merger agreement, Clarcor (i) agreed that it will not, and will not permit its affiliates to, bring or support any proceeding, cause of action, claim, crossclaim or third-party claim of any kind or description,
whether in law or in equity and whether in contract or in tort or otherwise, against Parkers financing sources in any way related to the merger agreement or any of the transactions contemplated by the merger agreement (including any dispute
arising out of or relating to the financing or the performance thereof) in any forum other than the United States District Court for the Southern District of New York or the Supreme Court of the State of New York, New York County, located in the
Borough of Manhattan
82
or, in either case, any appellate court thereof, (ii) agreed that any such proceeding will be governed by the laws of the State of New York, (iii) agreed to irrevocably and
unconditionally waive any right to a trial by jury in any such proceeding and (iv) agreed to waive, to the fullest extent permitted by law, any objection which such party has or may have to the laying of venue of, and the defense of an
inconvenient forum to the maintenance of any such proceeding in any such court.
Amendments; Waivers
The merger agreement may be amended by the parties (with respect to Clarcor and Merger Sub by action taken by their respective boards of
directors), at any time before or after adoption of the merger agreement by the Clarcor stockholders, but, after any such adoption, no amendment will be made which by law would require the further approval of Clarcor stockholders without first
obtaining such approval. The merger agreement may be modified or amended solely by written agreement executed and delivered by duly authorized officers of the respective parties. Notwithstanding the foregoing, the financing source designated
provisions in the merger agreement may not be amended in a manner adverse to any financing sources without the written consent of such financing source.
The conditions to each of the parties obligations to consummate the merger are for the sole benefit of such party and may be waived by
such party in whole or in part to the extent permitted by law. At any time prior to the effective time, Clarcor, Parker or Merger Sub may (in the case of Clarcor, by action taken or authorized by the Clarcor board of directors or authorized officers
of Clarcor), to the extent permitted by law, (a) extend the time for the performance of any of the obligations or other acts of the other parties, (b) waive any inaccuracies in the representations and warranties contained herein or in any
document delivered pursuant hereto and (c) waive compliance with any of the agreements or conditions contained herein. Any agreement on the part of a party to any such extension or waiver shall be valid only if set forth in a written instrument
signed on behalf of such party. The failure of Clarcor, Parker or Merger Sub to assert any of its rights under the merger agreement or otherwise will not constitute a waiver of such rights, nor shall any single or partial exercise by Clarcor, Parker
or Merger Sub of any of its rights under the merger agreement preclude any other or further exercise of such rights or any other rights under the merger agreement.
83
THIS PROXY STATEMENT DOES NOT CONSTITUTE THE SOLICITATION OF A PROXY IN ANY JURISDICTION TO OR
FROM ANY PERSON TO WHOM OR FROM WHOM IT IS UNLAWFUL TO MAKE SUCH PROXY SOLICITATION IN THAT JURISDICTION. YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED OR INCORPORATED BY REFERENCE IN THIS PROXY STATEMENT TO VOTE YOUR SHARES AT THE SPECIAL
MEETING. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT FROM WHAT IS CONTAINED IN THIS PROXY STATEMENT. THIS PROXY STATEMENT IS DATED [ ], 2017.
YOU SHOULD NOT ASSUME THAT THE INFORMATION CONTAINED IN THIS PROXY STATEMENT IS ACCURATE AS OF ANY DATE OTHER THAN THAT DATE, AND THE MAILING OF THIS PROXY STATEMENT TO STOCKHOLDERS DOES NOT CREATE ANY IMPLICATION TO THE CONTRARY.
97
Annex A
AGREEMENT AND PLAN OF MERGER
DATED AS OF DECEMBER 1, 2016
BY AND AMONG
PARKER-HANNIFIN CORPORATION,
PARKER EAGLE CORPORATION
AND
CLARCOR INC.
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE I
|
|
|
THE MERGER; CERTAIN RELATED MATTERS
|
|
|
|
|
Section 1.1
|
|
The Merger
|
|
|
A-8
|
|
Section 1.2
|
|
Closing
|
|
|
A-9
|
|
Section 1.3
|
|
Effective Time
|
|
|
A-9
|
|
Section 1.4
|
|
Certificate of Incorporation
|
|
|
A-9
|
|
Section 1.5
|
|
Bylaws
|
|
|
A-9
|
|
Section 1.6
|
|
Board of Directors
|
|
|
A-9
|
|
Section 1.7
|
|
Officers
|
|
|
A-9
|
|
|
ARTICLE II
|
|
|
CONVERSION OF SECURITIES; EXCHANGE OF CERTIFICATES
|
|
|
|
|
Section 2.1
|
|
Effect on Capital Stock
|
|
|
A-9
|
|
Section 2.2
|
|
Certain Adjustments
|
|
|
A-10
|
|
Section 2.3
|
|
Dissenting Shares
|
|
|
A-10
|
|
Section 2.4
|
|
Exchange of Company Common Stock
|
|
|
A-10
|
|
Section 2.5
|
|
Treatment of Company Stock Plans
|
|
|
A-13
|
|
Section 2.6
|
|
Treatment of Employee Stock Purchase Plan
|
|
|
A-14
|
|
|
ARTICLE III
|
|
|
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
|
|
|
|
|
Section 3.1
|
|
Corporate Organization
|
|
|
A-14
|
|
Section 3.2
|
|
Capitalization
|
|
|
A-15
|
|
Section 3.3
|
|
Corporate Authorization
|
|
|
A-16
|
|
Section 3.4
|
|
No Conflicts
|
|
|
A-17
|
|
Section 3.5
|
|
Governmental Approvals
|
|
|
A-17
|
|
Section 3.6
|
|
Company SEC Filings; Financial Statements; Controls
|
|
|
A-17
|
|
Section 3.7
|
|
No Undisclosed Liabilities
|
|
|
A-18
|
|
Section 3.8
|
|
Absence of Certain Changes or Events
|
|
|
A-19
|
|
Section 3.9
|
|
Compliance with Laws; Permits
|
|
|
A-19
|
|
Section 3.10
|
|
Litigation
|
|
|
A-20
|
|
Section 3.11
|
|
Taxes
|
|
|
A-20
|
|
Section 3.12
|
|
Employee Benefit Plans and Related Matters; ERISA
|
|
|
A-21
|
|
Section 3.13
|
|
Material Contracts
|
|
|
A-23
|
|
Section 3.14
|
|
Intellectual Property
|
|
|
A-25
|
|
Section 3.15
|
|
Properties
|
|
|
A-26
|
|
Section 3.16
|
|
Environmental Matters
|
|
|
A-26
|
|
Section 3.17
|
|
Insurance
|
|
|
A-26
|
|
Section 3.18
|
|
Labor and Employment Matters
|
|
|
A-27
|
|
Section 3.19
|
|
Affiliate Transactions
|
|
|
A-27
|
|
Section 3.20
|
|
Customers and Suppliers
|
|
|
A-27
|
|
Section 3.21
|
|
Product Liability
|
|
|
A-27
|
|
Section 3.22
|
|
Takeover Statutes
|
|
|
A-28
|
|
Section 3.23
|
|
Brokers and Finders Fees
|
|
|
A-28
|
|
Section 3.24
|
|
Opinion of Financial Advisor
|
|
|
A-28
|
|
Section 3.25
|
|
No Other Representations and Warranties; Disclaimers
|
|
|
A-28
|
|
A-2
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE IV
|
|
|
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
|
|
|
|
|
Section 4.1
|
|
Corporate Organization
|
|
|
A-29
|
|
Section 4.2
|
|
Corporate Authorization
|
|
|
A-29
|
|
Section 4.3
|
|
No Conflicts
|
|
|
A-29
|
|
Section 4.4
|
|
Governmental Approvals
|
|
|
A-30
|
|
Section 4.5
|
|
Litigation
|
|
|
A-30
|
|
Section 4.6
|
|
Operations of Merger Sub
|
|
|
A-30
|
|
Section 4.7
|
|
No Vote of Parent Stockholders
|
|
|
A-30
|
|
Section 4.8
|
|
Brokers and Finders Fees
|
|
|
A-30
|
|
Section 4.9
|
|
Available Funds
|
|
|
A-30
|
|
Section 4.10
|
|
No Ownership of Company Common Stock
|
|
|
A-31
|
|
Section 4.11
|
|
No Other Representations and Warranties; Disclaimers
|
|
|
A-31
|
|
|
ARTICLE V
|
|
|
CONDUCT OF BUSINESS
|
|
|
|
|
Section 5.1
|
|
Conduct of Business by the Company
|
|
|
A-32
|
|
Section 5.2
|
|
No Control of the Companys Business
|
|
|
A-35
|
|
Section 5.3
|
|
PBGC
|
|
|
A-35
|
|
Section 5.4
|
|
Process
|
|
|
A-35
|
|
|
ARTICLE VI
|
|
|
ADDITIONAL AGREEMENTS
|
|
|
|
|
Section 6.1
|
|
Preparation of the Proxy Statement
|
|
|
A-35
|
|
Section 6.2
|
|
Stockholders Meeting; Company Board Recommendation
|
|
|
A-36
|
|
Section 6.3
|
|
No Solicitation
|
|
|
A-37
|
|
Section 6.4
|
|
Access to Information
|
|
|
A-40
|
|
Section 6.5
|
|
Consents, Approvals and Filings
|
|
|
A-40
|
|
Section 6.6
|
|
Employee Matters
|
|
|
A-43
|
|
Section 6.7
|
|
Expenses
|
|
|
A-44
|
|
Section 6.8
|
|
Directors and Officers Indemnification and Insurance
|
|
|
A-44
|
|
Section 6.9
|
|
Public Announcements
|
|
|
A-46
|
|
Section 6.10
|
|
Transaction Litigation
|
|
|
A-46
|
|
Section 6.11
|
|
State Takeover Laws
|
|
|
A-47
|
|
Section 6.12
|
|
Delisting
|
|
|
A-47
|
|
Section 6.13
|
|
Section 16(b)
|
|
|
A-47
|
|
Section 6.14
|
|
Financing
|
|
|
A-47
|
|
Section 6.15
|
|
Financing Cooperation
|
|
|
A-49
|
|
Section 6.16
|
|
Adoption by Merger Sub
|
|
|
A-50
|
|
A-3
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE VII
|
|
|
CONDITIONS
|
|
|
|
|
Section 7.1
|
|
Conditions to Each Partys Obligation to Effect the Merger
|
|
|
A-51
|
|
Section 7.2
|
|
Conditions to Obligations of Parent and Merger Sub
|
|
|
A-51
|
|
Section 7.3
|
|
Conditions to Obligations of the Company
|
|
|
A-52
|
|
Section 7.4
|
|
Frustration of Closing Conditions
|
|
|
A-52
|
|
|
ARTICLE VIII
|
|
|
TERMINATION
|
|
|
|
|
Section 8.1
|
|
Termination
|
|
|
A-52
|
|
Section 8.2
|
|
Effect of Termination
|
|
|
A-53
|
|
Section 8.3
|
|
Termination Fee
|
|
|
A-54
|
|
Section 8.4
|
|
Procedure for Termination
|
|
|
A-55
|
|
|
ARTICLE IX
|
|
|
GENERAL PROVISIONS
|
|
|
|
|
Section 9.1
|
|
Non-Survival of Representations, Warranties, Covenants and Agreements
|
|
|
A-55
|
|
Section 9.2
|
|
Notices
|
|
|
A-55
|
|
Section 9.3
|
|
Interpretation; Construction
|
|
|
A-56
|
|
Section 9.4
|
|
Counterparts; Effectiveness
|
|
|
A-57
|
|
Section 9.5
|
|
Entire Agreement; No Third-Party Beneficiaries
|
|
|
A-57
|
|
Section 9.6
|
|
Severability
|
|
|
A-58
|
|
Section 9.7
|
|
Assignment
|
|
|
A-58
|
|
Section 9.8
|
|
Modification or Amendment
|
|
|
A-58
|
|
Section 9.9
|
|
Extension; Waiver
|
|
|
A-58
|
|
Section 9.10
|
|
Governing Law and Venue; Waiver of Jury Trial; Specific Performance
|
|
|
A-58
|
|
Section 9.11
|
|
Obligation of Parent and of the Company
|
|
|
A-60
|
|
Section 9.12
|
|
No Recourse
|
|
|
A-60
|
|
Section 9.13
|
|
Liability of Financing Sources
|
|
|
A-60
|
|
Section 9.14
|
|
Definitions
|
|
|
A-60
|
|
A-4
Index of Defined Terms
|
|
|
Acceptable Confidentiality Agreement
|
|
Section 9.14
|
Acquisition Proposal
|
|
Section 6.3(g)
|
Affiliate
|
|
Section 9.14
|
Agreement
|
|
Preamble
|
Amended and Restated Credit Agreement
|
|
Section 9.14
|
Antitrust Laws
|
|
Section 9.14
|
Appraisal Shares
|
|
Section 2.3
|
Bankruptcy and Equity Exception
|
|
Section 3.3(c)
|
Benefits Continuation Period
|
|
Section 6.6(a)
|
Book-Entry Shares
|
|
Section 2.1(b)
|
Business Day
|
|
Section 9.14
|
Certificate
|
|
Section 2.1(b)
|
Certificate of Merger
|
|
Section 1.3
|
Closing
|
|
Section 1.2
|
Closing Date
|
|
Section 1.2
|
Code
|
|
Section 2.4(h)
|
Commitment Letter
|
|
Section 4.9
|
Company
|
|
Preamble
|
Company Benefit Plans
|
|
Section 3.12(a)
|
Company Board Recommendation
|
|
Section 3.3(b)
|
Company Bylaws
|
|
Section 3.1(c)
|
Company Charter
|
|
Section 3.1(c)
|
Company Common Stock
|
|
Section 2.1
|
Company Disclosure Letter
|
|
Article III
|
Company Material Adverse Effect
|
|
Section 9.14
|
Company Material Contract
|
|
Section 3.13(a)
|
Company Option
|
|
Section 2.5(a)
|
Company Preferred Stock
|
|
Section 3.2(a)
|
Company PSU Award
|
|
Section 2.5(b)
|
Company RSU Award
|
|
Section 2.5(b)
|
Company SEC Documents
|
|
Section 3.6(a)
|
Company SEC Financial Statements
|
|
Section 3.6(c)
|
Company Stock Plans
|
|
Section 9.14
|
Company Stockholder Approval
|
|
Section 3.3(a)
|
Company Stockholders Meeting
|
|
Section 6.2
|
Confidentiality Agreement
|
|
Section 9.14
|
Consents
|
|
Section 3.5
|
Continuing Employees
|
|
Section 6.6(a)
|
Contract
|
|
Section 9.14
|
Credit Agreement Obligor
|
|
Section 5.1(b)(ii)
|
Current Insurance
|
|
Section 6.8(b)
|
CVA
|
|
Section 6.6(a)
|
DGCL
|
|
Section 1.1(a)
|
Domestic Subsidiary
|
|
Section 9.14
|
Effective Time
|
|
Section 1.3
|
Environmental Laws
|
|
Section 9.14
|
ERISA
|
|
Section 3.12(a)
|
ERISA Affiliate
|
|
Section 3.12(c)
|
ESPP
|
|
Section 2.6
|
Exchange Act
|
|
Section 3.5
|
A-5
|
|
|
Exchange Fund
|
|
Section 2.4(a)
|
Filings
|
|
Section 3.5
|
Financing
|
|
Section 4.9
|
Financing Agreements
|
|
Section 6.14(a)
|
Financing Conditions
|
|
Section 4.9
|
Financing Source Designated Provisions
|
|
Section 9.5(b)
|
Financing Sources
|
|
Section 9.14
|
Foreign Subsidiary
|
|
Section 9.14
|
GAAP
|
|
Section 9.14
|
Governmental Entity
|
|
Section 3.5
|
Hazardous Substances
|
|
Section 9.14
|
HSR Act
|
|
Section 3.5
|
Indemnified Party
|
|
Section 6.8(a)
|
Initial Outside Date
|
|
Section 8.1(b)(i)
|
Insurance Policies
|
|
Section 3.17
|
Intellectual Property
|
|
Section 9.14
|
Interim RSU Award
|
|
Section 2.5(b)
|
International Trade Laws
|
|
Section 9.14
|
Intervening Event
|
|
Section 6.3(g)
|
IRS
|
|
Section 3.12(a)
|
Knowledge
|
|
Section 9.14
|
Law
|
|
Section 9.14
|
Lease
|
|
Section 3.15(b)
|
Leased Real Property
|
|
Section 9.14
|
Lien
|
|
Section 9.14
|
Merger
|
|
Recitals
|
Merger Amounts
|
|
Section 4.9
|
Merger Consideration
|
|
Section 2.1(b)
|
Merger Sub
|
|
Preamble
|
Merger Sub Bylaws
|
|
Section 4.1(b)
|
Merger Sub Charter
|
|
Section 4.1(b)
|
Merger Sub Stockholder Approval
|
|
Section 4.2(a)
|
Non-U.S. Company Benefit Plans
|
|
Section 3.12(a)
|
NYSE
|
|
Section 3.5
|
OFAC
|
|
Section 9.14
|
Option Payment
|
|
Section 2.5(a)
|
Order
|
|
Section 9.14
|
Other Antitrust Approvals
|
|
Section 6.5(a)
|
Outside Date
|
|
Section 8.1(b)(i)
|
Owned Intellectual Property
|
|
Section 9.14
|
Owned Real Property
|
|
Section 9.14
|
Parent
|
|
Preamble
|
Parent Bylaws
|
|
Section 4.1(b)
|
Parent Charter
|
|
Section 4.1(b)
|
Parent Disclosure Letter
|
|
Article IV
|
Parent Material Adverse Effect
|
|
Section 9.14
|
party
|
|
Preamble
|
Paying Agent
|
|
Section 2.4(a)
|
PBGC
|
|
Section 5.3
|
Pension Plan
|
|
Section 3.12(c)
|
Permits
|
|
Section 3.9(d)
|
Permitted Individuals
|
|
Section 6.5(e)
|
A-6
|
|
|
Permitted Lien
|
|
Section 9.14
|
Person
|
|
Section 9.14
|
Proceeding
|
|
Section 9.14
|
Proxy Statement
|
|
Section 3.5
|
Recommendation Withdrawal
|
|
Section 6.3(c)
|
Remedial Action
|
|
Section 6.5(c)
|
Replacement Financing
|
|
Section 4.9
|
Reporting Tail Endorsement
|
|
Section 6.8(b)
|
Representatives
|
|
Section 6.3(a)
|
Required Financial Information
|
|
Section 6.15(a)
|
Requisite Regulatory Approvals
|
|
Section 7.1(c)
|
Restricted Information
|
|
Section 6.4
|
RSU/PSU Payment
|
|
Section 2.5(b)
|
Sarbanes-Oxley Act
|
|
Section 3.6(a)
|
SEC
|
|
Article III
|
Section 262
|
|
Section 2.3
|
Securities Act
|
|
Section 9.14
|
Subsidiary
|
|
Section 9.14
|
Substitute Financing
|
|
Section 6.14(e)
|
Superior Proposal
|
|
Section 6.3(g)
|
Surviving Corporation
|
|
Section 1.1(a)
|
Takeover Statute
|
|
Section 3.22
|
Tax
|
|
Section 9.14
|
Tax Return
|
|
Section 9.14
|
Taxes
|
|
Section 9.14
|
Taxing Authority
|
|
Section 9.14
|
Terminated Plan
|
|
Section 6.6(c)
|
Termination Fee
|
|
Section 8.3(a)
|
Top Customer
|
|
Section 9.14
|
Top Supplier
|
|
Section 9.14
|
Trade Secrets
|
|
Section 9.14
|
Trademarks
|
|
Section 9.14
|
Transaction Litigation
|
|
Section 6.10
|
Triggering Divestiture
|
|
Section 9.14
|
U.S. Company Benefit Plans
|
|
Section 3.12(a)
|
Willful and Material Breach
|
|
Section 9.14
|
A-7
AGREEMENT AND PLAN OF MERGER
This AGREEMENT AND PLAN OF MERGER, dated as of December 1, 2016 (this
Agreement
), is by and among PARKER-HANNIFIN
CORPORATION, an Ohio corporation (
Parent
), PARKER EAGLE CORPORATION, a newly formed Delaware corporation and a wholly owned Subsidiary of Parent (
Merger Sub
), and CLARCOR INC., a Delaware corporation (the
Company
). The Company, Parent and Merger Sub may be referred to herein as a
party
and collectively as the
parties
.
RECITALS
WHEREAS,
subject to the terms and conditions of this Agreement and in accordance with the DGCL, the parties intend that Merger Sub be merged with and into the Company, with the Company surviving the Merger as a wholly owned Subsidiary of Parent (the
Merger
);
WHEREAS, the Board of Directors of the Company has unanimously (i) declared it advisable and in the best
interests of the Company and its stockholders to enter into this Agreement, (ii) approved the execution, delivery and performance of this Agreement by the Company and the consummation of the Merger and the other transactions contemplated hereby
and (iii) resolved, subject to the terms and conditions set forth in this Agreement, to recommend adoption of this Agreement by the stockholders of the Company;
WHEREAS, the Board of Directors of Parent has approved this Agreement, the Merger and the other transactions contemplated hereby and approved
the execution, delivery and performance of this Agreement by Parent, and the consummation of the Merger and the other transactions contemplated hereby;
WHEREAS, the Board of Directors of Merger Sub (i) has declared it advisable and in the best interests of Merger Sub and its stockholders to
enter into this Agreement and (ii) has approved the execution, delivery and performance of this Agreement by Merger Sub, and the consummation of the Merger and the other transactions contemplated hereby; and
WHEREAS, Parent, Merger Sub and the Company desire to make certain representations, warranties, covenants and agreements specified herein in
connection with the Merger and the other transactions contemplated hereby and to prescribe certain conditions to the Merger.
NOW,
THEREFORE, in consideration of the foregoing and the representations, warranties, covenants and agreements set forth in this Agreement, and intending to be legally bound hereby, the parties agree as follows:
ARTICLE I
THE MERGER; CERTAIN
RELATED MATTERS
Section 1.1
The Merger
.
(a) Upon the terms and subject to the conditions set forth in this Agreement and in accordance with the General Corporation Law of the
State of Delaware (the
DGCL
), at the Effective Time, Merger Sub shall be merged with and into the Company, whereupon the separate existence of Merger Sub shall cease and the Company shall continue its existence under Delaware law
as the surviving corporation in the Merger (the
Surviving Corporation
) and a wholly owned Subsidiary of Parent.
(b) The Merger shall have the effects set forth in this Agreement and the applicable provisions of the DGCL. Without limiting the
generality of the foregoing and subject thereto, at the Effective Time, all the property, rights, privileges, immunities, powers and franchises of the Company and Merger Sub shall vest in the Surviving
A-8
Corporation and all debts, liabilities and duties of the Company and Merger Sub shall become the debts, liabilities and duties of the Surviving Corporation, all as provided under the DGCL and
other applicable Law.
Section 1.2
Closing
. The closing of the Merger (the
Closing
) shall take place at
10:00 a.m., local time, on the third Business Day after the satisfaction or, to the extent permitted by applicable Law, waiver of the conditions set forth in Article VII (other than those conditions that, by their nature or terms, are to be
satisfied at Closing, but subject to the satisfaction or, to the extent permitted by applicable Law, waiver of such conditions), at the offices of Bass, Berry & Sims, 150 Third Avenue South, Suite 2800, Nashville, TN, unless another time, date
or place is agreed to in writing by the parties. The date on which the Closing actually occurs is hereinafter referred to as the
Closing Date
.
Section 1.3
Effective Time
. Immediately following the Closing on the Closing Date, the parties shall cause a certificate of merger
relating to the Merger (the
Certificate of Merger
) to be filed with the Secretary of State of the State of Delaware, in such form as required by, and executed and acknowledged in accordance with, the applicable provisions of the
DGCL. The Merger shall become effective at the time when the Certificate of Merger has been duly filed with the Secretary of State of the State of Delaware or at such later time as the parties shall agree and specify in the Certificate of Merger in
accordance with the relevant provisions of the DGCL (such time is hereinafter referred to as the
Effective Time
).
Section 1.4
Certificate of Incorporation
. At the Effective Time, the certificate of incorporation of the Surviving Corporation
shall be amended in its entirety to read as set forth on Exhibit A hereto, until thereafter changed or amended as provided by the DGCL or therein, subject to Section 6.8(c).
Section 1.5
Bylaws
. Subject to Section 6.8(c), at the Effective Time, the bylaws of the Company as in effect immediately prior to
the Effective Time shall be the bylaws of the Surviving Corporation, until thereafter changed or amended as provided by the DGCL, the certificate of incorporation of the Surviving Corporation and such bylaws.
Section 1.6
Board of Directors
. The parties shall take, or cause to be taken, all actions reasonably necessary so that the
directors of Merger Sub immediately prior to the Effective Time shall be the initial directors of the Surviving Corporation from and after the Effective Time, until the earlier of their death, resignation or removal or until their respective
successors are duly elected and qualified.
Section 1.7
Officers
. Except as otherwise determined by Parent prior to the
Effective Time, the officers of the Company immediately prior to the Effective Time shall be the initial officers of the Surviving Corporation from and after the Effective Time, until the earlier of their death, resignation or removal or until their
respective successors are duly appointed and qualified.
ARTICLE II
CONVERSION OF SECURITIES; EXCHANGE OF CERTIFICATES
Section 2.1
Effect on Capital Stock
. At the Effective Time, by virtue of the Merger and without any action on the part of the
Company, Parent, Merger Sub or any holder of any shares of common stock, $1.00 par value per share, of the Company (the
Company Common Stock
):
(a) All shares of Company Common Stock that are held by the Company as treasury stock or that are owned by the Company or any wholly owned
Subsidiary of the Company, Parent, Merger Sub or any wholly owned Subsidiary of the Company or Parent immediately prior to the Effective Time, by virtue of the Merger and without any action on the part of the holder thereof, shall cease to be
outstanding and shall be cancelled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor.
A-9
(b) Subject to Section 2.1(a), Section 2.2 and Section 2.3, each share of Company Common
Stock issued and outstanding immediately prior to the Effective Time (including any shares of Company Common Stock held in a Company Benefit Plan or related trust) shall be converted into and shall thereafter represent the right to receive an amount
in cash equal to $83.00, without interest (the
Merger Consideration
). As of the Effective Time, all such shares of Company Common Stock shall cease to be outstanding, shall be automatically cancelled and shall cease to exist, and
each holder of a certificate representing any such shares of Company Common Stock (a
Certificate
) or shares of Company Common Stock held in book-entry form (
Book-Entry Shares
) shall cease to have any rights with
respect thereto, except the right to receive, in accordance with this Section 2.1(b), the Merger Consideration, upon surrender of such Certificate or cancellation of such Book-Entry Shares, without interest.
(c) Each share of common stock of Merger Sub issued and outstanding immediately prior to the Effective Time, without any action on the
part of the holder thereof, shall be converted into one share of common stock of the Surviving Corporation.
Section 2.2
Certain
Adjustments
. Notwithstanding anything in this Agreement to the contrary, if, from the date of this Agreement until the Effective Time, the outstanding shares of Company Common Stock shall have been changed into a different number of shares or a
different class by reason of any reclassification, stock split (including a reverse stock split), recapitalization, split-up, combination, subdivision, exchange of shares, readjustment, or other similar transaction, or a stock dividend or stock
distribution thereon shall be declared with a record date within said period, the Merger Consideration and any other similarly dependent items, as the case may be, shall be equitably adjusted to provide the holders of Company Common Stock the same
economic effect as contemplated by this Agreement prior to such event.
Section 2.3
Dissenting Shares
. Notwithstanding
anything in this Agreement to the contrary, shares (
Appraisal Shares
) of Company Common Stock that are issued and outstanding immediately prior to the Effective Time and that are held by any Person who is entitled to demand and
properly demands appraisal of such Appraisal Shares pursuant to, and who complies in all respects with, Section 262 of the DGCL (
Section 262
) shall not be converted into the right to receive the Merger Consideration as provided in
Section 2.1(b), but rather the holders of Appraisal Shares shall be entitled to payment by the Surviving Corporation of the fair value of such Appraisal Shares in accordance with and to the extent provided in Section 262;
provided
,
however
, that if any such holder shall fail to perfect or otherwise shall waive, withdraw or lose the right to appraisal under Section 262 with respect to Appraisal Shares, then the right of such holder to seek appraisal of
such shares of Company Common Stock shall cease and such shares of Company Common Stock shall be deemed to have been converted as of the Effective Time into, and to have become exchangeable solely for, the right to receive the Merger Consideration
as provided in Section 2.1(b), without interest. The Company shall give prompt notice, and in any event within 48 hours of receipt, to Parent of any demands received by the Company for appraisal of any shares of Company Common Stock, and Parent
shall participate in and control all negotiations and Proceedings with respect to such demands. Prior to the Effective Time, the Company shall not, without the prior written consent of Parent, make any payment with respect to, or settle or offer to
settle, any such demands, or agree to do any of the foregoing.
Section 2.4
Exchange of Company Common Stock
.
(a)
Paying Agent
. Prior to the Effective Time, Parent and Merger Sub shall deposit or cause to be deposited with a financial
institution or trust company selected by Parent with the Companys prior approval (which approval shall not be unreasonably withheld, delayed or conditioned) (the
Paying Agent
), for the benefit of the holders of shares of
Company Common Stock, for exchange in accordance with this Article II, through the Paying Agent, all of the cash sufficient to pay the aggregate Merger Consideration (such cash provided to the Paying Agent being hereinafter referred to as the
Exchange Fund
). Parent and the Surviving Corporation shall cause the Paying Agent to deliver the cash contemplated to be paid pursuant to Section 2.1 out of the Exchange Fund. The Exchange Fund shall not be used for any other
purpose. Parent shall or shall cause the Surviving
A-10
Corporation to promptly replace or restore the cash in the Exchange Fund so as to ensure that the Exchange Fund is at all times maintained at a level sufficient for the Paying Agent to make such
payments under Section 2.1(b). Nothing contained in this Section 2.4(a) and no investment losses resulting from investment of the funds deposited with the Paying Agent shall diminish the rights of any holder of Company Common Stock to receive the
Merger Consideration. The paying agent agreement pursuant to which Parent shall appoint the Paying Agent shall be in form and substance reasonably acceptable to the Company.
(b)
Exchange Procedures
.
(i)
Certificates
. Parent shall instruct the Paying Agent to mail (or in the case of The Depository Trust Company on
behalf of street holders, deliver), as soon as reasonably practicable (but no later than three Business Days) following the Effective Time, to each holder of record of a Certificate whose shares were converted into the right to receive
the Merger Consideration pursuant to Section 2.1(b), (i) a letter of transmittal (which shall be in such form and have such other provisions as the Company and Parent shall mutually agree and shall specify that delivery shall be effected, and risk
of loss and title to the Certificates shall pass, only upon delivery of the Certificates to the Paying Agent) and (ii) instructions for use in effecting the surrender of the Certificates in exchange for the Merger Consideration. Upon surrender
of a Certificate for cancellation to the Paying Agent, together with such letter of transmittal, duly executed, and such other documents as may reasonably be required by Parent or the Paying Agent, the holder of such Certificate shall be entitled to
receive in exchange therefor, and Parent and the Surviving Corporation shall cause the Paying Agent to pay and deliver in exchange thereof as promptly as practicable, the cash amount equal to (x) the number of shares of Company Common Stock
represented by such Certificate multiplied by (y) the Merger Consideration, and the Certificate so surrendered shall forthwith be cancelled. In the event of a transfer of ownership of Company Common Stock that is not registered in the transfer
records of the Company, payment may be made to a Person other than the Person in whose name the Certificate so surrendered is registered, if such Certificate shall be properly endorsed or otherwise be in proper form for transfer and the Person
requesting such payment shall pay any transfer or other taxes required by reason of the payment to a Person other than the registered holder of such Certificate or establish to the satisfaction of Parent that such tax has been paid or is not
applicable. Subject to Section 2.3, until surrendered as contemplated by this Section 2.4, each Certificate shall be deemed at any time after the Effective Time to represent only the right to receive upon such surrender the Merger Consideration into
which the shares of Company Common Stock theretofore represented by such Certificate have been converted into pursuant to Section 2.1(b). No interest shall be paid or accrue on any cash payable upon surrender of any Certificate.
(ii)
Book-Entry Shares
. Notwithstanding anything to the contrary contained in this Agreement, any holder of
Book-Entry Shares shall not be required to deliver a Certificate to the Paying Agent to receive the Merger Consideration that such holder is entitled to receive pursuant to this Article II. Parent shall instruct the Paying Agent to mail, as soon as
reasonably practicable (but no later than three Business Days) following the Effective Time, to each holder of record of one or more Book-Entry Shares whose shares were converted into the right to receive the Merger Consideration pursuant to Section
2.1(b), (i) a letter of transmittal (which shall be in such form and have such other provisions as the Company and Parent shall mutually agree) and (ii) instructions for use in effecting the surrender of the Book-Entry Shares in exchange for the
Merger Consideration. Upon delivery of such letter of transmittal to the Paying Agent, duly executed, and such other documents as may reasonably be required by Parent or the Paying Agent, each holder of record of one or more Book-Entry Shares whose
shares of Company Common Stock were converted into the right to receive the Merger Consideration pursuant to Section 2.1(b) shall be entitled to receive in exchange therefor, and Parent and the Surviving Corporation shall cause the Paying Agent to
pay and deliver in exchange thereof as promptly as practicable, the cash amount equal to (x) the number of shares of Company Common Stock represented by such Book-Entry Shares multiplied by (y) the Merger Consideration.
(c)
No Further Ownership Rights in Company Common Stock; Closing of Transfer Books
. The Merger Consideration paid in accordance
with the terms of this Article II shall be deemed to have been paid in full
A-11
satisfaction of all rights pertaining to such shares of Company Common Stock (other than the right to receive the payments contemplated by this Article II). After the Effective Time, there shall
be no further registration of transfers on the stock transfer books of the Surviving Corporation of shares of Company Common Stock that were outstanding immediately prior to the Effective Time. If, after the Effective Time, any Certificates formerly
representing shares of Company Common Stock are presented to the Surviving Corporation or the Paying Agent for any reason, they shall be cancelled and exchanged as provided in this Article II.
(d)
Termination of Exchange Fund
. Any portion of the Exchange Fund that remains undistributed to the holders of Company Common
Stock for six months after the Effective Time shall be delivered to the Surviving Corporation, upon demand, and any holder of Company Common Stock who has not theretofore complied with this Article II shall thereafter look only to Parent and the
Surviving Corporation (subject to Section 2.4(e)) for payment of its claim for the Merger Consideration.
(e)
No Liability
.
None of Parent, Merger Sub, the Surviving Corporation, the Paying Agent or any other Person shall be liable to any Person in respect of any cash from the Exchange Fund (including any amounts delivered to Parent in accordance with Section 2.4(d))
properly delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law.
(f)
Lost, Stolen
or Destroyed Certificates
. In the event any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, to the extent reasonably
required by Parent, the posting by such Person of a bond in reasonable amount as indemnity against any claim that may be made against it with respect to such Certificate, the Paying Agent shall pay in exchange for such lost, stolen or destroyed
Certificate the Merger Consideration that would be payable in respect thereof pursuant to this Agreement had such lost, stolen or destroyed Certificate been surrendered as provided in this Article II.
(g)
Investment
. The Paying Agent shall invest the Exchange Fund, as directed by Parent;
provided
,
however
, that such
investments shall be in (i) obligations of, or guaranteed by, the United States of America and backed by the full faith and credit of the United States of America, (ii) commercial paper obligations of issuers organized under the Laws of a state of
the United States of America rated A-1 or P-1 or better by Moodys Investors Service, Inc. or Standard & Poors Corporation, respectively, (iii) certificates of deposit, bank repurchase agreements or bankers acceptances of
commercial banks with capital exceeding $10,000,000,000 (based on the most recent financial statements of such bank which are then publicly available) or (iv) a combination of the foregoing. Any interest and other income resulting from such
investments shall be the property of and paid to the Surviving Corporation;
provided
that no losses on any investment made pursuant to this Section 2.4(g) shall affect the Merger Consideration payable to holders of Company Common Stock
entitled to receive such consideration, and following any such losses, Parent and the Surviving Corporation shall promptly cause to be provided additional funds to the Paying Agent for the benefit of holders of shares of Company Common Stock
entitled to receive such consideration in the amount of any such losses or if for any reason such funds are unavailable for payment to the holders of shares of Company Common Stock.
(h)
Withholdings
. Each of Parent, the Surviving Corporation and the Paying Agent shall be entitled to deduct and withhold from the
consideration otherwise payable to any Person pursuant to this Article II such amounts as it is required to deduct and withhold with respect to the making of such payment under the Internal Revenue Code of 1986, as amended (the
Code
) or under any provision of state, local or foreign tax Law. Any amount properly deducted or withheld pursuant to this Section 2.4(h) shall be treated for all purposes of this Agreement as having been paid to the Person in
respect of which such deduction or withholding was made. Parent shall pay, or shall cause to be paid, all amounts so deducted or withheld to the appropriate Taxing Authority within the period required under applicable Law.
A-12
Section 2.5
Treatment of Company Stock Plans
.
(a)
Treatment of Options
. At the Effective Time, each option granted by the Company to purchase shares of Company Common Stock
that is outstanding as of immediately prior to the Effective Time, whether vested or unvested (any such option, a
Company Option
), shall be cancelled and shall entitle the holder to receive, as soon as reasonably practicable (but
no later than the next regularly scheduled payroll date that occurs no less than five Business Days after the Closing Date) following the Effective Time, a cash payment (without interest and subject to applicable withholding Taxes) from the
Surviving Corporation with respect thereto equal to the product of (i) the total number of shares of Company Common Stock subject to such Company Option as of immediately prior to the Effective Time and (ii) the excess, if any, of the Merger
Consideration over the exercise price per share of Company Common Stock subject to such Company Option as of immediately prior to the Effective Time (the
Option Payment
). For the avoidance of doubt, any Company Option with an
exercise price equal to or in excess of the Merger Consideration shall be cancelled by virtue of the Merger without any action on the part of the holder thereof and without any payment to the holder thereof. As of the Effective Time, each holder of
a Company Option shall cease to have any rights with respect thereto except the right to receive the Option Payment, if applicable.
(b)
Company RSU Awards and Company PSU Awards
. At the Effective Time, each time-vesting restricted stock unit award granted by the
Company in respect of shares of Company Common Stock (a
Company RSU Award
) (including any Company RSU Award that previously vested but receipt of which has been deferred by the holder) and each performance based restricted stock
unit award granted by the Company in respect of shares of Company Common Stock (a
Company PSU Award
) that is outstanding as of immediately prior to the Effective Time shall be cancelled and shall entitle the holder to receive, as
promptly as practicable (but no later than the next regularly scheduled payroll date that occurs no less than five Business Days after the Closing Date) following the Effective Time, a cash payment (without interest and subject to applicable
withholding Taxes) from the Surviving Corporation with respect thereto equal to the product of (i) the total number of shares of Company Common Stock subject to such Company RSU Award or Company PSU Award as of immediately prior to the Effective
Time and (ii) the sum of (A) the Merger Consideration plus (B) any cash dividend equivalents per share accrued but unpaid immediately prior to the Effective Time with respect to such Company RSU Award or Company PSU Award payable in accordance with
the underlying award agreement (the
RSU/PSU Payment
);
provided
,
however
, that to the extent that any Company RSU Award or Company PSU Award constitutes nonqualified deferred compensation subject to Section 409A of
the Code, such cash payment shall be paid in accordance with the applicable awards terms and at the earliest time permitted under the terms of such award that will not result in the application of a tax or penalty under Section 409A of the
Code, including payment in accordance with any applicable exception or permitted payment event under Section 409A of the Code and Section 1.409A-3(j) of the Treasury Regulations provided the use of such exception would not impact any other deferred
compensation arrangement. Notwithstanding the foregoing, each holder of a Company RSU Award granted after the date of this Agreement (an
Interim RSU Award
) that is outstanding as of immediately prior to the Effective Time shall
not be entitled to receive an RSU/PSU Payment with respect to the portion of such Interim RSU Award that is not vested as of immediately prior to the Effective Time in accordance with the underlying award agreement, so that the RSU/PSU Payment paid
to such holder in respect of an Interim RSU Award shall equal the product of (i) the total number of shares of Company Common Stock subject to the vested portion of such Interim RSU Award as of immediately prior to the Effective Time and (ii) the
sum of (A) the Merger Consideration plus (B) any cash dividend equivalents per share accrued but unpaid immediately prior to the Effective Time with respect to the vested portion of such Interim RSU Award immediately prior to the Effective Time
payable in accordance with the underlying award agreement. For the avoidance of doubt, the unvested portion of all Interim RSU Awards will be cancelled at the Effective Time without any action on the part of the holder thereof and without any
payment to the holder thereof. As of the Effective Time, each holder of a Company RSU Award (including Interim RSU Awards) or a Company PSU Award shall cease to have any rights with respect thereto except the right to receive the RSU/PSU Payment as
provided herein.
A-13
(c)
Company Actions
. Prior to the Effective Time, the Company, the Board of Directors
of the Company or the appropriate committee of the Board of Directors of the Company, as applicable, shall adopt any resolutions and take any actions which are reasonably necessary to effectuate the provisions of this Section 2.5, including any
participant notice requirements in accordance with the terms of any Company Stock Plan or the ESPP. The Company shall take all actions necessary to ensure that from and after the Effective Time neither Parent nor the Surviving Corporation shall be
required to deliver shares of Company Common Stock or other capital stock of the Company to any Person pursuant to, or in settlement of, the Company Stock Plans, ESPP, Company Options, Company RSU Awards, Company PSU Awards or otherwise.
Section 2.6
Treatment of Employee Stock Purchase Plan
. Prior to the Effective Time, the Company, the Board of Directors of the
Company or the appropriate committee of the Board of Directors of the Company, as applicable, shall adopt any resolutions and take any actions which are necessary to: (i) terminate the Companys Employee Stock Purchase Plan
(
ESPP
) subject to, and effective as of immediately prior to, the Effective Time, (ii) ensure that no new offering period under the ESPP shall be commenced after the date of this Agreement, (iii) prohibit participants in the ESPP
from altering their payroll deductions from those in effect on the date of this Agreement (other than to discontinue their participation in the ESPP in accordance with the terms and conditions of the ESPP), (iv) ensure participant accounts are
applied in accordance with the terms and conditions of the ESPP to purchase shares of Company Common Stock prior to the Effective Time and (v) provide that the amount of the accumulated contributions of each participant in the ESPP as of immediately
prior to the Effective Time shall, to the extent not used to purchase shares of Company Common Stock in accordance with the terms and conditions of the ESPP, be refunded to such participant as soon as reasonably practicable following the Effective
Time (without interest) all in accordance with Section 19(b) of the ESPP. Any shares of Company Common Stock purchased under the ESPP shall be treated in accordance with Section 2.1(b).
ARTICLE III
REPRESENTATIONS AND
WARRANTIES OF THE COMPANY
Except as (x) disclosed in the Company SEC Documents filed with or furnished to the Securities and Exchange
Commission (the
SEC
) on or after November 28, 2015 and publicly available prior to the date of this Agreement (but excluding any risk factors or forward-looking disclosures set forth under the heading Risk Factors or
under the heading Special Note Regarding Forward-looking Statements, or in any such case, similarly titled captions, and any other disclosures that are cautionary, predictive or forward-looking in nature, in any such Company SEC
Documents) or (y) set forth in the disclosure letter delivered by the Company to Parent and Merger Sub concurrently with the execution and delivery of this Agreement (the
Company Disclosure Letter
) (it being agreed that (i)
disclosure of any item in any section or subsection of the Company Disclosure Letter shall be deemed disclosure with respect to any section of this Agreement or any other section or subsection of the Company Disclosure Letter to which the relevance
of such disclosure is reasonably apparent on its face and (ii) the mere inclusion of an item in such Company Disclosure Letter as an exception to a representation or warranty shall not be deemed an admission (A) that such item represents a material
exception or material fact, event or circumstance or that such item has had, or would be reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect or that such item did not arise in the ordinary course of
business, or rise to any particular threshold, or (B) of any non-compliance with, or violation or breach of, any Contract, any other third party rights (including any Intellectual Property rights) or any Law or Order, such disclosures having been
made solely for the purposes of creating exceptions to the representations made herein and/or disclosing information required to be disclosed pursuant to this Agreement), the Company represents and warrants to Parent and Merger Sub as follows:
Section 3.1
Corporate Organization
.
(a) The Company and each of its Subsidiaries is a corporation or other entity validly existing and, to the extent applicable, in good
standing under the Laws of the jurisdiction of its organization and has the requisite corporate or other entity power and authority to own, lease and operate all of its properties and assets and to carry
A-14
on its business as it is now being conducted, except, in the case of the Companys Subsidiaries, where the failure to be validly existing or in good standing has not had and would not be
reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect. Each of the Company and its Subsidiaries is duly licensed, qualified or otherwise authorized to do business, and, to the extent applicable, is in good
standing, in each jurisdiction where the nature of the business conducted by it or the character or location of the properties and assets owned, leased or operated by it makes such licensing or qualification necessary, except where the failure to be
so licensed, qualified or in good standing has not had and would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect.
(b) Section 3.1(b) of the Company Disclosure Letter sets forth a true and complete list, including jurisdiction of organization or
incorporation, of all of the Subsidiaries of the Company and any joint ventures, partnerships or similar arrangements in which the Company or any of its Subsidiaries has a limited liability, partnership or other equity interest.
(c) The copies of (i) the Second Restated Certificate of Incorporation, as amended (the
Company Charter
), and (ii) the
Second Amended and Restated By-Laws (the
Company Bylaws
) of the Company made available to Parent prior to the date hereof are true and complete copies of such documents as in effect as of the date of this Agreement.
Section 3.2
Capitalization
.
(a) The authorized capital stock of the Company consists of 120,000,000 shares of Company Common Stock and 5,000,000 shares of preferred
stock, par value $1.00 per share (
Company Preferred Stock
). As of the close of business on November 28, 2016, (i) 48,562,842 shares of Company Common Stock were issued and outstanding (not including shares held in treasury), (ii)
no shares of Company Common Stock were held in treasury, (iii) no shares of Company Preferred Stock were issued and outstanding, (iv) Company Options with respect to an aggregate of 1,885,432 shares of Company Common Stock were outstanding, (v)
Company RSU Awards with respect to an aggregate of 109,649 shares of Company Common Stock were outstanding (including Company RSU Awards that previously vested but receipt of which has been deferred by the holder) and (vi) Company PSU Awards with
respect to an aggregate of 77,731 shares of Company Common Stock were outstanding. As of the close of business on November 28, 2016 (A) an aggregate of 4,889,112 shares of Company Common Stock were reserved and available for issuance pursuant to the
Company Stock Plans and (B) an aggregate of 38,241.05 shares of Company Common Stock were reserved and available for issuance pursuant to the ESPP. Except as set forth in this Section 3.2(a) or in Section 3.2(a) of the Company Disclosure Letter, or
as expressly permitted by Section 5.1(b)(iii) or Section 5.1(b)(viii) (including as set forth on Section 5.1 of the Company Disclosure Letter or as Parent may otherwise consent in accordance with Section 5.1(b)), there are no and there will not be
any outstanding securities, options, warrants, calls, rights, commitments, agreements, derivative contracts, forward sale contracts or undertakings of any kind to which the Company or any of its Subsidiaries is a party, or by which the Company or
any of its Subsidiaries is bound, obligating the Company or any of its Subsidiaries to issue, deliver or sell, or cause to be issued, delivered or sold, additional shares of capital stock or other voting securities of the Company or any of its
Subsidiaries or obligating the Company or any of its Subsidiaries to issue, grant, extend or enter into any such security, option, warrant, call, right, commitment, agreement, derivative contract, forward sale contract or undertaking, or obligating
the Company or any of its Subsidiaries to make any payment based on or resulting from the value or price of Company Common Stock or of any such security, option, warrant, call, right, commitment, agreement, derivative contract, forward sale contract
or undertaking.
(b) Except as set forth in Section 3.2(b) of the Company Disclosure Letter and except for acquisitions, or deemed
acquisitions, of Company Common Stock or other equity securities of the Company in connection with (i) the payment of the exercise price of Company Options with Company Common Stock (including in connection with net exercises), (ii) tax
withholding in connection with the exercise of Company Options or vesting of Company RSU Awards or Company PSU Awards and (iii) forfeitures of Company Options, Company
A-15
RSU Awards or Company PSU Awards, there are no outstanding contractual obligations of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any shares of Company
Common Stock or the capital stock of any of its Subsidiaries. All Company Options, Company RSU Awards and Company PSU Awards were granted under a Company Stock Plan.
(c) Except as set forth in Section 3.2(c) of the Company Disclosure Letter, the Company or a Subsidiary of the Company owns, directly or
indirectly, all of the issued and outstanding shares of capital stock or other equity interests of each of its Subsidiaries, and all of such shares and equity interests are duly authorized, validly issued, fully paid and nonassessable and are not
subject to any preemptive rights in favor of any Person other than the Company or a direct or indirect wholly owned Subsidiary of the Company. No Subsidiary of the Company owns any shares of Company Common Stock.
(d) All outstanding shares of Company Common Stock have been, and all shares of Company Common Stock that may be issued under the ESPP or
pursuant to the Company Stock Plans upon the settlement or exercise (as applicable) of Company Options, Company RSU Awards and Company PSU Awards will be, when issued in accordance with the respective terms thereof, duly authorized and validly
issued and will be fully paid and nonassessable and are not subject to preemptive rights.
(e) Section 3.2(e) of the Company
Disclosure Letter contains a true and complete list of each holder of Company Options, Company RSU Awards and Company PSU Awards as of the close of business on November 28, 2016, including for each such holder, the type of such awards, date of
grant, number of shares of Company Common Stock underlying such awards and, with respect to any Company Options, exercise price. Each Company Option (i) was granted in all material respects in compliance with all applicable Laws and with all of the
terms and conditions of the Company Stock Plan pursuant to which it was issued and (ii) has an exercise price per share of Company Common Stock equal to or greater than the fair market value of a share of Company Common Stock on the date of grant.
Section 3.3
Corporate Authorization
.
(a) The Company has all necessary corporate power and authority to execute and deliver this Agreement, and, subject only to the adoption
of this Agreement by the affirmative vote of the holders of a majority of the outstanding shares of Company Common Stock entitled to vote on such matter at a stockholders meeting duly called and held for such purpose (the
Company
Stockholder Approval
) and the filing of the Certificate of Merger with the Secretary of State of the State of Delaware, to perform its obligations hereunder and consummate the Merger and the other transactions contemplated hereby. The
execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the Merger and the other transactions contemplated hereby have been duly and validly authorized by the Board of Directors of the Company, and
no other corporate proceedings on the part of the Company are necessary to authorize this Agreement or to consummate the Merger or the other transactions contemplated hereby, subject, in the case of the Merger, to obtaining the Company Stockholder
Approval and the filing of the Certificate of Merger with the Secretary of State of the State of Delaware in accordance with the DGCL. There are no bonds, debentures, notes or other indebtedness of the Company or any of its Subsidiaries having the
right to vote (or convertible into, or exchangeable for, securities having the right to vote) on any matters on which stockholders of the Company may vote.
(b) The Board of Directors of the Company, at a meeting duly called and held, has unanimously adopted resolutions (i) determining that
the Merger is fair to, and in the best interests of, the Company and its stockholders, (ii) approving and declaring advisable this Agreement, the Merger and the other transactions contemplated hereby, (iii) approving the execution, delivery and
performance of this Agreement and the consummation of the Merger and the other transactions contemplated hereby, (iv) directing that the adoption of this Agreement be submitted to the holders of Company Common Stock for consideration and (v)
recommending, subject to Section 6.3, the adoption of this Agreement by the holders of Company Common Stock (such recommendation, the
Company Board Recommendation
). As of the date of this Agreement, such resolutions have not been
subsequently rescinded, modified or withdrawn.
A-16
(c) This Agreement has been duly executed and delivered by the Company and, assuming due
power and authority of and due execution and delivery by, Parent and Merger Sub, constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to bankruptcy, insolvency, fraudulent
transfer, moratorium, reorganization or similar Laws affecting the rights of creditors generally and the availability of equitable remedies (regardless of whether such enforceability is considered in a proceeding in equity or at Law) (together, the
Bankruptcy and Equity Exception
).
Section 3.4
No Conflicts
. The execution and delivery of this Agreement
by the Company do not, and the performance of this Agreement by the Company and the consummation by the Company of the Merger and the other transactions contemplated hereby will not (a) breach, conflict with or violate any provision of the Company
Charter or Company Bylaws or any of the similar organizational documents of any of its Subsidiaries or (b) assuming that the authorizations, consents and approvals referred to in Section 3.5 and the Company Stockholder Approval are obtained, (i)
violate, conflict with, result in the loss of any benefit under, constitute a default (or an event which, with or without notice or lapse of time, or both, would constitute a default) under, give rise to a right of termination under, or result in
the creation of any Lien, other than any Permitted Liens, upon any of the respective properties or assets of the Company or any of its Subsidiaries under, any Contract or Permit to which the Company or any of its Subsidiaries is a party, or by which
they or any of their respective properties or assets are bound or affected or (ii) conflict with or violate any Laws or Orders applicable to the Company or any of its Subsidiaries or any of their respective properties or assets, other than, in the
case of clause (b), any such violation, conflict, loss, default, right or Lien that would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Section 3.5
Governmental Approvals
. No consent, approval, waiver, license, permit, franchise, authorization or Order
(
Consents
) of, or registration, declaration, notice, report, submission or other filing (
Filings
) with, any federal, state or local court, administrative or regulatory agency or commission or other governmental
authority, domestic or foreign (each a
Governmental Entity
), is required to be made in connection with the execution, delivery or performance of this Agreement by the Company or the consummation of the Merger and the other
transactions contemplated hereby, other than (i) the filing with the SEC of a proxy statement relating to the Company Stockholders Meeting (such proxy statement, as amended, supplemented or modified from time to time, the
Proxy
Statement
) and such Filings under, and other compliance with, the Securities Exchange Act of 1934, as amended (the
Exchange Act
) as may be required in connection with this Agreement, (ii) the filing of the Certificate of
Merger with the Secretary of State of the State of Delaware in accordance with the DGCL, (iii) compliance with the applicable requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the
HSR Act
) and
such other Antitrust Laws as are set forth on Schedule 7.1(c), (iv) compliance with the applicable rules and regulations of the New York Stock Exchange (
NYSE
), or (v) such other Consents or Filings the failure of which to
obtain or make prior to the Closing would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Section 3.6
Company SEC Filings; Financial Statements; Controls
.
(a) The Company has filed or furnished (as applicable) all reports, schedules, forms, statements, certifications and other documents
required to be filed or furnished (as applicable) by the Company with the SEC pursuant to the Exchange Act and the Securities Act since November 30, 2013 (collectively, and together with such reports, schedules, forms, statements, certifications and
other documents filed with or furnished to the SEC subsequent to the date of this Agreement, including any amendments thereto, the
Company SEC Documents
). As of their respective dates or, if amended, as of the date of the last
such amendment, the Company SEC Documents (i) complied in all material respects with the applicable requirements of the Exchange Act, the Securities Act and the Sarbanes-Oxley Act of 2002 (the
Sarbanes-Oxley Act
), and any rules
and regulations promulgated thereunder applicable to the Company SEC Documents and (ii) did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made, not misleading. There are no outstanding or unresolved comments in comment letters received by the Company from the SEC or its staff.
A-17
There has been no written comment letter or response between the SEC (and its staff) and the Company between November 30, 2013 and the date of this Agreement that is not available on the
SECs Electronic Data Gathering Analysis and Retrieval database.
(b) The Company has established and maintains disclosure
controls and procedures and internal control over financial reporting (as such terms are defined in paragraphs (e) and (f), respectively, of Rule 13a-15 and paragraph (e) of Rule 15d-15 under the Exchange Act) as required by Rules 13a-15 and 15d-15
under the Exchange Act. The Companys disclosure controls and procedures are designed to ensure that all material information (both financial and non-financial) required to be disclosed by the Company in the reports that it files or furnishes
under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such information is accumulated and communicated to the Companys management as appropriate
to allow timely decisions regarding required disclosure and to make the certifications required pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act. The Companys internal control over financial reporting is designed to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes policies and procedures that (i) pertain to the maintenance of records that
in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company and its Subsidiaries, (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with GAAP, and that receipts and expenditures of the Company and its Subsidiaries are being made only in accordance with authorizations of management and directors of the Company, and (iii) provide reasonable assurance
regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Companys or any of its Subsidiaries assets that would be reasonably expected to have a material effect on its financial statements. The
Company has disclosed based on its most recently completed evaluation of the Companys internal control over financial reporting prior to the date of this Agreement to the Companys auditors and the audit committee of the Board of
Directors of the Company (A) any significant deficiencies and material weaknesses in the design or operation of its internal controls over financial reporting that are reasonably likely to adversely affect the Companys
ability to record, process, summarize and report financial information and (B) any fraud, whether or not material, that involves management or other employees who have a significant role in the Companys internal control over financial
reporting. The terms significant deficiencies and material weaknesses have the meanings assigned to such terms in Rule 13a-15(f) of the Exchange Act. Since November 30, 2013, neither the Company nor any of its Subsidiaries
has received any complaint, allegation, assertion or claim regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or its Subsidiaries or their respective internal accounting procedures, except as has not
had and would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect.
(c) The
consolidated financial statements (including all related notes and schedules thereto) of the Company included in or incorporated by reference into the Company SEC Documents (the
Company SEC Financial Statements
) comply in all
material respects as to form with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. The Company SEC Financial Statements fairly present in all material respects the consolidated financial
position of the Company and its consolidated Subsidiaries, as at the respective dates thereof, and the consolidated results of their operations and their consolidated cash flows for the respective periods then ended (subject, in the case of the
unaudited statements, to normal year-end audit adjustments that are not material and to the absence of information or notes not required by GAAP to be included in interim financial statements), all in conformity with GAAP applied on a consistent
basis during the periods involved (except as may be indicated therein or in the notes thereto).
Section 3.7
No Undisclosed
Liabilities
. There are no liabilities or obligations of the Company or any of its Subsidiaries of any nature, whether accrued, contingent, absolute or otherwise, whether known or unknown and whether due or to become due, in each case, other
than: (a) liabilities or obligations reflected or reserved against in the Companys audited consolidated balance sheet as of November 28, 2015 or its unaudited consolidated balance sheet as of August 27, 2016 included in the Company SEC
Documents (including the notes thereto), (b)
A-18
liabilities or obligations that were incurred since November 28, 2015 in the ordinary course of business, (c) liabilities or obligations which have not had and would not be reasonably expected to
have, individually or in the aggregate, a Company Material Adverse Effect and (d) liabilities or obligations arising or incurred in connection with this Agreement, the Merger and the other transactions contemplated hereby.
Section 3.8
Absence of Certain Changes or Events
. Except as set forth on Section 3.8 of the Company Disclosure Letter, since
August 28, 2016 until the date of this Agreement, except for liabilities or obligations incurred in connection with, or permitted or contemplated by, this Agreement, the Merger and the other transactions contemplated hereby, (a) the Company and its
Subsidiaries have conducted their respective businesses in the ordinary course of such businesses in all material respects, (b) there has not been any event, change, effect, development or occurrence that has had or would reasonably be expected to
have, individually or in the aggregate, a Company Material Adverse Effect and (c) neither the Company nor any of its Subsidiaries has taken any actions of the type described in Section 5.1(b)(ii), Section 5.1(b)(v), Section 5.1(b)(viii), Section
5.1(b)(xi), Section 5.1(b)(xii) or Section 5.1(b)(xiv), in each case, that would have been a breach of any such Section if taken after the date of this Agreement.
Section 3.9
Compliance with Laws; Permits
.
(a) Other than those violations that have not had and would not be reasonably expected to have, individually or in the aggregate, a
Company Material Adverse Effect, since November 30, 2013, the Company and its Subsidiaries have not violated and are not in violation of any Laws or Orders applicable to the Company, any of its Subsidiaries or any assets owned or used by any of
them.
(b) None of the Company, its Domestic Subsidiaries, any of their respective directors or officers, or, to the Companys
Knowledge, any of the Companys Foreign Subsidiaries or their respective directors or officers (in each case to the extent not also a director and/or officer of the Company or any of its Domestic Subsidiaries), or to the Companys
Knowledge, any of the Companys or its Subsidiaries respective employees, consultants, sales representatives, distributors or agents, in each case, acting in such capacity and on behalf of the Company, has (i) used any funds for unlawful
contributions, gifts, entertainment or other unlawful payments relating to political activity, (ii) violated, directly or indirectly, any applicable money laundering or anti-terrorism Law or directly or indirectly lent, contributed or otherwise made
available any funds to any Person for the purpose of financing the activities of any Person where making available any funds to that Person constitutes a violation of U.S. sanctions administered by OFAC, or (iii) violated, directly or
indirectly, any International Trade Law, in each case, except for such payments and violations that would not be material to the Company and its Subsidiaries, taken as a whole. The Company, its Domestic Subsidiaries and each of their respective
directors and officers, and to the Companys Knowledge, each of the Companys Foreign Subsidiaries and their respective directors and officers (in each case to the extent not also a director and/or officer of the Company or any of its
Domestic Subsidiaries) and each of the Companys and its Subsidiaries respective employees, consultants, sales representatives, distributors and agents, in each case, acting in such capacity and on behalf of the Company, have complied at
all times, and are in compliance, with all applicable U.S. and non-U.S. anti-corruption and anti-bribery Laws with respect to the Company and its Subsidiaries, including the U.S. Foreign Corrupt Practices Act (15 U.S.C. §§ 78dd-1 et
seq.), in each case, except for failures to comply that would not be material to the Company and its Subsidiaries, taken as a whole. The Company and its Subsidiaries have instituted and maintain policies and procedures which are reasonably designed
to promote compliance with any such U.S. and non-U.S. anti-bribery, anti-corruption, money laundering and anti-terrorism Laws, in each case, except where the failure to institute and maintain such policies and procedures would not be material to the
Company and its Subsidiaries, taken as a whole.
(c) None of the Company, its Domestic Subsidiaries, any of their respective
directors or officers, or, to the Companys Knowledge, any of the Companys Foreign Subsidiaries or their respective directors or officers (in each case to the extent not also a director and/or officer of the Company or any of its Domestic
Subsidiaries), or to the Companys Knowledge, any of the Companys or its Subsidiaries respective employees, consultants or
A-19
agents, in each case, acting in such capacity and on behalf of the Company, is or has been engaged in any cartel activities, including agreements or arrangements with one or more competitors to
fix prices of any products or services, control or rig bids to be submitted to any customers or allocate any customers or markets to itself or to competitors, in each case, except for such activities or any liability arising therefrom that would not
be material to the Company and its Subsidiaries, taken as a whole.
(d) The Company and each of its Subsidiaries have and are in
compliance with all governmental licenses, permits, certificates, approvals and authorizations of a Governmental Entity (
Permits
) necessary for the conduct of their business and the use of their properties and assets, as presently
conducted and used, and each of the Permits is valid, subsisting and in full force and effect, in each case, except where the failure to have, maintain or be in compliance with such Permit has not had and would not be reasonably expected to have,
individually or in the aggregate, a Company Material Adverse Effect.
Section 3.10
Litigation
. Except as set forth on Section
3.10 of the Company Disclosure Letter, as of the date of this Agreement, there is no Proceeding pending before any Governmental Entity, or to the Knowledge of the Company, threatened in writing against the Company or any of its Subsidiaries, which,
if decided adversely against the Company or any of its Subsidiaries, involves or would reasonably be expected to involve liabilities of the Company and its Subsidiaries in an amount in excess of $1,000,000, net of any insurance and indemnity,
contribution and similar obligations for the benefit of the Company or any of its Subsidiaries in respect thereof. There is no Order outstanding against the Company or any of its Subsidiaries which has had or would be reasonably expected to have,
individually or in the aggregate, a Company Material Adverse Effect.
Section 3.11
Taxes
.
(a) Except as has not had or would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse
Effect:
(i) The Company and each of its Subsidiaries (A) have prepared in good faith and duly and timely filed
(taking into account any extension of time within which to file) all Tax Returns required to be filed by any of them and all such filed Tax Returns are complete and accurate; (B) have paid all Taxes that are required to be paid (whether or not
shown on any Tax Return), except with respect to Taxes contested in good faith; (C) have paid all Taxes that the Company or any of its Subsidiaries are obligated to withhold from amounts owing to any employee, independent contractor, creditor
or third party; and (D) have collected and remitted all material sales, value added, use, or similar Taxes that the Company or any of its Subsidiaries are obligated to remit to a Taxing Authority.
(ii) There are no unresolved questions or Proceeding concerning the Tax liability of the Company or any of its
Subsidiaries that are not disclosed and adequately reserved for in the Company SEC Financial Statements.
(iii) There
is no Lien on any of the assets of the Company or those of any of its Subsidiaries that arose in connection with any failure (or alleged failure) to pay, or delay (or alleged delay) in paying, any Tax.
(iv) Neither the Company nor any of its Subsidiaries is a party to any Tax allocation, Tax sharing or similar Contract
entered into before the Closing pursuant to which it will have any obligation after the Closing.
(v) Neither the
Company nor any of its Subsidiaries has any liability for Taxes of any other Person, including any obligation to indemnify or otherwise succeed to the liability of any other Person for Taxes, as a transferee or successor, or pursuant to any Law
(including Treasury Regulations Section 1.1502-6 (or any similar provision of state, local or non-U.S. Law)), Contract, or otherwise.
(vi) The Company and its Subsidiaries have properly and timely documented their transfer pricing methodology in compliance
with Sections 482 and 6662 of the Code and any similar provision of applicable Law.
A-20
(vii) Neither the Company nor any of its Subsidiaries will be required to
include any item of income in, or exclude any item of deduction from, taxable income for any taxable period ending after the Closing as a result of any (i) change in method of accounting under Section 481 of the Code (or any similar provision of
state, local or foreign Law), (ii) use of an improper method of accounting, (iii) intercompany transaction or excess loss account under Section 1502 of the Code and the Treasury Regulations thereunder (or any similar provision of state, local or
non-U.S. Law), (iv) closing agreement as described under Section 7121 of the Code (or any similar provision of state, local or non-U.S. Law), (v) installment sale or open transaction disposition; (vi) any prepaid amount; or (vii) an election under
Section 108(i) of the Code.
(viii) Neither the Company nor any of its Subsidiaries has any liability with respect to
income, franchise or similar Taxes that accrued on or before October 30, 2015 in excess of the amounts accrued with respect thereto that are reflected in the financial statements included in the Company SEC Financial Statements filed on or prior to
the date of this Agreement.
(b) There is no Proceeding pending or, to the Knowledge of the Company, threatened in writing against or
with respect to the Company or any of its Subsidiaries in respect of any material Tax; neither the Company nor any of its Subsidiaries has waived any statute of limitations with respect to Taxes or agreed to any extension of time with respect to a
Tax assessment or deficiency.
(c) To the Companys Knowledge, no written claim has ever been made by a Taxing Authority in a
jurisdiction where the Company or any of its Subsidiaries do not file Tax Returns that the Company or its Subsidiary is or may be subject to Tax by that jurisdiction.
(d) There are no Tax rulings, requests for rulings or closing Contracts in effect or pending with any Taxing Authority relating to the
Company or any of its Subsidiaries.
(e) Neither the Company nor any of its Subsidiaries has distributed stock of another Person, or
has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Sections 355 or 361 of the Code.
(f) Neither the Company nor any of its Subsidiaries has entered into any listed transaction within the meaning of
Section 6707A(c)(2) of the Code and Treasury Regulations Section 1.6011-4(b)(2).
(g) Neither the Company nor any of its
Subsidiaries has a permanent establishment (within the meaning of an applicable Tax treaty) or otherwise has an office or fixed place of business in a country other than the country in which it is organized.
Section 3.12
Employee Benefit Plans and Related Matters; ERISA
.
(a) Section 3.12(a) of the Company Disclosure Letter sets forth as of the date of this Agreement a true and complete list of material
Company Benefit Plans, including all Company Benefit Plans subject to the Employee Retirement Income Security Act of 1974 (
ERISA
). With respect to each material Company Benefit Plan, the Company has made available to Parent prior
to the date hereof a true, correct and complete copy of such written Company Benefit Plan or a written description of any unwritten Company Benefit Plan, and, to the extent applicable, (i) all trust agreements, insurance contracts or other funding
arrangements, (ii) the two most recent actuarial and trust reports for both ERISA funding and financial statement purposes, (iii) the most recent Form 5500 with all attachments filed with the Internal Revenue Service (
IRS
) or the
Department of Labor, (iv) the most recent IRS determination letter (or opinion letter upon which the Company is entitled to rely), (v) all current summary plan descriptions and summaries of material modification thereto, and (vi) all material
correspondence relating to any Company Benefit Plan between the Company, any of its Subsidiaries or their representatives and any Governmental Entity regarding any matter that remains unresolved as of the date of this Agreement.
Company
Benefit Plans
means each employee benefit plan, scheme, program, policy, arrangement and contract
A-21
(including any employee benefit plan, as defined in Section 3(3) of ERISA, and any bonus, deferred compensation, stock bonus, stock purchase, restricted stock, stock option or other
equity-based arrangement, and any employment, termination, retention, bonus, change in control or severance agreement, plan, program, policy, arrangement or contract) under which any current or former director, officer or employee of the Company or
any of its Subsidiaries has any present or future right to benefits, that is maintained, sponsored or contributed to by the Company or any of its Subsidiaries or which the Company or any of its Subsidiaries has any obligation to maintain, sponsor or
contribute, or with respect to which the Company or any of its Subsidiaries could incur any direct or indirect liability.
Non-U.S. Company Benefit Plans
means each Company Benefit Plan that is maintained outside the jurisdiction
of the United States.
U.S. Company Benefit Plans
means each Company Benefit Plan that is not a Non-U.S. Company Benefit Plan.
(b) Except as has not had or would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse
Effect, (i) each Company Benefit Plan has been administered and operated in accordance with its terms and with applicable Law, (ii) there have been no prohibited transactions or breaches of any of the duties imposed on fiduciaries
(within the meaning of Section 3(21) of ERISA) by ERISA with respect to the U.S. Company Benefit Plans that could result in any liability or excise Tax under ERISA or the Code being imposed on the Company or any of its Subsidiaries, (iii) each U.S.
Company Benefit Plan intended to be qualified under Section 401(a) of the Code is so qualified and has received a determination letter or opinion from the IRS regarding the U.S. Company Benefit Plan, and nothing has occurred since the date of any
such determination that would reasonably be expected to give the IRS grounds to revoke such determination, or has submitted a request to the IRS for a current determination letter regarding such U.S. Company Benefit Plan.
(c) Except as has not had or would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse
Effect, (i) no liability under Title IV or Section 302 of ERISA has been incurred by the Company or any ERISA Affiliate that has not been satisfied in full, and no condition exists that presents a risk to the Company or any ERISA Affiliate of
incurring any such liability (exclusive of the liability to pay insurance premiums to the Pension Benefit Guaranty Corporation under Title IV of ERISA), (ii) no reportable event within the meaning of Section 4043 of ERISA (excluding any
such event for which the 30-day notice requirement has been waived under the regulations to Section 4043 of ERISA) has occurred in the preceding six (6) years with respect to any U.S. Company Benefit Plan or will be required to be filed in
connection with the transactions contemplated by this Agreement, (iii) no U.S. Company Benefit Plan is, or is expected to be, in at-risk status (within the meaning of Section 303(i)(4)(A) of ERISA or Section 430(i)(4)(A) of the Code),
(iv) neither the Company nor any of its Subsidiaries has provided, or is required to provide, security to any employee pension benefit plan within the meaning of Section 3(2) of ERISA (each, a
Pension Plan
) or to any
single-employer plan of an ERISA Affiliate pursuant to Section 436 of the Code or (v) under each Pension Plan which is a single-employer plan, there has been no material change in the financial condition, whether or not as a result of a change in
funding method, of such Pension Plan since the valuation date used for the most recent actuarial valuation report delivered or made available to Parent prior to the date hereof. As used in this Agreement,
ERISA Affiliate
means any
trade or business (whether or not incorporated) under common control with the Company or any of its Subsidiaries within the meaning of Section 4001(b)(1) of ERISA or which together with the Company or any of its Subsidiaries is treated as a single
employer under Section 414(t) of the Code.
(d) There are no pending or, to the Knowledge of the Company, threatened Proceedings with
respect to any of the Company Benefit Plans by any employee or otherwise involving any such plan or the assets of any such plan (other than routine claims for benefits), which, if decided adversely against the Company or any of its Subsidiaries,
would, individually or in the aggregate, be reasonably expected to be material to the Company and its Subsidiaries, taken as a whole.
(e) No Company Benefit Plan is a multiemployer plan within the meaning of Section 4001(a)(3) of ERISA or Section 414(f) of
the Code or is a multiple employer plan within the meaning of Section 4063 or 4064 of ERISA or Section 413(c) of the Code. None of the Company, its Subsidiaries or any ERISA Affiliate has at any time during the last six (6) years
contributed to or been obligated to contribute to any such type of plan.
A-22
(f) Except as set forth on Section 3.12(f) of the Company Disclosure Letter, and except as
provided in this Agreement or as required by applicable Law, the consummation of the Merger and the other transactions contemplated hereby will not (i) entitle any current or former director, officer or employee of the Company or of any of its
Subsidiaries to severance pay or any similar payment under any U.S. Company Benefit Plan, or, except as would not reasonably be expected to result in a material liability to the Company and its Subsidiaries, taken as a whole, any Non-U.S. Company
Benefit Plan, or (ii) result in any payment becoming due, accelerate the time of payment or vesting, or increase the amount of compensation due to any such director, officer or employee under any U.S. Company Benefit Plan, or, except as would not
reasonably be expected to result in a material liability to the Company and its Subsidiaries, taken as a whole, any Non-U.S. Company Benefit Plan.
(g) Except as has not had or would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse
Effect, each Non-U.S. Company Benefit Plan (i) if intended to qualify for special tax treatment, meets all the requirements for such treatment and (ii) if required to be funded, book-reserved or secured by an insurance policy, is funded,
book-reserved, or secured by an insurance policy, as applicable, based on reasonable actuarial assumptions in accordance with applicable accounting principles.
(h) No Company Benefit Plan provides death or medical benefits beyond termination of service or retirement other than coverage required
to be offered by Law.
(i) Neither the Company nor any of its Subsidiaries have agreed or committed to institute any material plan,
program, arrangement or agreement for the benefit of employees or former employees of the Company or any of its Subsidiaries other than the Company Benefit Plans, or to make any amendments to any of the Company Benefit Plans.
(j) Except as set forth in Section 3.12(j) of the Company Disclosure Letter, no amount that is likely to be received (whether in cash or
property or the vesting of property) as a result of any of the transactions contemplated by this Agreement by any employee, officer or director of the Company or any of its Subsidiaries or any of their Affiliates who is a disqualified
individual (as such term is defined in Treasury Regulation Section 1.280G-1) would be characterized as an excess parachute payment (as such term is defined in Section 280G(B)(1) of the Code. The Company has made available to Parent
true, complete and correct copies of any Code Section 280G calculations prepared (whether or not final) by or for the Company with respect to any disqualified individual in connection with the Merger and the other transactions contemplated by this
Agreement.
(k) Except as has not had or would not be reasonably expected to have, individually or in the aggregate, a Company
Material Adverse Effect, each Company Benefit Plan and any other payment or arrangement for which the Company or any of its Subsidiaries has liability that is subject to Section 409A of the Code is in documentary compliance with and has been
operated in compliance with Section 409A of the Code, and no individual has a right to any gross up or indemnification from the Company or any of its Subsidiaries with respect to any such Company Benefit Plan, payment or arrangement subject to
Section 409A of the Code.
Section 3.13
Material Contracts
.
(a) Section 3.13(a) of the Company Disclosure Letter sets forth, as of the date of this Agreement, a true and complete list of each
Contract to which the Company or any of its Subsidiaries is a party or bound, and which falls within any of the following categories:
(i) a material contract (as such term is defined in Item 601(b)(10) of Regulation S-K of the Securities Act);
(ii) a Contract (A) pursuant to which the Company or any of its Subsidiaries (1) has purchased or sold during the
twelve months prior to the date of this Agreement goods or services that involved payments by or to the Company and its Subsidiaries in excess of $10,000,000 during such period, or (2) purchase or sell goods or services that would reasonably be
expected to involve payments by or to the Company and its
A-23
Subsidiaries in excess of $10,000,000 during the twelve month period beginning on the date of this Agreement or any future twelve month period, in each case of clauses (1) and (2), other than
purchase orders and pricing agreements entered into in the ordinary course of business and (B) between the Company or any of its Subsidiaries, on the one hand, and any Top Customer or Top Supplier, on the other hand, with a term of more than 12
months, in each case, other than purchase orders and pricing agreements entered into in the ordinary course of business;
(iii) a Contract that is a license, royalty, covenant not to sue or similar Contract with respect to Intellectual Property
that involved license, royalty or similar payments by or to the Company and its Subsidiaries in excess of $2,500,000 during the twelve months prior to the date of this Agreement, other than (A) generally commercially available
off-the-shelf software programs, (B) non-exclusive license grants to Owned Intellectual Property granted by the Company or any of its Subsidiaries in connection with the sale or distribution of products in the ordinary course of business
or (C) non-exclusive license grants to contract manufacturers that manufacture products on behalf of the Company or any of its Subsidiaries in the ordinary course of business;
(iv) a joint venture, partnership or limited liability company agreement or other similar Contract relating to the
formation, creation, operation, management or control of any joint venture, partnership or limited liability company in which the Company owns, directly or indirectly, any voting or economic interest of 10% or more, or any interest valued at more
than $5,000,000, without regard to percentage voting or economic interest, other than any such Contract solely between the Company and its wholly owned Subsidiaries or among the Companys wholly owned Subsidiaries;
(v) a mortgage, indenture, guarantee, loan, or credit agreement, security agreement, or other Contracts, in each case
relating to indebtedness for borrowed money, whether as borrower or lender, in each case with an outstanding principal balance as of the date of this Agreement in excess of $10,000,000, other than (A) letters of credit, performance bonds or similar
instruments issued for the account of the Company and/or any of its Subsidiaries in the ordinary course of business, (B) accounts receivable and accounts payable in the ordinary course of business and (C) intercompany loans owed by the Company or
any direct or indirect wholly owned Subsidiary of the Company to any other direct or indirect wholly owned Subsidiary of the Company, or by any direct or indirect wholly owned Subsidiary to the Company;
(vi) a Contract that provides for the acquisition or disposition of any assets (other than acquisitions or dispositions of
inventory in the ordinary course of business) or business or capital stock or other equity interests of any Person (in each case, whether by merger, sale of stock, sale of assets or otherwise), in each case for aggregate consideration in excess of
$25,000,000 (A) that was entered into after November 27, 2010, or (B) pursuant to which the Company or any of its Subsidiaries has any liability for any earn-out or other deferred or contingent payment obligations that remain outstanding, in excess
of $10,000,000;
(vii) a Contract containing a covenant that materially limits the right of the Company or any of its
Subsidiaries (or after the Effective Time, Parent or its Subsidiaries) to engage or compete in any line of business, or to purchase, sell, supply or distribute any product or services other than (A) Contracts with suppliers to sole source certain
raw materials and/or components in the ordinary course of business (none of which Contracts with suppliers will bind and adversely impact in any material respect Parent or any of its Subsidiaries (other than the Company and its Subsidiaries) after
the Effective Time) and (B) Contracts with distributors or sales representatives pursuant to which the Company or any of its Subsidiaries has agreed not to sell or otherwise compete with such distributor with respect to specific products in a
particular geographic area (none of which Contracts with distributors will bind and adversely impact in any material respect Parent or any of its Subsidiaries (other than the Company and its Subsidiaries) after the Effective Time);
(viii) a Contract that grants most favored nation status to the counterparty that would, in each case, bind
and adversely impact in any material respect Parent or any of its Subsidiaries (other than the Company and its Subsidiaries) after the Effective Time;
A-24
(ix) a Contract that grants any right of first refusal or right of first
offer to purchase or acquire any material assets or business of the Company or its Subsidiaries;
(x) a Contract
containing a standstill or similar agreement pursuant to which the Company or any of its Subsidiaries has agreed not to acquire assets or securities of any other party;
(xi) a Contract between the Company or any of its Subsidiaries and any director or officer of the Company, any Person
holding more than 5% of the capital stock of the Company, or their immediately family members, in each case, that would be required to be disclosed under Item 404(a) of Regulation S-K promulgated under the Exchange Act; or
(xii) a Contract to which the Company or any of its Subsidiaries is a party or bound, the ultimate contracting party of
which is a Governmental Entity (including any subcontract with a prime contractor or other subcontractor who is a party to any such Contract) and (A) which requires the Company or any of its Subsidiaries or personnel to possess material security
clearances or to be subject to specific material business or cost accounting standards, or (B) which, if breached, could reasonably be expected to subject the Company or its Subsidiaries or personnel to any material suspension or debarment
proceeding (or equivalent proceeding).
Each Contract of the type described in this Section 3.13(a), whether or not set forth in Section 3.13(a) of the
Company Disclosure Letter and whether or not entered into on or prior to the date of this Agreement, is referred to herein as a
Company Material Contract
.
(b) A true, complete and correct copy of each Company Material Contract has been made available to Parent prior to the date hereof.
Except as has not had and would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect, each Company Material Contract is valid, binding and in full force and effect with respect to the Company and
any of its Subsidiaries to the extent a party thereto and, to the Companys Knowledge, each other party thereto, subject to the Bankruptcy and Equity Exception. Neither the Company nor any of its Subsidiaries is in material breach of or
material default under any Company Material Contract, and, to the Knowledge of the Company, no other party to a Company Material Contract is in material breach of or material default under any such Company Material Contract.
Section 3.14
Intellectual Property
.
(a) Except as has not had and would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse
Effect, either the Company or a Subsidiary of the Company owns, or is licensed or otherwise possesses adequate rights to use, the Intellectual Property used in or held for use in connection with the business of the Company and its Subsidiaries as
currently conducted and neither the Merger nor the other transactions contemplated hereby will materially impair or otherwise materially adversely affect any such rights. Except as has not had and would not be reasonably expected to have,
individually or in the aggregate, a Company Material Adverse Effect, all Owned Intellectual Property is valid, subsisting and enforceable, and is not subject to any outstanding Order or Contract adversely affecting or that would be reasonably
expected to adversely affect the Companys or its Subsidiaries use of, or its rights to, Owned Intellectual Property.
(b) To the Knowledge of the Company, (i) the conduct of the business as currently conducted by the Company and its Subsidiaries does not
infringe upon, misappropriate or otherwise violate any Persons Intellectual Property, and, as of the date of this Agreement, there is no such claim pending or, to the Knowledge of the Company, threatened against the Company or its Subsidiaries
(including in the form of offers or invitations to license) and (ii) as of the date of this Agreement, no Person is infringing, misappropriating or otherwise violating any Owned Intellectual Property, and no such claims are pending or threatened
against any Person by the Company or its Subsidiaries.
(c) No registrations or applications for registered Owned Intellectual
Property have expired or been cancelled or abandoned except (i) in accordance with the expiration of the term of such rights, (ii) intentional
A-25
cancellations and abandonments in the ordinary course of business or (iii) as has not had or would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse
Effect.
(d) Except as has not had and would not be reasonably expected to have, individually or in the aggregate, a Company Material
Adverse Effect, the Company and its Subsidiaries have taken reasonable measures to protect and maintain the confidentiality of all Trade Secrets that are owned or held by the Company and its Subsidiaries, as applicable, and, to the Knowledge of the
Company, there has been no unauthorized disclosure by the Company or any of its Subsidiaries of any such Trade Secrets.
Section
3.15
Properties
.
(a) Section 3.15(a) of the Company Disclosure Letter sets forth a true and complete list of all
material Owned Real Property (including the address or location). Except as has not had or would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company or one of its Subsidiaries has good
and marketable title to all Owned Real Property, free and clear of all Liens, except for Permitted Liens.
(b) Section 3.15(b) of the
Company Disclosure Letter sets forth a true and complete list of all Leased Real Property (including the address or location) (the leases, subleases or other occupancy arrangements pursuant to which the Company or any of its Subsidiaries is a party
or has a right to use such Leased Real Property, each, a
Lease
). Except as has not had or would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) each Lease for the Leased
Real Property is valid, binding and in full force and effect with respect to the Company and any of its Subsidiaries to the extent a party thereto and, to the Companys Knowledge, each other party thereto, subject to the Bankruptcy and Equity
Exception and (ii) neither the Company nor any of its Subsidiaries is in breach of or default under any Lease with respect to Leased Real Property, and, to the Knowledge of the Company, no other party is in breach of or default under any lease with
respect to Leased Real Property.
Section 3.16
Environmental Matters
. Except as has not had and would not be reasonably
expected to have, individually or in the aggregate, a Company Material Adverse Effect:
(a) The Company and its Subsidiaries are, and
have been since December 3, 2011, in compliance with all applicable Environmental Laws, including possessing and complying with all Permits required for their respective ownership and operations under applicable Environmental Laws.
(b) There is no Proceeding pending or threatened in writing against the Company or any of its Subsidiaries under or pursuant to any
Environmental Law. As of the date of this Agreement, neither the Company nor any of its Subsidiaries has received written notice from any Person, including any Governmental Entity, alleging that they have been or are in violation of any applicable
Environmental Law or otherwise may be liable under any applicable Environmental Law, which violation or liability is unresolved. Neither the Company nor any Subsidiary is a party or subject to any administrative or judicial Order pursuant to any
Environmental Law.
(c) There have been no releases, spills or discharges of Hazardous Substances on or underneath any real property
that is currently owned or leased by the Company or its Subsidiaries, or, to the Knowledge of the Company, any real property that was formerly owned or leased by the Company or its Subsidiaries, that in each case would be reasonably likely to
require reporting, investigation, assessment, cleanup, removal, remediation or other responsive action, or would otherwise be reasonably likely to give rise to any material liability or obligation on the part of the Company or any of its
Subsidiaries, under applicable Environmental Laws. To the Knowledge of the Company, neither the Company nor any of its Subsidiaries is subject to any material liability for any Hazardous Substance disposal or contamination on any third party
property.
Section 3.17
Insurance
. Except as has not been and would not be reasonably expected to be, individually or in the
aggregate, material to the Company and its Subsidiaries, taken as a whole, (i) the Company and its
A-26
Subsidiaries maintain insurance policies that, together with adequately capitalized self-insured or retention arrangements (collectively, the
Insurance Policies
), provide
coverage in such amounts and with respect to such risks and losses as is customary for the industries in which the Company and its Subsidiaries operate and that management of the Company has in good faith determined to be adequate for the respective
businesses and operations of the Company and its Subsidiaries, (ii) each such Insurance Policy is in full force and effect, (iii) neither the Company nor any of its Subsidiaries is in breach or default (including any such breach or default with
respect to the payment of premiums) under any such Insurance Policy and (iv) no notice of cancellation has been received by the Company or any of its Subsidiaries with respect to any Insurance Policy which has not been cured by the payment of
premiums that are due.
Section 3.18
Labor and Employment Matters
. Except as set forth on Section 3.18 of the Company
Disclosure Letter, neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement or other written labor union Contract with a labor union, works council or other labor organization. Except as has not been and
would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect, since November 30, 2013, (i) the Company and its Subsidiaries are and have been in compliance with all applicable Laws relating to
employment and employment practices, labor, fair employment practices, terms and conditions of employment, workers compensation, occupational safety, plant closings, compensation and benefits and wages and hours, (ii) neither the Company nor
its Subsidiaries are or have been the subject of any Proceeding asserting that the Company or any of its Subsidiaries has committed an unfair labor practice or seeking to compel it to bargain with any labor union or labor organization, nor, to the
Companys Knowledge, has any such Proceeding been threatened, (iii) to the Knowledge of the Company, there is not and has not been any union organizing, representation or similar proceedings, or the threat of any strikes, work slowdowns or
similar organized actions, in each case by or with respect to employees of the Company or any of its Subsidiaries and (iv) there is no, and there has not been any, work stoppage, labor strike or lockout by the employees of the Company or its
Subsidiaries.
Section 3.19
Affiliate Transactions
. As of the date of this Agreement, there are no transactions, arrangements
or Contracts between the Company and its Subsidiaries, on the one hand, and its Affiliates (other than its wholly owned Subsidiaries) or other Persons, on the other hand, that would be required to be and have been disclosed under Item 404 of
Regulation S-K under the Securities Act.
Section 3.20
Customers and Suppliers
.
(a) Section 3.20(a) of the Company Disclosure Letter sets forth the Top Customers of the Company and its Subsidiaries. As of the date of
this Agreement, none of the Top Customers has cancelled or otherwise terminated, or, to the Knowledge of the Company, threatened to cancel or otherwise terminate its relationship with the Company or any of its Subsidiaries. Except as set forth on
Section 3.20(a) of the Company Disclosure Letter, as of the date of this Agreement, neither the Company nor any of its Subsidiaries has received written or, to the Knowledge of the Company, oral notice that any such Top Customer intends to cancel or
otherwise materially and adversely modify its relationship with the Company or any of its Subsidiaries.
(b) Section 3.20(b) of the
Company Disclosure Letter sets forth the Top Suppliers of the Company and its Subsidiaries. As of the date of this Agreement, none of the Top Suppliers has cancelled or otherwise terminated, or, to the Knowledge of the Company, threatened to cancel
or otherwise terminate its relationship with the Company or any of its Subsidiaries. Except as set forth on Section 3.20(b) of the Company Disclosure Letter, as of the date of this Agreement, neither the Company nor any of its Subsidiaries has
received written or, to the Knowledge of the Company, oral notice that any such supplier intends to cancel or otherwise materially and adversely modify its relationship with the Company or any of its Subsidiaries.
Section 3.21
Product Liability
.
(a) Since November 30, 2013, (i) no product recall claims have been made against the Company or any of its Subsidiaries, and (ii) neither
the Company nor any of its Subsidiaries has received written notice of any claim
A-27
or allegation of personal injury, death or property or economic damages with respect to the products or services of the Company or any of its Subsidiaries, which, in each case, involved or
involves liabilities of the Company and its Subsidiaries in an amount in excess of $5,000,000.
(b) Neither the Company nor any of its
Subsidiaries has manufactured, sold, distributed or marketed any asbestos-containing products. Except as has not been or would not be reasonably expected to be individually or in the aggregate, material to the Company and its Subsidiaries, taken as
a whole, no claims or litigation have ever been made or instituted against the Company or any of its Subsidiaries alleging injury or death resulting from, or exposure to, asbestos containing products allegedly manufactured, sold, distributed or
marketed by the Company or any of its Subsidiaries.
Section 3.22
Takeover Statutes
. Assuming the accuracy of the
representations and warranties set forth in Section 4.10, no business combination, fair price, moratorium, control share acquisition or other similar anti-takeover statute or regulation (including
Section 203 of the DGCL) (each a
Takeover Statute
), or any comparable anti-takeover provision of the Company Charter or Company Bylaws, is applicable to this Agreement, the Merger or the other transactions contemplated hereby.
Section 3.23
Brokers and Finders Fees
. Except for Goldman, Sachs & Co., the fees and expenses of which will be paid
by the Company, no broker, investment banker, financial advisor or other Person is entitled to any brokers, finders, financial advisors or other similar fee or commission in connection with the Merger based upon arrangements made
by or on behalf of the Company or any of its Subsidiaries. The Company has disclosed to Parent the amount of all fees and expenses (or, if such amount is not able to be known, the method for determining such amount) to which Goldman, Sachs & Co.
is entitled in connection with the Merger or any of the other transactions contemplated by this Agreement.
Section 3.24
Opinion
of Financial Advisor
. The Board of Directors of the Company has received an opinion from Goldman, Sachs & Co. to the effect that, as of the date of this Agreement and based upon and subject to the assumptions, qualifications, limitations and
other matters set forth therein, the Merger Consideration to be paid to the holders of shares of Company Common Stock pursuant to this Agreement is fair, from a financial point of view, to such holders, and, as of the date of this Agreement, such
opinion has not been withdrawn, revoked or modified.
Section 3.25
No Other Representations and Warranties; Disclaimers
.
Except for the representations and warranties expressly contained in Article IV, the Company agrees and acknowledges that none of Parent, Merger Sub or any Person on behalf of Parent or Merger Sub is making or has made, and the Company hereby agrees
it is not relying upon, any other express or implied representation or warranty with respect to Parent, Merger Sub or any of their respective Subsidiaries or with respect to any other information, including the accuracy or completeness of such other
information, provided or made available to the Company in connection with the transactions contemplated by this Agreement, including information conveyed at management presentations, in virtual data rooms or in due diligence sessions and, without
limiting the foregoing, including any estimates, projections, predictions or other forward-looking information.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
Except as set forth in the disclosure letter delivered by Parent to the Company concurrently with the execution and delivery of this Agreement
(the
Parent Disclosure Letter
) (it being agreed that (a) disclosure of any item in any section or subsection of the Parent Disclosure Letter shall be deemed disclosure with respect to any section of this Agreement or any other
section or subsection of the Parent Disclosure Letter to which the relevance of such disclosure is reasonably apparent on its face and (b) the mere inclusion of an item in such Parent Disclosure Letter as an exception to a representation or warranty
shall not be deemed an admission (i) that
A-28
such item represents a material exception or material fact, event or circumstance or that such item would have a Parent Material Adverse Effect or (ii) of any non-compliance with, or violation or
breach of, any Contract, any other third party rights (including any Intellectual Property rights) or any Law or Order, such disclosures having been made solely for the purposes of creating exceptions to the representations made herein and/or
disclosing information required to be disclosed pursuant to this Agreement), Parent and Merger Sub represent and warrant to the Company as follows:
Section 4.1
Corporate Organization
.
(a) Each of Parent and Merger Sub is a corporation validly existing and in good standing under the Laws of the jurisdiction of its
organization, has the requisite corporate power and authority to own, lease and operate all of its properties and assets and to carry on its business as it is now being conducted. Each of Parent and Merger Sub is duly licensed, qualified or
otherwise authorized to do business and, to the extent applicable, is in good standing in each jurisdiction where the nature of the business conducted by it or the character or location of the properties and assets owned or leased by it makes such
licensing or qualification necessary, except where the failure to be so licensed, qualified or in good standing has not had and would not be reasonably expected to have a Parent Material Adverse Effect.
(b) The copies of the Amended Articles of Incorporation (the
Parent Charter
) and Code of Regulations, as amended (the
Parent Bylaws
) of Parent made available to the Company prior to the date hereof are true, complete and correct copies of such documents as in effect as of the date of this Agreement. The copies of the certificate of incorporation
of Merger Sub (the
Merger Sub Charter
) and the bylaws of Merger Sub (the
Merger Sub Bylaws
) made available to the Company prior to the date hereof are true, complete and correct copies of such documents as in
effect as of the date of this Agreement.
Section 4.2
Corporate Authorization
.
(a) Each of Parent and Merger Sub has all necessary corporate power and authority to execute and deliver this Agreement and, subject to
the adoption of this Agreement by Parker Gibraltar Acquisitions Ltd., the sole stockholder of Merger Sub (the
Merger Sub Stockholder Approval
), which adoption Parent shall cause to occur promptly following the execution of this
Agreement on the date of this Agreement, and the filing of the Certificate of Merger with the Secretary of State of the State of Delaware, to perform its obligations hereunder and to consummate the Merger, the Financing and the other transactions
contemplated hereby. The execution, delivery and performance by Parent and Merger Sub of this Agreement and the consummation of the Merger, the Financing and the other transactions contemplated hereby have been duly and validly authorized by the
Board of Directors of Parent and the Board of Directors of Merger Sub, and no other corporate proceedings on the part of Parent or Merger Sub are necessary to authorize this Agreement or to consummate the Merger, the Financing or the other
transactions contemplated hereby, subject, in the case of the Merger, to obtaining the Merger Sub Stockholder Approval and the filing of the Certificate of Merger with the Secretary of State of the State of Delaware in accordance with the DGCL.
(b) This Agreement has been duly executed and delivered by Parent and Merger Sub and, assuming due power and authority of, and due
execution and delivery by, the Company, constitutes a valid and binding obligation of Parent and Merger Sub, enforceable against Parent and Merger Sub in accordance with its terms, subject to the Bankruptcy and Equity Exception.
Section 4.3
No Conflicts
. The execution, delivery and performance of this Agreement by Parent and Merger Sub do not and the
consummation by Parent and Merger Sub of the Merger, the Financing and the other transactions contemplated hereby will not (a) breach, conflict with or violate any provision of the Parent Charter, Parent Bylaws, Merger Sub Charter or Merger Sub
Bylaws or (b) assuming that the authorizations, consents and approvals referred to in Section 4.4 and the Merger Sub Stockholder Approval are obtained, (i) violate, conflict with, result in the loss of any benefit under, constitute a default (or an
event which, with or without notice or
A-29
lapse of time, or both, would constitute a default) under, give rise to a right of termination under, or result in the creation of any Lien, other than any Permitted Liens, upon any of the
respective properties or assets of Parent or Merger Sub under, any Contract or Permit to which Parent, Merger Sub or any of their respective Subsidiaries is a party, or by which they or any of their respective properties or assets are bound or
affected or (ii) conflict with or violate any Laws or Orders applicable to Parent or Merger Sub or any of their respective properties or assets, other than, in the case of clause (b), any such violation, conflict, loss, default, right or Lien that
would not be reasonably expected to have, individually or in the aggregate, a Parent Material Adverse Effect.
Section
4.4
Governmental Approvals
. No Consent of, or Filing with, any Governmental Entity is required to be made in connection with the execution, delivery or performance of this Agreement by Parent and Merger Sub or the consummation of the
Merger, the Financing and the other transactions contemplated hereby, other than (a) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware in accordance with the DGCL, (b) routine filings with the SEC under the
Exchange Act and the Securities Act as may be required in connection with this Agreement, (c) compliance with the applicable requirements of the HSR Act and such other Antitrust Laws as are set forth in Schedule 7.1(c), (d) compliance with the
applicable rules and regulations of the NYSE or (e) such other Consents or Filings the failure of which to obtain or make prior to the Closing would not be reasonably expected to have, individually or in the aggregate, a Parent Material Adverse
Effect.
Section 4.5
Litigation
. As of the date of this Agreement, there are no Proceedings pending, or to the Knowledge of
Parent, threatened in writing, against Parent or any of its Subsidiaries before any Governmental Entity, which has had or would be reasonably expected to have a Parent Material Adverse Effect. As of the date of this Agreement, there is no Order
outstanding against Parent or any of its Subsidiaries which has had or would be reasonably expected to have a Parent Material Adverse Effect.
Section 4.6
Operations of Merger Sub
. Merger Sub is a wholly owned Subsidiary of Parent, was formed solely for the purpose of
engaging in the Merger and the other transactions contemplated hereby, has engaged in no other business activities and has conducted its operations only as contemplated by this Agreement.
Section 4.7
No Vote of Parent Stockholders
. No vote of the stockholders of Parent or the holders of any other securities of Parent
(equity or otherwise) is required by Law, the Parent Charter or Parent Bylaws or the applicable rules of the NYSE in order for Parent to consummate the transactions contemplated by this Agreement, including the Merger and the Financing.
Section 4.8
Brokers and Finders Fees
. Except for Morgan Stanley & Co. LLC, the fees and expenses of which will be paid
by Parent, no broker, investment banker, financial advisor or other Person is entitled to any brokers, finders, financial advisors or other similar fee or commission in connection with the Merger or any of the other transactions
contemplated by this Agreement based upon arrangements made by or on behalf of Parent or any of its Subsidiaries.
Section
4.9
Available Funds
. Parent has delivered to the Company prior to the execution and delivery of this Agreement a true, correct and complete fully executed copy of the commitment letter, dated as of the date hereof, among Parent and
Morgan Stanley Senior Funding, Inc., including all exhibits, schedules, annexes and amendments to such letter in effect as of the date of this Agreement (the
Commitment Letter
), pursuant to the terms of which, and subject to the
conditions set forth therein, each of the Financing Sources party thereto has severally committed to lend the amounts set forth therein (the provision of such funds as set forth therein, and as may be modified to the extent permitted by this
Agreement, the
Financing
). The Commitment Letter has not been amended, restated or otherwise modified or waived prior to the execution and delivery of this Agreement, and the respective commitments contained in the Commitment
Letter have not been withdrawn, rescinded, amended, restated or otherwise modified in any respect prior to the execution and delivery of this Agreement. As of the date hereof, the Commitment Letter is in full force and effect and constitutes the
legal, valid and binding obligation of each of Parent and, to the Knowledge of Parent, the other parties thereto. There are no conditions precedent or contingencies (including pursuant to any flex provisions) related to the funding of
the full amount
A-30
of the Financing pursuant to the Commitment Letter, other than the conditions precedent expressly set forth in the Commitment Letter (the
Financing Conditions
). The proceeds of
the Financing (both before and after giving effect to the exercise of any or all market flex provisions related thereto), together with cash on hand of Parent and, in the event that Parent effects any long-term debt financing that
replaces all or a portion of the Financing in accordance with Section 6.14(d), the proceeds of such debt financing (any such long-term debt financing, a
Replacement Financing
), will be sufficient for the payment of the aggregate
amount of the Merger Consideration when due on the Closing Date and the payment of all costs, fees and expenses required to be borne by Parent and its Subsidiaries in connection with this Agreement on the Closing Date, as well as the repayment of
all outstanding indebtedness under the Amended and Restated Credit Agreement (such amounts, collectively, the
Merger Amounts
). As of the date hereof, no event has occurred which would constitute a breach or default (or an event
which with notice or lapse of time or both would constitute a default), on the part of Parent under the Commitment Letter or, to the Knowledge of Parent, any other party to the Commitment Letter, which breach or default would reasonably be expected
to result in the inability of Parent to satisfy any of the Financing Conditions on the Closing Date. Subject to the satisfaction of the conditions contained in Section 7.1 and Section 7.2, as of the date of this Agreement, Parent has no reason to
believe that any of the Financing Conditions will not be satisfied on or prior to the Closing Date. Except for fee letters with respect to fees and related arrangements with respect to the Financing, of which Parent has delivered true, correct and
complete copies (in a redacted form so long as such redaction does not cover terms that would adversely affect the conditionality, availability or termination of the Financing) to the Company prior to the execution and delivery of this Agreement,
there are no side letters or other agreements, Contracts or arrangements related to the funding of the full amount of the Financing, other than as expressly set forth in the Commitment Letter. Parent has fully paid (or caused to be paid) all
commitment fees, and other amounts required to be paid on or prior to the date of this Agreement in connection with the Financing.
Section 4.10
No Ownership of Company Common Stock
. Neither Parent nor any of its Subsidiaries (including Merger Sub) nor any of
Parents affiliates or associates (as such terms are defined in Section 203 of the DGCL and in Article Eleventh of the Company Charter), currently, or at any time in the three (3) years prior to the date of this
Agreement, (a) beneficially owns or owned, directly or indirectly, any shares of Company Common Stock or other securities convertible into, exchangeable for or exercisable for shares of Company Common Stock or any securities of any Subsidiary of the
Company, (b) has or had any rights to acquire any shares of Company Common Stock except pursuant to this Agreement and (c) is or was an interested stockholder of the Company, as such term is defined in Section 203 of the DGCL or
Article Eleventh of the Company Charter. There are no voting trusts or other agreements or understandings to which Parent or any of its Subsidiaries is a party with respect to the voting of the capital stock or other equity interest of the Company
or any of its Subsidiaries.
Section 4.11
No Other Representations and Warranties; Disclaimers
. Except for the representations
and warranties expressly contained in Article III, each of Parent and Merger Sub agrees and acknowledges that neither the Company nor any other Person on behalf of the Company is making or has made, and each of Parent and Merger Sub hereby agrees
that it is not relying upon, any other express or implied representation or warranty with respect to the Company or any of its Subsidiaries or with respect to any other information, including the accuracy or completeness of such other information,
provided or made available to Parent or Merger Sub in connection with the transactions contemplated by this Agreement, including information conveyed at management presentations, in virtual data rooms or in due diligence sessions and, without
limiting the foregoing, including any estimates, projections, predictions or other forward-looking information.
A-31
ARTICLE V
CONDUCT OF BUSINESS
Section
5.1
Conduct of Business by the Company
.
(a) From the date of this Agreement until the earlier of the Effective Time and
the date, if any, on which this Agreement is terminated in accordance with Section 8.1, except (i) as prohibited or required by applicable Law or Order, (ii) as set forth in Section 5.1 of the Company Disclosure Letter or (iii) as otherwise
required or expressly permitted by this Agreement, unless Parent shall otherwise consent (which consent shall not be unreasonably withheld, conditioned or delayed), the Company shall use reasonable best efforts to (x) conduct the businesses of the
Company and its Subsidiaries in the ordinary course in all material respects and (y) preserve intact, in all material respects, the business organization of the Company and its Subsidiaries and the current relationships of the Company and its
Subsidiaries with Persons having material business dealings with the Company or any of its Subsidiaries.
(b) Without limiting the
generality of the foregoing, from the date of this Agreement until the earlier of the Effective Time and the date, if any, on which this Agreement is terminated in accordance with Section 8.1, except (x) as prohibited or required by applicable Law,
(y) as set forth in Section 5.1 of the Company Disclosure Letter or (z) as otherwise required or permitted by this Agreement, unless Parent shall otherwise consent (which consent shall not be unreasonably withheld, conditioned or delayed), the
Company shall not, and shall not permit any of its Subsidiaries to:
(i) amend, modify, waive any provision of or
otherwise change its certificate of incorporation, bylaws or similar organizational documents;
(ii) (A) declare, set
aside, make or pay any dividend or other distribution (whether in cash, stock, property or otherwise) in respect of any of its capital stock, except for dividends or distributions by any direct or indirect Subsidiary of the Company to the Company or
to (1) any borrower or guarantor under the Amended and Restated Credit Agreement (a
Credit Agreement Obligor
) or (2) any other direct or indirect wholly owned Subsidiary of the Company, (B) adjust, split, combine, subdivide, or
reclassify any of its capital stock or securities convertible into capital stock or issue or propose or authorize the issuance of any other securities (including options, warrants or any similar security exercisable for, or convertible into, such
other security) in respect of, in lieu of, or in substitution for, shares of its capital stock, except with respect to the capital stock or securities of any direct or indirect wholly owned Subsidiary, in connection with transactions among the
Company and its direct or indirect wholly owned Subsidiaries or among the Companys direct or indirect wholly owned Subsidiaries or (C) repurchase, redeem or otherwise acquire, directly or indirectly, any shares of the capital stock or
securities of the Company or any of its Subsidiaries, or any other equity interests or any rights, warrants or options to acquire any such shares, securities or interests, except (1) for quarterly cash dividends in respect of shares of Company
Common Stock (and, with respect to Company RSU Awards and Company PSU Awards, dividends or dividend equivalents to the extent required by the terms of such awards as in effect on the date hereof) on a schedule consistent with the Companys
current practices and in an amount per share not in excess of $0.25 per quarter, (2) for acquisitions, or deemed acquisitions, of shares of Company Common Stock or other equity securities of the Company solely in connection with forfeitures of
awards, the exercise of Company Options or in connection with the vesting or settlement of Company RSU Awards or Company PSU Awards (including in satisfaction of any amounts required to be deducted or withheld under applicable Law), in each case
outstanding as of the date of this Agreement or (3) with respect to the capital stock or securities of any direct or indirect wholly owned Subsidiary, in connection with transactions among the Company and one or more of its direct or indirect wholly
owned Subsidiaries or among the Companys direct or indirect wholly owned Subsidiaries;
(iii) issue, sell,
grant, pledge, dispose of or otherwise encumber, or, with respect to any Subsidiary of the Company, transfer, any shares of its capital stock or other securities (including any options, warrants or
A-32
any similar security exercisable for, or convertible into, such capital stock or similar security), including Company Common Stock and/or Company Preferred Stock, except for (A) the issuance of
shares of Company Common Stock pursuant to Contracts in effect prior to the execution and delivery of this Agreement, true, correct and complete copies of which have been made available to Parent prior to the date hereof, (B) the issuance of shares
of Company Common Stock pursuant to the ESPP during the current offering period pursuant to participant elections and the terms thereof as of the date of this Agreement, (C) the issuance of shares of Company Common Stock in connection with the
exercise of Company Options or the vesting or settlement of Company RSU Awards or Company PSU Awards, in each case outstanding as of the date of this Agreement, (D) issuances by a wholly owned Subsidiary of the Company of capital stock to such
Subsidiarys parent, the Company or another wholly owned Subsidiary of the Company, (E) transfers to a Credit Agreement Obligor or (F) Liens granted by the Company and its Subsidiaries in connection with the Amended and Restated Credit
Agreement;
(iv) (A) merge or consolidate with any other Person, or (B) acquire any assets from or make an investment
in (whether through the acquisition of stock, assets or otherwise) any other Person (excluding Subsidiaries of the Company), except in the case of clause (B) for (1) acquisitions of inventory, equipment and other assets in the ordinary course of
business, (2) any such acquisition or investment where the consideration is not in excess of $5,000,000 individually or $25,000,000 in the aggregate, or (3) any capital expenditures permitted by Section 5.1(b)(vi);
(v) transfer, sell, lease, license, subject to a Lien (except for Permitted Liens or Liens granted by the Company and its
Subsidiaries in connection with the Amended and Restated Credit Agreement), divest, cancel, abandon, allow to lapse or expire or otherwise dispose of any assets (including any Owned Intellectual Property), product lines or businesses of the Company
or any of its Subsidiaries (including capital stock or other equity interests of any Subsidiary) except (A) pursuant to Contracts which were entered into in the ordinary course of business or which are set forth on Section 3.13(a)(vi) of the Company
Disclosure Letter, in each case, which are in effect prior to the execution and delivery of this Agreement and ordinary course renewals thereof, (B) sales, leases or licenses of inventory and dispositions of obsolete or surplus equipment in the
ordinary course of business consistent with past practice, (C) transfers, sales, leases, licenses or other dispositions between and/or among the Company or any of its Subsidiaries, (D) abandonment, cancellation, lapses or expirations of immaterial
Owned Intellectual Property in the ordinary course of business, (E) non-exclusive license grants to Owned Intellectual Property granted by the Company or any of its Subsidiaries in connection with the sale or distribution of products in the ordinary
course of business, (F) non-exclusive license grants to contract manufacturers that manufacture products on behalf of the Company or any of its Subsidiaries in the ordinary course of business and (G) any such transaction involving assets of the
Company or any of its Subsidiaries with a fair market value not in excess of $1,000,000 individually or $10,000,000 in the aggregate;
(vi) make any capital expenditures except to the extent set forth in, consistent with, the Companys capital
expenditure budget for the fiscal year ending December 2, 2017 (plus a 5% variance) that was made available to Parent prior to the date hereof;
(vii) (A) make any loans, advances (other than to directors and officers with respect to any indemnification obligation)
or capital contributions to any other Person other than in the ordinary course of business so long as such loans, advances or capital contributions are not material to the Company and its Subsidiaries, taken as a whole or (B) create, incur,
guarantee or assume any indebtedness for borrowed money, or issue or sell any debt securities or warrants or other rights to acquire any debt security of the Company or any of its Subsidiaries, in excess of $5,000,000 in the aggregate, except for,
in the case of each of clause (A) and clause (B), (1) transactions among the Company and its direct or indirect wholly owned Subsidiaries or among the Companys direct or indirect wholly owned Subsidiaries, (2) borrowings under the revolving
credit facility of the Companys Amended and Restated Credit Agreement that are (A) incurred in the ordinary course of business or (B) that are incurred in order to pay any fees and expenses of financial or other advisors of the Company in
connection with the transactions contemplated by this Agreement, (3) guarantees by the Company of indebtedness for borrowed money of any of its Subsidiaries
A-33
or guarantees by any of the Companys Subsidiaries of indebtedness of the Company or any of its Subsidiaries, which indebtedness is incurred in compliance with this clause (vii) or is
outstanding on the date hereof, (4) obligations in respect of letters of credit, performance bonds or similar instruments issued for the account of the Company and/or any of its Subsidiaries in the ordinary course of business, (5) any hedging, swap
or similar arrangement entered into in the ordinary course of business and consistent with the Companys Hedging Policy, (6) indebtedness for borrowed money incurred to replace, renew, extend, refinance or refund any existing indebtedness and
in amounts not materially in excess of such existing indebtedness, provided that such amounts are prepayable at any time without penalty or premium, or (C) cancel any debt of any Person owed to the Company or any of its Subsidiaries (other than in
connection with transactions between or among the Company and/or any of its Subsidiaries) or waive any claims or rights of value, except for cancellations or waivers that are not reasonably expected to be outside the ordinary course of business and
that are not in excess of $2,500,000 individually;
(viii) except as required by Contracts in effect prior to the date
of this Agreement, Company Benefit Plans as in effect on the date of this Agreement or applicable Law, (A) increase the compensation or other benefits payable or provided to the Companys or its Subsidiaries officers, directors or
employees; (B) enter into any employment, change of control, severance or retention agreement with any employee, director or officer of the Company or any of its Subsidiaries; (C) amend any Company Benefit Plan, except (1) in the ordinary course of
business consistent with past practices and as would not result in a material increase in cost to the Company and its Subsidiaries with respect to such Company Benefit Plan or (2) as is required to comply with Section 409A of the Code or other
applicable Law; (D) change in any material respect any actuarial or other assumptions used to calculate funding obligations with respect to any Company Benefit Plan or to change the manner in which contributions to such plans are made or the basis
on which such contributions are determined, except as may be required by applicable Law; (E) forgive any loans to directors, officers or employees of the Company or any of its Subsidiaries; or (F) hire or terminate without cause any executive
officer or any employee with a base salary in excess of $150,000.
(ix) other than in respect of claims, liabilities
or obligations in connection with any Transaction Litigation, which is subject to Section 6.10, (A) waive, release, settle or compromise any Proceeding for an amount in excess of the amount of the corresponding reserve established on the
consolidated balance sheet of the Company as reflected in the most recent applicable Company SEC Document, except (1) for any settlements or compromises involving payments not in excess of $1,000,000 individually or $5,000,000 in the aggregate, net
of any insurance and indemnity, contribution and similar obligations for the benefit of the Company or any of its Subsidiaries in respect thereof (it being understood that this clause (1) shall operate in addition to and not in limitation of clause
(A) above) and (2) settlements of any workers compensation or U.S. Equal Employment Opportunity Commission charges, or (B) agree or enter into any settlement agreement, consent decree, injunction or similar restraint or form of equitable
relief in settlement of any claim (including in connection with any Proceeding) or audit, in each case, that would materially restrict the operations of the business of the Company or its Subsidiaries after the Effective Time;
(x) (A) enter into any Contract that would have been a Company Material Contract under Sections 3.13(a)(vii), (viii), (ix)
or (x), (B) except in the ordinary course of business, enter into any Contract (other than those subject to clause (A) above) that would have been a Company Material Contract had it been entered into prior to this Agreement, or (C) except in the
ordinary course of business, materially amend or terminate any Company Material Contract, or cancel, modify or waive any material debts, rights or claims thereunder;
(xi) materially alter or amend any existing accounting methods, principles or material practices, except as may be
required by GAAP or applicable Law (including changes thereto);
(xii) (A) make or change any material Tax election
other than in the ordinary course of filing annual Tax Returns, (B) materially change any method of accounting of the Company or any of its Subsidiaries for Tax purposes, (C) file any material amended Tax Return, (D) settle, concede, compromise or
abandon any material Tax claim or assessment, (E) surrender any right to a refund of material Taxes, or (F) consent to
A-34
any extension or waiver of the limitation period applicable to any claim or assessment with respect to any U.S. federal, state or local income Tax Return;
(xiii) adopt or initiate any plan of complete or partial liquidation, dissolution, restructuring, closure or
recapitalization of the Company or any of its Subsidiaries or any of their respective operations or facilities to the extent outside of the ordinary course of business.
(xiv) fail to maintain in full force and effect material insurance policies or comparable replacement policies covering
the Company and its Subsidiaries and their respective properties, assets and businesses in a form and amount consistent with past practice; or
(xv) authorize, agree or obligate itself to take any of, the foregoing actions.
Section 5.2
No Control of the Companys Business
. The Company, on the one hand, and Parent and Merger Sub on the other,
acknowledge and agree that: (a) nothing contained in this Agreement shall give Parent or Merger Sub, directly or indirectly, the right to control or direct the Companys or its Subsidiaries operations prior to the Effective Time and (b)
prior to the Effective Time, each of the Company, Parent and Merger Sub shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its and its respective Subsidiaries operations.
Section 5.3
PBGC
. The Company and its Subsidiaries (as necessary) will timely submit, prior to the Closing Date, any
reportable event notices required under Section 4043 of ERISA to the Pension Benefit Guaranty Corporation (the
PBGC
) that become due as a result of this Agreement and will consult with Parent with respect to any such
notices prior to such submission. From and after the date of this Agreement, the Company will notify Parent promptly of any notice or other communication received by the Company or any of its Subsidiaries from the PBGC regarding any defined benefit
pension plan of the Company or any of its Subsidiaries. In the event of any such notice or communication, the Company will consult with Parent with respect to any communications with the PBGC or its representatives and will not enter into any
Contract with the PBGC without Parents prior consent (which shall not be unreasonably withheld, conditioned or delayed).
Section
5.4
Process
. Parent will, promptly following the date of this Agreement, designate two individuals from either of whom the Company may seek approval to undertake any actions not permitted to be taken under Section 5.1(b) and will cause
such individuals to respond, on behalf of Parent, to the Companys written requests in an expeditious manner but in any event, no later than three Business Days from delivery of the Companys request by email or facsimile as contemplated
by Section 9.2.
ARTICLE VI
ADDITIONAL AGREEMENTS
Section
6.1
Preparation of the Proxy Statement
.
(a) As soon as reasonably practicable following the date of this Agreement, and
in any event, within 20 Business Days (subject to Parents compliance in all material respects with this Section 6.1(a)) after the date of this Agreement, the Company shall prepare and file with the SEC the Proxy Statement in preliminary form.
The Company shall use reasonable best efforts to provide to Parent a substantially complete draft of the preliminary Proxy Statement as soon as reasonably practicable but in any event within 17 Business Days after the date of this Agreement. Each of
the Company and Parent shall furnish all information concerning itself and its Affiliates that is required to be included in the Proxy Statement or that is customarily included in proxy statements prepared in connection with transactions of the type
contemplated by this Agreement. Each of the Company and Parent covenant that none of the information supplied or to be supplied by such party for inclusion or incorporation in the Proxy Statement will, at the date it is first mailed to the
stockholders of the Company or at the time of the Company Stockholders Meeting, contain any untrue statement of a material fact or omit to state any material fact
A-35
required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. The Company shall promptly notify
Parent of the receipt of all comments from the SEC or the staff of the SEC with respect to the Proxy Statement and of any request by the SEC or the staff of the SEC for any amendment or supplement thereto or for additional information and will
promptly provide to Parent copies of all written correspondence between the Company and/or any of its Representatives, on the one hand, and the SEC or the staff of the SEC, on the other hand, with respect to the Proxy Statement. Each of the Company
and Parent shall use its reasonable best efforts to respond promptly to any comments from the SEC or the staff of the SEC on the Proxy Statement. The Company shall cause the definitive Proxy Statement to be mailed to the stockholders of the Company
(i) if the SEC provides comments to the preliminary Proxy Statement, as soon as reasonably practicable (and in any event within five Business Days) after the date the SEC staff confirms that it has no further comments thereon or (ii) if, within 10
calendar days after the filing of the preliminary Proxy Statement, the SEC has not indicated that it expects to have comments to the preliminary Proxy Statement, as soon as reasonably practicable (and in any event within 10 Business Days after such
10
th
calendar day). Except in the case of a filing, amendment or supplement to the Proxy Statement in connection with a Recommendation Withdrawal, no filing of, or amendment or supplement to, the
Proxy Statement shall be made by the Company, without providing Parent and its counsel a reasonable opportunity to review and comment thereon and giving due consideration to such comments.
(b) If at any time prior to the Company Stockholders Meeting (or any adjournment or postponement thereof) any information relating to the
Company or Parent, or any of their respective Affiliates, directors or officers, should be discovered by the Company or Parent which should be set forth in an amendment or supplement to the Proxy Statement, so that such document would not include
any misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the party which discovers such information shall promptly
notify the other parties and an appropriate amendment or supplement describing such information shall be promptly filed with the SEC and, to the extent required by Law, disseminated to the stockholders of the Company.
Section 6.2
Stockholders Meeting; Company Board Recommendation
. As promptly as reasonably practicable (and in any event no more
than 25 Business Days) after the date of mailing of the Proxy Statement, the Company, acting through its Board of Directors, and in accordance with applicable Law, the rules and regulations of NYSE and the Company Charter and Company Bylaws, shall
duly call, give notice of, convene and hold a meeting of the stockholders of the Company to consider and vote upon the adoption of this Agreement (the
Company Stockholders Meeting
). Notwithstanding anything in this Agreement to
the contrary, the Company shall be permitted to adjourn, delay or postpone the Company Stockholders Meeting (a) with the consent of Parent, (b) as of the time for which the Company Stockholders Meeting is scheduled, there are insufficient shares of
Company Common Stock represented (either in person or by proxy) to constitute a quorum necessary to conduct business at such Company Stockholders Meeting, (c) as of the time for which the Company Stockholders Meeting is scheduled, there are
insufficient shares of Company Common Stock with respect to which proxies have been submitted to vote in favor of the adoption of this Agreement to obtain the Company Stockholder Approval or (d) to allow additional time for the filing and/or mailing
of any supplemental or amended disclosure that the Company has determined in good faith (after consultation with its outside legal advisors) is required under applicable Law and for such supplemental or amended disclosure to be disseminated and
reviewed in compliance with applicable Law by the Companys stockholders prior to the Company Stockholders Meeting. Subject to Section 6.3, the Company shall include in the Proxy Statement the Company Board Recommendation and use its reasonable
best efforts to solicit the Company Stockholder Approval at the Company Stockholders Meeting. The Company shall keep Parent reasonably informed regarding its solicitation efforts and proxy tallies following the mailing of the Proxy Statement,
including by allowing Parent and its Representatives to participate in any substantive meeting or discussion with such proxy solicitor and directing such proxy solicitor to deliver proxy tally reports to Parent concurrently with delivery of such
reports to the Company. The Companys obligations pursuant to this Section 6.2 shall continue in full force and effect and shall not be affected by (i) the commencement, public proposal, public disclosure or communication to the Company of any
Acquisition Proposal, or (ii) the Board of Directors making a Recommendation Withdrawal.
A-36
Section 6.3
No Solicitation
.
(a) The Company shall immediately cease all existing discussions or negotiations with any Person (other than Parent and Merger Sub) that
may be ongoing with respect to an Acquisition Proposal and promptly inform any such Person of the obligations under this Section 6.3 and to return or destroy all confidential information. Except as permitted by this Section 6.3, from the date of
this Agreement until the earlier of the Effective Time or the date of termination of this Agreement in accordance with Section 8.1, the Company shall not, and shall cause each of its Subsidiaries and its and their respective officers, directors,
employees and agents not to, and shall direct each of its investment bankers, financial advisors, attorneys, accountants and other representatives (collectively,
Representatives
) not to, directly or indirectly, (i) solicit,
initiate or knowingly facilitate or encourage any inquiries or the making of any proposal or offer which constitutes, or could reasonably be expected to lead to, any Acquisition Proposal, (ii) furnish any nonpublic information regarding the Company
or its Subsidiaries to any Person in connection with or in response to an Acquisition Proposal, (iii) engage in, continue or otherwise participate in, any negotiations or discussions regarding any Acquisition Proposal or (iv) approve, recommend or
enter into, or propose to approve, recommend or enter into, any letter of intent, memorandum of understanding, agreement in principle, acquisition agreement, merger agreement or similar agreement (other than an Acceptable Confidentiality Agreement
entered into in accordance with the terms of this Section 6.3) with respect to any Acquisition Proposal.
(b) Notwithstanding
anything to the contrary contained in Section 6.3(a), if contacted by a Person making an Acquisition Proposal after the date of this Agreement (i) the Company and its Representatives may contact the Person making such Acquisition Proposal and its
Representatives to ascertain facts or clarify terms and conditions for the sole purpose of the Board of Directors of the Company informing itself about the Acquisition Proposal and the Person that made it and (ii) if, prior to obtaining Company
Stockholder Approval but not after, following the receipt of a bona fide written proposal, that did not result from a breach of Section 6.3, which the Board of Directors of the Company determines in good faith, after consultation with its advisors,
constitutes, or could reasonably be expected to lead to, a Superior Proposal, the Company and the Company Representatives may, in response to such Acquisition Proposal, and subject to compliance with Section 6.3(d), (A) furnish information with
respect to the Company and its Subsidiaries to the Person making such Acquisition Proposal and its Representatives and financing sources pursuant to an Acceptable Confidentiality Agreement;
provided
that, to the extent not previously made
available to Parent, the Company furnishes Parent with all such nonpublic information delivered to such Person promptly after its delivery to such Person and (B) engage in discussions or negotiations with such Person regarding such Acquisition
Proposal. A breach of this Section 6.3 by any Representative of the Company, acting by or on behalf of the Company, will constitute a breach by the Company of this Section 6.3.
(c) Notwithstanding any other provision of this Agreement, including Section 6.1 and Section 6.2, but subject to compliance with this
Section 6.3, prior to receipt of the Company Stockholder Approval but not after, the Board of Directors of the Company or any committee thereof may, in response to any unsolicited, bona fide Acquisition Proposal from any Person that did not result
from a breach of this Section 6.3, (i) withdraw (or modify or qualify in a manner adverse to Parent) the Company Board Recommendation, (ii) fail to include the Company Board Recommendation in the Proxy Statement or (iii) approve, adopt or recommend,
or publicly propose to approve, adopt or recommend, any Acquisition Proposal (any action described in these clauses (i), (ii) or (iii) being referred to as a
Recommendation Withdrawal
), and subject to compliance with this Section
6.3(c) and Section 8.3(a), terminate this Agreement in order to enter into a binding, definitive acquisition agreement, merger agreement or similar agreement in respect of such Acquisition Proposal, if (A) the Board of Directors of the Company
concludes in good faith, after consultation with its outside financial advisors and outside legal counsel, that such Acquisition Proposal constitutes a Superior Proposal; (B) the Board of Directors of the Company concludes in good faith, after
consultation with its outside legal counsel, that the failure to make a Recommendation Withdrawal would be inconsistent with its fiduciary duties to the stockholders of the Company under applicable Law; (C) the Board of Directors of the Company,
prior to making a Recommendation Withdrawal or terminating this Agreement, as applicable, provides Parent four Business Days prior written notice
A-37
of its intention to take such action, which notice shall include the information with respect to such Acquisition Proposal that is specified in Section 6.3(d), as well as a copy of such
Acquisition Proposal (it being agreed that the delivery of such notice by the Company shall not constitute a Recommendation Withdrawal); (D) during the four Business Days following such written notice (or such shorter period as is specified below),
if requested by Parent, the Board of Directors of the Company and its Representatives shall have negotiated in good faith with Parent regarding any revisions to the terms of this Agreement proposed by Parent in response to such Acquisition Proposal;
and (E) at the end of the four Business Day period described in the foregoing clause (D), the Board of Directors of the Company concludes in good faith, after consultation with its outside legal counsel and financial advisors (and taking into
account any adjustment or modification of the terms of this Agreement proposed by Parent), that the Acquisition Proposal continues to be a Superior Proposal and that the failure to make a Recommendation Withdrawal in respect of a Superior Proposal
would be inconsistent with its fiduciary duties to the stockholders of the Company under applicable Law. Any material amendment to any Superior Proposal will be deemed to be a new Acquisition Proposal for purposes of this Section 6.3(c);
provided
,
however
, that the notice period and the period during which the Company and its Representatives are required, if requested by Parent, to negotiate with Parent regarding any revisions to the terms of this Agreement proposed in
writing by Parent in response to such new Acquisition Proposal pursuant to clauses (C), (D) and (E) above shall expire two Business Days after the Company provides written notice of such new Acquisition Proposal to Parent.
(d) In addition to the obligations of the Company set forth in Section 6.3(a), Section 6.3(b) and Section 6.3(c), the Company shall
promptly, and in any event no later than 48 hours after it receives any Acquisition Proposal or request for information, advise Parent in writing of any request for confidential information in connection with an Acquisition Proposal or of any
Acquisition Proposal, the material terms and conditions of such request or Acquisition Proposal and the identity of the Person making such request or Acquisition Proposal and, if applicable, provide copies of any such written request or Acquisition
Proposal, including any proposed agreements between the Company and the parties making the Acquisition Proposal, to Parent and shall keep Parent reasonably informed on a reasonably current basis (but in no event more often than once every 48 hours)
of all material modifications to the terms of any Acquisition Proposal.
(e) Nothing in this Agreement shall prohibit or restrict the
Board of Directors of the Company, from effecting, and the Board of Directors of the Company may effect, a Recommendation Withdrawal at any time prior to obtaining the Company Stockholder Approval, but not after, if (i) an Intervening Event has
occurred and is continuing and (ii) the Board of Directors of the Company concludes in good faith, after consultation with its outside legal counsel, that the failure to effect a Recommendation Withdrawal in response to such Intervening Event would
be inconsistent with its fiduciary duties to the stockholders of the Company under applicable Law;
provided
,
however
, that no Recommendation Withdrawal pursuant to this Section 6.3(e) may be made unless (i) the Board of Directors of
the Company provides Parent four Business Days prior written notice that it intends to take such action and provides reasonable detail with respect to such Intervening Event (it being agreed that the delivery of such notice by the Company shall not
constitute a Recommendation Withdrawal) and (ii) during the four Business Days following such written notice, if requested by Parent, (A) the Board of Directors of the Company and its Representatives shall have negotiated in good faith with Parent
regarding any revisions to the terms of this Agreement proposed by Parent in response to such notice and (B) at the end of such four Business Day period, the Board of Directors of the Company concludes in good faith, after consultation with its
outside legal counsel and financial advisors (and taking into account any adjustment or modification of the terms of this Agreement proposed by Parent), that the failure to make a Recommendation Withdrawal would be inconsistent with its fiduciary
duties to the stockholders of the Company under applicable Law.
(f) Nothing contained in this Section 6.3 shall prohibit the Company
or the Board of Directors of the Company from (i) taking and disclosing to the stockholders of the Company a position contemplated by Rule 14e-2(a) under the Exchange Act or making a statement contemplated by Item 1012(a) of Regulation M-A or Rule
14d-9 under the Exchange Act, (ii) making any disclosure to the stockholders of the Company if the Board of Directors of the Company determines in good faith, after consultation with its outside legal counsel, that the failure to make such
disclosure would be inconsistent with applicable Law or (iii) informing any Person of the
A-38
existence of the provisions contained in this Section 6.3;
provided
, that any Recommendation Withdrawal may only be made in accordance with Section 6.3(c) or Section 6.3(e); and
provided
,
further
, that if any disclosure permitted under clause (i) above or, to the extent related to an Acquisition Proposal or Intervening Event, clause (ii) above does not reaffirm the Company Board Recommendation, such disclosure
will be deemed to be a Recommendation Withdrawal and Parent will have the right to terminate this Agreement as set forth in Section 8.1(c)(ii); it being understood that, notwithstanding anything herein to the contrary, any stop, look and
listen communication to the stockholders of the Company pursuant to Rule 14d-9(f) under the Exchange Act shall not in and of itself be deemed to be or constitute a Recommendation Withdrawal. Notwithstanding anything in this Agreement to the
contrary, a factually accurate statement that describes the Companys receipt of an Acquisition Proposal and the operation of this Agreement with respect thereto shall not, in and of itself, be deemed to be a Recommendation Withdrawal.
(g) For purposes of this Agreement:
Acquisition Proposal
means any proposal or offer (whether or not in writing) from any Person (other than Parent or any of
its Subsidiaries or Affiliates) relating to, or that would reasonably be expected to lead to, (i) any direct or indirect acquisition or purchase, in one transaction or a series of related transactions, of assets (including equity securities of any
Subsidiary of the Company) or businesses that constitute 20% or more of the assets of the Company and its Subsidiaries, taken as a whole, or 20% or more of any class of equity securities of the Company, (ii) any tender offer or exchange offer that
if consummated would result in any Person or group of Persons beneficially owning (which has the meaning under Section 13(d) of the Exchange Act) securities of the Company representing 20% or more of the aggregate voting power of all securities of
the Company or (iii) any merger, consolidation, business combination, recapitalization, liquidation, dissolution, joint venture, share exchange or similar transaction involving the Company or any of its Subsidiaries, in each case, pursuant to which
any Person or the stockholders of any Person would own securities of the Company or of any resulting direct or indirect parent company of the Company representing 20% or more of the aggregate voting power of all securities of the Company or of any
resulting direct or indirect parent company of the Company.
Intervening Event
means a material event or circumstance
that first arises or occurs after the date of this Agreement and prior to the Company Stockholder Approval that was not known and was not reasonably foreseeable to the Board of Directors of the Company on the date of this Agreement, which material
event or circumstance becomes known to the Board of Directors of the Company prior to the time at which the Company obtains the Company Stockholder Approval and does not relate to (i) any Acquisition Proposal (which shall be addressed by and be
subject to Section 6.3), (ii) the Requisite Regulatory Approvals or any action taken by Parent or Merger Sub or any of their Subsidiaries or Affiliates in accordance with Section 6.2 or the consequences of any such action, (iii) changes in the
market price or trading volume of shares of Company Common Stock (except that the facts or occurrences giving rise to or contributing to any such change, to the extent such facts or circumstances otherwise fall within the definition of
Intervening Event, may be considered in evaluating whether an Intervening Event has occurred) or (iv) the Company or any of its Subsidiaries exceeding, or failing to meet, internal or published projections, forecasts, estimates or
predictions in respect of revenues, earnings or other financial or operating metrics for any period (except that the facts or occurrences giving rise to or contributing to the foregoing, to the extent such facts or occurrences otherwise fall within
the definition of Intervening Event, may be considered in evaluating whether an Intervening Event has occurred).
Superior Proposal
means any unsolicited bona fide written Acquisition Proposal (with all references to 20% in
the definition of Acquisition Proposal being deemed to be references to 50%) made that is on terms that the Board of Directors of the Company determines in good faith (after consulting with its financial advisor and outside legal
counsel), taking into account the timing and likelihood of consummation, legal, financial, regulatory and other aspects of the proposal (including any conditions to consummation and financing terms), and such other factors as the Board of Directors
considers to be appropriate, is more favorable to the stockholders of the Company than the Merger and the other transactions contemplated hereby (after taking into account any revisions to the terms of this Agreement pursuant to this Section 6.3).
A-39
Section 6.4
Access to Information
. The Company shall, and shall cause each of its
Subsidiaries to, afford the Representatives of Parent reasonable access during normal business hours to its and its Subsidiaries properties, books and records (including Tax records and information to the extent reasonably necessary to confirm
disclosures in the Proxy Statement) and personnel, and shall furnish, and shall cause to be furnished, as promptly as reasonably practicable to Parent consistent with its legal obligations and obligations pursuant to Contracts all other information
concerning the Companys and its Subsidiaries business, properties and personnel as Parent may reasonably request;
provided
,
however
, that (a) such access shall not unreasonably interfere with the business or operations of
the Company and its Subsidiaries, (b) the Company shall not be obligated to provide such access or information if the Company determines, in its reasonable judgment, that doing so would violate applicable Law or a Contract or obligation of
confidentiality owing to a third party, jeopardize the protection of the attorney-client or any other privilege, or expose such party to risk of liability for disclosure of sensitive or personal information (any such information, the
Restricted Information
) (provided that in such instances the Company shall inform Parent of the general nature of the access or information being withheld and, upon Parents request, reasonably cooperate with Parent to
provide such access or information in a manner that would not result in any of the outcomes described in the foregoing clause (b)) and (c) the Company will be permitted to redact any information or documentation provided to the extent that such
information or documentation includes competitively or commercially sensitive information;
provided
,
further
, that the Company may restrict the foregoing access to those Persons who have entered into or are bound by a confidentiality
agreement with it or who are Representatives of Parent that are permitted to have access to such information in accordance with the terms of the Confidentiality Agreement, and to the extent required by applicable Law or Contract to which the Company
or its respective Subsidiaries is a party. In conducting any inspection of any properties of the Company and its Subsidiaries, Parent and its Representatives shall not (i) unreasonably interfere with the business conducted at such property or (ii)
damage any property or any portion thereof. Prior to the Effective Time, Parent and its Representatives shall not have the right to conduct environmental testing or sampling at any of the facilities or properties of the Company or any of its
Subsidiaries. All information obtained pursuant to this Section 6.4 (or otherwise pursuant to this Agreement) shall continue to be governed by the Confidentiality Agreement which shall remain in full force and effect in accordance with its terms.
Nothing in this Section 6.4 shall require the Company to permit the inspection of, or to disclose, any Acquisition Proposals (except as required by Section 6.3) or any information regarding or related to the deliberations of the Board of Directors
of the Company with respect to the transactions contemplated by this Agreement, the entry into the Agreement or any materials provided to the Board of Directors of the Company in connection therewith.
Section 6.5
Consents, Approvals and Filings
.
(a) Upon the terms and subject to the conditions set forth in this Agreement, Parent and the Company shall, and shall cause their
respective Subsidiaries to, use their reasonable best efforts to take, or cause to be taken, as promptly as practicable, all actions necessary, proper or advisable to consummate the Merger as promptly as practicable, including to use reasonable best
efforts to, as promptly as practicable, (i) cause all of the conditions to Closing to be satisfied, (ii) prepare and file all filings and submissions under the HSR Act, in connection with the Requisite Regulatory Approvals and in connection with any
other Antitrust Law that the parties mutually agree is advisable (the
Other Antitrust Approvals
), (iii) obtain all Consents, Orders, actions or nonactions, waivers and clearances required under the HSR Act and in connection with
the Requisite Regulatory Approvals and the Other Antitrust Approvals and (iv) obtain all necessary material consents or waivers from non-Governmental Entity third parties (provided that in no event shall the Company or its Subsidiaries be obligated
to pay or to commit to pay to any Person whose consent or waiver is being sought any cash or other consideration, or make any accommodation or commitment or incur any liability or other obligation to such Person in connection with such consent or
waiver). In furtherance and not in limitation thereof, (i) not later than ten Business Days following the date of this Agreement or when the parties mutually agree advisable, the Company and Parent shall each make an appropriate filing of a
notification and report form pursuant to the HSR Act with the Federal Trade Commission and the Antitrust Division of the United States Department of Justice with respect to the Merger and the transactions contemplated hereby and (ii) not later than
twenty Business Days following the date of this Agreement or when the parties mutually agree advisable, the Company and Parent shall each
A-40
make the appropriate Filings in connection with the Requisite Regulatory Approvals, and when the parties mutually agree advisable with respect to the Other Antitrust Approvals. Parent and the
Company shall promptly notify the other party of any notice or other communication from any Governmental Entity received by such party alleging that such Governmental Entitys consent is or may be required in connection with or as a condition
of the Merger. If requested by Parent, the Company will promptly provide the Parent with a certificate executed by the Company that meets the requirements of Treasury Regulation Sections 1.897-2(h) and 1.1445-2(c)(3), dated no earlier than five days
prior to the Closing Date and in form and substance reasonably satisfactory to Parent, along with written authorization for Parent to deliver such certificate to the IRS on behalf of the Company upon Closing.
(b) The Company and Parent shall use reasonable best efforts to (i) cooperate and coordinate with the other party in the taking of
the actions contemplated by Section 6.5, (ii) provide such assistance as the other party may reasonably request in connection with the foregoing, including supplying the other party with any information that the other party may reasonably
request in order to effectuate the taking of such actions and (iii) keep the other party reasonably and timely informed of any developments, meetings, or discussions with any Governmental Entity under any Antitrust Laws, and any inquiries or
requests for additional information, from any Governmental Entity under any Antitrust Laws. If the Company or Parent receives a formal or informal request for additional information or documentary material from any Governmental Entity under any
Antitrust Laws with respect to the Merger or the transactions contemplated hereby, then it shall use reasonable best efforts to make, or cause to be made, as promptly as reasonably practicable and after consultation with the other party, an
appropriate response in compliance with such request. In addition, to the extent practicable, none of the parties shall agree to participate in any substantive meeting or conference (telephone, in-person or otherwise) with any Governmental Entity,
or any member of the staff of any Governmental Entity, in respect of any Filing, proceeding, investigation (including any settlement of the investigation), litigation, or other inquiry under any Antitrust Laws unless it consults with the other party
in advance and, where permitted by such Governmental Entity, allows the other party to participate. To the extent reasonably practicable, legal counsel for Parent and for the Company shall have the right to review in advance, and will consult with
the other party on and consider in good faith the views of the other party in connection with, all of the information relating to Parent or the Company, as the case may be, and any of their respective Subsidiaries and Representatives, that appears
in any Filing made with, or written materials submitted to, any third party or Governmental Entity in connection with the Merger and the other transactions contemplated hereby. In exercising the foregoing rights, each of Parent and the Company shall
act reasonably and as promptly as practicable. Subject to its obligations under this Section 6.5, Parent shall (i) have the principal responsibility for devising and implementing the strategy for obtaining any Requisite Regulatory Approvals or any
Other Antitrust Approvals and (ii) lead and direct all submissions to, meetings and communications with any Governmental Entity or other party in connection with related antitrust matters, including litigation matters with respect to any Antitrust
Laws;
provided
,
however
, that Parent shall consult in advance (to the extent reasonably practicable) with the Company, and in good faith take the Companys views into account regarding the overall strategic direction with respect
to such process, consult with the Company prior to taking any material substantive positions, making dispositive motions or other material substantive filings or submissions or entering in any negotiations concerning such approvals, if applicable.
Information disclosed pursuant to this Section 6.5 shall be subject to the Confidentiality Agreement and Section 6.5(e) hereof. Neither Parent nor the Company shall be required to comply with any of the foregoing provisions of this Section 6.5(b) to
the extent that such compliance would be prohibited by applicable Law. The parties shall not voluntarily extend any waiting period associated with any Consent of any Governmental Entity or enter into any agreement with any Governmental Entity not to
consummate the Merger and the other transactions contemplated hereby, except with the prior written consent of the other party(ies).
(c) In furtherance and not in limitation of the other provisions in this Section 6.5, Parent and Merger Sub agree to take, and to cause
their respective Subsidiaries (including, with respect to any action to be effective as of or after the Effective Time, the Company and its Subsidiaries) to take, in each case as promptly as practicable (and in any event prior to the Outside Date),
any and all steps necessary to avoid, eliminate or resolve each and every impediment under any Antitrust Law that may be asserted by any Governmental Entity and obtain all
A-41
clearances, consents, approvals and waivers under Antitrust Laws that may be required by any Governmental Entity (including complying with all restrictions and conditions, if any, imposed or
requested by any Governmental Entity in connection with granting any necessary Consent, Order, actions or nonactions, waiver or clearance, or terminating any applicable waiting period), so as to enable the parties to consummate the Merger and the
transactions contemplated hereby as soon as practicable (and in any event prior to the Outside Date), including proposing, negotiating, committing to and effecting, by consent decree, hold separate orders, trust, or otherwise, (i) the sale,
divestiture, license or other disposition of any Subsidiaries, operations, divisions, businesses, product lines, customers or assets of Parent and/or the Company or any of their respective Subsidiaries, (ii) any limitation or modification of any of
the businesses, services, products or operations of Parent and/or the Company or any of their respective Subsidiaries, (iii) the termination, relinquishment, modification, or waiver of existing relationships, ventures, contractual rights,
obligations or other arrangements of Parent and/or the Company or any of their respective Subsidiaries and/or (iv) the creation of any relationships, ventures, contractual rights, obligations or other arrangements of Parent and/or the Company or any
of their respective Subsidiaries (each a
Remedial Action
);
provided,
however
, that (i) Parent and the Company (and their respective Subsidiaries) will not be required to take any Remedial Action that is not
conditioned upon consummation of the Merger and (ii) notwithstanding anything in this Agreement to the contrary, Parent will not be required to take or commit to take any Remedial Action that would constitute a Triggering Divestiture. In addition,
in furtherance and not in limitation of the other provisions in this Section 6.5, Parent shall take all actions (A) necessary to defend, including through pursuing litigation on the merits, any administrative or judicial action or proceeding
asserted or threatened by any Governmental Entity or any other Person under Antitrust Laws (including pursuing all available avenues of administrative and/or judicial appeal) that seeks, or would reasonably be expected to seek, to prevent, restrain,
impede, delay, enjoin, or otherwise prohibit the consummation of the Merger and the transactions contemplated hereby and (B) necessary in order to avoid entry of, or to have vacated or terminated, any Order (whether temporary, preliminary or
permanent) entered, issued or threatened that would prevent, restrain, impede, delay, enjoin or otherwise prohibit the consummation of the Merger and the transactions contemplated hereby, prior to the Outside Date;
provided
,
however
,
that the obligations set forth in this sentence shall not limit the obligation of Parent to take, and/or to cause its Subsidiaries to take, any Remedial Action or to otherwise comply with its obligations set forth in this Section 6.5(c).
(d) Neither Parent nor the Company shall, and each shall cause its respective Subsidiaries not to, directly or indirectly, acquire,
purchase, lease or license (or agree to acquire, purchase, lease or license), by merging with or into or consolidating with, or by purchasing a substantial portion of the assets of or equity in, any business or any corporation, partnership,
association or other business organization or division or part thereof, or any securities or collection of assets, if doing so would reasonably be expected to: (i) impose any material delay in the obtaining of, or materially increase the risk of not
obtaining, any Consent, action or nonaction, waiver, clearance or exemption of any Governmental Entity necessary to consummate the Merger and the transactions contemplated hereby or the expiration or termination of any applicable waiting period;
(ii) materially increase the risk of any Governmental Entity entering an Order preventing, restraining, impeding, delaying, enjoining or otherwise prohibiting the consummation of the Merger and the other transactions contemplated hereby; (iii)
materially increase the risk of not being able to remove any such Order on appeal or otherwise or (iv) prevent or materially delay the consummation of the Merger and the transactions contemplated hereby.
(e) Notwithstanding anything to the contrary in this Section 6.5, (i) if any information or documentation provided by the delivering
party to the other party pursuant to this Section 6.5 contains competitively or commercially sensitive material, if requested by the delivering party, such information or documentation will only be provided to outside antitrust counsel of the
receiving party (and/or to such other individuals of the receiving party or the Representatives thereof to whom the delivering party expressly provides permission, including pursuant to the terms of that certain Joint Defense, Common Interest, and
Confidentiality Agreement, by and among the Company, Parent, and their respective counsel (the
Permitted Individuals
)), and shall not be disclosed by such outside antitrust counsel or other Permitted Individuals to any individuals
other than Permitted Individuals (including employees, officers or directors of the receiving party) unless express permission is
A-42
obtained in advance from the delivering party and (ii) any information or documentation provided pursuant to this Section 6.5 may be redacted to the extent necessary (A) to comply with any
contractual arrangement, (B) to remove references concerning valuation or (C) to address privilege or confidentiality concerns.
Section
6.6
Employee Matters
.
(a) Until the first anniversary of the Effective Time (the
Benefits Continuation
Period
), the Surviving Corporation shall provide, or cause to be provided, for those employees of the Company and its Subsidiaries who continue as employees of the Surviving Corporation or any of its Subsidiaries during all or a portion of
the Benefits Continuation Period (the
Continuing Employees
), compensation (including base salary or hourly wage rate and annual target and maximum bonus opportunity but excluding equity-based incentive compensation opportunities
and employee stock purchase plans) and employee benefits that in the aggregate shall be substantially similar to the compensation and employee benefits provided by the Company or the applicable Subsidiary to the Continuing Employees immediately
prior to the Effective Time. Notwithstanding the foregoing, with respect to the fiscal year during which the Closing occurs, the Surviving Corporation shall pay a pro rata portion of the bonus each Continuing Employee would be eligible to receive
under the Company Value Added Plan (the
CVA
) for such fiscal year as if the applicable performance goals had been achieved at the target level of performance based on the number of days that lapse beginning on the first day of
such fiscal year and ending on the Closing (provided such Continuing Employee is not otherwise eligible or entitled to receive a CVA cash bonus for the same period). Nothing herein shall be deemed to be a guarantee of employment for any current or
former employee of the Company or any of its Subsidiaries, or, other than as provided in any applicable employment agreement or other Contract, to restrict the right of Parent or the Surviving Corporation to terminate the employment of any such
employee.
(b) The Surviving Corporation shall use reasonable best efforts to (i) waive any applicable pre-existing condition
exclusions and waiting periods with respect to participation and coverage requirements in any replacement or successor welfare benefit plan of the Surviving Corporation in which a Continuing Employee is eligible to participate following the
Effective Time to the extent such exclusions or waiting periods were inapplicable to, or had been satisfied by, such Continuing Employee immediately prior to the Effective Time under the analogous Company Benefit Plan in which such Continuing
Employee participated, (ii) provide each Continuing Employee with credit for any co-payments and deductibles paid prior to the Effective Time during the plan year that includes the Effective Time (to the same extent such credit was given under the
analogous Company Benefit Plan prior to the Effective Time) in satisfying any applicable deductible or out-of-pocket requirements for the plan year that includes the Effective Time and (iii) recognize service prior to the Effective Time with the
Company or any of its Subsidiaries for purposes of eligibility to participate and vesting and level of benefits for vacation and severance benefits under any employee benefit plan of the Surviving Corporation in which a Continuing Employee is
eligible to participate following the Effective Time that is analogous and corresponding to a Company Benefit Plan in which such Continuing Employee participated immediately prior to the Effective Time to the same extent such service was recognized
by the Company or any of its Subsidiaries under such analogous and corresponding Company Benefit Plan;
provided
,
however
, that the foregoing shall not apply to the extent it would result in any duplication of benefits for the same
period of service;
provided
,
further
, that, for the avoidance of doubt, the Surviving Corporation shall not be obligated to provide credit for years of service for benefit accrual purposes under any defined benefit pension plan
maintained by the Surviving Corporation or its Subsidiaries prior to the date on which the Continuing Employee actually becomes a participant in such plan (it being understood that the Surviving Corporation shall in all cases provide credit for
years of service for benefit accrual as required by any Company Benefit Plan).
(c) If requested by Parent in writing within 30
Business Days prior to the Effective Time, effective immediately prior to, and contingent upon, the Effective Time, the Company will adopt such resolutions and/or amendments to terminate each Company Benefit Plan listed in Section 6.6(c) of the
Company Disclosure Letter (each, a
Terminated Plan
). Prior to the Effective Time, the Company will provide Parent with a copy of the resolutions and/or plan amendments (the form and substance of which will be subject to review and
approval by Parent) evidencing that each Terminated Plan has been terminated.
A-43
(d) From and after the Effective Time, Parent shall or shall cause the Surviving Corporation
to honor, in accordance with its terms, each change in control agreement and nonqualified deferred compensation plan identified in Section 6.6(d) of the Company Disclosure Letter and each other Company Benefit Plan expressly requiring the Surviving
Corporation or its successor to assume such Company Benefit Plan. Parent and Merger Sub acknowledge that the consummation of the Merger and the transactions contemplated by this Agreement will constitute a change in control of the Company under the
terms of the Company Benefit Plans containing provisions triggering payment, vesting or other rights upon a change in control or similar transaction.
(e) Notwithstanding any other provision of this Agreement to the contrary, Parent shall or shall cause the Surviving Corporation to
provide Continuing Employees who experience a qualifying employment termination during the Benefits Continuation Period with severance benefits as set forth on Section 6.6(e) of the Company Disclosure Letter.
(f) If requested by Parent in writing within 30 days prior to the Effective Time, the Company will, at least one day prior to the
Effective Time, adopt the amendments described in Section 6.6(f) of the Company Disclosure Letter, in a form reasonably satisfactory to Parent, to the benefit plans and arrangements set forth and described on Section 6.6(f) of the Company Disclosure
Letter. Prior to the Effective Time, the Company will provide Parent with a copy of the amendments evidencing that such amendments have been adopted.
(g) Notwithstanding anything contained herein to the contrary, with respect to any Continuing Employees who are covered by a collective
bargaining agreement or labor union contract or who are based outside of the United States, Parent s obligations under this Section 6.6 shall be in addition to, but without duplication, and not in contravention of, any obligations under the
applicable collective bargaining agreement or labor union contract or under the Laws of the foreign countries and political subdivisions thereof in which such Continuing Employees are based.
(h) Nothing contained in this Agreement, whether express or implied, (i) shall be treated as an amendment or other modification of any
Company Benefit Plan or any employee benefit plan maintained or sponsored by Parent or its Subsidiaries, (ii) shall create any third-party beneficiary rights in any Continuing Employee or any other Person or (iii) shall limit the right of Parent or
the Surviving Corporation or any of their Subsidiaries to amend, terminate or otherwise modify any Company Benefit Plan following the Closing Date.
Section 6.7
Expenses
. Whether or not the Merger is consummated, all expenses incurred in connection with this Agreement and the
transactions contemplated hereby shall be paid by the party incurring such expenses, except as otherwise provided in this Agreement (including Section 6.8 and Section 6.15(b)).
Section 6.8
Directors and Officers Indemnification and Insurance
.
(a) From and after the Effective Time, Parent shall cause the Surviving Corporation, to the fullest extent permitted by Law (including to
the fullest extent authorized or permitted by any amendments to or replacements of applicable Law adopted after the date of this Agreement that increase the extent to which indemnification may be provided), to indemnify, defend and hold harmless
(and promptly advance expenses from time to time as incurred to the fullest extent permitted by Law,
provided
, the Person to whom expenses are advanced provides a reasonable and customary undertaking (which shall not include posting of any
collateral) to repay such advances, if it is ultimately determined that such Person is not entitled to indemnification) each Person who is now, or has been at any time prior to the Effective Time or who becomes prior to the Effective Time, a
director or officer of the Company or any of its Subsidiaries, any Person acting as director, officer, trustee, fiduciary, employee or agent of another entity or enterprise (including any Company Benefit Plan) who is or has acted as such at the
request of the Company (each an
Indemnified Party
) from and against any and all costs or expenses (including attorneys fees, expenses and disbursements), judgments, fines, losses, claims, damages, penalties, liabilities and
amounts paid in settlement or incurred in connection with any actual or threatened claim (including a claim of violation of applicable Law), action, audit, demand, suit, proceeding or investigation, whether civil, criminal,
A-44
administrative, regulatory or investigative or other proceeding at law or in equity or order or ruling, arising out of, relating to or in connection with any circumstances, developments or
matters in existence, or acts or omissions occurring or alleged to occur prior to or at the Effective Time (including by reason of such Indemnified Partys service as such a director or officer of the Company or its Subsidiaries or as such a
director, officer, trustee, fiduciary, employee or agent of another Person), including the approval of this Agreement and the Merger and the other transactions contemplated hereby or arising out of or pertaining to the Merger and the other
transactions contemplated hereby, whether asserted or claimed prior to, at or after the Effective Time. Parent and the Surviving Corporation shall reasonably cooperate with any Indemnified Party in the defense of any matter covered by this Section
6.8.
(b) Subject to the following sentence, the Surviving Corporation shall, and Parent shall cause the Surviving Corporation to, at
no expense to the beneficiaries, either (i) continue to maintain in full force and effect for six years from the Effective Time, if available, the current directors and officers liability insurance and fiduciary liability insurance (the
Current Insurance
) with respect to matters existing or occurring at or prior to the Effective Time (including the Merger and the other transactions contemplated hereby);
provided
that the Surviving Corporation may
substitute for the Current Insurance policies of at least the same coverage containing terms and conditions that are not less favorable in the aggregate with respect to matters existing or occurring at or prior to the Effective Time (including the
Merger and the other transactions contemplated hereby); or (ii) purchase a six year extended reporting period endorsement with respect to the Current Insurance (a
Reporting
Tail Endorsement
) and maintain this endorsement in
full force and effect for its full term. To the extent purchased after the date of this Agreement and prior to the Effective Time, such insurance policies shall be placed through such broker(s) and with such insurance carriers as may be specified by
Parent and as are reasonably acceptable to the Company;
provided
that such insurance carrier has at least an A rating by A.M. Best with respect to directors and officers liability insurance and fiduciary liability
insurance. Notwithstanding the first sentence of this Section 6.8(b), but subject to the second sentence of this Section 6.8(b), the Company will use reasonable best efforts to purchase a Reporting Tail Endorsement prior to the Effective Time upon
terms and conditions reasonably acceptable to each of Parent and the Company. Notwithstanding the foregoing, in no event shall Parent or the Surviving Corporation be required to expend for such policies an annual premium amount in excess of 300% of
the annual premiums currently paid by the Company for such insurance; and, if the annual premiums of such insurance coverage exceed such amount, the Surviving Corporation shall obtain a policy with the greatest coverage available for a cost not
exceeding such amount;
provided
that in the event of the Current Insurance, Parent or the Surviving Corporation shall be required to obtain as much coverage as is possible under substantially similar policies for such maximum annual amount in
aggregate annual premiums.
(c) The certificate of incorporation and bylaws of the Surviving Corporation shall include provisions for
indemnification, advancement and reimbursement of expenses and exculpation of the Indemnified Parties on the same basis as set forth in the Company Charter and the Company Bylaws in effect on the date of this Agreement. Following the Effective Time,
the Surviving Corporation shall, and Parent shall cause the Surviving Corporation to, maintain in effect the provisions in its certificate of incorporation and bylaws providing for indemnification, advancement and reimbursement of expenses and
exculpation of Indemnified Parties, as applicable, with respect to the facts or circumstances occurring at or prior to the Effective Time, to the fullest extent permitted from time to time under applicable Law, which provisions shall not be amended
except as required by applicable Law or except to make changes permitted by applicable Law that would enlarge the scope of the Indemnified Parties indemnification and advancement rights thereunder.
(d) If Parent or the Surviving Corporation or any of their respective successors or assigns (i) consolidates with or merges into any
other Person and is not the continuing or surviving corporation or entity of such consolidation or merger or (ii) transfers all or substantially all of its properties and assets to any Person, then, and in each such case, Parent shall cause proper
provisions to be made prior to the consummation of any transaction of the type described in clause (i) or clause (ii) of this sentence so that the successors and assigns of Parent or the Surviving Corporation, as the case may be, shall assume all of
the obligations set forth in this Section 6.8.
A-45
(e) From and after the Effective Time, Parent and the Surviving Corporation shall not,
directly or indirectly, amend, modify, limit or terminate the advancement and reimbursement of expenses, exculpation, indemnification provisions of the agreements listed in Section 6.8(e) of the Company Disclosure Letter between the Company or any
Subsidiary and any of the Indemnified Parties, or any such provisions contained in the Surviving Corporation bylaws.
(f) This
Section 6.8 is intended for the irrevocable benefit of, and to grant third-party rights to, the Indemnified Parties and shall be binding on all successors and assigns of Parent and the Surviving Corporation. The obligations of Parent and the
Surviving Corporation under this Section 6.8 shall not be terminated or modified in such a manner as to adversely affect any Indemnified Party unless the affected Indemnified Party shall have consented in writing to such termination or modification.
It is expressly agreed that each Indemnified Party shall be a third-party beneficiary of this Section 6.8, and entitled to enforce the covenants contained in this Section 6.8. If any Indemnified Party makes any claim for indemnification or
advancement of expenses under this Section 6.8 that is denied by Parent and/or the Surviving Corporation, and a court of competent jurisdiction determines that the Indemnified Party is entitled to such indemnification or advancement, then Parent or
the Surviving Corporation shall pay such Indemnified Partys costs and expenses, including legal fees and expenses, incurred in connection with pursuing such claim against Parent and/or the Surviving Corporation. The rights of the Indemnified
Parties under this Section 6.8 shall be in addition to, and not in substitution for, any rights such Indemnified Parties may have under the Company Charter and the Company Bylaws, the certificate of incorporation and bylaws (or comparable
organizational documents) of any of the Companys Subsidiaries or the bylaws of the Surviving Corporation or under any applicable Contracts, insurance policies or Laws and Parent shall, and shall cause the Surviving Corporation to, honor and
perform under all indemnification agreements entered into by the Company or any of its Subsidiaries.
(g) Nothing in this Agreement
is intended to, shall be construed to or shall release, waive or impair any rights to directors and officers insurance claims under any policy that is or has been in existence with respect to the Company or any of its respective
Subsidiaries for any of their respective directors, officers or other employees, it being understood and agreed that the indemnification provided for in this Section 6.8 is not prior to or in substitution for any such claims under such policies.
Section 6.9
Public Announcements
. The initial press release concerning this Agreement and the transactions contemplated
hereby shall be a joint press release approved in advance by the Company and Parent. Following such initial press release, Parent and the Company shall consult with each other before issuing, and give each other the opportunity to review and comment
upon, any press release or other public statements with respect to the Merger and the other transactions contemplated hereby and shall not issue any such press release or make any such public statement prior to such consultation, except as such
party may reasonably conclude may be required by applicable Law, court process or by obligations pursuant to any listing agreement with any national securities exchange or national securities quotation system;
provided
,
however
, that
the restrictions set forth in this Section 6.9 shall not apply to any press release or other public statement (a) to the extent, but only to the extent, such press release or other public statement relates to a Recommendation Withdrawal, or (b) that
is consistent in all material respects with previous press releases or other public statements that were made in compliance with this Section 6.9.
Section 6.10
Transaction Litigation
. The Company shall promptly notify Parent in writing of any stockholder litigation or other
litigation or proceedings arising from this Agreement or the Merger that is brought against the Company or any of its Affiliates or members of its board of directors (
Transaction Litigation
). The Company shall keep Parent
sufficiently informed on a reasonably current basis with respect to the status of any Transaction Litigation (including by promptly furnishing to Parent such information relating to the Transaction Litigation as may be reasonably requested). The
Company shall give Parent the opportunity to participate in the defense (at Parents sole cost and subject to a joint defense agreement) of any Transaction Litigation. No settlement of any Transaction Litigation shall be agreed to by the
Company without Parents prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed).
A-46
Section 6.11
State Takeover Laws
. The Company and Parent shall each use reasonable
best efforts to ensure that no Takeover Statute (or any comparable anti-takeover provisions of the Company Charter or Company Bylaws) is or becomes applicable to this Agreement, the Merger or the other transactions contemplated hereby. If any
Takeover Statute (or any comparable anti-takeover provisions of the Company Charter or Company Bylaws) becomes applicable to this Agreement, the Merger or the other transactions contemplated hereby, the Company and Parent shall each use reasonable
best efforts to ensure that the Merger and the other transactions contemplated hereby may be consummated as promptly as practicable on the terms contemplated by this Agreement and otherwise to minimize the effect of such Law (or provision) on this
Agreement, the Merger and the other transactions contemplated hereby.
Section 6.12
Delisting
. Prior to the Effective Time,
the Company and, following the Effective Time, Parent and the Surviving Corporation, shall use reasonable best efforts to take, or cause to be taken, all actions, and do or cause to be done all things, necessary, proper or advisable under applicable
Law and rules and policies of the NYSE to delist the Company and the Company Common Stock from the NYSE as soon as practicable following the Effective Time and terminate its registration under the Exchange Act as soon as practicable following such
delisting.
Section 6.13
Section 16(b)
. Prior to the Effective Time, the Company shall take all steps reasonably necessary to
cause the transactions contemplated hereby and any other dispositions of equity securities of the Company (including derivative securities) in connection with the transactions contemplated hereby by each individual who is a director or executive
officer of the Company to be exempt under Rule 16b-3 promulgated under the Exchange Act.
Section 6.14
Financing
.
(a) Parent shall use its reasonable best efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things
necessary, proper or advisable to consummate the Financing contemplated by the Commitment Letter (or any Substitute Financing) on or prior to the Closing Date, including (i) complying with its obligations under the Commitment Letter, (ii)
negotiating and entering into definitive agreements with respect to the Financing on the terms and subject to the conditions contemplated by the Commitment Letter (or with other terms and conditions agreed by Parent, the Company and the Financing
Sources), including, if necessary, any market flex provisions (such definitive agreements, including any such definitive agreements entered into in connection with any Substitute Financing, the
Financing Agreements
),
(iii) satisfying (or, if deemed advisable by Parent, pursuing a waiver of) on a timely basis all the conditions to the Financing contemplated by the Commitment Letter and the Financing Agreements, in each case, within the control of Parent, (iv)
complying with any market flex contemplated by the Commitment Letter (including the fee letter relating thereto) and the Financing Agreements and (v) if the Financing is necessary to consummate the transactions contemplated hereby and
pay the Merger Amounts and the conditions set forth in Section 7.1 and Section 7.2 of this Agreement have been satisfied (other than those conditions that by their nature or terms, are to be satisfied at Closing, but subject to the satisfaction or,
to the extent permitted by applicable Law, waiver of such conditions) and the conditions set forth in Exhibit B to the Commitment Letter have been satisfied or upon funding would be satisfied, causing the Financing Sources to fund the Financing in
accordance with its terms on the Closing Date in the event the conditions set forth in Section 7.1 and Section 7.2 of this Agreement have been satisfied (other than those conditions that by their nature or terms, are to be satisfied at Closing, but
subject to the satisfaction or, to the extent permitted by applicable Law, waiver of such conditions), and the conditions to the Financing have been satisfied or, upon funding would be satisfied, in each case to the extent the Financing is needed to
consummate the transactions contemplated hereby and pay the Merger Amounts.
(b) Parent shall give the Company prompt written notice
(i) of, to the Knowledge of Parent, any material breach or default (or any event or circumstance that, with or without notice, lapse of time or both, could reasonably be expected to give rise to any material breach or default) by any party to the
Commitment Letter or any Financing Agreements, (ii) of, to the Knowledge of Parent, any withdrawal, repudiation or termination of the
A-47
Financing by any Financing Sources, (iii) of, to the Knowledge of Parent, any material dispute or disagreement between or among the parties to the Commitment Letter or any Financing Agreements,
(iv) of, to the Knowledge of Parent, any material amendment or modification of, or waiver under, the Commitment Letter or (v) if for any reason Parent believes in good faith that it will not be able to timely obtain all or any portion of the
Financing on the terms, in the manner or from the sources contemplated by the Commitment Letter or any Financing Agreements. Parent shall keep the Company informed on a reasonably current basis of the status of its efforts to arrange the Financing
contemplated by the Commitment Letter, including providing the Company complete, correct and executed copies of (A) any material amendment, waiver or modification of the Commitment Letter (including all exhibits, schedules and annexes thereto) or
any commitment letter (including all exhibits, schedules and annexes thereto and fee letters, provided that fee letters may be in redacted form so long as such redaction does not cover terms that would adversely affect the conditionality,
availability or termination of the Financing) with respect to any Substitute Financing or Replacement Financing and (B) the Financing Agreements.
(c) Parent shall not agree to any termination, amendment or other modifications to the Commitment Letter without the prior written
consent of the Company if such termination, amendment or other modification (i) would reduce the aggregate amount of the Financing below the amount necessary to pay the Merger Amounts or (ii) would impose new or additional conditions or would
otherwise modify any conditions or other terms to the Financing in a manner that would be reasonably likely to (A) materially delay or prevent the Closing or (B) make the timely funding of the Financing or satisfaction of the Financing Conditions
materially less likely to occur, other than, in each case, (1) a waiver of any closing conditions by any Financing Sources or their agent or (2) to add lenders, lead arrangers, bookrunners, syndication agents or similar entities who had not executed
the Commitment Letter as of the date hereof or to reassign titles to such parties who had executed the Commitment Letter as of the date hereof;
provided
, that Parent shall have the right to substitute other financing for all or any portion of
the Financing from the same or alternative Financing Sources as set forth (and subject to the requirements) in this Section 6.14, without the Companys prior written consent (except as otherwise required below). Upon any such amendment,
modification or substitution (including with any Replacement Financing), the term Commitment Letter and Financing Agreements shall mean the Commitment Letter or Financing Agreement, as applicable, as so amended or modified;
provided
, that in the event the commitments under the Commitment Letter are reduced as a result of or in connection with any Replacement Financing, the term Financing shall be deemed to include such Replacement Financing.
(d) Parent shall have the right to substitute the proceeds of consummated equity offerings or debt offerings or other incurrences of debt
for all or any portion of the Financing contemplated by the Commitment Letter by reducing commitments under the Commitment Letter;
provided
, that (i) to the extent any such equity or debt has a scheduled special or mandatory redemption right,
such right is not exercisable prior to the earliest of the consummation of the Merger on the Closing Date, the termination of this Agreement, and the Outside Date and (ii) the conditions to the use of such proceeds to pay the aggregate Merger
Consideration shall be no more restrictive, taken as a whole, than the conditions set forth in the Commitment Letter.
(e) If funds
in the amounts set forth in the Commitment Letter, or any portion thereof, become unavailable, Parent shall promptly notify the Company thereof and shall use its reasonable best efforts to arrange and obtain in replacement thereof, and negotiate and
enter into financing commitments (if applicable) and definitive agreements with respect to, alternative financing from the same or alternative Financing Sources in an amount sufficient to consummate the Merger and the transactions contemplated
hereby (the
Substitute Financing
), upon terms and conditions (including pricing) not materially less favorable, taken as a whole, to Parent than those in the Commitment Letter, as promptly as practicable following the occurrence
of such event;
provided
,
however
, that the Substitute Financing shall not, without the prior written consent of the Company, be subject to any additional or modified conditions or other contingencies to the funding of the Financing
than those conditions contained in the Commitment Letter that would be reasonably expected to materially delay or prevent the consummation of the Merger and the consummation of the transactions contemplated hereby. Upon obtaining any commitment for
any such Substitute Financing, for all purposes under this Agreement, such Substitute Financing shall be deemed to be a part of the Financing, any commitment letter for such Substitute Financing
A-48
shall be deemed included in references to the Commitment Letter, and any financing institutions contemplated to provide such Substitute Financing shall be deemed to be Financing
Sources.
(f) Notwithstanding anything contained in this Agreement to the contrary, Parent expressly acknowledges and agrees
that Parents and Merger Subs obligation to hold the Closing and consummate the Merger are not conditioned in any manner upon Parent or Merger Sub obtaining any Financing, and that, for the avoidance of doubt, Parent and Merger Sub shall
be required to hold the Closing and consummate the Merger on any date so required pursuant to the terms and conditions of Section 1.2, regardless of whether the Financing is available.
Section 6.15
Financing Cooperation
.
(a) The Company shall, and shall cause its Subsidiaries to, and shall use its reasonable best efforts to cause its and their
Representatives to, at the sole expense of Parent, use its and their reasonable best efforts to provide such customary cooperation as may reasonably be requested by Parent in connection with the Financing and any Replacement Financing, in each case,
to the extent such assistance is customarily provided in financings comparable to the Financing or any Replacement Financing, as the case may be, including (i) designating one or more members of senior management of the Company to assist with the
preparation of customary offering and syndication documents and materials, including registration statements, prospectuses and prospectus supplements, private placement or offering memoranda, bank information memoranda, bank syndication material and
packages, lender and investor presentations, rating agency materials and presentations, and similar documents and materials, in connection with the Financing, (ii) designating one or more members of senior management of the Company to participate in
a reasonable number of drafting sessions, management presentations, rating agency presentations, lender meetings (including one-on-one meetings) and one or more road shows, in each case, upon reasonable advance notice and at reasonable times, (iii)
providing all information that is reasonably available or readily obtainable regarding the Company and its Subsidiaries reasonably requested by Parent in connection with the Financing and any Replacement Financing, including (A) such information as
is reasonably necessary to assist Parent in the preparation of any pro forma financial statements required in connection therewith (it being understood that the Company need only to provide information to assist in the preparation thereof, and shall
not be required to provide pro forma financial statements or pro forma adjustments reflecting (x) the Financing or any description of all or any component of the Financing, or (y) the transactions contemplated or required hereunder), (B)
designating, upon request, whether any such information is suitable to be made available to lenders and other investors who do not wish to receive material non-public information, (C) executing customary authorization letters and management
representation letters, and (D) providing the financial statements of the Company required by clause (b)(i) of paragraph (4) in Exhibit B to the Commitment Letter (the
Required Financial Information
), (iv) providing the Financing
Sources with reasonable access to the properties, books and records of the Company and its Subsidiaries, (v) requesting the Companys independent accountants to provide customary and reasonable assistance to Parent, (vi) assisting Parent in
obtaining any corporate credit and family ratings and, if applicable, facility ratings from any ratings agency contemplated by the Commitment Letter or Financing Agreements, (vii) requesting the Companys independent auditors to cooperate with
Parents independent auditors, participate in accounting due diligence sessions and provide accountants comfort letters and consents, (viii) assisting in preparation of Financing Agreements and related definitive documents, guarantees (if
required) and other certificates and documents as may be reasonably requested by Parent, (ix) cooperating with Parent in seeking from the Companys existing lenders such waivers, amendments, supplements, consents or payoff letters which may be
reasonably requested by Parent or necessary in connection with the Financing, (x) providing at least five Business Days prior to the anticipated Closing all documentation and other information about the Company or any of its Affiliates required by
applicable know your customer and anti-money laundering rules and regulations, including the USA PATRIOT Act, to the extent reasonably requested at least ten Business Days prior to the anticipated Closing and (xi) taking all corporate
actions, subject to and conditioned on the occurrence of the Effective Time, reasonably requested by Parent to permit the consummation of the Financing;
provided
,
however
, that any such requested cooperation as set forth above shall
not unreasonably interfere with the ongoing operations of the Company or any of its Subsidiaries. Notwithstanding the foregoing, nothing in this Section 6.15 shall (A) require the
A-49
Company or its Subsidiaries to provide any Restricted Information, (B) take any action that would reasonably be expected to conflict with or violate any organizational documents of the Company or
any of its Subsidiaries, any applicable Law, or any material agreement to which the Company or any of its Subsidiaries is a party, (C) require the Company or any of its Subsidiaries to pay any commitment or similar fee, pay or reimburse any third
party expense, provide any indemnities, or incur or assume any liability or obligation, in connection with the Financing (or any other financing or refinancing transactions undertaken by Parent or its Subsidiaries in connection with the transactions
contemplated hereby) prior to the Closing (except for out-of-pocket expenses incurred by the Company in connection with the cooperation provided by the Company pursuant to Section 6.15(a), for which Parent is obligated to reimburse the Company
pursuant to Section 6.15(b) below), (D) subject to clause (iii)(C) of this Section 6.15(a), require the Company or any of its Subsidiaries to execute any document, agreement, certificate or instrument with respect to the Financing (or any other
financing or refinancing transactions undertaken by Parent or its Subsidiaries in connection with the transactions contemplated hereby) that is not contingent on the Closing or that would be effective prior to the Effective Time, (E) require the
Board of Directors of the Company or the board of directors (or other governing body) of any of the Companys Subsidiaries to approve or authorize any Financing (or any other financing or refinancing transactions undertaken by Parent or its
Subsidiaries in connection with the transactions contemplated hereby) or agreements related thereto or (F) require the Company to prepare any financial statements other than the Required Financial Information.
(b) Parent shall (i) promptly, upon request by the Company, reimburse the Company for all reasonable and documented out-of-pocket costs
and expenses (including reasonable costs and expenses of counsel and accountants but excluding, for the avoidance of doubt, the costs of the preparation of any annual or quarterly financial statements of the Company to the extent consistent with the
past practice of the Company) incurred by the Company or any of its Subsidiaries in connection with any cooperation of the Company and its Subsidiaries provided under this Section 6.15 and (ii) indemnify and hold harmless the Company, its
Subsidiaries and any of its and their respective Representatives from and against any and all claim, loss, damage, injury, liability, judgment, award, penalty, fine, Tax, cost (including cost of investigation), expense (including fees and expenses
of counsel and accountants), settlement or other losses, in each case, actually suffered or incurred by any of them, in connection with the arrangement of Financing and any other financing or refinancing transactions undertaken by Parent or its
Subsidiaries in connection with the Merger (other than to the extent resulting from information provided to Parent in writing by the Company or its Subsidiaries), except in the event such claim, loss, damage, injury, liability, judgment, award,
penalty, fine, Tax, cost, expense, settlement or loss arises out of or results from the gross negligence, willful misconduct or bad faith of the Company or its Subsidiaries in fulfilling their obligations pursuant to this Section 6.15. Subject to
Parents indemnification obligations under this Section 6.15, the Company hereby consents to the use of all of its and its Subsidiaries corporate logos in connection with the initial syndication or marketing of the Financing;
provided
, that such logos are used solely in a manner that is not intended to harm or disparage the Company or its Subsidiaries or the reputation or goodwill of the Company or any of its Subsidiaries.
Section 6.16
Adoption by Merger Sub
. As promptly as practicable following the execution of this Agreement, the parent company of
Merger Sub shall execute and deliver, in accordance with the DGCL and in its capacity as the sole stockholder of Merger Sub, a written consent adopting this Agreement.
A-50
ARTICLE VII
CONDITIONS
Section
7.1
Conditions to Each Partys Obligation to Effect the Merger
. The respective obligations of the Company, Parent and Merger Sub to effect the Merger are subject to the satisfaction or, to the extent permitted by applicable Law,
waiver (in writing), on or prior to the Closing Date of each of the following conditions:
(a)
Company Stockholder Approval
.
The Company shall have obtained the Company Stockholder Approval in accordance with applicable Law and the Company Charter and Company Bylaws.
(b)
Statutes and Injunctions
. (i) No Governmental Entity of competent jurisdiction shall have issued an Order or taken any
other action restraining, enjoining or otherwise prohibiting the Merger, in each case, that remains in effect, and (ii) no applicable Law prohibiting consummation of the Merger shall be in effect.
(c)
Governmental Consents
. Both (i) the early termination or expiration of the waiting period required under the HSR Act shall
have occurred and (ii) the foreign antitrust approvals set forth in Schedule 7.1(c) shall have been made or obtained (all such permits, approvals, filings and consents and the lapse or expiration of such waiting period being referred to as the
Requisite Regulatory Approvals
), and all such Requisite Regulatory Approvals shall be in full force and effect.
Section 7.2
Conditions to Obligations of Parent and Merger Sub
. The obligations of Parent and Merger Sub to effect the Merger are
further subject to the satisfaction or, to the extent permitted by applicable Law, waiver by Parent (in writing) on or prior to the Closing Date of each of the following conditions:
(a)
Representations and Warranties
. (i) Except for the representations and warranties in Section 3.2(a), (b) and (d)
(Capitalization) and Section 3.3(a) and (b) (Corporate Authorization), the representations and warranties of the Company set forth in this Agreement shall be true and correct in all respects as of the date of this Agreement and as of and as though
made on the Closing Date (except for such representations and warranties that are expressly stated to have been made as of a specified date, which shall have been true and correct as of such specified date), except where the failure or failures of
such representations and warranties to be so true and correct, individually or in the aggregate, has not had or is not reasonably expected to have a Company Material Adverse Effect;
provided
,
however
, that for purposes of determining
the satisfaction of this condition, no effect shall be given to any exception set forth in such representations and warranties relating to materiality or a Company Material Adverse Effect; (ii) the representations and warranties in Section 3.2(a)
(Capitalization) shall be true and correct in all respects as of the date of this Agreement and as of and as though made on the Closing Date (except for any representations and warranties that are expressly stated to have been made as of a specified
date, which shall have been true and correct as of such specified date) except for
de minimis
inaccuracies; and (iii) the representations and warranties in Section 3.2(b) and (d) (Capitalization) and Section 3.3(a) and (b) (Corporate
Authorization) shall be true and correct in all material respects as of the date of this Agreement and as of and as though made on the Closing Date (except for any representations and warranties that are expressly stated to have been made as of a
specified date, which shall have been true and correct as of such specified date).
(b)
Performance of Obligations of the
Company
. The Company shall have performed or complied in all material respects with all obligations required to be performed by the Company under this Agreement at or prior to the Closing.
(c)
No Company Material Adverse Effect
. Since the date of this Agreement, no event, change, circumstance or effect shall have
occurred that has had or is reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect.
(d)
Officers Certificate
. Parent shall have received a certificate from a senior executive officer of the Company confirming
the satisfaction of the conditions set forth in Section 7.2(a), Section 7.2(b) and Section 7.2(c).
A-51
Section 7.3
Conditions to Obligations of the Company
. The obligations of the Company
to effect the Merger are further subject to the satisfaction or, to the extent permitted by applicable Law, waiver by the Company (in writing), on or prior to the Closing Date of each of the following conditions:
(a)
Representations and Warranties
. (i) Except for the representations and warranties set forth in Section 4.2(a) (Corporate
Authorization), the representations and warranties of Parent and Merger Sub set forth in this Agreement shall be true and correct in all respects as of the date of this Agreement and as of and as though made on the Closing Date (except for any
representations and warranties that are expressly stated to have been made as of a specified date, which shall have been true and correct as of such specified date), except where the failure or failures of such representations and warranties to be
so true and correct, individually or in the aggregate, do not have a Parent Material Adverse Effect; and (ii) the representations and warranties in Section 4.2(a) (Corporate Authorization) shall be true and correct in all material respects as of the
date of this Agreement and as of and as though made on the Closing Date (except for any representations and warranties that are expressly stated to have been made as of a specified date, which shall have been true and correct as of such specified
date).
(b)
Performance of Obligations of Parent and Merger Sub
. Each of Parent and Merger Sub shall have performed or
complied in all material respects with all obligations required to be performed by Parent or Merger Sub, as applicable, under this Agreement at or prior to the Closing.
(c)
Officers Certificate
. The Company shall have received a certificate from an executive officer of Parent confirming the
satisfaction of the conditions set forth in Section 7.3(a) and Section 7.3(b).
Section 7.4
Frustration of Closing Conditions
.
None of the Company, Parent or Merger Sub may rely on the failure of any condition set forth in this Article VII to be satisfied if such failure was principally caused by such partys breach of any of its obligations under this Agreement.
ARTICLE VIII
TERMINATION
Section 8.1
Termination
. This Agreement may be terminated and the Merger and the other transactions contemplated hereby may be
abandoned at any time prior to the Effective Time, whether (except as expressly set forth in this Agreement) before or after obtaining the Company Stockholder Approval (with any termination by Parent also being an effective termination by Merger
Sub):
(a) by mutual written consent of Parent and the Company;
(b) by either Parent or the Company, if:
(i) the Merger shall not have been consummated on or before December 1, 2017 (the
Initial Outside
Date
);
provided
,
however
, that if on the Initial Outside Date any of the conditions to Closing set forth in Section 7.1(b) (but only if such failure to be so satisfied relates solely to an Order under any Antitrust Law) or
Section 7.1(c) shall not have been satisfied or, to the extent permitted by applicable Law, waived, by all parties entitled to the benefit of such condition but all other applicable conditions to Closing set forth in Article VII shall have been
satisfied or waived (except for those conditions that by their nature or terms are to be satisfied at the Closing, which conditions were capable of being satisfied at such time), then the Initial Outside Date shall be extended to March 1, 2018 if
Parent or the Company notifies the other in writing on or prior to the Initial Outside Date of its election to extend the Initial Outside Date (as so extended, the
Outside Date
);
provided
,
however
, that the right to
extend the Initial Outside Date or terminate this Agreement pursuant to this Section 8.1(b)(i) shall not be available to any party if its action or failure to act constitutes a breach or violation of any of its obligations hereunder, and such breach
has been the principal
A-52
cause of or directly resulted in (1) the failure to satisfy the conditions to the obligations of the terminating party to consummate the Merger set forth in Article VII prior to the Initial
Outside Date or the Outside Date or (2) the failure of the Closing to occur by Initial Outside Date or the Outside Date;
(ii) any Governmental Entity of competent jurisdiction shall have issued an Order or taken any other action permanently
restraining, enjoining or otherwise prohibiting the Merger and such Order or other action shall have become final and non-appealable;
provided
,
however
, that the party seeking to terminate this Agreement pursuant to this Section
8.1(b)(ii) shall have complied with Section 6.5 of this Agreement; or
(iii) the Company Stockholder Approval shall
not have been obtained upon a vote taken thereon at the Company Stockholders Meeting or at any adjournment or postponement thereof taken in accordance with this Agreement.
(c) by Parent:
(i) if the Company shall have breached or failed to perform any of its representations, warranties, covenants or
agreements contained in this Agreement, which breach or failure to perform (A) would result in a failure of any condition set forth in Section 7.2(a) or Section 7.2(b) and (B)(1) is incapable of being cured by the Company by the Outside Date or (2)
if capable of being cured, has not been cured by the Company within 30 days following written notice to the Company from Parent or Merger Sub of such breach, which notice states Parents intention to terminate this Agreement pursuant to this
Section 8.1(c)(i);
provided
that Parent shall not have the right to terminate this Agreement pursuant to this Section 8.1(c)(i) if it is then in material breach of any representation, warranty, covenant or agreement hereunder;
(ii) prior to obtaining the Company Stockholder Approval, if the Board of Directors of the Company or any committee
thereof shall have (A) effected a Recommendation Withdrawal; (B) failed to include the Company Board Recommendation in the Proxy Statement or (C) following the public announcement of an Acquisition Proposal, failed to reaffirm the Company Board
Recommendation within five Business Days of receipt of any written request to do so from Parent; or
(iii) prior to
obtaining the Company Stockholder Approval, in the event of a Willful and Material Breach by the Company of any covenant contained in Section 6.3, the first sentence of Section 6.1(a) or the first sentence of Section 6.2.
(d) by the Company:
(i) if Parent or Merger Sub shall have breached or failed to perform any of its representations, warranties, covenants or
agreements contained in this Agreement, which breach or failure to perform (A) would result in a failure of any condition set forth in Section 7.3(a) or Section 7.3(b) and (B)(1) is incapable of being cured by Parent or Merger Sub, as the case may
be, by the Outside Date or (2) if capable of being cured, has not been cured by Parent or Merger Sub, as the case may be, within 30 days following written notice to Parent or Merger Sub, as the case may be, from the Company of such breach, which
notice states the Companys intention to terminate this Agreement pursuant to this Section 8.1(d)(i);
provided
that the Company shall not have the right to terminate this Agreement pursuant to this Section 8.1(d)(i) if it is then in
material breach of any representation, warranty, covenant or agreement hereunder; or
(ii) prior to obtaining the
Company Stockholder Approval, in accordance with, and subject to the terms and conditions of, Section 6.3(c), if the Company, prior to or concurrently with such termination, pays to Parent the Termination Fee in accordance with Section 8.3(a).
Section 8.2
Effect of Termination
. In the event of any termination of this Agreement as provided in Section 8.1, the obligations
of the parties shall terminate and there shall be no liability on the part of any party with respect thereto, except for the confidentiality provisions of Section 6.4 and the provisions of Section 3.25, Section 4.11, Section 6.7, Section 6.14(f),
Section 6.15(b), this Section 8.2, Section 8.3 and Article IX, each of
A-53
which shall survive the termination of this Agreement and remain in full force and effect;
provided
,
however
, that, nothing contained herein shall relieve any party from liability
to the other party for damages arising out of any Willful and Material Breach of this Agreement occurring prior to such termination, in which case the aggrieved party shall be entitled to all rights and remedies available at law or equity.
Notwithstanding anything contained in this Agreement to the contrary, Parent expressly acknowledges and agrees that Parents and Merger Subs obligations to hold the Closing and consummate the Merger and the transactions contemplated by
this Agreement are not conditioned in any manner upon Parent or Merger Sub obtaining any Financing. The parties acknowledge and agree that any failure by a party to consummate the Merger and the other transactions contemplated by this Agreement
(regardless of whether, in the case of Parent, Parent has obtained or received any proceeds of any Financing) on or prior to the third Business Day after the applicable conditions to Closing set forth in Article VII have been satisfied or waived
(except for those conditions that by their nature or terms are to be satisfied at the Closing, which conditions were capable of being satisfied at the time of such failure to consummate the Merger) shall constitute a Willful and Material Breach of
this Agreement. The parties acknowledge and agree that nothing in this Section 8.2 shall be deemed to affect their right to specific performance under Section 9.10(c). In addition, the parties agree that the terms of the Confidentiality Agreement
shall survive any termination of this Agreement pursuant to Section 8.1 in accordance with its terms.
Section 8.3
Termination
Fee
.
(a) In the event that this Agreement is terminated by the Company pursuant to Section 8.1(d)(ii), then, prior to or
concurrently with, and as a condition to the termination of this Agreement, the Company shall pay or cause to be paid to Parent (or its designees) an amount in cash equal to $113,000,000 (the
Termination Fee
) by wire transfer of
immediately available funds to an account designated in writing by Parent.
(b) In the event that this Agreement is terminated by
Parent pursuant to Section 8.1(c)(ii) or Section 8.1(c)(iii), then the Company shall promptly, but in no event later than two (2) Business Days after the date of such termination, pay or cause to be paid to Parent (or its designees) the Termination
Fee by wire transfer of immediately available funds to an account designated in writing by Parent.
(c) In the event that this
Agreement is terminated:
(i) by Parent or the Company pursuant to Section 8.1(b)(i) or Section 8.1(c)(i) and an
Acquisition Proposal was publicly proposed or announced by any Person after the date of this Agreement and prior to such termination; or
(ii) by Parent or the Company pursuant to Section 8.1(b)(iii) and an Acquisition Proposal was publicly proposed or
announced by any Person after the date of this Agreement and prior to such termination; and
(iii) in any such event,
(A) the Company enters into a definitive agreement with respect to any Acquisition Proposal within 12 months after such termination of this Agreement or (B) the Company consummates any Acquisition Proposal within 12 months after the termination of
this Agreement, then, on the date of entering into such definitive agreement (in the case of Clause (A)), or consummating such Acquisition Proposal (in the case of Clause (B)), the Company shall pay or cause to be paid to Parent (or its designees)
the Termination Fee by wire transfer of immediately available funds to an account designated in writing by Parent. For purposes of this Section 8.3(c), each reference to 20% in the definition of Acquisition Proposal shall be
deemed to be a reference to 50%.
(d) The parties agree and understand that in no event shall the Company be required to
pay the Termination Fee on more than one occasion. Notwithstanding anything to the contrary in this Agreement, if Parent receives the Termination Fee from the Company pursuant to this Section 8.3, such payment shall be the sole and exclusive remedy
of Parent and Merger Sub against the Company and its Subsidiaries and their respective former, current or future officers, directors, partners, stockholders, managers, members, Affiliates and Representatives and none of the Company, any of its
Subsidiaries or any of their respective former, current or future officers, directors,
A-54
partners, stockholders, managers, members, Affiliates or Representatives shall have any further liability or obligation relating to or arising out of this Agreement or the transactions
contemplated hereby;
provided
,
however
, that the foregoing shall not relieve the Company from liability to Parent for any Willful and Material Breach of this Agreement by the Company. In addition, notwithstanding anything to the
contrary in this Agreement, if Parent or Merger Sub receives any payments from the Company in respect of any breach of this Agreement, and thereafter Parent receives the Termination Fee under this Section 8.3, the amount of such Termination Fee
shall be reduced by the aggregate amount of any payments made by the Company to Parent or Merger Sub in respect of any such breaches of this Agreement. The parties acknowledge that the agreements contained in this Section 8.3 are an integral part of
the transactions contemplated hereby, and that, without these agreements, the parties would not enter into this Agreement, and that any amounts payable pursuant to this Section 8.3 do not constitute a penalty. If the Company fails to pay when due
any amount payable pursuant to Section 8.3, then (i) the Company will reimburse Parent for all reasonable costs and expenses (including reasonable legal fees and expenses) incurred in connection with any action taken to collect such payment and in
connection with the enforcement by Parent of its rights under Section 8.3, and (ii) the Company will pay to Parent interest on the overdue amount (for the period commencing as of the date such overdue amount was originally required to be paid and
ending on the date such overdue amount is actually paid to Parent in full) at a rate per annum equal to the prime rate (as published in
The Wall Street Journal
) in effect on the date such overdue amount was originally required to
be paid.
Section 8.4
Procedure for Termination
. Termination of this Agreement prior to the Effective Time shall require
action by the Board of Directors of either Parent or the Company, as the case may be, but shall not require the approval of the stockholders of the Company. A terminating party shall provide written notice of termination to the other parties
specifying the Section or Sections pursuant to which such party is terminating the Agreement. If more than one provision in Section 8.1 is available to a terminating party in connection with a termination, a terminating party may rely on any or all
available provisions in Section 8.1 for any termination.
ARTICLE IX
GENERAL PROVISIONS
Section
9.1
Non-Survival of Representations, Warranties, Covenants and Agreements
. None of the representations, warranties, covenants and agreements in this Agreement or in any instrument or agreement delivered pursuant to this Agreement,
including any rights arising out of any breach of such representations, warranties, covenants and agreements, shall survive the Effective Time;
provided
,
however
, that this Section 9.1 shall not limit any covenant or agreement of the
parties which by its terms contemplates performance after the Effective Time.
Section 9.2
Notices
. All notices and other
communications hereunder shall be in writing and shall be deemed duly given (a) on the date of delivery if delivered personally, or by facsimile or email, upon confirmation of receipt, (b) on the first Business Day following the date of dispatch if
delivered by a recognized next-day courier service or (c) on the third Business Day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered as
set forth below, or pursuant to such other instructions as may be designated in writing by the party to receive such notice:
If to Parent
or Merger Sub, to:
Parker Hannifin Corporation
6035 Parkland Boulevard
Cleveland, Ohio 44124
Attention: Joseph R. Leonti, Vice President, General Counsel and
Secretary
Facsimile: (216) 896-4027
Email: jleonti@parker.com
A-55
with a copy to (which shall not constitute notice):
Jones Day
901 Lakeside Avenue
Cleveland, Ohio 44114
Attention: Patrick J. Leddy
James P. Dougherty
Benjamin L. Stulberg
Facsimile No.: (216) 579-0212
Email: pjleddy@jonesday.com;
jpdougherty@jonesday.com;
blstulberg@jonesday.com
If to the Company, to:
CLARCOR Inc.
840 Crescent Centre
Drive, Suite 600
Franklin, Tennessee 37067
Attention: Richard M. Wolfson
Facsimile: (615) 771-5616
Email: Richard.Wolfson@clarcor.com
with a copy to (which shall not constitute notice):
Bass, Berry & Sims PLC
150
Third Avenue South, Suite 2800
Nashville, Tennessee 37201
Attention: J. Page Davidson
Kevin H. Douglas
Andrea N. Orr
Facsimle No.: (615) 742-2753
(615) 742-0454
(615) 742-0446
Email: PDavidson@bassberry.com;
KDouglas@bassberry.com;
AOrr@bassberry.com
and
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Wilmington, Delaware 19899-1347
Attention: James D. Honaker
Facsimile No.: (302) 658-3989
Email: JHonaker@MNAT.com
Section 9.3
Interpretation; Construction
.
(a) When a reference is made in this Agreement to a Section, clause, Annex, Exhibit or Section of a disclosure letter, such reference
shall be to a Section or clause of or Annex or Exhibit or Section of a disclosure letter to this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not
affect in any way the meaning or interpretation of this Agreement. The phrase the date of this Agreement and terms of similar import, shall be deemed to refer to the date first written above. Whenever the content of this Agreement
permits, the masculine gender shall include the feminine and neuter genders, and a reference to singular or plural shall be interchangeable with the other.
A-56
(b) References to any agreement or contract are to that agreement or contract as amended,
modified or supplemented from time to time in accordance with the terms hereof and thereof. References to any Person include the successors and permitted assigns of that Person. References to any statute are to that statute, as amended from time to
time, and to the rules and regulations promulgated thereunder. References to $ and dollars are to the currency of the United States. References from or through any date mean, unless otherwise specified, from and including or
through and including, respectively. The words hereby, herein, hereof, hereunder and words of similar import refer to this Agreement as a whole (including any disclosure letters delivered herewith) and
not merely to the specific section, paragraph or clause in which such word appears. Whenever the words include, or includes or including are used in this Agreement, they shall be deemed to be followed by the words
without limitation.
(c) The parties have participated jointly in negotiating and drafting this Agreement. In the event
that an ambiguity or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the
authorship of any provision of this Agreement.
(d) No summary of this Agreement or any Exhibit attached hereto or Section of a
disclosure letter delivered herewith prepared by or on behalf of any party shall affect the meaning or interpretation of this Agreement or any such Exhibit or Section of a disclosure letter.
Section 9.4
Counterparts; Effectiveness
. This Agreement may be executed in any number of counterparts, including by facsimile or
by email with .pdf attachments, each of which shall be deemed to be an original but all of which shall constitute one and the same instrument. This Agreement shall become effective when each party has received counterparts thereof signed and
delivered (by electronic communication, facsimile or otherwise) by all of the other parties.
Section 9.5
Entire Agreement; No
Third-Party Beneficiaries
.
(a) This Agreement, the Company Disclosure Letter, the Parent Disclosure Letter, the Exhibit attached
hereto and the Confidentiality Agreement constitute the entire agreement, and supersede all prior agreements, understandings, representations and warranties, both written and oral, among the parties with respect to the subject matter hereof and
thereof.
(b) This Agreement shall be binding upon and inure solely to the benefit of each party except for: (i) only following the
Effective Time, the provisions of Article II shall inure to the benefit of, and be enforceable by, holders of Company Common Stock, Company Options, Company RSU Awards and Company PSU Awards, to the extent necessary to receive the consideration due
to such persons thereunder, (ii) the provisions of Section 6.8 shall inure to the benefit of, and be enforceable by, the Indemnified Parties and (iii) the provisions in the first sentence of Section 8.2 (Effect of Termination) stating that the
provisions of Article IX will survive the termination of this Agreement, and the provisions of this clause (iii) of Section 9.5(b) (Entire Agreement; No Third-Party Beneficiaries), Section 9.6 (Severability), Section 9.8 (Modification or Amendment),
Section 9.10 (Governing Law and Venue; Waiver of Jury Trial; Specific Performance) and Section 9.13 (Liability of Financing Sources) (such provisions, the
Financing Source Designated Provisions
) will inure to the benefit of the
Financing Sources.
(c) The representations and warranties in this Agreement are the product of negotiations among the parties and
are for the sole benefit of the parties. Any inaccuracies in such representations and warranties are subject to waiver by the parties in accordance with Section 9.9 without notice or liability to any other Person. In some instances, the
representations and warranties in this Agreement may represent an allocation among the parties of risks associated with particular matters regardless of the Knowledge of any of the parties. Consequently, Persons other than the parties may not rely
upon the representations and warranties in this Agreement as characterizations of actual facts or circumstances as of the date of this Agreement or as of any other date.
A-57
Section 9.6
Severability
. If any term or other provision of this Agreement is
invalid, illegal or incapable of being enforced by any Law or public policy, all other terms and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the Merger or the other
transactions contemplated hereby are not affected in any manner materially adverse to any party. Notwithstanding the foregoing, upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties
shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner in order that the Merger and the other transactions contemplated hereby are consummated as
originally contemplated to the greatest extent possible.
Section 9.7
Assignment
. Neither this Agreement nor any of the
rights, interests or obligations hereunder shall be assigned by any of the parties, in whole or in part (whether by operation of law or otherwise), without the prior written consent of the other parties, and any attempt to make any such assignment
without such consent shall be null and void,
provided
, that Parent and Merger Sub may assign their rights and obligations to any Subsidiary of Parent, although no such assignment will relieve Parent or Merger Sub, as the case may be, of any
obligation so assigned. This Agreement shall be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns.
Section 9.8
Modification or Amendment
. This Agreement may be amended by the parties (with respect to the Company and Merger Sub by
action taken by their respective Boards of Directors), at any time before or after adoption of this Agreement by the stockholders of the Company, but, after any such adoption, no amendment shall be made which by Law would require the further
approval by such stockholders without first obtaining such approval. This Agreement may be modified or amended solely by written agreement executed and delivered by duly authorized officers of the respective parties. Notwithstanding the foregoing,
the Financing Source Designated Provisions may not be amended in a manner adverse to any Financing Sources without the written consent of such Financing Source.
Section 9.9
Extension; Waiver
. The conditions to each of the parties obligations to consummate the Merger are for the sole
benefit of such party and may be waived by such party in whole or in part to the extent permitted by applicable Laws. At any time prior to the Effective Time, the parties may (in the case of the Company, by action taken or authorized by its Board of
Directors or authorized officers of the Company), to the extent permitted by applicable Law, (a) extend the time for the performance of any of the obligations or other acts of the other parties, (b) waive any inaccuracies in the representations
and warranties contained herein or in any document delivered pursuant hereto and (c) waive compliance with any of the agreements or conditions contained herein. Any agreement on the part of a party to any such extension or waiver shall be valid only
if set forth in a written instrument signed on behalf of such party. The failure of any party to this Agreement to assert any of its rights under this Agreement or otherwise shall not constitute a waiver of such rights, nor shall any single or
partial exercise by any party to this Agreement of any of its rights under this Agreement preclude any other or further exercise of such rights or any other rights under this Agreement.
Section 9.10
Governing Law and Venue; Waiver of Jury Trial; Specific Performance
.
(a) This Agreement, and any dispute arising out of or relating to this Agreement, shall be deemed to be made in and in all respects shall
be interpreted, construed and governed by and enforced in accordance with the Laws of the State of Delaware without regard to the conflicts of laws rules thereof.
(b) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY DISPUTE WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND
DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE
MERGER OR THE OTHER TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY
A-58
HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF THIS WAIVER, (III) EACH PARTY MAKES THIS WAIVER VOLUNTARILY AND (IV) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.10.
(c) The parties acknowledge and agree that irreparable harm would occur for which monetary damages would not be an adequate remedy in the
event that any of the provisions of this Agreement are not performed in accordance with their specific terms or are otherwise breached. It is accordingly agreed that, in the event of any breach or threatened breach by any other party of any covenant
or obligation contained in this Agreement, the non-breaching party shall be entitled to (in addition to any other remedy that may be available to it in law and equity, including monetary damages) (i) an injunction restraining such breach or
threatened breach and (ii) an Order of specific performance to enforce the observance and performance of such covenant or obligation (including the obligation of the parties to consummate the transactions contemplated by this Agreement and the
obligation of Parent and Merger Sub to pay, and the Companys equity holders right to receive, the aggregate consideration payable to them pursuant to the transactions contemplated by this Agreement, in each case in accordance with the terms
and conditions set forth in this Agreement) without proof of actual damages, and each party further agrees to waive any requirement for the securing or posting of any bond in connection with such remedy. Each party agrees not to raise any objections
(including any defense or counterclaim that there is an adequate remedy in law) to the availability of the equitable remedy of specific performance to prevent or restrain breaches or threatened breaches of, or to enforce compliance with, the
covenants and obligations of such party under this Agreement all in accordance with the terms of this Section 9.10(c).
(d) Each of
the parties (i) irrevocably submits itself to the personal jurisdiction of each state or federal court sitting in the State of Delaware, as well as to the jurisdiction of all courts to which an appeal may be taken from such courts, in any suit,
action or proceeding arising out of or relating to this Agreement or any of the transactions contemplated hereby (including any proceeding seeking equitable relief pursuant to Section 9.10(c)), (ii) agrees that every such suit, action or proceeding
shall be brought, heard and determined exclusively in the Court of Chancery of the State of Delaware (or, only if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any state or federal court within the State of
Delaware), (iii) agrees that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from such court, (iv) agrees not to bring any suit, action or proceeding arising out of or relating to this Agreement
or any of the transactions contemplated herein in any other court and (v) waives any defense of inconvenient forum to the maintenance of any suit, action or proceeding so brought. Each party irrevocably consents to the service of process outside the
territorial jurisdiction of the courts referred to in this Section 9.10(d) in any such action or proceeding by mailing copies thereof by registered or certified United States mail, postage prepaid, return receipt requested, to its address as
specified in or pursuant to this Article IX. However, the foregoing shall not limit the right of a party to effect service of process on the other party by any other legally available method. Each of Parent, Merger Sub and the Company agrees that a
final judgment in any action or proceeding in such court as provided above shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law.
(e) Notwithstanding the provisions of this Section 9.10 and without limiting the provisions of Section 9.13, the Company (i) agrees that
it will not, and will not permit its controlled Affiliates to, bring or support any Proceeding, cause of action, claim, crossclaim or third-party claim of any kind or description, whether in Law or in equity and whether in contract or in tort or
otherwise, against the Financing Sources in any way related to this Agreement or any of the transactions contemplated by this Agreement (including any dispute arising out of or relating to the Financing or the performance thereof) in any forum other
than the United States District Court for the Southern District of New York or the Supreme Court of the State of New York, New York County, located in the Borough of Manhattan or, in either case, any appellate court thereof, (ii) agrees that any
such Proceeding will be governed by the Laws of the State of New York, (iii) agrees to waive and hereby waives, irrevocably and
A-59
unconditionally, any right to a trial by jury in any such Proceeding and (iv) agrees to waive and hereby waives, to the fullest extent permitted by Law, any objection which such party may now or
hereafter have to the laying of venue of, and the defense of an inconvenient forum to the maintenance of any such Proceeding in any such court.
Section 9.11
Obligation of Parent and of the Company
. Whenever this Agreement requires a Subsidiary of Parent to take any action,
such requirement shall be deemed to include an undertaking on the part of Parent to cause such Subsidiary to take such action. Whenever this Agreement requires a Subsidiary of the Company to take any action, such requirement shall be deemed to
include an undertaking on the part of the Company to cause such Subsidiary to take such action and, after the Effective Time, on the part of the Surviving Corporation to cause such Subsidiary to take such action.
Section 9.12
No Recourse
. This Agreement may only be enforced by a party, and any claims or causes of action that may be based
upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement, may only be made by a party, against another party and no past, present or future director, officer or employee of any party shall have
any liability to any party for any obligations or liabilities of a party or for any claim (whether in tort, contract or otherwise) based on, in respect of, or by reason of, the transactions contemplated hereby. Without limiting the rights of any
party against another party hereunder, in no event shall any party or any of its Affiliates, and each party agrees not to and to cause its Affiliates not to, seek to enforce this Agreement against, make any claims for breach against, or seek to
recover monetary damages from, any past, present or future director, officer or employee of another party.
Section 9.13
Liability
of Financing Sources
. Notwithstanding anything to the contrary contained herein, the Company agrees that it and its controlled Affiliates will not have any rights or claims against any Financing Source (in its capacity as such) in connection
with this Agreement, the Financing or the transactions contemplated hereby or thereby.
Section 9.14
Definitions
. As used in
this Agreement, the following terms and those set forth in the Index of Defined Terms, when used in this Agreement, and the Exhibit, disclosure letters, and other documents delivered in connection herewith, shall have the meanings specified in this
Section 9.14 or on the corresponding section reference the Index of Defined Terms:
Acceptable Confidentiality
Agreement
means an executed confidentiality agreement with terms no less favorable, in the aggregate, to the Company than those contained in the Confidentiality Agreement; provided, however, that such confidentiality agreement need not
include any standstill or similar obligation and such confidentiality agreement shall not restrict the Company or any of its Subsidiaries or Representatives from sharing information with Parent.
Affiliate
of any Person means another Person that directly or indirectly, through one or more intermediaries, controls, is
controlled by, or is under common control with, such first Person, and control has the meaning specified in Rule 405 under the Securities Act.
Amended and Restated Credit Agreement
means the Amended and Restated Credit Agreement, dated as of November 2, 2015, by and
among the Company, the Companys Subsidiaries party thereto, the lenders party thereto and Bank of America, N.A., as administrative agent, as swing line lender and as a letter of credit issuer.
Antitrust Laws
shall mean the Sherman Act of 1890, as amended; the Clayton Act of 1914, as amended; the Federal Trade
Commission Act of 1914, as amended; the HSR Act, and all other federal, state, foreign or supranational Laws or Orders in effect from time to time that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect
of monopolization or restraint of trade or lessening of competition through merger or acquisition.
Business Day
means
a day except a Saturday, a Sunday or other day on which the SEC or commercial banks in the City of New York are authorized or required by Law to be closed.
A-60
Company Material Adverse Effect
means any event, change, circumstance, or
effect that (a) has a material adverse effect on the business, results of operations or financial condition of the Company and its Subsidiaries, taken as a whole,
provided
,
however
, that no event, change, circumstance, or effect shall
be deemed to constitute, nor shall any of the foregoing be taken into account in determining whether there has been or would reasonably be expected to be, a Company Material Adverse Effect, to the extent that such event, change, circumstance, or
effect results from, arises out of, or relates to: (i) any changes in general United States or global economic conditions, except to the extent that such changes have a materially disproportionate adverse effect on the Company and its Subsidiaries,
taken as a whole, relative to the adverse effect such changes have on others operating in the industries in which the Company and any of its Subsidiaries operate, (ii) any changes in conditions generally affecting any industry or geographic region
in which the Company or any of its Subsidiaries operate, except to the extent that such changes have a materially disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the adverse effect such changes have
on others operating in the industries in which the Company and any of its Subsidiaries operate, (iii) any decline in the market price or trading volume of Company Common Stock (it being understood that the foregoing shall not preclude Parent from
asserting that the facts or occurrences giving rise to or contributing to such decline that are not otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute, or be taken into account in determining
whether there has been a Company Material Adverse Effect), (iv) any changes in regulatory, legislative or political conditions or securities, credit, financial, debt or other capital markets conditions, including interest or currency exchange rates,
except to the extent that such changes or conditions have a materially disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the adverse effect such changes or conditions have on others operating in the
industries in which the Company and any of its Subsidiaries operate, (v) any failure, in and of itself, by the Company to meet any internal or published projections, forecasts, estimates or predictions, or analysts estimates, in respect of
revenues, earnings or other financial or operating metrics for any period (it being understood that the foregoing shall not preclude Parent from asserting that the facts or occurrences giving rise to or contributing to such failure that are not
otherwise excluded from the definition of Company Material Adverse Effect should be deemed to constitute, or be taken into account in determining whether there has been, a Company Material Adverse Effect), (vi) the public announcement or pendency of
this Agreement, the Merger or the taking of any action required by this Agreement or the identity of, or any facts or circumstances relating to, Parent, Merger Sub or their respective Subsidiaries, including the impact of any of the foregoing on the
relationships, contractual or otherwise, of the Company or any of its Subsidiaries with customers, suppliers, officers or employees, (vii) any adoption, implementation, promulgation, repeal, modification, amendment, reinterpretation, change or
proposal of any Law following the date hereof, except to the extent that such changes have a materially disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the adverse effect such changes have on others
operating in the industries in which the Company and any of its Subsidiaries operate, (viii) any change in accounting requirements or principles required by GAAP (or authoritative interpretations thereof) following the date hereof, (ix) any
geopolitical conditions, the outbreak or escalation of hostilities, any acts of war, sabotage or terrorism, or any escalation or worsening of any such acts of war, sabotage or terrorism threatened or underway as of the date of this Agreement, except
to the extent that such changes have a materially disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the adverse effect such changes have on others operating in the industries in which the Company and
any of its Subsidiaries operate, (x) any taking of any action at the request of Parent or Merger Sub, or (xi) any hurricane, strong winds, ice event, fire, tornado, tsunami, flood, earthquake or other natural disaster, acts of God or any change
resulting from weather events, conditions or circumstances, except to the extent that such changes have a materially disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to the adverse effect such changes
have on others operating in the industries in which the Company and any of its Subsidiaries operate, or (b) prevents or materially impairs or would reasonably be expected to delay to a date following the Initial Outside Date the ability of the
Company to consummate the Merger or the other transactions contemplated hereby.
Company Stock Plans
means the Company
2004 Incentive Plan, as amended, 2009 Incentive Plan and 2014 Incentive Plan.
A-61
Confidentiality Agreement
means the confidentiality agreement, dated October
4, 2016 between the Company and Parent, as the same may be further amended, supplemented or otherwise modified by the parties.
Contract
means any binding agreement, lease, sublease, license, contract, note, mortgage, indenture, deed of trust,
franchise, concession, arrangement or obligation (whether written or oral).
Domestic Subsidiary
means any Subsidiary
of the Company that is organized or incorporated within the United States of America.
Environmental Laws
shall mean
all foreign, federal, state and local laws, statutes, regulations, rules, orders, common law, decrees, ordinances, authorizations or legally enforceable requirements of any Governmental Entity relating to (a) the protection, investigation or
restoration of the environment or natural resources; (b) the handling, use, presence, disposal, recycling, sale, distribution, labeling, importation, exportation, release or threatened release of any Hazardous Substance or (c) indoor air quality,
employee or other human exposure to any Hazardous Substance, wetlands, or pollution.
Financing Sources
means the
entities that have committed to provide or otherwise entered into agreements in connection with the Financing (including any Substitute Financing or Replacement Financing), together with their Affiliates, and including the parties to the Commitment
Letter and any joinder agreements or credit agreements (including the definitive agreements relating thereto).
Foreign
Subsidiary
means any Subsidiary of the Company that is organized or incorporated in a jurisdiction outside of the United States of America.
GAAP
means generally accepted accounting principles in the United States.
Hazardous Substances
means any (a) substance that is listed, classified or regulated pursuant to any Environmental Law; (b)
any petroleum product or by-product, asbestos-containing material, lead-containing paint or plumbing, polychlorinated biphenyls, mold, radioactive material or radon; or (c) any other chemicals, materials or substances defined as a hazardous
substance, hazardous waste, hazardous material, hazardous constituent, restricted hazardous material, extremely hazardous substance, toxic substance,
contaminant, pollutant, toxic pollutant, or words of similar meaning and regulatory effect under any applicable Environmental Law.
Intellectual Property
means all intellectual property rights throughout the world, including all (a) inventions and
discoveries, whether patentable or not, and all patents, registrations, invention disclosures and applications therefor, including divisions, continuations, continuations-in-part and renewal applications, and including renewals, extensions and
reissues; (b) Trade Secrets; (c) published and unpublished works of authorship, including databases and other compilations of information, copyrights therein and thereto, and registrations and applications therefor, and all renewals, extensions,
restorations and reversions thereof; (d) Trademarks; and (e) Internet domain names.
International Trade Laws
means all
Laws concerning the importation of merchandise, the export or re-export of products, services and technology, making or receiving international payments and the authorization to hold an ownership interest in a business located in a country other
than the United States, including the Tariff Act of 1930 as amended and other laws administered by United States Customs and Border Protection regulations issued or enforced by United States Customs and Border Protection, the Export Administration
Act of 1979 as amended, the Export Administration Regulations, the International Emergency Economic Powers Act, the Arms Export Control Act, the International Traffic in Arms Regulations, any other export controls administered by a Governmental
Entity, executive orders regarding embargoes and restrictions on trade with designated countries and Persons, the embargoes and restrictions administered by the United States Office of Foreign Assets Control, the Foreign Corrupt Practices Act, the
anti-boycott regulations administered by the
A-62
United States Department of Commerce, the anti-boycott regulations administered by the United States Department of the Treasury, legislation and regulations of the United States and other
countries implementing the North American Free Trade Agreement, antidumping and countervailing duty laws and regulations, laws and regulations by other countries concerning the ability of U.S. Persons to own businesses and conduct business in those
countries, laws and regulations by other countries implementing the OECD Convention on Combating Bribery of Foreign Officials, restrictions by other countries on holding foreign currency and repatriating funds and other Laws adopted by the
Governmental Entities of foreign countries relating to the same subject matter as the United States statutes and regulations described above.
Knowledge
means the actual knowledge of the officers of the Company or Parent, as the case may be, as set forth in Section
9.14 of the Company Disclosure Letter and Section 9.14 of the Parent Disclosure Letter, respectively.
Law
means any
federal, state, local or foreign law, constitution, treaty, convention, ordinance, code, rule, common law, order, writ, injunction, decree, agency requirement, statute or regulation enacted, issued, adopted, promulgated, entered into, issued by or
applied by a Governmental Entity.
Leased Real Property
means all material real property leased, subleased or otherwise
occupied by the Company or any of its Subsidiaries.
Lien
means any lien, charge, pledge, mortgage, adverse right or
claim, security interest or other restriction or title matter or any encumbrance of any kind, excluding restrictions imposed by securities laws.
OFAC
means the Office of Foreign Assets Control of the US Department of the Treasury.
Order
means any order, writ, injunction, decree, judgment, award, injunction, settlement or stipulation issued,
promulgated, made, rendered or entered into by or with any Governmental Entity (in each case, whether temporary, preliminary or permanent).
Owned Intellectual Property
means all Intellectual Property currently owned or purported to be owned by the Company or any
of its Subsidiaries.
Owned Real Property
means all real property currently owned by the Company or any of its
Subsidiaries.
Parent Material Adverse Effect
means any event, change, circumstance or effect that, individually or in
the aggregate with any other event, change, circumstance or effect, has prevented or materially impaired or would reasonably be expected to prevent or materially impair or would reasonably be expected to delay to a date following the Initial Outside
Date the ability of Parent to consummate the Merger or the other transactions contemplated hereby.
Permitted Lien
means (a) any Liens for Taxes not yet due and payable or which are being contested in good faith by appropriate proceedings and with respect to which adequate reserves have been taken, (b) carriers, warehousemens, mechanics,
materialmens, workers, repairmens or other similar Liens, (c) pledges or deposits in connection with workers compensation, unemployment insurance and other social security legislation, (d) easements, rights-of-way,
covenants, restrictions and other encumbrances incurred in the ordinary course of business that, in the aggregate, are not material in amount or that do not, in any case, materially detract from the value or the use of the property subject thereto,
(e) statutory landlords Liens and Liens granted to landlords under any lease, (f) licenses to Intellectual Property in the ordinary course of business, (g) any purchase money security interests, equipment leases or similar financing
arrangements, (h) any Liens that are disclosed on the most recent consolidated balance sheet of the Company or notes thereto and (i) any Liens that do not materially impact the Companys current or contemplated use, or the value, of the
applicable property.
A-63
Person
means any individual, corporation, partnership, limited liability
company, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof.
Proceeding
means any suit, action, claim, proceeding, arbitration or litigation commenced, brought, conducted or heard by
or before, or otherwise involving, any Governmental Entity.
Securities Act
means the Securities Act of 1933.
Subsidiary
means, with respect to any Person (a) a corporation more than fifty percent (50%) of the combined voting power
of the outstanding voting stock of which is owned by such Person or by one or more other Subsidiaries of such Person, (b) a partnership of which such Person, or one or more other Subsidiaries of such Person is the general partner and has the power
to direct the policies, management and affairs of such partnership, (c) a limited liability company of which such Person or one or more other Subsidiaries of such Person is the managing member and has the power to direct the policies, management and
affairs of such company or (d) any other Person (other than a corporation, partnership or limited liability company) in which such Person, or one or more other Subsidiaries of such Person has at least a majority ownership and power to direct the
policies, management and affairs thereof. For the avoidance of doubt, Merger Sub is a Subsidiary of Parent.
Tax
or
Taxes
means (a) net income, alternative or add-on minimum tax, gross income, gross receipts, sales, use, ad valorem, value added, transfer, franchise, profits, license, withholding, payroll, employment, excise, severance, stamp,
occupation, premium, unemployment, capital stock, net worth, privilege, intangible, real or personal property, environmental or windfall profit tax, custom, duty or other tax, governmental fee or other like assessment or charge of any kind
whatsoever, including any liability under any state abandonment or unclaimed property, escheat or similar Law, together with any interest, penalty, addition to tax or additional amount imposed by any Law or Taxing Authority, whether disputed or not,
(b) any liability for the payment of any amounts of any liabilities described in clauses (a) or (c) as a result of being a party to any agreement or arrangement whereby liability for payment of such amounts was determined or taken into account with
reference to the liability of any other Person, (c) any liability for the payment of any amounts of liabilities described in clauses (a) or (b) as a result of being a party to any tax sharing agreements or arrangements or with respect to the payment
of any amounts of any liabilities described in clauses (a) or (b) or this clause (c) as a result of any express or implied obligation to indemnify any other Person or to otherwise assume or succeed to the liability of any other Person described in
clauses (a) or (b) or this clause (c).
Tax Return
means any return, report or statement required to be filed with
respect to any Tax (including any attachments thereto, and any amendment thereof), including any information return, claim for refund, amended return or declaration of estimated Tax, and including, where permitted or required, combined, consolidated
or unitary returns for any group of entities that includes the Company or any of its Affiliates.
Taxing Authority
means, with respect to any Tax, the Governmental Entity that imposes such Tax, and the agency (if any) charged with the collection of such Tax for such Governmental Entity.
Top Customers
means the top 10 customers measured by dollar value of total sales for the twelve months ended October 31,
2016 of the Company and its Subsidiaries, taken as a whole.
Top Suppliers
means the top 10 suppliers measured by
dollar value of total sales for the twelve months ended October 31, 2016 of the Company and its Subsidiaries, taken as a whole.
Trade Secrets
means confidential trade secrets and know-how, including processes, schematics, business methods, formulae,
compositions, algorithms, procedures, methods, techniques, drawings, prototypes, models, designs, customer lists and supplier lists.
A-64
Trademarks
means trademarks, service marks, brand names, certification marks,
collective marks, d/b/as, logos, symbols, trade dress, trade names, and other indicia of origin, all applications and registrations for the foregoing, and all goodwill associated therewith and symbolized thereby, including all renewals of
same.
Triggering Divestiture
means the sale, divestiture, license or other disposition of any Subsidiaries,
operations, divisions, businesses, product lines, customers or assets of Parent, the Company or any of their respective Subsidiaries representing, in the aggregate, in excess of $200 million of net sales, measured, (a) with respect to the Company
and its Subsidiaries, by reference to the net sales associated with any such Subsidiary, operation, division, business, product line, customer or asset for the fiscal year ended November 28, 2015, and (b) with respect to the Parent and its
Subsidiaries, by reference to the net sales associated with any such Subsidiary, operation, division, business, product line, customer or asset for the fiscal year ended June 30, 2016.
Willful and Material Breach
means a material breach that is a consequence of an act undertaken or a failure to take an act
by the breaching party with knowledge that the taking of such act or the failure to take such act would, or would reasonably be expected to, result in a material breach of this Agreement.
[Signature Page Follows]
A-65
IN WITNESS WHEREOF, Parent, Merger Sub and the Company have caused this Agreement to be signed by
their respective officers thereunto duly authorized, all as of the date first written above.
|
|
|
PARKER-HANNIFIN CORPORATION
|
By:
|
|
/s/ Thomas L. Williams
|
|
|
Name: Thomas L. Williams
|
|
|
Title: Chairman and Chief Executive
|
|
|
Officer
|
PARKER EAGLE CORPORATION
|
By:
|
|
/s/ Thomas L. Williams
|
|
|
Name: Thomas L. Williams
|
|
|
Title: President and Chief Executive
|
|
|
Officer
|
A-66
|
|
|
CLARCOR INC.
|
By:
|
|
/s/ Christopher L. Conway
|
|
|
Name: Christopher L. Conway
|
|
|
Title: President and Chief Executive
|
|
|
Officer
|
A-67
EXHIBIT A
Certificate of Incorporation of Surviving Corporation
See attached.
A-68
CERTIFICATE OF INCORPORATION
OF
CLARCOR INC.
A STOCK CORPORATION
FIRST: The name of the corporation (the
Corporation
) is:
CLARCOR Inc.
SECOND: The
address of the Corporations registered office in the State of Delaware is 1209 Orange Street, City of Wilmington, County of New Castle, Delaware 19801. The name of the Corporations registered agent at such address is The Corporation
Trust Company.
THIRD: The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be
organized under the General Corporation Law of the State of Delaware (the
DGCL
).
FOURTH: The total number of
shares that the Corporation has authority to issue is one hundred thousand (100,000) shares of Common Stock, par value of $1.00 per share.
FIFTH: No director of the Corporation shall be liable to the Corporation or its stockholders for monetary damages for breach of fiduciary
duty as a director, except for liability (i) for any breach of the directors duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of
law, (iii) under Section 174 of the DGCL, or (iv) for any transaction from which the director derived an improper personal benefit. If the DGCL is amended after approval by the stockholders of the Corporation of this article to authorize corporate
action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. Any repeal or
modification of the foregoing paragraph by the stockholders of the Corporation shall not adversely affect any right or protection of a director of the Corporation existing at the time of such repeal or modification.
SIXTH:
(a) Each person who was
or is made a party or is threatened to be made a party to or is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a proceeding), by reason of the fact that he or she, or a
person of whom he or she is the legal representative, is or was a director or officer of the Corporation or is or was serving at the request of the Corporation as a director, officer, employee or agent of another Corporation or of a partnership,
joint venture, trust or other enterprise, including service with respect to employee benefit plans, whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent or in any other capacity
while serving as a director, officer, employee or agent, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the DGCL, as the same exists or may hereafter be amended (but, in the case of any such amendment,
only to the extent that such amendment permits the Corporation to provide broader indemnification rights than said law permitted the Corporation to provide prior to such amendment), against all expense, liability and loss (including attorneys
fees, judgments, fines, ERISA excise taxes or penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by such person in connection therewith and such indemnification shall continue as to a person who has ceased to be
a director, officer, employee or agent and shall inure to the benefit of his or her heirs, executors and administrators; provided, however, that, except as provided in this Article, the Corporation shall indemnify any such person seeking
indemnification in connection with a proceeding (or part thereof) initiated by such person only if such proceeding (or part thereof) was authorized by the board of directors of the Corporation (the
Board of Directors
). The right
to indemnification conferred in this Article shall be a contract right and shall include the right to be paid by the Corporation the expenses incurred in defending any such
A-69
proceeding in advance of its final disposition; provided, however, that, if the DGCL requires, the payment of such expenses incurred by a director or officer in his or her capacity as a director
or officer (and not in any other capacity in which service was or is rendered by such person while a director or officer, including, without limitation, service to an employee benefit plan) in advance of the final disposition of a proceeding, shall
be made only upon delivery to the Corporation of an undertaking, by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be determined that such director or officer is not entitled to be indemnified under
this Article or otherwise. The Corporation may, by action of its Board of Directors, provide indemnification to employees and agents of the Corporation with the same scope and effect as the foregoing indemnification of directors and officers.
(b) If a claim under this Article is not paid in full by the Corporation within thirty days after a written claim has been received by the
Corporation, the claimant may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim and, if successful in whole or in part, the claimant shall be entitled to be paid also the expense of prosecuting such
claim. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in advance of its final disposition where the required undertaking, if any is required, has been
tendered to the Corporation) that the claimant has not met the standards of conduct which make it permissible under the DGCL for the Corporation to indemnify the claimant for the amount claimed, but the burden of proving such defense shall be on the
Corporation. Neither the failure of the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is
proper in the circumstances because he or she has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) that
the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that the claimant has not met the applicable standard of conduct.
(c) The right to indemnification and the payment of expenses incurred in defending a proceeding in advance of its final disposition conferred
in this Article shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, provision of the Certificate of Incorporation, bylaw, agreement, vote of stockholders or disinterested directors or
otherwise.
(d) The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of
the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any such expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability
or loss under the DGCL.
SEVENTH: In furtherance and not in limitation of the rights, powers, privileges, and discretionary authority
granted or conferred by the DGCL or other statutes or laws of the State of Delaware, the Board of Directors is expressly authorized to make, alter, amend or repeal the bylaws of the Corporation, without any action on the part of the stockholders,
but the stockholders may make additional bylaws and may alter, amend or repeal any bylaw whether adopted by them or otherwise. The Corporation may in its bylaws confer powers upon the Board of Directors in addition to the foregoing and in
addition to the powers and authorities expressly conferred upon the Board of Directors by applicable law.
EIGHTH: The Corporation
reserves the right at any time and from time to time to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, and other provisions authorized by the laws of the State of Delaware at the time in force may be
added or inserted, in the manner now or hereafter prescribed herein or by applicable law; and all rights, preferences and privileges of whatsoever nature conferred upon stockholders, directors or any other persons whomsoever by and pursuant to this
Certificate of Incorporation in its present form or as hereafter amended are granted subject to this reservation.
A-70
ANNEX B
PERSONAL AND CONFIDENTIAL
December 1, 2016
Board of Directors
CLARCOR Inc.
840 Crescent Center Drive, Suite 600
Franklin, Tennessee 37067
Ladies and Gentlemen:
You have requested our opinion as
to the fairness from a financial point of view to the holders (other than Parker-Hannifin Corporation (Parker-Hannifin) and its affiliates) of the outstanding shares of common stock, par value $1.00 per share (the
Shares), of CLARCOR Inc. (the Company) of the $83.00 in cash per Share to be paid to such holders pursuant to the Agreement and Plan of Merger, dated as of December 1, 2016 (the Agreement), by and among
Parker-Hannifin, Parker Eagle Corporation, a wholly owned subsidiary of Parker-Hannifin, and the Company.
Goldman, Sachs & Co. and its
affiliates are engaged in advisory, underwriting and financing, principal investing, sales and trading, research, investment management and other financial and non-financial activities and services for various persons and entities. Goldman,
Sachs & Co. and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short
positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the Company, Parker-Hannifin, any of their respective affiliates and third parties, or any currency or
commodity that may be involved in the transaction contemplated by the Agreement (the Transaction). We have acted as financial advisor to the Company in connection with, and have participated in certain of the negotiations leading to, the
Transaction. We expect to receive fees for our services in connection with the Transaction, the principal portion of which is contingent upon consummation of the Transaction, and the Company has agreed to reimburse certain of our expenses arising,
and indemnify us against certain liabilities that may arise, out of our engagement. We have provided certain financial advisory and/or underwriting services to the Company and/or its affiliates from time to time. We also have provided certain
financial advisory and/or underwriting services to Parker-Hannifin and/or its affiliates from time to time. We may also in the future provide financial advisory and/or underwriting services to the Company, Parker-Hannifin and their respective
affiliates for which our Investment Banking Division may receive compensation.
In connection with this opinion, we have reviewed, among other things, the
Agreement; annual reports to stockholders and Annual Reports on Form 10-K of the Company for the five fiscal years ended November 28, 2015; certain interim reports to stockholders and Quarterly Reports on Form 10-Q of the Company;
certain other communications from the Company to its stockholders; certain publicly available research analyst reports for the Company; and certain internal financial analyses and forecasts for the Company prepared by its management, as approved for
our use by the Company (the Forecasts). We have also held discussions with members of the senior management of the Company regarding their assessment of the past and current business operations, financial condition and future prospects
of the Company; reviewed the reported price and trading activity for the Shares; compared certain financial and stock market information for the Company with similar information for certain other companies the securities of which are publicly
traded; reviewed the financial terms of certain recent business combinations in the filtration industry and in other industries; and performed such other studies and analyses, and considered such other factors, as we deemed appropriate.
B-1
For purposes of rendering this opinion, we have, with your consent, relied upon and assumed the accuracy and
completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by, us, without assuming any responsibility for independent verification thereof. In that regard, we have assumed
with your consent that the Forecasts have been reasonably prepared on a basis reflecting the best currently available estimates and judgments of the management of the Company. We have not made an independent evaluation or appraisal of the assets and
liabilities (including any contingent, derivative or other off-balance-sheet assets and liabilities) of the Company or any of its subsidiaries and we have not been furnished with any such evaluation or appraisal. We have assumed that all
governmental, regulatory or other consents and approvals necessary for the consummation of the Transaction will be obtained without any adverse effect on the expected benefits of the Transaction in any way meaningful to our analysis. We have assumed
that the Transaction will be consummated on the terms set forth in the Agreement, without the waiver or modification of any term or condition the effect of which would be in any way meaningful to our analysis.
Our opinion does not address the underlying business decision of the Company to engage in the Transaction, or the relative merits of the Transaction as
compared to any strategic alternatives that may be available to the Company; nor does it address any legal, regulatory, tax or accounting matters. We were not requested to solicit, and did not solicit, interest from other parties with respect to an
acquisition of, or other business combination with, the Company or any other alternative transaction. This opinion addresses only the fairness from a financial point of view to the holders (other than Parker-Hannifin and its affiliates) of Shares,
as of the date hereof, of the $83.00 in cash per Share to be paid to such holders pursuant to the Agreement. We do not express any view on, and our opinion does not address, any other term or aspect of the Agreement or Transaction or any term
or aspect of any other agreement or instrument contemplated by the Agreement or entered into or amended in connection with the Transaction, including, the fairness of the Transaction to, or any consideration received in connection therewith by, the
holders of any other class of securities, creditors, or other constituencies of the Company; nor as to the fairness of the amount or nature of any compensation to be paid or payable to any of the officers, directors or employees of the Company, or
class of such persons, in connection with the Transaction, whether relative to the $83.00 in cash per Share to be paid to the holders (other than Parker-Hannifin and its affiliates) of Shares pursuant to the Agreement or otherwise. We are not
expressing any opinion as to the impact of the Transaction on the solvency or viability of the Company or Parker-Hannifin or the ability of the Company or Parker-Hannifin to pay their respective obligations when they come due. Our opinion is
necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to us as of, the date hereof and we assume no responsibility for updating, revising or reaffirming this opinion based on
circumstances, developments or events occurring after the date hereof. Our advisory services and the opinion expressed herein are provided for the information and assistance of the Board of Directors of the Company in connection with its
consideration of the Transaction and such opinion does not constitute a recommendation as to how any holder of Shares should vote with respect to such Transaction or any other matter. This opinion has been approved by a fairness committee of
Goldman, Sachs & Co.
Based upon and subject to the foregoing, it is our opinion that, as of the date hereof, the $83.00 in cash per Share
to be paid to the holders (other than Parker-Hannifin and its affiliates) of Shares pursuant to the Agreement is fair from a financial point of view to such holders.
Very truly yours,
/s/ Goldman, Sachs & Co.
(GOLDMAN, SACHS & CO.)
B-2
ANNEX C
SECTION 262 OF THE GENERAL CORPORATION LAW OF THE STATE OF DELAWARE
§ 262 Appraisal rights
|
(a)
|
Any stockholder of a corporation of this State who holds shares of stock on the date of the making of a demand pursuant to subsection (d) of this section with respect to such shares, who continuously holds such
shares through the effective date of the merger or consolidation, who has otherwise complied with subsection (d) of this section and who has neither voted in favor of the merger or consolidation nor consented thereto in writing pursuant to
§ 228 of this title shall be entitled to an appraisal by the Court of Chancery of the fair value of the stockholders shares of stock under the circumstances described in subsections (b) and (c) of this section. As used in this
section, the word stockholder means a holder of record of stock in a corporation; the words stock and share mean and include what is ordinarily meant by those words; and the words depository receipt
mean a receipt or other instrument issued by a depository representing an interest in 1 or more shares, or fractions thereof, solely of stock of a corporation, which stock is deposited with the depository.
|
|
(b)
|
Appraisal rights shall be available for the shares of any class or series of stock of a constituent corporation in a merger or consolidation to be effected pursuant to § 251 (other than a merger effected pursuant
to § 251(g) of this title and, subject to paragraph (b)(3) of this section, § 251(h) of this title), § 252, § 254, § 255, § 256, § 257, § 258, § 263 or § 264 of this title:
|
|
(1)
|
Provided, however, that, except as expressly provided in § 363(b) of this title, no appraisal rights under this section shall be available for the shares of any class or series of stock, which stock, or depository
receipts in respect thereof, at the record date fixed to determine the stockholders entitled to receive notice of the meeting of stockholders to act upon the agreement of merger or consolidation, were either: (i) listed on a national securities
exchange or (ii) held of record by more than 2,000 holders; and further provided that no appraisal rights shall be available for any shares of stock of the constituent corporation surviving a merger if the merger did not require for its
approval the vote of the stockholders of the surviving corporation as provided in § 251(f) of this title.
|
|
(2)
|
Notwithstanding paragraph (b)(1) of this section, appraisal rights under this section shall be available for the shares of any class or series of stock of a constituent corporation if the holders thereof are required by
the terms of an agreement of merger or consolidation pursuant to §§ 251, 252, 254, 255, 256, 257, 258, 263 and 264 of this title to accept for such stock anything except:
|
|
a.
|
Shares of stock of the corporation surviving or resulting from such merger or consolidation, or depository receipts in respect thereof;
|
|
b.
|
Shares of stock of any other corporation, or depository receipts in respect thereof, which shares of stock (or depository receipts in respect thereof) or depository receipts at the effective date of the merger or
consolidation will be either listed on a national securities exchange or held of record by more than 2,000 holders;
|
|
c.
|
Cash in lieu of fractional shares or fractional depository receipts described in the foregoing paragraphs (b)(2)a. and b. of this section; or
|
|
d.
|
Any combination of the shares of stock, depository receipts and cash in lieu of fractional shares or fractional depository receipts described in the foregoing paragraphs (b)(2) a., b. and c. of this section.
|
|
(3)
|
In the event all of the stock of a subsidiary Delaware corporation party to a merger effected under § 251(h), § 253 or § 267 of this title is not owned by the parent immediately prior to the merger,
appraisal rights shall be available for the shares of the subsidiary Delaware corporation.
|
C-1
|
(4)
|
In the event of an amendment to a corporations certificate of incorporation contemplated by § 363(a) of this title, appraisal rights shall be available as contemplated by § 363(b) of this title, and the
procedures of this section, including those set forth in subsections (d) and (e) of this section, shall apply as nearly as practicable, with the word amendment substituted for the words merger or consolidation, and
the word corporation substituted for the words constituent corporation and/or surviving or resulting corporation.
|
|
(c)
|
Any corporation may provide in its certificate of incorporation that appraisal rights under this section shall be available for the shares of any class or series of its stock as a result of an amendment to its
certificate of incorporation, any merger or consolidation in which the corporation is a constituent corporation or the sale of all or substantially all of the assets of the corporation. If the certificate of incorporation contains such a provision,
the provisions of this section, including those set forth in subsections (d), (e), and (g) of this section, shall apply as nearly as is practicable.
|
|
(d)
|
Appraisal rights shall be perfected as follows:
|
|
(1)
|
If a proposed merger or consolidation for which appraisal rights are provided under this section is to be submitted for approval at a meeting of stockholders, the corporation, not less than 20 days prior to the meeting,
shall notify each of its stockholders who was such on the record date for notice of such meeting (or such members who received notice in accordance with § 255(c) of this title) with respect to shares for which appraisal rights are available
pursuant to subsection (b) or (c) of this section that appraisal rights are available for any or all of the shares of the constituent corporations, and shall include in such notice a copy of this section and, if 1 of the constituent
corporations is a nonstock corporation, a copy of § 114 of this title. Each stockholder electing to demand the appraisal of such stockholders shares shall deliver to the corporation, before the taking of the vote on the merger or
consolidation, a written demand for appraisal of such stockholders shares. Such demand will be sufficient if it reasonably informs the corporation of the identity of the stockholder and that the stockholder intends thereby to demand the
appraisal of such stockholders shares. A proxy or vote against the merger or consolidation shall not constitute such a demand. A stockholder electing to take such action must do so by a separate written demand as herein provided. Within 10
days after the effective date of such merger or consolidation, the surviving or resulting corporation shall notify each stockholder of each constituent corporation who has complied with this subsection and has not voted in favor of or consented to
the merger or consolidation of the date that the merger or consolidation has become effective; or
|
|
(2)
|
If the merger or consolidation was approved pursuant to § 228, § 251(h), § 253, or § 267 of
this title, then either a constituent corporation before the effective date of the merger or consolidation or the surviving or resulting corporation within 10 days thereafter shall notify each of the holders of any class or series of stock of such
constituent corporation who are entitled to appraisal rights of the approval of the merger or consolidation and that appraisal rights are available for any or all shares of such class or series of stock of such constituent corporation, and shall
include in such notice a copy of this section and, if 1 of the constituent corporations is a nonstock corporation, a copy of § 114 of this title. Such notice may, and, if given on or after the effective date of the merger or consolidation,
shall, also notify such stockholders of the effective date of the merger or consolidation. Any stockholder entitled to appraisal rights may, within 20 days after the date of mailing of such notice or, in the case of a merger approved pursuant to
§ 251(h) of this title, within the later of the consummation of the offer contemplated by § 251(h) of this title and 20 days after the date of mailing of such notice, demand in writing from the surviving or resulting corporation the
appraisal of such holders shares. Such demand will be sufficient if it reasonably informs the corporation of the identity of the stockholder and that the stockholder intends thereby to demand the appraisal of such holders shares. If such
notice did not notify stockholders of the effective date of the merger or consolidation, either (i) each such constituent corporation shall send a second notice before the effective date of the merger or consolidation notifying each of the
|
C-2
|
holders of any class or series of stock of such constituent corporation that are entitled to appraisal rights of the effective date of the merger or consolidation or (ii) the surviving or
resulting corporation shall send such a second notice to all such holders on or within 10 days after such effective date; provided, however, that if such second notice is sent more than 20 days following the sending of the first notice or, in the
case of a merger approved pursuant to § 251(h) of this title, later than the later of the consummation of the offer contemplated by § 251(h) of this title and 20 days following the sending of the first notice, such second notice need only
be sent to each stockholder who is entitled to appraisal rights and who has demanded appraisal of such holders shares in accordance with this subsection. An affidavit of the secretary or assistant secretary or of the transfer agent of the
corporation that is required to give either notice that such notice has been given shall, in the absence of fraud, be prima facie evidence of the facts stated therein. For purposes of determining the stockholders entitled to receive either notice,
each constituent corporation may fix, in advance, a record date that shall be not more than 10 days prior to the date the notice is given, provided, that if the notice is given on or after the effective date of the merger or consolidation, the
record date shall be such effective date. If no record date is fixed and the notice is given prior to the effective date, the record date shall be the close of business on the day next preceding the day on which the notice is given.
|
|
(e)
|
Within 120 days after the effective date of the merger or consolidation, the surviving or resulting corporation or any stockholder who has complied with subsections (a) and (d) of this section hereof and who
is otherwise entitled to appraisal rights, may commence an appraisal proceeding by filing a petition in the Court of Chancery demanding a determination of the value of the stock of all such stockholders. Notwithstanding the foregoing, at any time
within 60 days after the effective date of the merger or consolidation, any stockholder who has not commenced an appraisal proceeding or joined that proceeding as a named party shall have the right to withdraw such stockholders demand for
appraisal and to accept the terms offered upon the merger or consolidation. Within 120 days after the effective date of the merger or consolidation, any stockholder who has complied with the requirements of subsections (a) and (d) of this
section hereof, upon written request, shall be entitled to receive from the corporation surviving the merger or resulting from the consolidation a statement setting forth the aggregate number of shares not voted in favor of the merger or
consolidation and with respect to which demands for appraisal have been received and the aggregate number of holders of such shares. Such written statement shall be mailed to the stockholder within 10 days after such stockholders written
request for such a statement is received by the surviving or resulting corporation or within 10 days after expiration of the period for delivery of demands for appraisal under subsection (d) of this section hereof, whichever is later.
Notwithstanding subsection (a) of this section, a person who is the beneficial owner of shares of such stock held either in a voting trust or by a nominee on behalf of such person may, in such persons own name, file a petition or request
from the corporation the statement described in this subsection.
|
|
(f)
|
Upon the filing of any such petition by a stockholder, service of a copy thereof shall be made upon the surviving or resulting corporation, which shall within 20 days after such service file in the office of the
Register in Chancery in which the petition was filed a duly verified list containing the names and addresses of all stockholders who have demanded payment for their shares and with whom agreements as to the value of their shares have not been
reached by the surviving or resulting corporation. If the petition shall be filed by the surviving or resulting corporation, the petition shall be accompanied by such a duly verified list. The Register in Chancery, if so ordered by the Court, shall
give notice of the time and place fixed for the hearing of such petition by registered or certified mail to the surviving or resulting corporation and to the stockholders shown on the list at the addresses therein stated. Such notice shall also be
given by 1 or more publications at least 1 week before the day of the hearing, in a newspaper of general circulation published in the City of Wilmington, Delaware or such publication as the Court deems advisable. The forms of the notices by mail and
by publication shall be approved by the Court, and the costs thereof shall be borne by the surviving or resulting corporation.
|
C-3
|
(g)
|
At the hearing on such petition, the Court shall determine the stockholders who have complied with this section and who have become entitled to appraisal rights. The Court may require the stockholders who have demanded
an appraisal for their shares and who hold stock represented by certificates to submit their certificates of stock to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings; and if any stockholder fails to comply
with such direction, the Court may dismiss the proceedings as to such stockholder. If immediately before the merger or consolidation the shares of the class or series of stock of the constituent corporation as to which appraisal rights are available
were listed on a national securities exchange, the Court shall dismiss the proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (1) the total number of shares entitled to appraisal exceeds 1% of the
outstanding shares of the class or series eligible for appraisal, (2) the value of the consideration provided in the merger or consolidation for such total number of shares exceeds $1 million, or (3) the merger was approved pursuant to
§ 253 or § 267 of this title.
|
|
(h)
|
After the Court determines the stockholders entitled to an appraisal, the appraisal proceeding shall be conducted in accordance with the rules of the Court of Chancery, including any rules specifically governing
appraisal proceedings. Through such proceeding the Court shall determine the fair value of the shares exclusive of any element of value arising from the accomplishment or expectation of the merger or consolidation, together with interest, if any, to
be paid upon the amount determined to be the fair value. In determining such fair value, the Court shall take into account all relevant factors. Unless the Court in its discretion determines otherwise for good cause shown, and except as provided in
this subsection, interest from the effective date of the merger through the date of payment of the judgment shall be compounded quarterly and shall accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from
time to time during the period between the effective date of the merger and the date of payment of the judgment. At any time before the entry of judgment in the proceedings, the surviving corporation may pay to each stockholder entitled to appraisal
an amount in cash, in which case interest shall accrue thereafter as provided herein only upon the sum of (1) the difference, if any, between the amount so paid and the fair value of the shares as determined by the Court, and (2) interest
theretofore accrued, unless paid at that time. Upon application by the surviving or resulting corporation or by any stockholder entitled to participate in the appraisal proceeding, the Court may, in its discretion, proceed to trial upon the
appraisal prior to the final determination of the stockholders entitled to an appraisal. Any stockholder whose name appears on the list filed by the surviving or resulting corporation pursuant to subsection (f) of this section and who has
submitted such stockholders certificates of stock to the Register in Chancery, if such is required, may participate fully in all proceedings until it is finally determined that such stockholder is not entitled to appraisal rights under this
section.
|
|
(i)
|
The Court shall direct the payment of the fair value of the shares, together with interest, if any, by the surviving or resulting corporation to the stockholders entitled thereto. Payment shall be so made to each such
stockholder, in the case of holders of uncertificated stock forthwith, and the case of holders of shares represented by certificates upon the surrender to the corporation of the certificates representing such stock. The Courts decree may be
enforced as other decrees in the Court of Chancery may be enforced, whether such surviving or resulting corporation be a corporation of this State or of any state.
|
|
(j)
|
The costs of the proceeding may be determined by the Court and taxed upon the parties as the Court deems equitable in the circumstances. Upon application of a stockholder, the Court may order all or a portion of the
expenses incurred by any stockholder in connection with the appraisal proceeding, including, without limitation, reasonable attorneys fees and the fees and expenses of experts, to be charged pro rata against the value of all the shares
entitled to an appraisal.
|
|
(k)
|
From and after the effective date of the merger or consolidation, no stockholder who has demanded appraisal
rights as provided in subsection (d) of this section shall be entitled to vote such stock for any purpose or to receive payment of dividends or other distributions on the stock (except dividends or
|
C-4
|
other distributions payable to stockholders of record at a date which is prior to the effective date of the merger or consolidation); provided, however, that if no petition for an appraisal shall
be filed within the time provided in subsection (e) of this section, or if such stockholder shall deliver to the surviving or resulting corporation a written withdrawal of such stockholders demand for an appraisal and an acceptance of the
merger or consolidation, either within 60 days after the effective date of the merger or consolidation as provided in subsection (e) of this section or thereafter with the written approval of the corporation, then the right of such stockholder
to an appraisal shall cease. Notwithstanding the foregoing, no appraisal proceeding in the Court of Chancery shall be dismissed as to any stockholder without the approval of the Court, and such approval may be conditioned upon such terms as the
Court deems just; provided, however that this provision shall not affect the right of any stockholder who has not commenced an appraisal proceeding or joined that proceeding as a named party to withdraw such stockholders demand for appraisal
and to accept the terms offered upon the merger or consolidation within 60 days after the effective date of the merger or consolidation, as set forth in subsection (e) of this section.
|
|
(l)
|
The shares of the surviving or resulting corporation to which the shares of such objecting stockholders would have been converted had they assented to the merger or consolidation shall have the status of authorized and
unissued shares of the surviving or resulting corporation.
|
C-5
PRELIMINARY COPY
IMPORTANT SPECIAL MEETING INFORMATION 000004
ENDORSEMENT_LINE SACKPACK
MR A SAMPLE
DESIGNATION (IF ANY) ADD 1 ADD 2 ADD
3 ADD 4 ADD 5 ADD 6
C123456789
000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext
Electronic Voting Instructions
Available 24 hours a day, 7 days a week!
Instead
of mailing your proxy, you may choose one of the voting methods outlined below to vote your proxy.
VALIDATION
DETAILS ARE LOCATED BELOW IN THE TITLE BAR.
Proxies submitted by the Internet or telephone must be received by
1:00 AM EST on [].
Vote by Internet
Go to www.investorvote.com/CLC
Or scan the QR code with your smartphone
Follow the steps outlined on the secure website
Vote by telephone
Call toll free
1-800-652-VOTE
(8683) within the USA, US
territories & Canada on a touch tone telephone
Follow the instructions provided by the
recorded message
Using a black ink pen, mark your votes with an X as shown in this example. Please do not
write outside the designated areas.